{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Defining Prediction Tasks for Biomedical Text Mining"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "import pandas as pd\n",
    "\n",
    "# location for the datasets\n",
    "data_dir = \"./baseline/data\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Loading PubMed Toxicogenomics Dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# PubMed training dataset from PubTator\n",
    "with open(data_dir + \"/train.json\") as f:\n",
    "    train_json = json.loads(f.read())\n",
    "\n",
    "# validation split of 1521 examples (2%)\n",
    "with open(data_dir + \"/valid.json\") as f:\n",
    "    valid_json = json.loads(f.read())\n",
    "\n",
    "# manually curated by biologists (1939)\n",
    "with open(data_dir + \"/test.json\") as f:\n",
    "    test_json = json.loads(f.read())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "for doc in valid_json:\n",
    "    title_length = len(doc['title'])\n",
    "    for entity in doc['entity']:\n",
    "        entity['label'] = entity.pop('type')\n",
    "\n",
    "for doc in test_json:\n",
    "    title_length = len(doc['title'])\n",
    "    for entity in doc['entity']:\n",
    "        entity['label'] = entity.pop('type')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# toxicogenomics interactions that are annotated in the dataset \n",
    "relation_map = json.loads(open(data_dir + \"/relation_map.json\").read())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Biomedical Text Mining"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "\n",
    "# \n",
    "abstracts = [doc['title']+\" \"+doc['abstract'] for doc in test_json]\n",
    "\n",
    "pubmed = pd.DataFrame({'text': abstracts})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Importing necessary libraries\n",
    "from wordcloud import WordCloud\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "text = \" \".join(abstracts)\n",
    "\n",
    "wordcloud = WordCloud(width=800, height=400, background_color='white').generate(text)\n",
    "                     \n",
    "plt.figure(figsize=(8, 4), facecolor=None)\n",
    "plt.imshow(wordcloud)\n",
    "plt.axis(\"off\")\n",
    "plt.tight_layout(pad=0)\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "In biomedical text we find common terms like \"effect\", \"expression\", and \"treatment\" as well as specialized jargon and abbreviations"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     /Users/ramonreszat/nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n",
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     /Users/ramonreszat/nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import nltk\n",
    "import string\n",
    "\n",
    "nltk.download('stopwords')\n",
    "nltk.download('punkt')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from nltk.corpus import stopwords\n",
    "from nltk.probability import FreqDist\n",
    "from nltk.tokenize import word_tokenize\n",
    "\n",
    "tokens = word_tokenize(text.lower())\n",
    "stop_words = set(stopwords.words('english'))\n",
    "tokens = [token for token in tokens if token not in stop_words]\n",
    "tokens = [token for token in tokens if token not in string.punctuation]\n",
    "freq_dist = FreqDist(tokens)\n",
    "\n",
    "plt.figure(figsize=(10, 5))\n",
    "freq_dist.plot(50, cumulative=False)\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Lexical diversity in technical writing: 9.9%\n"
     ]
    }
   ],
   "source": [
    "TTR = len(set(tokens)) / len(tokens)\n",
    "print(\"Lexical diversity in technical writing: {:.1f}%\".format(TTR*100))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_items([('mtor', 40), ('signalling', 66), ('jack-of-all-trades', 1), ('1.', 14), ('mechanistic', 63), ('target', 291), ('rapamycin', 23), ('evolutionarily', 3), ('conserved', 22), ('serine/threonine', 6), ('kinase', 296), ('senses', 2), ('integrates', 2), ('environmental', 205), ('information', 58), ('cellular', 278), ('regulation', 194), ('homeostasis', 86), ('accumulating', 16), ('evidence', 188), ('suggested', 187), ('master', 9), ('role', 711), ('many', 139), ('fundamental', 11), ('aspects', 15), ('cell', 1874), ('biology', 9), ('organismal', 2), ('development', 510), ('deregulation', 12), ('implicated', 65), ('broad', 16), ('range', 84), ('pathological', 88), ('conditions', 116), ('including', 417), ('diabetes', 141), ('cancer', 1151), ('neurodegenerative', 68), ('diseases', 218), ('myopathies', 1), ('inflammatory', 382), ('infectious', 10), ('autoimmune', 15), ('review', 63), ('recent', 84), ('advances', 7), ('knowledge', 48), ('mammalian', 37), ('physiology', 10), ('also', 861), ('discuss', 8), ('impact', 154), ('alteration', 37), ('human', 1262), ('targeting', 138), ('function', 352), ('treat', 50), ('hearing', 17), ('paget', 2), (\"'s\", 279), ('disease', 510), ('bone', 168), ('introduction', 29), ('objectives', 57), ('pdb', 8), ('may', 697), ('lead', 98), ('loss', 144), ('present', 417), ('study', 1747), ('conducted', 91), ('aim', 163), ('measuring', 28), ('characterizing', 7), ('determining', 19), ('risk', 374), ('factors', 212), ('group', 652), ('subjects', 61), ('methods', 341), ('observational', 7), ('transversal', 1), ('case-control', 14), ('cohort', 71), ('76', 5), ('diagnosed', 38), ('case', 67), ('control', 402), ('134', 1), ('included', 110), ('clinical', 278), ('demographic', 8), ('audiometric', 1), ('data', 400), ('analysed', 14), ('results', 1334), ('comparative', 16), ('analysis', 599), ('found', 611), ('showed', 799), ('higher', 278), ('thresholds', 3), ('39,51db', 1), ('compared', 486), ('37.28db', 1), ('p=.069', 1), ('presented', 45), ('greater', 48), ('rate', 139), ('conductive', 2), ('22.76', 1), ('12.05', 1), ('p=.0062', 1), ('skull', 6), ('involvement', 101), ('scintigraphy', 1), ('age', 121), ('high', 332), ('blood', 249), ('pressure', 61), ('impairment', 99), ('conclusions', 163), ('profound', 19), ('proportion', 18), ('patients', 868), ('severe', 125), ('without', 139), ('assessment', 87), ('cannabinoids', 85), ('agonist', 133), ('antagonist', 107), ('invasion', 136), ('potential', 683), ('k562', 35), ('cells', 2930), ('background', 170), ('prominent', 14), ('hallmark', 6), ('malignancies', 11), ('metastatic', 50), ('spread', 11), ('studies', 541), ('reported', 237), ('nature', 16), ('invasive', 23), ('could', 501), ('changed', 42), ('phenomenon', 12), ('causing', 44), ('chemotherapy', 86), ('resistance', 181), ('demonstrated', 372), ('up-regulated', 84), ('expression', 2455), ('matrix', 79), ('metalloproteinase', 11), ('mmp', 20), ('2/mmp-9', 1), ('metastasis', 88), ('biomarker', 56), ('fortify', 1), ('leukemia', 74), ('furthermore', 308), ('investigations', 29), ('confirmed', 165), ('inhibitory', 127), ('effect', 998), ('cannabinoid', 135), ('endocannabinoid', 29), ('proliferation', 443), ('vitro', 597), ('vivo', 425), ('win', 20), ('55212-2', 3), ('cb1/cb2', 7), ('receptor', 716), ('am251', 6), ('selective', 88), ('cb1', 110), ('chronic', 247), ('myelogenous', 1), ('cml', 7), ('model', 607), ('evaluated', 290), ('using', 712), ('mtt', 59), ('assay', 324), ('expressions', 149), ('mmp-2', 33), ('mmp-9', 55), ('assessed', 210), ('western', 233), ('blot', 146), ('obtained', 112), ('attenuate', 35), ('however', 699), ('less', 95), ('effective', 156), ('regard', 16), ('considerably', 6), ('reduced', 594), ('invasiveness', 14), ('exhibited', 120), ('converse', 2), ('moreover', 322), ('activation', 808), ('resulted', 176), ('decreased', 745), ('conclusion', 338), ('findings', 351), ('clarifies', 2), ('receptors', 216), ('responsible', 94), ('anti-invasive', 4), ('effects', 1570), ('line', 188), ('epithelial', 227), ('il-6', 144), ('trans-signaling', 2), ('defines', 4), ('new', 251), ('asthma', 43), ('phenotype', 80), ('increased', 1284), ('airway', 100), ('inflammation', 384), ('although', 170), ('several', 196), ('link', 23), ('levels', 1353), ('soluble', 22), ('sil-6r', 3), ('severity', 49), ('lung', 441), ('il-6ts', 6), ('asthmatic', 5), ('unclear', 145), ('objective', 109), ('sought', 23), ('explore', 119), ('association', 180), ('pathway', 755), ('molecular', 426), ('phenotypes', 29), ('gene', 695), ('signature', 16), ('air-liquid', 12), ('interface', 25), ('cultures', 50), ('bronchial', 49), ('stimulated', 68), ('used', 711), ('stratify', 4), ('transcriptomic', 32), ('unbiased', 1), ('biomarkers', 133), ('prediction', 22), ('respiratory', 77), ('outcomes', 103), ('u-biopred', 1), ('cohorts', 19), ('means', 18), ('hierarchical', 3), ('clustering', 6), ('il-6ts-specific', 1), ('protein', 1057), ('markers', 237), ('sputum', 5), ('wessex', 1), ('phenotyping', 6), ('based', 171), ('transcriptional', 129), ('profiling', 41), ('brushings', 2), ('immunohistochemical', 21), ('biopsy', 6), ('specimens', 21), ('integrity', 30), ('induced', 1034), ('specific', 157), ('enriched', 36), ('genes', 729), ('associated', 664), ('remodeling', 38), ('identified', 239), ('subset', 15), ('il-6ts-high', 2), ('il-6ts-inducible', 1), ('absence', 47), ('systemic', 62), ('overrepresentation', 1), ('frequent', 18), ('exacerbators', 1), ('eosinophilia', 3), ('submucosal', 2), ('infiltration', 44), ('macrophages', 121), ('toll-like', 32), ('upregulated', 160), ('whereas', 169), ('junction', 35), ('correlated', 109), ('innate', 31), ('immune', 173), ('particular', 37), ('ykl-40', 1), ('3', 325), ('macrophage', 59), ('1beta', 4), ('il-8', 30), ('il-1beta', 135), ('local', 39), ('type', 192), ('2', 473), ('novel', 284), ('might', 181), ('drive', 11), ('dysfunction', 190), ('vitamin', 102), ('d3', 24), ('supplementation', 50), ('improves', 26), ('testicular', 93), ('diabetic', 103), ('rats', 810), ('peroxisome', 59), ('proliferator-activated', 54), ('receptor-gamma/transforming', 1), ('growth', 365), ('factor-beta', 6), ('1/nuclear', 2), ('factor-kappa', 12), ('b.', 11), ('aims/introduction', 2), ('deficiency', 66), ('male', 312), ('hypogonadism', 2), ('mellitus', 39), ('organs', 32), ('mechanism', 532), ('driving', 10), ('disorder', 72), ('experiment', 28), ('designed', 36), ('relationship', 59), ('materials', 68), ('streptozotocin-induced', 9), ('randomly', 46), ('divided', 57), ('four', 100), ('groups', 329), ('treated', 385), ('different', 313), ('doses', 146), ('blank', 5), ('low', 229), ('0.025', 6), ('mug/kg/day', 12), ('0.1', 49), ('bisphenol', 193), ('diglycidyl', 2), ('ether', 9), ('gamma', 43), ('inhibitor', 387), ('30', 128), ('mg/kg/day', 65), ('wild-type', 68), ('12', 103), ('weeks', 204), ('supplements', 19), ('partially', 78), ('restored', 71), ('changes', 405), ('shown', 213), ('fibrosis', 319), ('related', 280), ('downregulation', 118), ('transforming', 34), ('factor', 521), ('beta', 70), ('1', 613), ('apoptosis', 839), ('nuclear', 342), ('kappa', 30), ('b', 195), ('pituitary', 13), ('gland', 21), ('inhibit', 133), ('significantly', 962), ('treatment', 1231), ('suggest', 307), ('improve', 81), ('gamma/transforming', 1), ('signaling', 838), ('autonomous', 4), ('hypercortisolism', 2), ('definition', 3), ('implications', 45), ('current', 128), ('practice', 20), ('adrenal', 29), ('adenoma', 6), ('usually', 15), ('comes', 2), ('unexpected', 7), ('byproduct', 5), ('imaging', 65), ('performed', 226), ('unrelated', 6), ('reasons', 3), ('prior', 54), ('suspect', 2), ('therefore', 211), ('tumors', 101), ('currently', 39), ('represent', 36), ('public', 26), ('health', 195), ('challenge', 19), ('increasingly', 12), ('recognized', 32), ('due', 205), ('widespread', 20), ('use', 248), ('high-resolution', 6), ('cross-sectional', 18), ('diagnostic', 51), ('purposes', 10), ('radiology', 1), ('series', 26), ('prevalence', 32), ('adenomas', 6), ('increases', 171), ('steeply', 1), ('around', 23), ('50', 133), ('years', 152), ('10', 363), ('ageing', 2), ('population', 93), ('relevance', 26), ('able', 90), ('secrete', 2), ('cortisol', 17), ('autonomously', 2), ('independently', 24), ('20-30', 2), ('cases', 117), ('resulting', 86), ('excess', 25), ('insufficient', 16), ('produce', 34), ('typical', 21), ('cushing', 2), ('consequences', 31), ('hypertension', 58), ('obesity', 88), ('dyslipidemia', 16), ('osteoporosis', 25), ('despite', 73), ('controversy', 5), ('algorithm', 7), ('define', 19), ('subtle', 5), ('mounting', 7), ('simple', 20), ('approach', 123), ('1-mg', 1), ('overnight', 3), ('dexamethasone', 36), ('suppression', 111), ('test', 149), ('dst', 2), ('cardiovascular', 104), ('retrospective', 23), ('following', 206), ('adverse', 145), ('profile', 66), ('death', 273), ('morbidity', 29), ('mortality', 134), ('mainly', 70), ('origin', 14), ('intervention', 73), ('folic', 48), ('acid', 515), ('benzo', 31), ('pyrene', 28), ('toxic', 153), ('necessary', 31), ('micronutrient', 1), ('normal', 181), ('bap', 37), ('ubiquitously', 6), ('distributed', 9), ('pollutant', 35), ('metabolite', 79), ('pyrene-diol-epoxide', 1), ('known', 216), ('exert', 41), ('strong', 46), ('teratogenic', 10), ('carcinogenic', 20), ('body', 184), ('tissues', 221), ('investigate', 306), ('measured', 211), ('16hbe', 6), ('activity', 1036), ('affected', 111), ('counting', 17), ('kit-8', 12), ('cycle', 209), ('distribution', 59), ('flow', 86), ('cytometry', 54), ('time', 203), ('xeroderma', 4), ('pigmentosum', 4), ('c', 146), ('excision', 8), ('repair', 69), ('cross', 11), ('complementation', 3), ('cyclind1', 6), ('ckd4', 1), ('mrnas', 31), ('mouse', 312), ('tissue', 258), ('mechanisms', 504), ('mediated', 196), ('entirely', 6), ('elucidated', 50), ('possibly', 43), ('antagonizes', 5), ('upregulating', 29), ('dna', 438), ('turn', 25), ('accelerating', 7), ('speed', 7), ('damage', 447), ('caused', 319), ('meanwhile', 54), ('restrain', 3), ('bap-induced', 4), ('help', 36), ('return', 6), ('nitrated', 3), ('meat', 13), ('products', 91), ('mania', 7), ('humans', 104), ('altered', 124), ('behavior', 88), ('brain', 239), ('serious', 34), ('neuropsychiatric', 6), ('condition', 45), ('significant', 461), ('previous', 136), ('exposures', 74), ('contribute', 91), ('pathogenesis', 89), ('dietary', 83), ('individuals', 61), ('psychiatric', 19), ('disorders', 120), ('well', 420), ('history', 21), ('eating', 3), ('dry', 19), ('cured', 4), ('fish', 46), ('strongly', 57), ('adjusted', 32), ('odds', 42), ('ratio', 155), ('3.49', 1), ('95', 195), ('confidence', 36), ('interval', 37), ('ci', 175), ('2.24-5.45', 1), ('p', 760), ('lt', 352), ('8.97', 1), ('x', 99), ('10-8', 11), ('lower', 175), ('feeding', 15), ('preparations', 12), ('added', 18), ('nitrate', 5), ('hyperactivity', 4), ('reminiscent', 3), ('alterations', 141), ('pathways', 354), ('bipolar', 5), ('intestinal', 133), ('microbiota', 34), ('preventing', 45), ('developing', 71), ('therapeutic', 322), ('interventions', 23), ('endocrine', 114), ('disruptor', 26), ('promotes', 95), ('errgamma', 14), ('translocation', 87), ('facilitating', 13), ('grade', 26), ('endometrial', 36), ('via', 579), ('egf-dependent', 1), ('egf-independent', 1), ('disruptors', 14), ('become', 21), ('global', 80), ('social', 40), ('problem', 16), ('since', 75), ('late', 45), ('1980s', 1), ('bpa', 427), ('steroid-like', 1), ('skeleton', 3), ('similar', 168), ('estrogen', 150), ('progesterone', 37), ('disturbs', 7), ('physiological', 63), ('hormone', 107), ('balance', 24), ('malignancy', 18), ('overexposure', 3), ('steroid', 19), ('hormones', 27), ('remains', 163), ('incompletely', 4), ('understood', 87), ('aimed', 184), ('understanding', 97), ('regulatory', 94), ('underlying', 251), ('bpa-induced', 16), ('hormone-sensitive', 1), ('selectively', 35), ('hec265', 4), ('ishikawa', 11), ('estrogen-related', 8), ('time-dependent', 28), ('manner', 174), ('bpa/errgamma-target', 2), ('promoted', 131), ('influx', 12), ('ca2+', 58), ('followed', 94), ('epidermal', 49), ('egf', 20), ('secretion', 114), ('extracellular', 99), ('space', 11), ('secreted', 16), ('autocrine', 3), ('leading', 148), ('egfr/erk', 1), ('contrastingly', 2), ('affect', 109), ('mobilization', 7), ('bpa/errgamma/egf/egfr/erk', 1), ('bpa/errgamma', 1), ('catastrophic', 3), ('expenditure', 11), ('among', 179), ('province-wide', 1), ('shandong', 1), ('china', 27), ('often', 54), ('causes', 101), ('economic', 13), ('burden', 20), ('households', 2), ('assess', 105), ('incidence', 90), ('intensity', 19), ('che', 22), ('relating', 1), ('care', 57), ('determinants', 8), ('total', 207), ('1,948', 1), ('defined', 42), ('out-of-pocket', 1), ('payments', 1), ('gt', 103), ('=40', 1), ('non-food', 1), ('household', 9), ('chi-square-test', 1), ('identify', 126), ('multivariate', 13), ('logistic', 25), ('regression', 61), ('explanatory', 1), ('variables', 37), ('13.8', 2), ('observed', 465), ('income', 2), ('level', 407), ('poorest', 1), ('likely', 70), ('experience', 15), ('result', 94), ('complications', 69), ('experienced', 10), ('outpatient', 4), ('inpatient', 2), ('services', 4), ('likelihood', 8), ('incur', 1), ('early', 161), ('screening', 57), ('high-risk', 9), ('management', 46), ('detected', 214), ('priorities', 2), ('reduce', 85), ('overall', 135), ('healthcare', 6), ('non-euphoric', 2), ('plant', 31), ('muscle', 105), ('quality', 56), ('performance', 50), ('dystrophic', 2), ('mdx', 3), ('mice', 1141), ('purpose', 87), ('duchenne', 1), ('muscular', 7), ('dystrophy', 2), ('dmd', 4), ('dystrophin', 1), ('irreversible', 14), ('skeletal', 51), ('degeneration', 47), ('autophagy', 309), ('greatly', 13), ('contributes', 73), ('aggravation', 4), ('explored', 87), ('possibility', 20), ('compounds', 200), ('cannabis', 45), ('sativa', 9), ('cannabidiol', 39), ('cbd', 123), ('cannabidivarin', 1), ('cbdv', 6), ('tetrahydrocannabidivarin', 1), ('thcv', 2), ('restore', 12), ('functional', 142), ('positively', 47), ('enhance', 47), ('experimental', 120), ('quantitative', 72), ('pcr', 67), ('blots', 3), ('measurements', 29), ('differentiation', 190), ('murine', 48), ('interaction', 184), ('trp', 4), ('channels', 43), ('injected', 52), ('i.p', 64), ('stages', 46), ('locomotor', 26), ('tests', 62), ('biochemical', 90), ('analyses', 132), ('evaluate', 179), ('key', 203), ('c2c12', 4), ('myoblast', 1), ('myotubes', 9), ('increasing', 172), ('mostly', 19), ('trpv1', 16), ('undergoes', 9), ('rapid', 41), ('desensitization', 4), ('primary', 267), ('satellite', 2), ('myoblasts', 2), ('isolated', 104), ('healthy', 75), ('and/or', 102), ('donors', 11), ('myotube', 1), ('formation', 258), ('trpa1', 18), ('60', 69), ('mg', 67), ('kg-1', 20), ('prevented', 112), ('provide', 174), ('insights', 70), ('interactions', 123), ('highlighting', 8), ('opportunity', 10), ('co-adjuvant', 1), ('therapies', 35), ('prevent', 65), ('linked', 64), ('articles', 14), ('article', 15), ('part', 72), ('themed', 1), ('section', 5), ('8th', 3), ('european', 6), ('workshop', 1), ('research', 111), ('view', 10), ('visit', 5), ('http', 3), ('//onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc', 1), ('mono', 13), ('2-ethylhexyl', 34), ('phthalate', 91), ('mehp', 28), ('2-ethyl-5-oxohexyl', 3), ('meohp', 5), ('di', 19), ('dehp', 73), ('bind', 30), ('productively', 1), ('rationale', 13), ('frequently', 37), ('occurring', 30), ('glucose', 226), ('insulin', 118), ('sensitivity', 106), ('models', 266), ('epidemiological', 29), ('thus', 196), ('far', 25), ('available', 47), ('phthalates', 18), ('one', 303), ('regulators', 34), ('metabolism', 315), ('ppargamma', 74), ('endogenous', 66), ('ligand', 63), ('15-deoxy-delta-12,14-prostaglandin', 1), ('j2', 2), ('15delta-pgj2', 2), ('features', 75), ('structural', 57), ('similarity', 10), ('main', 113), ('metabolites', 98), ('produced', 83), ('hepatic', 374), ('tested', 127), ('hypothesis', 49), ('direct', 84), ('transformation', 37), ('hydrogen/deuterium', 1), ('exchange', 9), ('mass', 93), ('spectrometry', 43), ('hdx-ms', 2), ('docking', 66), ('obtain', 9), ('surface', 82), ('plasmon', 6), ('resonance', 28), ('spr', 12), ('reveal', 52), ('binding', 229), ('confirm', 35), ('upon', 71), ('geneblazer', 1), ('bioassay', 9), ('pocket', 15), ('leads', 72), ('activation-associated', 1), ('conformational', 9), ('reporter', 63), ('productive', 1), ('inactive', 15), ('concentration', 206), ('14', 67), ('mum', 333), ('active', 135), ('micromolar', 12), ('concentrations', 392), ('summary', 53), ('gives', 6), ('shows', 51), ('modulate', 48), ('lipid', 188), ('trans-catheter', 1), ('aspiration', 3), ('air', 76), ('embolism', 3), ('cardiac', 235), ('compromise', 6), ('ct-guided', 2), ('potentially', 55), ('lifesaving', 1), ('maneuver', 1), ('artery', 43), ('rare', 32), ('complication', 27), ('immediate', 7), ('radiological', 3), ('recognitions', 1), ('crucial', 61), ('prevention', 42), ('fatal', 11), ('outcome', 46), ('hyperbaric', 1), ('oxygen', 214), ('mildly', 1), ('symptomatic', 6), ('embolization', 2), ('considered', 103), ('arrest', 95), ('height', 7), ('vkorc1', 9), ('1173', 3), ('cyp2c9', 18), ('genotypes', 21), ('determine', 162), ('warfarin', 50), ('dose', 237), ('pediatric', 26), ('kawasaki', 14), ('southwest', 1), ('long-term', 120), ('oral', 129), ('recommended', 18), ('large', 71), ('coronary', 14), ('aneurysms', 6), ('heterogeneity', 13), ('considerable', 17), ('affecting', 26), ('dosage', 16), ('enrolled', 32), ('194', 4), ('children', 78), ('lesions', 70), ('cal', 5), ('iv', 61), ('v', 14), ('degrees', 10), ('thrombogenesis', 1), ('assigned', 20), ('ii', 165), ('iii', 53), ('small', 108), ('medium-sized', 1), ('4', 254), ('relevant', 98), ('1639', 1), ('3730', 1), ('cyp4f2', 7), ('statistically', 47), ('differences', 101), ('mutation', 38), ('frequencies', 7), ('44', 7), ('characteristics', 62), ('recorded', 16), ('associations', 73), ('variability', 18), ('linear', 32), ('revealed', 353), ('accounted', 6), ('61.2', 1), ('7.9', 4), ('4.3', 3), ('dosing', 22), ('respectively', 320), ('patient', 99), ('genotype', 31), ('vary', 10), ('formula', 37), ('efficacy', 140), ('low-quality', 1), ('rice', 10), ('straw', 7), ('forage', 2), ('permeability', 34), ('mammary', 36), ('tight', 33), ('junctions', 12), ('lactating', 2), ('dairy', 26), ('cows', 19), ('milking', 1), ('frequency', 26), ('plasma', 163), ('play', 110), ('important', 299), ('roles', 96), ('regulating', 110), ('still', 107), ('whether', 247), ('nutritional', 14), ('influence', 89), ('udder', 1), ('design', 43), ('tight-junction', 1), ('fed', 54), ('forage-based', 1), ('diets', 27), ('twenty', 6), ('mid-lactating', 1), ('allocated', 12), ('ten', 14), ('blocks', 15), ('parity', 4), ('milk', 11), ('yield', 16), ('straw-based', 2), ('diet', 112), ('alfalfa-based', 2), ('contained', 21), ('15', 66), ('corn', 4), ('silage', 1), ('55', 5), ('concentrate', 1), ('matter', 51), ('basis', 45), ('terms', 38), ('sources', 15), ('rs', 6), ('ah', 2), ('23', 22), ('alfalfa', 1), ('hay', 3), ('plus', 44), ('7', 108), ('chinese', 51), ('wild', 22), ('rye', 1), ('na+', 9), ('/k+', 2), ('bovine', 11), ('serum', 335), ('albumin', 34), ('plasmin', 1), ('lactose', 4), ('mrna', 461), ('abundance', 36), ('bcl2', 26), ('phosphatase', 51), ('tensin', 4), ('homolog', 16), ('like', 53), ('5', 229), ('rs-fed', 2), ('ah-fed', 2), ('animals', 121), ('proliferating', 8), ('antigen', 19), ('occludin', 22), ('claudin-1', 8), ('-3', 14), ('-4', 6), ('zo-1', 20), ('two', 341), ('alveolar', 38), ('proliferation/apoptosis', 1), ('rates', 75), ('2018', 18), ('society', 5), ('chemical', 137), ('industry', 2), ('azd9291', 21), ('inhibits', 130), ('pi3k/akt', 49), ('nsclc', 69), ('third-generation', 2), ('tyrosine', 41), ('egfr-tki', 5), ('highly', 112), ('egfr', 71), ('t790m-mutant', 1), ('non-small', 20), ('investigating', 12), ('trigger', 32), ('autophagy-mediated', 6), ('a549', 89), ('h1975', 7), ('phosphatidylethanolamine-modified', 1), ('microtubule-associated', 8), ('light-chain', 2), ('lc3', 12), ('decreasing', 62), ('p62', 30), ('presence', 124), ('chloroquine', 16), ('azd9291-induced', 3), ('increase', 443), ('augmented', 26), ('phosphoinositide-3', 1), ('pi3k', 33), ('akt', 121), ('phosphorylated', 44), ('enhanced', 216), ('knockdown', 113), ('suppress', 36), ('tumor', 371), ('xenograft', 27), ('nude', 9), ('induce', 251), ('decrease', 228), ('show', 183), ('critical', 131), ('induces', 234), ('pomc', 9), ('neuroinflammatory', 10), ('receptor-mediated', 11), ('pomc-expressing', 2), ('hypothalamic', 27), ('neuronal', 125), ('disrupting', 41), ('chemicals', 137), ('pro-opiomelanocortin', 1), ('neurons', 124), ('regulate', 44), ('energy', 75), ('unexplored', 9), ('functionally', 12), ('characterized', 123), ('mhypoa-pomc/gfp-2', 1), ('mhypoe-43/5', 1), ('exposure', 1250), ('culture', 70), ('lines', 192), ('delineate', 5), ('nfkappab', 18), ('il6', 13), ('ikappaba', 1), ('esr1', 12), ('esr2', 2), ('gpr30', 6), ('esrrg', 1), ('pparg', 5), ('pre-treatment', 27), ('anti-inflammatory', 165), ('gonadotropin-releasing', 7), ('ps1145', 1), ('ikappab', 6), ('abrogated', 26), ('bpa-mediated', 2), ('induction', 239), ('t0070907', 2), ('abolished', 56), ('g15', 3), ('indicate', 175), ('hypothalamus', 10), ('utilizing', 12), ('olive', 16), ('oil', 62), ('lessened', 2), ('fatty', 133), ('liver', 964), ('independent', 63), ('cardiometabolic', 12), ('correction', 5), ('non-alcoholic', 18), ('randomized', 48), ('trial', 46), ('benefits', 28), ('metabolic', 208), ('consumption', 68), ('double-blind', 6), ('66', 11), ('receive', 11), ('either', 136), ('sunflower', 6), ('20', 150), ('g/d', 2), ('wk', 1), ('hypocaloric', 1), ('-500', 1), ('kcal/d', 2), ('participants', 58), ('enzymes', 229), ('anthropometric', 3), ('parameters', 106), ('malondialdehyde', 76), ('antioxidant', 298), ('capacity', 72), ('interleukin-6', 32), ('pre-', 8), ('postintervention', 1), ('weight', 157), ('waist', 4), ('circumference', 3), ('aspartate', 31), ('alanine', 47), ('aminotransferases', 2), ('aminotransferase', 57), ('fat-free', 3), ('triacylglycerols', 1), ('fat', 66), ('declined', 16), ('ingestion', 16), ('-0.29', 2), ('+-', 160), ('0.46', 4), ('versus', 40), ('-0.75', 1), ('0.45', 3), ('0.001', 126), ('-0.71', 1), ('1.36', 2), ('+0.45', 1), ('2.8', 5), ('0.04', 11), ('percentage', 28), ('+0.38', 1), ('5.2', 1), ('-3.4', 1), ('5.5', 6), ('alleviate', 36), ('correcting', 1), ('low-calorie', 2), ('benefit', 32), ('additionally', 138), ('mitigation', 8), ('emt', 109), ('transcription', 253), ('twist1', 17), ('overcomes', 3), ('inhibitors', 156), ('egfr-mutant', 11), ('non-small-cell', 7), ('benefited', 4), ('tkis', 6), ('limited', 77), ('de', 20), ('novo', 19), ('~30', 5), ('acquired', 20), ('epithelial-mesenchymal', 35), ('transition', 76), ('emt-tfs', 2), ('drivers', 9), ('emt-mediated', 2), ('strategies', 45), ('lacking', 30), ('third', 24), ('generation', 114), ('tki', 8), ('osimertinib', 5), ('adopted', 6), ('first-line', 10), ('setting', 24), ('t790m', 4), ('mutations', 78), ('previously', 140), ('common', 146), ('first', 221), ('importantly', 62), ('fda', 6), ('approved', 23), ('targeted', 50), ('progression', 204), ('investigated', 410), ('strategy', 72), ('overcome', 10), ('emt-tf', 1), ('genetic', 130), ('silencing', 63), ('harmine', 1), ('inhibition', 588), ('overexpression', 172), ('erlotinib', 4), ('conversely', 30), ('pharmacological', 83), ('tki-resistant', 1), ('twist1-mediated', 2), ('pro-apoptotic', 36), ('bh3-only', 1), ('bcl2l11', 2), ('bim', 2), ('directly', 68), ('intronic', 3), ('regions', 47), ('promoter', 99), ('pan-bcl2', 1), ('overcame', 3), ('finally', 96), ('autochthonous', 1), ('erlotinib-induced', 1), ('establish', 31), ('driver', 10), ('gap', 13), ('hacat', 13), ('widely', 118), ('raw', 7), ('material', 29), ('production', 311), ('plastics', 9), ('paper', 20), ('people', 34), ('exposed', 346), ('dermal', 19), ('contact', 41), ('particularly', 64), ('cashiers', 1), ('thermal', 9), ('every', 24), ('day', 146), ('weak', 28), ('junctional', 3), ('intercellular', 13), ('communication', 13), ('gjic', 8), ('possible', 158), ('action', 128), ('skin', 121), ('prolonged', 31), ('photobleaching', 2), ('fluorescence', 38), ('recovery', 27), ('times', 43), ('0.01', 60), ('downregulated', 95), ('connexin', 2), ('cx', 3), ('26', 11), ('er', 129), ('ici', 5), ('182', 1), ('780', 1), ('nm', 111), ('blocked', 74), ('indicating', 89), ('cx43', 13), ('immunofluorescence', 63), ('cx26', 3), ('expressed', 154), ('cytoplasm', 17), ('membrane', 129), ('involved', 348), ('adjacent', 8), ('promote', 56), ('downregulate', 11), ('hypothesize', 7), ('exhibit', 39), ('carcinogenicity', 13), ('inhibiting', 176), ('chlorine-induced', 1), ('budesonide', 5), ('chlorine', 8), ('threat', 10), ('agent', 112), ('harmful', 17), ('acute', 291), ('inhalation', 49), ('persistent', 48), ('hyperreactivity', 8), ('developed', 88), ('airways', 11), ('examination', 48), ('laser', 13), ('capture', 7), ('microdissection', 3), ('fibroproliferative', 1), ('fvb/nj', 1), ('240', 2), ('ppm-h', 1), ('upregulation', 148), ('chlorine-exposed', 2), ('corticosteroid', 3), ('drug', 292), ('daily', 62), ('days', 307), ('30-90', 1), ('mug/mouse', 2), ('i.m', 2), ('starting', 18), ('h', 291), ('m2', 32), ('budesonide-treated', 1), ('extensive', 22), ('denuded', 1), ('areas', 44), ('indicative', 9), ('poorly', 50), ('repaired', 5), ('epithelium', 28), ('damaged', 22), ('fibrogenesis', 9), ('ultimate', 4), ('later', 35), ('7-day', 3), ('continued', 14), ('cessation', 8), ('regrowth', 1), ('differentiated', 38), ('delay', 10), ('start', 8), ('countermeasure', 1), ('shed', 7), ('light', 48), ('initial', 30), ('injury', 577), ('preoperative', 15), ('microscopic', 11), ('navigation', 9), ('surgery', 58), ('avoid', 14), ('unnecessarily', 3), ('opening', 12), ('mastoid', 2), ('craniotomy', 2), ('retrosigmoid', 2), ('analyze', 31), ('microvascular', 8), ('decompression', 2), ('ra', 13), ('trigeminal', 7), ('neuralgia', 2), ('hemifacial', 2), ('spasm', 5), ('images', 25), ('combined', 163), ('intraoperative', 8), ('macs', 8), ('head', 28), ('magnetic', 35), ('angiography', 8), ('temporal', 9), ('computed', 11), ('tomography', 18), ('registered', 7), ('spm12', 1), ('fused', 2), ('mricron', 1), ('sigmoid', 6), ('sinuses', 4), ('o-arm', 1), ('transverse', 3), ('sinus', 8), ('projected', 1), ('microscope', 8), ('guide', 11), ('comprised', 7), ('139', 2), ('surgical', 34), ('procedure', 11), ('image', 11), ('processing', 25), ('ipsilateral', 5), ('classified', 20), ('follows', 10), ('exceed', 2), ('lateral', 19), ('edge', 5), ('10/60', 1), ('exceeded', 3), ('medial', 8), ('42/60', 1), ('8/60', 1), ('incidences', 7), ('0.003', 11), ('cerebrospinal', 3), ('fluid', 44), ('leakage', 9), ('scalp', 2), ('intracranial', 6), ('infection', 91), ('follow-up', 51), ('postoperative', 18), ('boric', 6), ('eif2alpha', 6), ('nrf2', 281), ('perk', 13), ('dependent', 76), ('explains', 1), ('boron', 4), ('prevents', 31), ('enhances', 38), ('status', 81), ('abundant', 33), ('vegetables', 13), ('nuts', 3), ('legumes', 1), ('fruit', 14), ('intake', 83), ('ba', 47), ('approximately', 39), ('men', 31), ('mean', 91), ('us', 25), ('du-145', 7), ('prostate', 114), ('stimulates', 16), ('phosphorylation', 236), ('elongation', 2), ('initiation', 23), ('2alpha', 1), ('ser51', 3), ('eif2alpha/atf4', 1), ('activates', 37), ('damage-inducible', 2), ('gadd34', 1), ('mef', 9), ('wt', 104), ('ba-activated', 1), ('requires', 24), ('rna-like', 2), ('endoplasmic', 44), ('reticulum', 47), ('response', 398), ('element', 41), ('-/-', 20), ('long', 56), ('6', 181), ('h.', 65), ('gcn2', 1), ('kinase-dependent', 1), ('activated', 170), ('amino', 30), ('starvation', 3), ('translocated', 6), ('nucleus', 47), ('acts', 43), ('cytoplasmic', 22), ('1.5-2', 1), ('real-time', 83), ('measure', 30), ('three', 186), ('hmox-1', 2), ('nqo1', 48), ('gclc', 11), ('1-4', 4), ('hmox1', 7), ('extend', 6), ('are-regulated', 1), ('schematic', 2), ('cadpr', 1), ('cadpr-ba', 1), ('perk/eif2alphap', 1), ('atf4', 2), ('stress', 624), ('atf6', 7), ('provides', 86), ('framework', 9), ('links', 2), ('underpin', 1), ('biological', 129), ('aryl', 58), ('hydrocarbon', 63), ('osteoblast', 24), ('mesenchymal', 54), ('stem', 118), ('multipotent', 2), ('mscs', 19), ('maintain', 17), ('ability', 126), ('differentiate', 10), ('adipogenic', 17), ('chondrogenic', 3), ('osteogenic', 28), ('lineages', 5), ('concern', 49), ('agents', 94), ('ahr', 162), ('ligands', 52), ('perturb', 3), ('prototypic', 1), ('2,3,7,8-tetrachlorodibenzo-p-dioxin', 6), ('tcdd', 29), ('disrupt', 26), ('bone-derived', 1), ('hbmscs', 7), ('interrogated', 2), ('select', 11), ('histological', 67), ('osteogenesis', 10), ('consistent', 67), ('attenuation', 20), ('alkaline', 20), ('alp', 28), ('mineralization', 5), ('terminal', 10), ('regulator', 58), ('dlx5', 5), ('additional', 48), ('opn', 15), ('ibsp', 1), ('displayed', 46), ('attenuated', 176), ('fgf9', 1), ('fgf18', 2), ('consistently', 20), ('donor', 18), ('potency', 32), ('sox2', 4), ('nanog', 6), ('sall4', 6), ('controls', 125), ('tcdd-treated', 1), ('resembled', 1), ('undifferentiated', 3), ('coexposure', 4), ('gnf351', 1), ('tcdd-mediated', 1), ('fully', 67), ('rescued', 22), ('maintenance', 31), ('multipotency', 1), ('suggests', 83), ('transactivation', 15), ('attenuates', 63), ('underscores', 2), ('osteoinductive', 1), ('osteotoxic', 1), ('pharmacologic', 9), ('down-regulation', 73), ('p23', 8), ('reduces', 67), ('toxicities', 19), ('cigarette', 29), ('smoke', 27), ('condensate', 1), ('receptor-dependent', 4), ('ligand-activated', 4), ('molecule', 60), ('sensitive', 68), ('immortalized', 12), ('little', 54), ('reduction', 162), ('content', 126), ('untransformed', 3), ('bronchial/tracheal', 1), ('48', 65), ('suppresses', 52), ('54', 10), ('p23-mediated', 1), ('ligand-dependent', 5), ('cyp1a1', 89), ('pyrene-', 1), ('condensate-induced', 1), ('enzyme', 181), ('condensate-mediated', 1), ('reactive', 209), ('species', 247), ('alter', 58), ('oxidative', 631), ('pge2', 36), ('types', 86), ('namely', 23), ('breast', 273), ('mcf-10a', 5), ('tr1', 2), ('collectively', 73), ('principle', 7), ('protect', 53), ('ahr-dependent', 3), ('environment', 64), ('smoking', 52), ('neural', 51), ('paternal', 7), ('mammals', 21), ('sensory', 8), ('neuroendocrine', 11), ('experiential', 2), ('influences', 18), ('across', 57), ('animal', 106), ('kingdom', 4), ('parents', 6), ('devote', 1), ('extraordinary', 1), ('effort', 4), ('toward', 31), ('caring', 1), ('offspring', 149), ('risking', 1), ('lives', 3), ('exhausting', 1), ('resources', 5), ('orchestrates', 3), ('parental', 17), ('biasing', 1), ('competing', 10), ('demands', 3), ('topic', 4), ('neuroscience', 1), ('maternal', 77), ('survival', 180), ('largely', 52), ('neuropeptides', 2), ('fluctuate', 1), ('massively', 1), ('pregnancy', 80), ('parturition', 3), ('lactation', 12), ('e.g.', 19), ('estradiol', 29), ('oxytocin', 6), ('prolactin', 1), ('relatively', 24), ('number', 144), ('fathers', 3), ('males', 45), ('undergo', 10), ('concurrent', 7), ('birth', 49), ('smaller', 14), ('scale', 18), ('females', 70), ('rely', 6), ('signals', 38), ('mates', 1), ('orchestrate', 4), ('engage', 3), ('variety', 45), ('infant-directed', 1), ('behaviors', 33), ('infanticide', 1), ('avoidance', 4), ('display', 12), ('lifetime', 5), ('plasticity', 19), ('underlies', 5), ('stark', 1), ('chapter', 2), ('summarize', 8), ('circuitry', 3), ('proposed', 34), ('underlie', 9), ('highlight', 30), ('gaps', 4), ('system', 297), ('propose', 14), ('future', 54), ('directions', 2), ('enable', 8), ('comprehensive', 25), ('proximate', 1), ('parenting', 1), ('prospective', 59), ('metal', 32), ('ceramic', 9), ('crowns', 9), ('private', 7), ('settings', 16), ('20-year', 3), ('posterior', 16), ('standard', 59), ('practitioners', 1), ('participated', 16), ('practice-based', 1), ('provided', 57), ('formed', 32), ('single', 102), ('crown', 7), ('190', 1), ('retainer', 4), ('138', 2), ('fixed', 7), ('dental', 21), ('prostheses', 2), ('276', 2), ('``', 71), ('tooth', 10), (\"''\", 71), ('78.8', 2), ('67.8', 1), ('veneering', 2), ('defects', 57), ('occurred', 40), ('rather', 29), ('respective', 15), ('technical', 3), ('success', 15), ('74.2', 1), ('62.9', 1), ('losses', 5), ('events', 85), ('treatments', 68), ('reliable', 13), ('option', 17), ('thyroid', 87), ('t3', 36), ('brown', 10), ('adipose', 50), ('mitochondrial', 386), ('biogenesis', 24), ('mtor-mediated', 2), ('mitophagy', 34), ('triiodothyronine', 8), ('thermogenesis', 6), ('uncoupling', 4), ('electron', 59), ('transport', 102), ('atp', 70), ('synthesis', 144), ('bat', 8), ('mitochondria', 74), ('sympathetic', 2), ('innervation', 2), ('examined', 179), ('adipocytes', 58), ('oxidation', 45), ('respiration', 16), ('autophagic', 52), ('flux', 42), ('interestingly', 76), ('intracellular', 137), ('ros', 362), ('ucp1', 6), ('atg5', 12), ('sirna', 51), ('block', 28), ('accompanied', 90), ('accumulation', 196), ('demonstrating', 13), ('turnover', 13), ('next', 25), ('generated', 41), ('conditional', 12), ('knockout', 53), ('cko', 3), ('injecting', 4), ('promoter-driven', 1), ('cre-expressing', 1), ('adenovirus', 10), ('atg5flox/flox', 1), ('examine', 73), ('bat-specific', 1), ('hyperthyroid', 5), ('temperature', 23), ('euthyroid', 3), ('metabolomic', 5), ('short', 35), ('chain', 119), ('acylcarnitines', 5), ('beta-oxidation', 4), ('conjunction', 5), ('sirt1', 90), ('stimulate', 27), ('essential', 67), ('stimulation', 61), ('analogs', 19), ('abbreviations', 1), ('acaca', 1), ('acetyl-coenzyme', 2), ('carboxylase', 7), ('alpha', 97), ('ampk', 34), ('amp-activated', 12), ('acsl1', 1), ('acyl-coa', 1), ('synthetase', 5), ('long-chain', 8), ('family', 93), ('member', 35), ('atg7', 3), ('adenosine', 23), ('triphosphate', 9), ('cox4i1', 2), ('cytochrome', 116), ('oxidase', 51), ('subunit', 47), ('4i1', 1), ('cpt1b', 1), ('carnitine', 5), ('palmitoyltransferase', 4), ('1b', 9), ('cq', 12), ('dapi', 2), (\"4',6-diamidino-2-phenylindole\", 3), ('dio2', 9), ('deiodinase', 6), ('iodothyronine', 1), ('dmem', 1), ('dulbecco', 1), ('modified', 36), ('eagle', 2), ('medium', 49), ('eif4ebp1', 2), ('eukaryotic', 5), ('translation', 8), ('4e', 1), ('fabp4', 3), ('adipocyte', 22), ('fbs', 4), ('fetal', 78), ('fccp', 1), ('carbonyl', 16), ('cyanide-4-', 1), ('trifluoromethoxy', 1), ('phenylhydrazone', 1), ('fgf', 2), ('fibroblast', 34), ('foxo1', 5), ('forkhead', 9), ('box', 26), ('o1', 2), ('gapdh', 1), ('glyceraldehyde-3-phosphate', 2), ('dehydrogenase', 70), ('gfp', 6), ('green', 14), ('fluorescent', 14), ('gpx1', 7), ('glutathione', 152), ('peroxidase', 36), ('lipe', 1), ('lipase', 4), ('map1lc3b', 2), ('messenger', 19), ('rna', 151), ('mtorc1', 13), ('complex', 116), ('nad', 11), ('nicotinamide', 14), ('adenine', 8), ('dinucleotide', 7), ('nrf1', 1), ('ocr', 2), ('pbs', 4), ('phosphate-buffered', 1), ('saline', 32), ('polymerase', 68), ('reaction', 97), ('ppargc1a', 8), ('proliferative', 24), ('coactivator', 7), ('pnpla2', 1), ('patatin-like', 1), ('phospholipase', 9), ('domain', 46), ('containing', 58), ('prdm16', 1), ('pr', 23), ('16', 39), ('prka', 1), ('rps6kb', 1), ('ribosomal', 8), ('s6', 3), ('rfp', 1), ('red', 23), ('sd', 24), ('deviation', 4), ('sem', 4), ('error', 7), ('interfering', 25), ('sirtuin', 19), ('sod1', 14), ('superoxide', 93), ('dismutase', 85), ('sod2', 14), ('sqstm1', 3), ('sequestosome', 1), (\"3,5,3'-triiodothyronine\", 1), ('tfeb', 7), ('eb', 13), ('tomm20', 1), ('translocase', 1), ('outer', 7), ('proton', 8), ('carrier', 9), ('ulk1', 7), ('unc-51', 1), ('vdac1', 7), ('voltage-dependent', 2), ('anion', 13), ('channel', 42), ('wat', 2), ('white', 33), ('ameliorates', 42), ('hepatotoxicity', 163), ('heme', 50), ('protects', 78), ('hepatocytes', 121), ('various', 170), ('toxicants', 22), ('cytoprotective', 26), ('5-diethoxycarbonyl-1', 1), ('4-dihydrocollidine', 1), ('ddc', 12), ('portal', 13), ('vein', 34), ('unlike', 6), ('cause', 180), ('hemorrhage', 4), ('necrosis', 136), ('centrilobular', 5), ('area', 71), ('livers', 46), ('nrf2ko', 4), ('keap1flox/flox', 1), ('keap1-knockdown', 1), ('keap1kd', 2), ('liver-specific', 6), ('keap1', 29), ('keap1-alb', 7), ('stepwise', 3), (':nrf2', 1), ('double-knockout', 1), (':nrf2-alb', 1), ('exploited', 5), ('contribution', 27), ('recovered', 17), ('liver-to-body-weight', 1), ('larger', 18), ('indicators', 25), ('bilirubin', 8), ('elevated', 186), ('ddc-feeding', 1), ('ddc-induced', 4), ('porphyrin', 7), ('suggesting', 134), ('activate', 52), ('excretion', 20), ('porphyrins', 1), ('contrary', 15), ('expectation', 1), ('damages', 20), ('appeared', 21), ('observations', 20), ('conclude', 19), ('ddc-elicited', 1), ('mifepristone', 8), ('potentiates', 10), ('etoposide', 9), ('toxicity', 478), ('hep', 3), ('g2', 3), ('modulating', 45), ('well-known', 27), ('anticancer', 114), ('displays', 14), ('side', 52), ('addition', 399), ('acquire', 6), ('develop', 38), ('combination', 199), ('therapy', 180), ('would', 60), ('augment', 5), ('malignant', 52), ('literature', 35), ('experiments', 116), ('selected', 69), ('ru486', 3), ('supporting', 18), ('described', 46), ('hepatocellular', 77), ('carcinoma', 115), ('xcelligence', 2), ('concomitant', 40), ('caspase-3', 114), ('bax', 115), ('proapoptotic', 22), ('hand', 35), ('abc', 12), ('transporters', 81), ('coupled', 33), ('demonstrate', 136), ('synergistic', 47), ('polycystic', 10), ('aetiology', 6), ('female', 192), ('gender', 19), ('international', 14), ('pld', 6), ('registry', 7), ('amp', 37), ('aims', 61), ('occurs', 28), ('autosomal-dominant', 2), ('kidney', 233), ('adpkd', 8), ('adpld', 5), ('compare', 35), ('diagnosis', 70), ('height-adjusted', 1), ('volume', 41), ('htlv', 8), ('endpoint', 8), ('cysts', 11), ('made', 19), ('september', 5), ('2017', 18), ('volume-reducing', 1), ('tertiary', 6), ('referred', 15), ('retrieved', 4), ('360', 1), ('n', 151), ('241', 1), ('119', 2), ('met', 25), ('inclusion', 17), ('criteria', 39), ('0.008', 2), ('index', 75), ('ct', 24), ('young', 29), ('=51', 1), ('volumes', 3), ('older', 17), ('51', 12), ('subgroup', 14), ('transient', 37), ('melastatin', 5), ('positive', 138), ('feedback', 13), ('species-induced', 4), ('delayed', 38), ('trpm2', 7), ('plays', 128), ('postischemia', 1), ('altering', 22), ('zn2+', 12), ('h2', 25), ('o2', 25), ('neuroblastoma', 47), ('sh-sy5y', 95), ('dependently', 7), ('ros-induced', 8), ('trpm2-mediated', 1), ('concentration-dependently', 4), ('lysosomal', 42), ('fragmentation', 39), ('suppressed', 196), ('poly', 61), ('diphosphate', 5), ('ribose', 3), ('adpr', 1), ('polymerase-1-dependent', 1), ('pj34', 15), (\"3,3',5,5'-tetra-tert-butyldiphenoquinone\", 1), ('2-aminoethoxydiphenyl', 1), ('borate', 1), ('2-apb', 2), ('n-', 7), ('p-amylcinnamoyl', 1), ('anthranilic', 1), ('chelating', 1), ('n-tetrakis', 1), ('2-pyridylmethyl', 1), ('-ethylenediamine', 1), ('tpen', 2), ('bafilomycin-induced', 1), ('inhibited', 427), ('sequela', 1), ('adpr-induced', 1), ('uptake', 101), ('-induced', 156), ('apocynin', 12), ('diphenyleneiodonium', 3), ('phosphate', 53), ('hydrogen', 49), ('nadph', 39), ('nox', 17), ('gkt137831', 1), ('nox1/4-specific', 1), ('go6983', 1), ('pkc', 15), ('pkc/nox', 1), ('release', 137), ('support', 68), ('coupling', 9), ('pkc/nox-mediated', 1), ('form', 71), ('vicious', 6), ('locus', 18), ('cns-specific', 6), ('pgc-1alpha', 15), ('isoforms', 15), ('parkinson', 54), ('pd', 94), ('second', 56), ('worldwide', 58), ('encoded', 10), ('co-activator', 3), ('recently', 74), ('discovered', 25), ('multiple', 127), ('transcripts', 41), ('initiate', 10), ('located', 21), ('upstream', 39), ('reference', 45), ('whole', 40), ('encode', 3), ('full-length', 6), ('truncated', 9), ('alternative', 39), ('splicing', 15), ('cns-isoforms', 1), ('include', 24), ('17', 29), ('kda', 3), ('proteins', 353), ('lack', 32), ('lxxll', 1), ('motif', 9), ('serving', 3), ('site', 62), ('determined', 192), ('cns-', 2), ('21', 45), ('8', 98), ('13', 33), ('deceased', 1), ('idiopathic', 11), ('lewy', 3), ('dementia', 18), ('reductions', 15), ('encoding', 36), ('substantia', 14), ('nigra', 18), ('pars', 3), ('compacta', 2), ('globus', 2), ('pallidus', 2), ('up-regulation', 70), ('co-activation', 1), ('transfection', 23), ('assays', 148), ('established', 95), ('profiles', 64), ('differed', 7), ('haplotypes', 1), ('region', 75), ('protective', 247), ('post-mortem', 2), ('sample', 32), ('.0002', 1), ('systematic', 27), ('graphene', 20), ('derivatives', 62), ('two-dimensional', 4), ('crystal', 18), ('stripped', 1), ('pristine', 2), ('graphite', 1), ('layer', 14), ('carbon', 55), ('atoms', 6), ('numerous', 44), ('gds', 6), ('easily', 7), ('aroused', 1), ('great', 28), ('attention', 36), ('applications', 27), ('biomedicine', 2), ('oxide', 87), ('go', 28), ('arouse', 1), ('screen', 24), ('biocompatibility', 6), ('applied', 65), ('general', 49), ('comparison', 46), ('six', 45), ('diverse', 23), ('modification', 27), ('size', 58), ('redox', 47), ('state', 52), ('rgo', 1), ('quantum', 10), ('dot', 2), ('gqd', 4), ('aminated', 1), ('gqd-nh2', 2), ('carboxyl', 3), ('gqd-cooh', 2), ('goqd', 2), ('contrast', 82), ('particle', 23), ('unfavorable', 5), ('viability', 216), ('destruction', 15), ('sharpened', 1), ('edges', 1), ('ldh', 30), ('hemolysis', 6), ('immuno-inflammatory', 1), ('responses', 213), ('apoptotic', 172), ('ikk/ikappabalpha/nf-kappab', 1), ('bax/bcl-2', 8), ('primarily', 30), ('safely', 4), ('biomedical', 4), ('application', 69), ('carriers', 14), ('administration', 244), ('alcalase', 2), ('potato', 3), ('hydrolysate-apph', 1), ('diet-induced', 15), ('tgf-beta/gsn', 1), ('axis', 111), ('aging', 9), ('hfd', 54), ('elderly', 13), ('induced-cardiac', 1), ('includes', 18), ('hypertrophy', 46), ('gelsolin', 1), ('gsn', 5), ('tgf-beta', 41), ('cytokine', 87), ('unknown', 119), ('22', 26), ('months', 86), ('old', 13), ('probucol', 3), ('hydrolysate', 1), ('apph', 4), ('blotting', 76), ('masson', 10), ('trichrome', 7), ('staining', 113), ('45', 22), ('75', 25), ('500', 42), ('hfd-induced', 7), ('echocardiograph', 1), ('hearts', 11), ('improved', 143), ('collected', 80), ('h9c2', 32), ('cultured', 72), ('serums', 1), ('separately', 9), ('exogenous', 45), ('hfd+', 1), ('along', 85), ('activator', 79), ('hence', 38), ('promising', 103), ('obese', 33), ('irritation', 3), ('bis-quaternary', 2), ('ammonium', 11), ('commonly', 90), ('antiseptics', 4), ('bis-qacs', 6), ('3-', 14), ('3-hydroxy-2-', 1), ('hydroxymethyl', 1), ('-2-', 2), ('1-dodecylpyridinium-3-yl', 1), ('oxy', 3), ('methyl', 17), ('propoxy', 1), ('-1-dodecylpyridinium', 1), ('dibromide', 2), ('3hhdmp-12', 2), (\"3,3'-\", 1), ('1,4-phenylenebis', 1), ('bis', 6), ('1-dodecylpyridinium', 1), ('3phbo-12', 2), ('commonly-used', 1), ('benzalkonium', 6), ('chloride', 56), ('bac', 13), ('octenidine', 1), ('dihydrochloride', 1), ('oct', 10), ('chlorhexidine', 1), ('digluconate', 1), ('chg', 2), ('polyhexamethylene', 9), ('biguanide', 1), ('phmb', 2), ('cytotoxicity', 220), ('il-1alpha', 5), ('cytotoxic', 92), ('human-derived', 2), ('quaternary', 4), ('biguanide-based', 1), ('ic50', 84), ('keratinocytes', 39), ('even', 55), ('actual', 2), ('reconstructed', 7), ('epidermis', 6), ('labcyte', 1), ('epi-model', 1), ('comparable', 25), ('existing', 11), ('useful', 47), ('butyl', 10), ('benzyl', 10), ('mir-34a', 8), ('esters', 10), ('class', 17), ('promoting', 50), ('rarely', 7), ('suppressor', 22), ('mirna', 31), ('bbp', 25), ('lncap', 9), ('pc-3', 9), ('10-6', 7), ('10-7', 7), ('mol/l', 3), ('pcna', 19), ('p21', 26), ('c-myc', 47), ('tranfection', 1), ('mimic', 19), ('mir-34a/c-myc', 1), ('insight', 53), ('tannic', 2), ('tlr4', 51), ('mapk', 91), ('ali', 28), ('distress', 14), ('syndrome', 94), ('ards', 23), ('remain', 119), ('major', 215), ('critically', 8), ('ill', 4), ('preventive', 17), ('ta', 7), ('natural', 107), ('polyphenol', 11), ('context', 32), ('lipopolysaccharide', 38), ('lps', 105), ('exposing', 9), ('j774', 1), ('beas-2b', 31), ('approaches', 51), ('lps-induced', 52), ('histopathological', 76), ('peroxidation', 55), ('proinflammatory', 47), ('mediators', 38), ('in-vitro', 6), ('ta-dampened', 1), ('downregulating', 24), ('extracellular-signal-regulated', 3), ('erk', 65), ('1/2', 32), ('p38', 84), ('mitogen-activated', 35), ('erk1/2', 77), ('pd98059', 7), ('sb203580', 10), ('mitigated', 14), ('cytokines', 122), ('required', 64), ('ali-associated', 1), ('allyl', 12), ('sulfide', 21), ('counteracts', 3), ('1-bromopropane-induced', 1), ('neurotoxicity', 131), ('neuroinflammation', 36), ('1-bromopropane', 1), ('1-bp', 9), ('ozone-depleting', 1), ('solvents', 3), ('produces', 17), ('occupational', 23), ('populations', 45), ('p4502e1', 3), ('cyp2e1', 47), ('1-bp-induced', 4), ('wistar', 58), ('intoxicated', 4), ('9', 86), ('continuous', 29), ('pretreatment', 108), ('clearly', 25), ('neun+', 1), ('cleaved', 67), ('tunel+', 3), ('motor', 39), ('cortex', 46), ('ameliorated', 63), ('mechanistically', 28), ('sulfide-inhibited', 1), ('microglia', 58), ('microglial', 62), ('m1', 26), ('polarization', 32), ('alone', 102), ('nf', 9), ('-kappab', 6), ('gsh/thioredoxin/ask1', 1), ('stress-related', 11), ('exerted', 29), ('neuroprotective', 73), ('combating', 1), ('blocking', 35), ('avenue', 3), ('elicited', 19), ('neurotoxicants', 5), ('identification', 71), ('modulators', 28), ('constitutive', 28), ('androstane', 17), ('tox21', 2), ('10k', 1), ('compound', 120), ('library', 7), ('car', 59), ('nr1i3', 1), ('phases', 10), ('disposition', 7), ('hcar', 6), ('predict', 27), ('drug-drug', 11), ('usage', 11), ('10,000', 3), ('collection', 5), ('characterize', 31), ('activators', 20), ('cluster', 10), ('nitazoxanide', 1), ('tenonitrozole', 1), ('clusters', 10), ('flavones', 4), ('prazoles', 1), ('neticonazole', 1), ('diphenamid', 3), ('phenothrin', 1), ('rimcazole', 2), ('selectivity', 12), ('sister', 1), ('pregnane', 22), ('pxr', 87), ('step', 21), ('estimation', 10), ('therapeutically', 6), ('beneficial', 56), ('drugs', 193), ('employing', 10), ('comparators', 2), ('perform', 15), ('assessments', 15), ('anti-androgens', 3), ('androgen', 48), ('ar', 54), ('non-animal', 1), ('exposure-led', 2), ('anti-androgenic', 10), ('put', 4), ('naturally', 23), ('comparator', 3), ('substance', 37), ('components', 57), ('screened', 23), ('interfered', 6), ('calux', 4), ('values', 100), ('dose-response', 13), ('together', 186), ('predicted', 47), ('calculate', 6), ('ratios', 27), ('ears', 4), ('substances', 46), ('diindolylmethane', 1), ('dim', 2), ('resveratrol', 46), ('specifically', 53), ('acting', 25), ('relative', 88), ('ear', 14), (\"'dietary\", 1), ('dcr', 4), ('make', 10), ('safety', 50), ('decisions', 1), ('botanical', 6), ('ingredient', 21), ('highlights', 20), ('pragmatic', 1), ('allows', 10), ('utility', 19), ('modes', 12), ('appropriate', 17), ('tgacg-binding', 2), ('tgas', 3), ('tga-interacting', 1), ('cc-type', 3), ('glutaredoxins', 3), ('hyponastic', 5), ('arabidopsis', 3), ('thaliana', 2), ('developmental', 147), ('defense-related', 1), ('processes', 109), ('functions', 119), ('least', 54), ('tga2', 1), ('perianthia', 1), ('pan', 1), ('repressed', 32), ('interacting', 19), ('tga1', 6), ('modulated', 45), ('planta', 2), ('analyzed', 143), ('roxys', 3), ('genome', 16), ('cysteines', 3), ('tga4', 2), ('mutant', 42), ('plants', 14), ('ectopically', 4), ('expressing', 26), ('roxy8', 2), ('roxy9', 2), ('impaired', 96), ('transfer', 32), ('hyponasty-inducing', 1), ('interfere', 19), ('growth-promoting', 1), ('tga1/tga4', 1), ('facilitate', 21), ('reversal', 12), ('redox-sensitive', 1), ('interact', 27), ('18', 31), ('19/grx480', 1), ('roxy18', 1), ('roxy19/grx480', 1), ('specificities', 3), ('individual', 49), ('distinct', 39), ('promiscuous', 2), ('protein-protein', 6), ('point', 23), ('repression', 27), ('depending', 13), ('tga/roxy', 1), ('vegetable', 10), ('pancreatic', 86), ('population-based', 12), ('japan', 12), ('pathogenic', 26), ('fruits', 13), ('antioxidants', 42), ('constituents', 16), ('inconsistent', 6), ('center-based', 1), ('90,185', 1), ('responded', 7), ('medical', 42), ('lifestyle', 15), ('questionnaire', 12), ('1995-1998.', 1), ('cox', 29), ('proportional', 10), ('hazards', 8), ('stratified', 8), ('median', 41), ('duration', 26), ('16.9', 1), ('577', 1), ('multivariate-adjusted', 1), ('inversely', 7), ('highest', 62), ('vs.', 81), ('lowest', 23), ('quartile', 7), ('hazard', 21), ('hr', 55), ('0.74', 4), ('0.57-0.95', 1), ('p-trend', 4), ('0.116', 1), ('1.30', 1), ('1.01-1.66', 1), ('0.151', 1), ('inverse', 14), ('apparent', 15), ('never', 10), ('smokers', 11), ('0.67', 3), ('0.47-0.97', 1), ('0.034', 3), ('ever', 5), ('1.49', 2), ('1.01-2.19', 2), ('0.043', 3), ('nonsignificant', 2), ('correlate', 10), ('partly', 23), ('aberrant', 24), ('methylation-induced', 1), ('p16', 27), ('fluoride', 14), ('continues', 1), ('thousands', 7), ('abnormal', 60), ('osteoclast', 21), ('fluorosis', 6), ('pain', 70), ('harm', 3), ('joints', 3), ('bones', 10), ('permanent', 4), ('disability', 14), ('nevertheless', 22), ('explain', 20), ('work', 107), ('relation', 18), ('methylation', 164), ('coded', 1), ('cdk', 1), ('cyclin-dependent', 8), ('4/cdk6-mediated', 1), ('phosphorylation4', 1), ('retinoblastoma', 1), ('product', 25), ('hypermethylation', 18), ('evident', 21), ('peripheral', 62), ('mononuclear', 13), ('osteoblasts', 14), ('sodium', 62), ('naf', 16), ('longer', 26), ('s-phase', 4), ('5-aza-2-deoxycytidine', 1), ('reversed', 115), ('antimetastatic', 11), ('terminalia', 7), ('catappa', 3), ('leaf', 13), ('extracts', 30), ('cervical', 53), ('metalloprotein-9', 1), ('tce', 17), ('antioxidative', 13), ('antidiabetic', 8), ('elucidate', 44), ('properties', 164), ('ethanol', 57), ('12-o-tetradecanoylphorbol-13-acetate', 4), ('process', 121), ('migration', 215), ('hela', 21), ('siha', 8), ('gelatin', 9), ('zymography', 9), ('reverse', 54), ('transcription-polymerase', 9), ('rt-pcr', 33), ('metalloproteinase-9', 11), ('concentration-dependent', 54), ('100', 186), ('mug/ml', 44), ('signal-regulated', 38), ('kinases', 30), ('46', 12), ('enniatin', 4), ('b1', 27), ('exerts', 50), ('embryotoxic', 1), ('blastocysts', 6), ('immunotoxicity', 22), ('embryo', 28), ('enniatins', 2), ('mycotoxins', 25), ('fusarium', 5), ('fungi', 4), ('exist', 12), ('mixtures', 27), ('cyclic', 9), ('depsipeptides', 1), ('reports', 30), ('documented', 18), ('hazardous', 7), ('post-implantation', 3), ('embryonic', 81), ('require', 8), ('clarification', 1), ('enn', 10), ('blastocyst-stage', 2), ('embryos', 121), ('fetuses', 11), ('co-incubation', 7), ('triggered', 68), ('led', 101), ('predominantly', 17), ('inner', 8), ('pre', 5), ('postimplantation', 1), ('1-10', 4), ('resorption', 10), ('dose-dependent', 107), ('intravenous', 19), ('injection', 109), ('mg/kg', 435), ('weight/d', 2), ('zygote', 1), ('blastocyst', 7), ('stage', 76), ('subsequent', 61), ('degradation', 81), ('effectively', 71), ('b1-mediated', 1), ('cxcl1', 1), ('immunity', 22), ('mir-96', 5), ('mir-184', 4), ('otic', 5), ('vesicle', 6), ('zebrafish', 259), ('beta-diketone', 2), ('antibiotics', 25), ('ototoxicity', 17), ('dkas', 1), ('danio', 18), ('rerio', 18), ('detail', 9), ('hearing-related', 1), ('mirnas', 74), ('otoliths', 2), ('embryonic-larval', 1), ('dka', 2), ('120-hpf', 1), ('larva', 1), ('acoustic', 2), ('otolith', 1), ('showing', 42), ('boundaries', 3), ('vacuolization', 2), ('72-hpf', 1), ('utricular', 1), ('enlargement', 4), ('saccular', 1), ('96-hpf', 1), ('latter', 16), ('larval', 18), ('knocked-down', 2), ('another', 29), ('over-expressed', 4), ('slight', 12), ('morphological', 41), ('micrna', 1), ('mimics', 6), ('yolk', 13), ('sac', 22), ('marked', 38), ('improvement', 43), ('hair', 18), ('numbers', 24), ('played', 32), ('construction', 3), ('advance', 6), ('owing', 9), ('antibiotic', 16), ('theoretical', 11), ('guidance', 4), ('drug-induced', 33), ('opiate', 15), ('urological', 4), ('improving', 19), ('disposal', 13), ('practices', 7), ('trends', 10), ('keeping', 9), ('foster', 1), ('educational', 4), ('handout', 2), ('retrospectively', 14), ('68', 9), ('undergone', 2), ('separate', 12), ('consecutive', 32), ('59', 7), ('detailing', 1), ('food', 84), ('obtainment', 1), ('telephone', 1), ('interviews', 5), ('prescription', 9), ('filling', 2), ('verified', 27), ('tennessee', 1), ('csmd', 1), ('controlled', 53), ('monitoring', 28), ('database', 26), ('possessing', 4), ('opiates', 1), ('whichever', 1), ('41', 7), ('72', 46), ('left', 30), ('medication', 19), ('unsecured', 1), ('home', 10), ('barriers', 8), ('29', 13), ('keepers', 2), ('knowledgeable', 1), ('safe', 26), ('nonkeepers', 1), ('vs', 44), ('85', 8), ('0.005', 7), ('scores', 43), ('77', 13), ('0.03', 12), ('comparing', 16), ('pre-education', 1), ('post-education', 1), ('detectable', 12), ('0.66', 2), ('proper', 7), ('1.0', 25), ('barrier', 68), ('limiting', 7), ('combine', 3), ('evidence-based', 4), ('education', 10), ('multiply', 3), ('charged', 4), ('ethylene', 4), ('oxide-co-propylene', 1), ('electrospray', 7), ('ionization-ion', 2), ('mobility', 19), ('spectrometry-mass', 2), ('propylene', 2), ('copolymer', 7), ('eo-co-po', 3), ('esi-ims-ms', 2), ('esi', 2), ('analytes', 4), ('additions', 1), ('2d', 10), ('map', 13), ('m/z', 1), ('value', 76), ('drift', 1), ('collision', 6), ('cross-section', 1), ('analyte', 3), ('polymers', 8), ('almost', 22), ('linearly', 8), ('0.644', 1), ('except', 27), ('2na+', 2), ('nonlinear', 3), ('called', 8), ('folding', 7), ('electrostatic', 5), ('repulsion', 1), ('polymer', 9), ('eo', 3), ('compositions', 3), ('composition', 23), ('tended', 5), ('separation', 12), ('contents', 30), ('successfully', 25), ('nicotine', 82), ('papillomavirus', 4), ('hpv', 7), ('-immortalized', 2), ('h8', 9), ('activating', 93), ('rps27a-mdm2-p53', 2), ('event', 22), ('carcinogenesis', 64), ('precancerous', 1), ('clear', 36), ('p53', 164), ('shortened', 4), ('half-life', 5), ('note', 5), ('change', 79), ('stabilization', 16), ('negative', 103), ('p53/p21', 1), ('rps27a', 1), ('mdm2', 3), ('serine', 25), ('residue', 9), ('166', 1), ('mdm2-mediated', 1), ('ubiquitination', 7), ('simply', 1), ('riluzole', 6), ('androgen-dependent', 2), ('castration-resistant', 7), ('pca', 46), ('non-cutaneous', 1), ('cancers', 71), ('united', 16), ('states', 23), ('ad', 80), ('drives', 7), ('pca-but', 1), ('biosynthesis', 37), ('remission', 6), ('aggressive', 22), ('cr', 125), ('re-activated', 1), ('ar-dependent', 2), ('combat', 6), ('down-regulating', 21), ('cr-pca', 2), ('ad-', 1), ('well-tolerated', 5), ('fda-approved', 5), ('medicine', 30), ('ar-fl', 2), ('constitutively', 8), ('ar-splice', 1), ('variant', 29), ('ar-v7', 2), ('immunoblotting', 20), ('ar-fl/ar-v7', 1), ('qrt-pcr', 45), ('ar-target', 1), ('indicator', 14), ('microplate', 1), ('ers', 15), ('co-immunoprecipitation', 9), ('downregulates', 11), ('ars', 4), ('psa', 17), ('tmprss2', 22), ('klk2', 2), ('anti-tumorigenic', 6), ('activity-based', 4), ('indole-', 2), ('indazole-3-carboxamide-based', 1), ('synthetic', 70), ('cb2', 78), ('scs', 10), ('chemically', 14), ('psychoactive', 27), ('intoxications', 5), ('advancements', 4), ('achieved', 24), ('pharmacology', 5), ('detection', 57), ('unresolved', 2), ('indazole-based', 1), ('applying', 9), ('stable', 39), ('correlating', 4), ('structure', 61), ('half-maximal', 4), ('ec50', 23), ('5-chloropentyl', 1), ('5-bromopentyl', 1), ('5-iodopentyl', 1), ('jwh-122', 6), ('varied', 12), ('74.1', 1), ('283.7', 1), ('7.05', 1), ('23.4', 2), ('atom', 10), ('bromo', 1), ('iodo', 1), ('am-2201', 1), ('within', 117), ('naphthoylindole', 1), ('23.5', 1), ('emax', 3), ('98.8', 1), ('indole-3-carboxamide', 1), ('5f-mdmb-pica', 1), ('3.26/0.87', 1), ('jwh-018', 13), ('adb-fubinaca', 1), ('potent', 120), ('sc', 19), ('0.69/0.59', 1), ('3-fold', 7), ('especially', 73), ('annexin', 30), ('v-conjugated', 2), ('ultrasmall', 2), ('superparamagnetic', 3), ('iron', 61), ('uspio', 3), ('pilot', 7), ('newly', 23), ('v-uspio', 6), ('camptothecin', 5), ('incubated', 21), ('0.089', 1), ('mmol', 2), ('fe/l', 1), ('t2', 4), ('suspensions', 2), ('0.47t', 1), ('nmr', 15), ('spectrometer', 2), ('tumor-bearing', 4), ('subjected', 21), ('1.5t', 1), ('mr', 3), ('scanner', 2), ('intraperitoneal', 49), ('cyclophosphamide', 11), ('pre-contrast', 1), ('t1-', 1), ('t2-weighted', 1), ('0', 97), ('post-contrast', 1), ('scan', 7), ('24', 189), ('mumol', 5), ('fe/kg', 1), ('mri', 14), ('v.', 1), ('signal', 86), ('si', 4), ('post-mri', 1), ('pre-mri', 1), ('post/pre-si', 2), ('calculated', 28), ('scanning', 22), ('resected', 2), ('suspension', 3), ('shorter', 16), ('t1-weighted', 2), ('1.46', 2), ('1.17.', 1), ('concordance', 3), ('post-t1-weighted', 1), ('adolescent', 24), ('delta9-tetrahydrocannabinol', 43), ('alters', 30), ('trajectory', 3), ('dendritic', 26), ('architecture', 14), ('prefrontal', 22), ('pyramidal', 8), ('circuits', 2), ('pfc', 15), ('mediate', 35), ('cognitive', 87), ('emotional', 1), ('disrupted', 26), ('maturation', 34), ('adolescence', 6), ('period', 81), ('vulnerability', 9), ('addiction', 7), ('schizophrenia', 39), ('rat', 198), ('thc', 170), ('component', 50), ('neurons-using', 1), ('type-', 1), ('layer-specific', 1), ('microscopy', 45), ('next-generation', 10), ('rna-sequencing', 7), ('expansions', 2), ('basal', 45), ('arborization', 4), ('spine', 7), ('pruning', 2), ('adulthood', 27), ('differential', 50), ('networks', 22), ('neurodevelopment', 11), ('inducing', 78), ('premature', 11), ('spines', 4), ('allostatic', 1), ('atrophy', 19), ('surprisingly', 14), ('minimal', 11), ('overlap', 7), ('transcriptomes', 1), ('thc-', 1), ('vehicle-exposed', 1), ('morphogenesis', 9), ('cytoskeleton', 13), ('organization', 12), ('network', 35), ('disturbances', 24), ('epigenetic', 111), ('co-expression', 3), ('chromatin-', 1), ('dendrite-related', 1), ('thc-treated', 4), ('dysregulated', 18), ('cytoskeletal', 5), ('neurite', 11), ('cortical', 32), ('excitability', 5), ('trkb', 6), ('rebound', 1), ('slow', 9), ('oscillations', 7), ('antidepressant', 10), ('ketamine', 5), ('psychotomimetic', 1), ('subside', 1), ('neurobiological', 1), ('lag', 2), ('laughing', 1), ('gas', 18), ('n2o', 5), ('nmda-r', 2), ('n-methyl-d-aspartate', 9), ('blocker', 12), ('bring', 4), ('rapidly', 25), ('discontinuation', 8), ('took', 3), ('advantage', 7), ('exceptional', 3), ('pharmacokinetic', 19), ('eeg', 4), ('electroencephalogram', 1), ('actions', 50), ('immediately', 7), ('blockade', 32), ('c57bl/6', 48), ('recordings', 6), ('qpcr', 26), ('learned', 2), ('helplessness', 1), ('lh', 12), ('antidepressant-like', 6), ('immediate-early', 1), ('bdnf', 32), ('kinase-markers', 1), ('excitability-were', 1), ('notably', 45), ('gsk3beta', 27), ('glycogen', 21), ('synthase', 65), ('3beta', 4), ('became', 10), ('regulated', 97), ('gradually', 11), ('dominated', 5), ('subanesthetic', 1), ('flurothyl-induced', 1), ('convulsions', 11), ('electroconvulsive', 1), ('evoked', 16), ('subsided', 1), ('correlation', 56), ('ongoing', 6), ('trkb-gsk3beta', 1), ('strengthened', 4), ('medetomidine', 2), ('hypnotic-sedative', 1), ('facilitates', 7), ('alpha2-adrenergic', 1), ('autoreceptors', 1), ('behavioral', 58), ('homeostatic', 3), ('emergence', 10), ('systems', 59), ('toxicology', 17), ('reveals', 26), ('importance', 48), ('bile', 74), ('tak-875-induced', 1), ('tak-875', 7), ('fasiglifam', 1), ('gpr40', 10), ('t2d', 6), ('voluntarily', 1), ('terminated', 2), ('phase', 129), ('trials', 36), ('combining', 17), ('qst', 2), ('dilisym', 2), ('mathematical', 1), ('representation', 3), ('tak-875-glu', 3), ('indicated', 228), ('salt', 19), ('export', 14), ('pump', 9), ('bsep', 7), ('mixed', 42), ('taurocholate', 3), ('co-transporting', 1), ('polypeptide', 18), ('ntcp', 5), ('competitive', 16), ('etc', 16), ('physiologically', 12), ('pbpk', 7), ('constructed', 14), ('estimate', 21), ('simulated', 10), ('simpops', 1), ('reflect', 11), ('16/245', 1), ('6.5', 8), ('alt', 56), ('elevations', 20), ('200', 66), ('mode', 36), ('transporter', 61), ('ki', 25), ('accurate', 13), ('predictions', 8), ('simulations', 21), ('simcohorts', 1), ('occur', 20), ('operate', 2), ('synergistically', 11), ('interpret', 2), ('clinically', 46), ('metformin', 19), ('renal', 221), ('uninephrectomized', 3), ('doca-salt', 4), ('cardioprotection', 6), ('cv', 6), ('intricacy', 1), ('end', 54), ('organ', 29), ('address', 26), ('deoxycorticosterone', 1), ('acetate', 8), ('doca', 3), ('-salt', 1), ('renin-angiotensin', 9), ('sprague', 12), ('dawley', 12), ('micrornas', 32), ('yet', 60), ('mitigating', 6), ('hypertension-induced', 2), ('administering', 7), ('offering', 3), ('abnormalities', 32), ('diastolic', 4), ('renin', 2), ('angiotensin', 28), ('rt-qpcr', 23), ('diseased', 1), ('heart', 115), ('serca2', 1), ('p-ampk', 1), ('mir-146a', 3), ('mir-99b', 1), ('mir-155', 15), ('administered', 125), ('300', 27), ('microrna', 18), ('reverses', 8), ('bps', 82), ('triggers', 33), ('deaths', 25), ('world-wide', 3), ('estrogenic', 45), ('industrial', 28), ('evidenced', 50), ('vimentin', 32), ('metalloproteinase-2', 10), ('il-10', 41), ('smad-2/3', 2), ('eralpha/beta', 3), ('g', 56), ('protein-coupled', 12), ('gper', 23), ('nanomolar', 11), ('tgf-beta/smad-2/3', 1), ('surfactant', 10), ('trimerized', 2), ('affinity', 33), ('viral', 52), ('fusion', 39), ('recognition', 26), ('viruses', 16), ('pathogens', 11), ('integral', 5), ('lungs', 61), ('free', 31), ('efficient', 41), ('gaseous', 9), ('identifying', 18), ('c-type', 1), ('collagen-containing', 1), ('lectins', 1), ('collectins', 3), ('pattern', 39), ('prrs', 3), ('recognise', 1), ('pathogen-associated', 3), ('patterns', 43), ('pamps', 2), ('glycoproteins', 1), ('composed', 11), ('units', 9), ('oligomerise', 1), ('higher-order', 3), ('structures', 30), ('clearance', 51), ('similarly', 37), ('trimeric', 3), ('configurations', 2), ('sequence', 32), ('similarities', 2), ('virus', 53), ('classes', 9), ('families', 12), ('belong', 3), ('i.e.', 20), ('sp-a', 1), ('sp-d', 1), ('focus', 20), ('complementarity', 1), ('hypothesise', 2), ('elegantly', 1), ('co-evolved', 1), ('recombinant', 46), ('versions', 1), ('anti-viral', 2), ('therapeutics', 27), ('isomeric', 8), ('structurally', 13), ('liquid', 30), ('chromatography', 24), ('resolution', 15), ('nps', 39), ('emerging', 20), ('abuse', 12), ('variations', 7), ('intended', 5), ('cns', 20), ('psychotropic', 7), ('physicochemical', 10), ('co-elute', 1), ('traditional', 40), ('column', 8), ('chromatographic', 1), ('techniques', 30), ('2d-lc', 6), ('applicability', 4), ('difficult', 15), ('separations', 1), ('molecules', 78), ('hypothesized', 37), ('technique', 27), ('co-eluting', 1), ('non-isomeric', 2), ('mobile', 3), ('gradient', 5), ('optimize', 5), ('method', 87), ('final', 26), ('on-line', 2), ('employed', 40), ('bonus-rp', 1), ('dimension', 3), ('1d', 4), ('uv', 10), ('biphenyl', 8), ('qtof-ms', 1), ('full', 11), ('mixes', 1), ('created', 7), ('five', 48), ('unresolvable', 1), ('1d-lc', 1), ('mix', 3), ('contour', 1), ('plots', 3), ('absorbance', 1), ('ms', 15), ('ion', 22), ('mixture', 45), ('resolved', 6), ('serves', 6), ('proof-of-concept', 2), ('optimization', 5), ('validation', 16), ('generally', 22), ('tool', 20), ('parp', 34), ('akt-mediated', 5), ('mitochondria-targeted', 2), ('phospho-atm-nemo-akt-mtor', 4), ('signalosome', 5), ('adp-ribose', 16), ('parp1', 20), ('wrl', 1), ('mcf7', 6), ('grown', 6), ('peroxide', 21), ('atm', 13), ('mtor-', 1), ('nemo', 4), ('silenced', 5), ('sirnas', 4), ('parp-atm', 1), ('pulldown', 2), ('visualized', 9), ('immunoprecipitation', 22), ('phospho-atm', 1), ('fractions', 13), ('continually', 4), ('construct', 2), ('introduced', 9), ('phospho-akt', 4), ('confocal', 14), ('parylation-dependent', 1), ('p-atm', 1), ('forms', 41), ('yielding', 5), ('parp-inhibition', 1), ('localizes', 4), ('parp-inhibition-mediated', 1), ('oxidatively', 1), ('stressed', 3), ('diminish', 5), ('constantly', 2), ('akt1', 4), ('confirming', 12), ('cytoprotection', 4), ('taken', 132), ('parylation', 1), ('atm-nemo', 1), ('exits', 1), ('combines', 3), ('cytosol', 19), ('act', 46), ('i.e', 22), ('disruption', 91), ('offer', 13), ('checkpoints', 2), ('lncrna', 47), ('nucleolar', 5), ('host', 25), ('1-methyl-4-phenylpyridinium', 6), ('ion-induced', 1), ('mir-15b-5p/gsk3beta', 2), ('dopaminergic', 44), ('noncoding', 21), ('snhg1', 24), ('pathology', 36), ('exact', 17), ('elusive', 23), ('mir-15b-5p', 7), ('mpp+', 20), ('-treated', 14), ('tdt-mediated', 2), ('dutp', 5), ('nick-end', 2), ('labeling-positive', 1), ('caspase', 61), ('elevation', 55), ('besides', 47), ('placentation', 2), ('preeclampsia-like', 6), ('pregnant', 66), ('reprogramming', 8), ('wnt2', 6), ('preeclampsia', 11), ('women', 110), ('bpa-exposed', 3), ('circulation', 7), ('placental', 70), ('angiogenesis', 26), ('fms-related', 1), ('placenta', 32), ('glomerular', 25), ('urinary', 93), ('retention', 9), ('smooth', 12), ('vessel', 8), ('zone', 9), ('invasion-related', 1), ('metalloproteinases', 7), ('wnt', 23), ('wnt2/beta-catenin', 1), ('methyltransferase', 17), ('dnmt', 5), ('impeded', 7), ('cytotrophoblast', 4), ('htr-8/svneo', 9), ('endothelium', 2), ('down-regulated', 68), ('trophoblast', 33), ('involves', 33), ('dnmt1.-ye', 1), ('y.', 5), ('tang', 1), ('xiong', 1), ('feng', 1), ('l.', 27), ('li', 7), ('x.', 1), ('fenvalerate', 5), ('overload', 14), ('calcium', 58), ('erk/ikk/nf-kappab', 3), ('fen', 14), ('mainstream', 3), ('pyrethroid', 10), ('pesticide', 50), ('initially', 9), ('low-toxicity', 1), ('controlling', 18), ('agricultural', 13), ('domestic', 6), ('pests', 3), ('fen-induced', 4), ('factory', 1), ('workers', 35), ('laborers', 1), ('working', 10), ('airborne', 5), ('much', 32), ('office', 2), ('histology', 15), ('compromised', 11), ('capability', 13), ('bioinformatics', 18), ('microarray', 32), ('buffalo', 1), ('brl', 1), ('ikk', 4), ('nf-kappab', 204), ('ions', 11), ('prompted', 7), ('pathophysiological', 9), ('furthers', 1), ('injuries', 30), ('pesticides.-qiu', 1), ('l.-l.', 1), ('wang', 2), ('c.', 26), ('yao', 1), ('s.', 41), ('n.', 6), ('hu', 3), ('yu', 1), ('xia', 1), ('r.', 6), ('zhu', 1), ('j.', 4), ('ji', 1), ('m.', 8), ('zhang', 1), ('z.', 1), ('s.-l.', 1), ('polychlorinated', 16), ('differentially', 83), ('nonalcoholic', 23), ('steatohepatitis', 17), ('biphenyls', 9), ('pcbs', 20), ('nash', 28), ('integrative', 4), ('pancreas', 13), ('pcb', 43), ('subtypes', 21), ('dioxin-like', 5), ('dl', 3), ('nondioxin-like', 1), ('ndl', 2), ('ndl/dl', 3), ('j', 11), ('aroclor', 4), ('1260', 4), ('congener', 2), ('126', 12), ('mug/kg', 27), ('vehicle', 60), ('pcb126', 11), ('greatest', 11), ('steatosis', 44), ('import', 1), ('hypolipidemia', 1), ('impacted', 5), ('manners', 6), (\"'nash\", 1), ('pnpla3', 2), ('hepatokines', 2), ('fgf21', 9), ('igf1', 30), ('betatrophin', 1), ('acinar', 2), ('mild', 21), ('ductal', 10), ('islet', 12), ('identity', 10), ('none', 19), ('homa-ir', 5), ('homa-b', 1), ('pcb-induced', 3), ('endocrine/metabolic', 1), (\"'pcb\", 1), ('pancreatopathy', 1), ('understand', 47), ('characterization', 38), ('zglp1', 3), ('tongue', 3), ('sole', 5), ('cynoglossus', 2), ('semilaevis', 2), ('zinc', 48), ('finger', 5), ('gata', 1), ('protein-1', 16), ('regulates', 81), ('somatic', 14), ('germ', 19), ('gonad', 4), ('cysezglp1', 9), ('cloned', 2), ('open', 31), ('reading', 3), ('frame', 3), ('exons', 3), ('chromosome', 12), ('9.', 1), ('consisted', 8), ('1692', 1), ('nucleotides', 4), ('583', 1), ('znf1', 2), ('znf2', 2), ('homologous', 12), ('gata-type', 1), ('alignment', 4), ('divergent', 4), ('gonads', 4), ('ovary', 21), ('testis', 22), ('fertilized', 2), ('egg', 9), ('cleavage', 32), ('subsequently', 43), ('declining', 3), ('blastula', 1), ('gastrulation', 1), ('onward', 1), ('120', 30), ('hatching', 8), ('situ', 19), ('hybridization', 10), ('oocytes', 18), ('oogenesis', 1), ('gate', 3), ('engineered', 4), ('mesoporous', 2), ('silica', 38), ('nanoparticles', 52), ('double', 19), ('efflux', 33), ('exocytosis', 10), ('antitumor', 48), ('msn', 3), ('extensively', 28), ('theranostics', 4), ('complexity', 7), ('achieve', 8), ('good', 27), ('photothermal', 9), ('shortcoming', 1), ('proven', 7), ('accelerate', 5), ('nanocarriers', 2), ('ablate', 1), ('fate', 13), ('herein', 36), ('lipophilic', 6), ('cyanine', 1), ('dye', 16), ('cypate', 1), ('converting', 6), ('conjugated', 14), ('external', 6), ('disulfide', 6), ('bond', 9), ('msn-cy', 2), ('d-alpha-tocopherol', 1), ('polyethylene', 7), ('glycol', 6), ('1000', 24), ('succinate', 3), ('tpgs', 2), ('coated', 6), ('outside', 7), ('hydrophobic', 13), ('tcmsn', 2), ('cover', 3), ('pores', 1), ('preleakage', 1), ('underwent', 29), ('lysosome-mediated', 3), ('moderate', 33), ('heat', 19), ('near-infrared', 6), ('lysosome', 10), ('meantime', 1), ('p-glycoprotein', 15), ('elaborated', 3), ('perspective-inhibiting', 1), ('as-designed', 1), ('realized', 1), ('sustaining', 4), ('enhancing', 45), ('arsenic', 67), ('trioxide', 12), ('fibroblasts', 47), ('myofibroblasts', 7), ('erythroid', 46), ('2-like', 3), ('nfe2l2', 7), ('smad2/3', 7), ('contraction', 9), ('deposition', 41), ('hypertrophic', 16), ('scars', 4), ('pulmonary', 177), ('myofibroblast', 9), ('dedifferentiation', 1), ('ato', 25), ('scar', 8), ('factor-beta1', 9), ('tgf-beta1', 35), ('/smad2/3', 1), ('rabbit', 18), ('antifibrotic', 5), ('tgf-beta1-induced', 7), ('ho-1', 84), ('implying', 8), ('migratory', 9), ('as2s2', 7), ('mcf-7', 75), ('mda-mb-231', 49), ('emphasis', 6), ('g2/m', 24), ('cyclin', 49), ('division', 3), ('2.', 7), ('caspase-7', 5), ('-8', 9), ('b-cell', 15), ('lymphoma', 18), ('bcl-2', 106), ('-associated', 5), ('protein/bcl-2', 1), ('anti-apoptotic', 32), ('extra-large', 1), ('1a/1b-light', 3), ('-ii', 3), ('lc3-ii/lc3-i', 5), ('occurrence', 35), ('assist', 5), ('alleviating', 15), ('attenuating', 17), ('intrinsic', 28), ('extrinsic', 8), ('pyrimidinyl', 2), ('biphenylureas', 2), ('allosteric', 13), ('beta-arrestin-dependent', 1), ('g-protein-coupled', 6), ('central', 72), ('nervous', 40), ('binds', 23), ('orthosteric', 4), ('endocannabinoids', 8), ('arachidonoyl', 1), ('ethanolamide', 1), ('anandamide', 11), ('2-arachidonoyl', 2), ('glycerol', 6), ('plant-derived', 8), ('marijuana', 3), ('couples', 2), ('gi/o', 1), ('adenylate', 2), ('cyclase', 7), ('typically', 10), ('downstream', 99), ('gi-dependent', 1), ('maladies', 1), ('interest', 23), ('tremendous', 2), ('receptor-', 2), ('cellular-level', 1), ('ldk1285', 1), ('ldk1288', 1), ('ldk1305', 1), ('psncbam1', 1), ('cp55940', 10), ('cooperativity', 3), ('sr141716a', 4), ('radioligand', 2), ('internalization', 8), ('recruitment', 27), ('beta-arrestin', 3), ('293', 7), ('monitored', 14), ('internal', 7), ('reflective', 1), ('g-protein-independent', 1), ('1-dependent', 1), ('src', 15), ('biased', 3), ('uremic', 15), ('toxin', 43), ('indole-3', 2), ('acetic', 9), ('receptor/nuclear', 1), ('endothelial', 161), ('ckd', 10), ('thrombosis', 17), ('iaa', 10), ('indolic', 1), ('tf', 15), ('umbilical', 22), ('huvec', 11), ('ahr-mediated', 10), ('microm', 80), ('maximal', 13), ('aortic', 39), ('haoec', 1), ('cardiac-derived', 1), ('hmvec-c', 1), ('chromatin', 21), ('luciferase', 41), ('plasmids', 3), ('drastically', 4), ('p50', 5), ('p38mapk', 4), ('92', 8), ('hemodialysis', 17), ('circulating', 36), ('non-genomic', 1), ('ahr/p38', 1), ('mapk/nf-kappab', 1), ('transduction', 21), ('thrombotic/inflammatory', 1), ('find', 13), ('targets', 122), ('thrombotic', 8), ('benzene', 36), ('1,2,4-benzenetriol', 2), ('histone', 68), ('acetylation', 37), ('erythroid-specific', 3), ('bt', 16), ('phenolic', 19), ('ubiquitous', 31), ('leukemogenic', 3), ('phenol', 13), ('hydroquinone', 15), ('hemin-induced', 6), ('bt-inhibited', 1), ('hemoglobin', 12), (\"5-aza-2'-deoxycytidine\", 1), ('5-aza-cdr', 1), ('trichostatin', 4), ('tsa', 8), ('deacetylases', 3), ('cpg', 12), ('sites', 54), ('h3', 8), ('h4', 4), ('occupancy', 2), ('gata-1', 2), ('alpha-globin', 1), ('beta-globin', 1), ('hemin', 4), ('explained', 16), ('hematotoxicity', 10), ('endometriotic', 5), ('microenvironment', 20), ('niclosamide', 12), ('endometriosis', 1), ('pelvic', 6), ('infertility', 15), ('endometriosis-like', 1), ('\\\\rm', 3), ('\\\\small', 3), ('k', 24), ('stat3', 63), ('affects', 67), ('12z', 9), ('monocytic', 4), ('thp-1', 42), ('conditioned', 22), ('media', 29), ('cm', 11), ('m0', 5), ('polarized', 1), ('lps/ifngamma', 1), ('il4/il13', 1), ('returned', 7), ('with/without', 3), ('cytokine/chemokine', 2), ('array', 30), ('kits', 6), ('cytokines/chemokines', 2), ('chlorantraniliprole', 2), ('flubendiamide', 2), ('hyperthermia-susceptible', 1), ('ryanodine', 7), ('intolerance', 13), ('cp', 46), ('fd', 4), ('agriculture', 16), ('globally', 5), ('lepidopteran', 1), ('insecticides', 15), ('ryrs', 2), ('leak', 6), ('sarcoplasmic', 2), ('sr', 13), ('insect', 11), ('purportedly', 1), ('devoid', 3), ('ryr1', 12), ('excitation-contraction', 3), ('confer', 7), ('hyperthermia', 10), ('susceptibility', 52), ('mhs', 5), ('lethal', 17), ('pharmacogenetic', 1), ('65-fold', 1), ('ca2+-loaded', 1), ('wt-ryr1', 1), ('vesicles', 10), ('negligible', 11), ('high-affinity', 5), ('3h', 14), ('ry', 4), ('membranes', 19), ('prepared', 24), ('adult', 189), ('c57bl/6j', 22), ('homozygous', 12), ('c-terminal', 4), ('t4826i', 3), ('heterozygous', 13), ('n-terminal', 28), ('r163c', 2), ('rank', 15), ('order', 45), ('r163c~wt', 1), ('regardless', 13), ('0.01-100', 1), ('p.o', 24), ('failed', 18), ('shift', 32), ('38', 12), ('characteristic', 22), ('lethality', 12), ('nm-microm', 1), ('diamide', 2), ('capable', 26), ('conformation', 7), ('putative', 22), ('domains', 15), ('hsi', 1), ('translational', 14), ('type-1', 2), ('attractive', 8), ('discovery', 22), ('historically', 2), ('efforts', 7), ('focused', 24), ('last', 20), ('decades', 7), ('substantial', 22), ('difficulties', 5), ('translating', 2), ('druggable', 4), ('candidates', 14), ('difficulty', 3), ('discoveries', 1), ('opportunities', 7), ('treating', 35), ('retinal', 38), ('mir-96-5p', 3), ('-124-3p', 3), ('183-5p', 1), ('retina', 7), ('mentioned', 7), ('n-methyl-n-nitrosourea', 1), ('mnu', 2), ('nmda', 11), ('nmol/eye', 1), ('intravitreal', 3), ('iodate', 1), ('naio3', 2), ('i.v.', 1), ('time-course', 7), ('week', 64), ('ophthalmologic', 2), ('histologic', 4), ('examinations', 9), ('electroretinogram', 1), ('recording', 4), ('photoreceptor', 2), ('-183-5p', 2), ('ganglion', 13), ('mir-124-3p', 2), ('parallel', 11), ('onset', 34), ('neuroretinal', 4), ('pigment', 9), ('correspond', 5), ('panel', 15), ('consisting', 15), ('detect', 44), ('methylmercury', 8), ('manganese', 14), ('l1', 2), ('cholinergic', 14), ('monoaminergic', 2), ('l4', 2), ('caenorhabditis', 9), ('elegans', 26), ('simultaneously', 24), ('neurotoxic', 34), ('mn', 25), ('mehg', 13), ('timely', 2), ('focusing', 10), ('acetylcholinesterase', 41), ('ace-2', 2), ('vesicular', 2), ('monoamine', 7), ('vmat', 1), ('cat-1', 2), ('enzymatic', 37), ('sod-3', 2), ('sod-4', 2), ('catalase', 73), ('ctl-3', 2), ('worm', 1), ('reproduction', 20), ('locomotion', 9), ('done', 14), ('worms', 11), ('ld50', 3), ('17.78', 1), ('mm', 73), ('30.63', 1), ('bends', 1), ('pharyngeal', 12), ('pumping', 1), ('brood', 2), ('metals', 24), ('undergoing', 28), ('co-exposed', 4), ('nonatopic', 3), ('eczema', 12), ('pollution', 39), ('atopic', 6), ('middle-aged', 3), ('adults', 35), ('atopy', 1), ('834', 1), ('germany', 5), ('incident', 12), ('symptoms', 70), ('prevalent', 31), ('investigation', 53), ('2007-2010', 1), ('ige', 12), ('baseline', 56), ('1985-1994', 1), ('2007-2010.', 1), ('land-use', 1), ('weighted', 7), ('eczema-related', 1), ('alleles', 10), ('oxides', 5), ('nitrogen', 38), ('dioxide', 22), ('particulate', 20), ('fine', 11), ('aerodynamic', 7), ('diameter', 15), ('=2.5', 1), ('pm2.5', 38), ('eg', 5), ('per', 73), ('4.7', 3), ('mug/m3', 6), ('1.45', 3), ('1.06-1.99', 1), ('slightly', 12), ('pronounced', 16), ('1.65', 3), ('1.15-2.34', 1), ('fever', 15), ('stronger', 17), ('fewer', 12), ('traffic-related', 1), ('pollutants', 60), ('differs', 3), ('genetically', 13), ('driven', 8), ('neurotransmitters', 5), ('5-hydroxytryptamine', 3), ('anorexia', 4), ('trichothecene', 2), ('t-2', 22), ('contaminants', 18), ('cereal', 5), ('grains', 2), ('negatively', 34), ('anorectic', 6), ('toxin-induced', 9), ('gut', 61), ('satiety', 2), ('neurotransmitter', 9), ('nocturnal', 1), ('refusal', 1), ('5-ht', 23), ('sp', 13), ('markedly', 83), ('corresponded', 6), ('5-ht3', 5), ('5-ht3r', 1), ('granisetron', 1), ('5-ht-', 1), ('neurokinin-1', 3), ('nk-1r', 7), ('emend', 1), ('dose-dependently', 30), ('sp-', 3), ('long-acting', 5), ('harnessing', 2), ('inhibitor-induced', 1), ('melanoma', 55), ('relapse', 5), ('braf', 5), ('mek', 7), ('meki', 5), ('cd271', 8), ('trametinib', 2), ('prosurvival', 6), ('immunohistochemistry', 61), ('naevi', 2), ('tumours', 12), ('analyse', 3), ('subpopulations', 8), ('trametinib-induced', 2), ('mts', 9), ('xenografts', 14), ('modulation', 78), ('trametinib-resistant', 1), ('melanomas', 5), ('benign', 12), ('braf-mutant', 4), ('cd271-expressing', 2), ('interference', 18), ('small-molecule', 6), ('applicable', 4), ('modulatory', 10), ('vps34', 3), ('meki-resistant', 2), ('mek/autophagy', 1), ('meki-induced', 1), ('translatable', 3), ('resensitize', 2), ('drug-resistant', 5), ('tlr3-mediated', 2), ('plasminogen', 9), ('inhibitor-1', 4), ('antimalarial', 2), ('lupus', 13), ('erythematosus', 7), ('sle', 14), ('detailed', 22), ('pai-1', 11), ('fibrinolysis', 5), ('fibrin', 4), ('glomeruli', 4), ('tlr3', 8), ('reportedly', 3), ('pivotal', 29), ('nephritis', 1), ('ln', 3), ('gecs', 4), ('polyinosinic-polycytidylic', 2), ('ic', 11), ('authentic', 1), ('double-stranded', 3), ('t-pa', 7), ('ic-induced', 3), ('reverse-transcriptase', 1), ('enzyme-linked', 17), ('immunosorbent', 19), ('time-', 13), ('pretreating', 4), ('hydroxychloroquine', 8), ('considering', 19), ('postulated', 7), ('renoprotective', 12), ('curcumin', 48), ('derivative', 25), ('nds27', 7), ('neutrophils', 17), ('substrate', 48), ('reversible', 19), ('myeloperoxidase', 21), ('water-soluble', 5), ('lysinate', 2), ('incorporated', 9), ('hydroxypropyl-beta-cyclodextrin', 4), ('parent', 8), ('polymorphonuclear', 2), ('pmns', 3), ('mpo', 36), ('excipients', 9), ('lysine', 14), ('chemiluminescence', 1), ('activities', 241), ('halogenation', 2), ('refined', 5), ('stopped-flow', 1), ('excellent', 23), ('intermediate', 20), ('~107', 1), ('m-1', 3), ('s-1', 4), ('~103', 1), ('thereby', 69), ('trapping', 2), ('calculations', 11), ('enter', 6), ('cavity', 7), ('pi-stacking', 1), ('bonds', 8), ('involving', 22), ('substituents', 3), ('aromatic', 33), ('rings', 5), ('bulky', 2), ('cyclodextrin', 1), ('allowing', 11), ('access', 12), ('solubilization', 1), ('capsaicin', 13), ('hyperlipidemia', 6), ('atherosclerosis', 24), ('guinea', 7), ('pigs', 8), ('high-fat', 42), ('8/group', 1), ('low-dose', 40), ('2.5', 30), ('moderate-dose', 1), ('high-dose', 18), ('simvastatin', 5), ('1.5', 23), ('lipids', 23), ('apolipoprotein', 5), ('b100', 2), ('mda', 79), ('sod', 73), ('nitric', 62), ('endothelin-1', 2), ('atherosclerotic', 10), ('histologically', 8), ('enos', 18), ('inos', 22), ('cholesterol', 139), ('triglycerides', 15), ('low-density', 16), ('lipoprotein', 29), ('b-100', 1), ('high-density', 9), ('0.05', 215), ('alleviated', 70), ('plaque', 10), ('-17.9-70.5', 1), ('intima', 2), ('-18.0-73.6', 1), ('thickness', 18), ('-20.5-83.6', 1), ('-45.5-76.1', 1), ('et-1', 1), ('-19.6-51.6', 1), ('average', 40), ('gray', 10), ('agv', 2), ('-10.9-48.8', 1), ('+31.7-76.1', 1), ('+11.2-36.8', 1), ('+6.8-+93.0', 1), ('methylglyoxal', 16), ('de-regulates', 1), ('hoxa5', 6), ('impairing', 6), ('glyoxalase', 5), ('knock-down', 3), ('contributor', 10), ('dm', 32), ('mgo', 6), ('glycolysis', 30), ('accumulates', 4), ('detoxified', 2), ('glo1', 3), ('vascular', 85), ('clarified', 10), ('glo1-knockdown', 1), ('glo1kd', 5), ('maecs', 7), ('littermates', 4), ('mgo-modified', 1), ('anti-angiogenic', 2), ('nf-kb-p65', 4), ('2.5-fold', 3), ('2-fold', 10), ('spbrbzgshcp2', 1), ('gi', 14), ('mcecs', 1), ('demonstrates', 30), ('antiangiogenic', 3), ('angiogenic', 8), ('beta-ars', 1), ('doxorubicin', 53), ('cardiomyopathy', 14), ('hrv', 4), ('bpv', 3), ('short-term', 14), ('estimated', 30), ('course', 24), ('autonomic', 3), ('doxorubicin-induced', 17), ('dcm', 13), ('beta-1', 2), ('beta-1ar', 5), ('beta-2', 1), ('beta-2ar', 3), ('adrenoceptors', 1), ('equipped', 1), ('indwelling', 1), ('catheters', 1), ('bp', 24), ('withdrawal', 35), ('cumulative', 14), ('n=18', 1), ('hemodynamic', 8), ('echocardiography', 11), ('n=6', 3), ('35', 22), ('dox35', 2), ('70', 29), ('dox70', 1), ('post-treatment', 15), ('spectral', 3), ('poincare', 1), ('approximate', 1), ('entropy', 2), ('doxorubicin-treated', 1), ('poor', 50), ('saline-treated', 2), ('signs', 21), ('decompensation', 2), ('troponins', 1), ('cardiotoxicity', 87), ('seen', 34), ('over-expression', 12), ('troponin', 16), ('matches', 3), ('compensate', 4), ('decompensate', 1), ('volatile', 13), ('handling', 6), ('ppm', 62), ('h/day', 2), ('hepa-filtered', 1), ('indices', 15), ('inhaling', 1), ('.05', 37), ('.03', 3), ('establishing', 3), ('insulin-stimulated', 3), ('diminished', 38), ('.001', 11), ('benzene-exposed', 2), ('.025', 1), ('mip1-alpha', 1), ('socs1', 3), ('irs-2', 2), ('.0001', 10), ('mimetic', 2), ('tempol', 4), ('benzene-induced', 10), ('inhaled', 15), ('ambient', 26), ('heretofore', 1), ('unrecognized', 2), ('epidemics', 2), ('pparalpha', 68), ('adaptation', 10), ('cholestatic', 24), ('alpha-naphthylisothiocyanate', 4), ('cholestasis', 25), ('challenging', 10), ('hepatology', 1), ('difference', 81), ('pparalpha-null', 11), ('orally', 53), ('anit', 8), ('biochemistry', 2), ('histopathology', 15), ('metabolome', 5), ('adapted', 4), ('shp', 3), ('fxr', 20), ('doubled', 4), ('discriminated', 1), ('cross-talked', 1), ('antibacterial', 16), ('zirconia', 5), ('glass', 6), ('ag', 7), ('streptococcus', 5), ('mutans', 3), ('powder', 6), ('f', 13), ('eight', 26), ('powders', 1), ('adhesion', 58), ('glass-coated', 1), ('antimicrobial', 25), ('wst-8', 1), ('bacterial', 39), ('11.8', 1), ('15.4', 1), ('5~15', 1), ('counts', 10), ('4.2~65.4', 1), ('bacteria', 38), ('29.4', 1), ('limitations', 9), ('ceramics', 1), ('task-1', 20), ('pore', 7), ('potassium', 21), ('arterial', 24), ('points', 36), ('kcnk3', 3), ('disease-causing', 3), ('heritable', 4), ('pah', 35), ('mutated', 21), ('substantially', 10), ('degree', 32), ('ono-rs-082', 2), ('ph', 46), ('8.4', 3), ('recover', 9), ('guanylate', 2), ('riociguat', 4), ('abstract', 5), ('~15-50', 1), ('million', 3), ('encodes', 7), ('k2p3.1', 1), ('g106r', 2), ('l214r', 2), ('currents', 10), ('transiently', 6), ('tsa201', 1), ('whole-cell', 2), ('patch', 4), ('clamp', 1), ('electrophysiology', 1), ('localization', 25), ('fluorescence-tagged', 1), ('quantified', 24), ('in-cell', 1), ('on-cell', 1), ('westerns', 1), ('enhancement', 33), ('bergenin', 13), ('tnbs-induced', 3), ('colitis', 76), ('nlrp3/asc', 3), ('inflammasome', 64), ('ulcerative', 21), ('bowel', 19), ('efficiency', 28), ('bg', 4), ('tnbs', 12), ('2,4,6-trinitrobenzenesulfonic', 2), ('5-asa', 1), ('25', 74), ('vi', 108), ('instillation', 7), ('observer', 1), ('blinded', 7), ('macroscopic', 3), ('neutrophilic', 4), ('colon', 105), ('down-regulate', 7), ('cox-2', 74), ('ikb-alpha', 1), ('pstat3', 2), ('protocol', 22), ('indirect', 13), ('elisa', 49), ('quantification', 16), ('ifn-gamma', 21), ('canonical', 11), ('il-1', 7), ('non-canonical', 5), ('il-11', 1), ('pro-inflammatory', 91), ('probably', 31), ('galectin-1', 7), ('facilitated', 13), ('cisplatin', 86), ('nb', 5), ('solid', 22), ('extracranial', 2), ('babies', 1), ('galectin', 1), ('radiotherapy', 10), ('resisitance', 1), ('sk-n-sh', 7), ('galectin-1/sirna', 1), ('si-gal-1', 1), ('lc3b', 9), ('beclin-1', 16), ('lc3b-ii/lc3b-i', 1), ('cisplatin-induced', 41), ('galectin-1-induced', 1), ('provid', 1), ('sirtuin3', 2), ('exacerbates', 8), ('tetrachloride-induced', 5), ('sirt3', 37), ('maintaining', 26), ('tetrachloride', 15), ('ccl4', 54), ('chemical-induced', 5), ('verify', 10), ('ccl', 9), ('given', 72), ('ko', 36), ('dynamin-related', 4), ('aggravated', 13), ('exacerbated', 22), ('quercetin', 54), ('radiation-induced', 6), ('deleterious', 21), ('unfolded', 6), ('dorsal', 23), ('root', 14), ('drg', 13), ('mature', 23), ('pretreated', 22), ('5-100', 1), ('hours', 60), ('gy', 12), ('radiation', 24), ('bip', 1), ('c/ebp-homologous', 1), ('marker', 82), ('factor-alpha', 49), ('jnk', 74), ('irradiated', 2), ('tuj1', 1), ('neurotrophin', 2), ('brain-derived', 13), ('neurotrophic', 20), ('neuron', 25), ('radiation-mediated', 1), ('hesperidin', 27), ('chronically', 6), ('ethanol-induced', 9), ('protection', 71), ('alcohol', 99), ('ameliorative', 17), ('sixty', 6), ('albino', 23), ('hesperidin-treated', 2), ('untreated', 24), ('alcoholic', 7), ('factor-eb', 1), ('1-alpha', 4), ('pgc1-alpha', 2), ('poly-', 1), ('-polymerase-1', 1), ('parp-1', 23), ('tenascin', 1), ('spectrophotometrically', 2), ('portrayed', 1), ('judged', 3), ('offsetting', 1), ('principal', 11), ('culprits', 1), ('mediating', 27), ('cardioprotective', 23), ('alcohol-induced', 7), ('candesartan', 5), ('epigallocatechin-3-gallate', 6), ('ameliorate', 29), ('gentamicin-induced', 8), ('p38-mapk', 9), ('pointed', 2), ('impacts', 35), ('egcg', 27), ('nephrotoxicity', 52), ('gentamicin', 19), ('creatinine', 36), ('urea', 23), ('glutathione-s-transferase', 5), ('interleukin-1', 6), ('extreme', 5), ('enlightening', 1), ('pretreatments', 1), ('coadministration', 9), ('monotherapy', 5), ('noncovalent', 2), ('tartrazine', 7), ('lysozyme', 5), ('spectroscopic', 7), ('computational', 13), ('azo', 9), ('additive', 18), ('pose', 8), ('threats', 5), ('biophysical', 4), ('isothermal', 4), ('titration', 5), ('calorimetry', 8), ('itc', 2), ('multispectroscopic', 1), ('quench', 2), ('microenvironmental', 1), ('forces', 3), ('residues', 23), ('trp108', 1), ('nicotinic', 13), ('acetylcholine', 18), ('-thc', 5), ('dependence', 12), ('-tetrahydrocannabinol', 7), ('cannabimimetic', 1), ('laboratory', 26), ('manipulations', 3), ('asked', 16), ('reciprocal', 4), ('question', 11), ('nachrs', 13), ('nachr', 8), ('transgenic', 17), ('preclinical', 27), ('alpha3beta4', 4), ('auib', 1), ('partial', 25), ('at-1001', 1), ('thc-dependent', 2), ('challenged', 13), ('cannabinoid-1', 1), ('rimonabant', 14), ('alpha5', 2), ('alpha6', 2), ('precipitated', 3), ('counterparts', 6), ('beta2', 2), ('alpha7', 1), ('deletion', 37), ('preferred', 8), ('alpha6beta4', 2), ('bula', 1), ('t5a', 1), ('p60', 1), ('code', 2), ('alpha3', 1), ('beta4', 1), ('viable', 10), ('medications', 10), ('counteract', 7), ('aristolochic', 10), ('slit2-induced', 2), ('tube', 15), ('inactivation', 47), ('robo1/robo2-nck1/nck2', 3), ('sprouting', 1), ('slit2', 3), ('vegf', 28), ('peritubular', 1), ('capillary', 4), ('ptc', 16), ('rarefaction', 2), ('nephropathy', 34), ('aan', 6), ('aa', 31), ('huvecs', 33), ('lentivirus-mediated', 2), ('nck1-overexpressing', 1), ('aai', 13), ('1-3', 6), ('slit2/robo1/robo2-nck1/nck2', 1), ('nck1', 3), ('aai-impaired', 1), ('nck2', 1), ('rac1', 11), ('dispatched', 2), ('rnd', 2), ('diaphragmatic', 32), ('mesenchyme', 7), ('nitrofen-induced', 7), ('congenital', 24), ('hernia', 16), ('cdh', 17), ('hypoplasia', 7), ('thought', 14), ('malformation', 16), ('disp-1', 9), ('transmembrane', 20), ('palmitoyl', 1), ('compartments', 6), ('diaphragms', 5), ('time-mated', 3), ('received', 107), ('nitrofen', 3), ('gestational', 62), ('d9', 2), ('microdissected', 1), ('endpoints', 17), ('d13', 6), ('d15', 6), ('d18', 6), ('nitrofen-exposed', 6), ('time-point', 1), ('wt-1', 2), ('sox-9', 1), ('localize', 1), ('pleuroperitoneal', 2), ('folds/primordial', 2), ('0.18', 6), ('0.08', 8), ('0.41', 3), ('0.05/1.06', 1), ('0.27', 4), ('1.34', 1), ('0.79', 2), ('diaphragms/lungs', 2), ('0.06', 4), ('0.44', 2), ('0.23', 4), ('0.05/0.73', 1), ('0.36', 3), ('1.16', 3), ('muscularized', 2), ('diaphragms/differentiated', 2), ('0.22', 2), ('0.32', 4), ('0.05/0.56', 1), ('0.16', 5), ('0.77', 5), ('0.14', 3), ('predominately', 1), ('branching', 6), ('interrupt', 2), ('delphi', 5), ('survey', 19), ('classification', 9), ('familial', 10), ('mediterranean', 4), ('mevalonate', 2), ('tnf', 25), ('receptor-associated', 6), ('periodic', 7), ('syndromes', 9), ('cryopyrin-associated', 1), ('provisional', 1), ('hereditary', 6), ('hpf', 32), ('consensus', 8), ('reached', 15), ('physicians', 2), ('consider', 9), ('surveys', 7), ('sent', 1), ('professionals', 2), ('field', 26), ('autoinflammation', 1), ('124', 2), ('researchers', 9), ('list', 4), ('monogenic', 4), ('researcher', 1), ('complete', 29), ('162', 3), ('items', 2), ('coming', 2), ('top', 15), ('assigning', 1), ('score', 59), ('session', 7), ('87', 4), ('corresponding', 35), ('cryopyrinopathies', 1), ('candidate', 51), ('set', 32), ('egfr-tkis', 12), ('oligometastatic', 5), ('oligoprogressive', 5), ('metastases', 11), ('lm', 8), ('progression-free', 9), ('pfs', 15), ('secondary', 45), ('os', 46), ('failure', 61), ('8.6', 3), ('31.2', 3), ('18.5', 1), ('12.9', 2), ('0.041', 2), ('36.8', 1), ('21.3', 2), ('continuation', 2), ('switching', 7), ('pfs2', 1), ('13.9', 1), ('9.2', 3), ('0.007', 5), ('28.3', 1), ('17.1', 2), ('0.011', 2), ('distant', 6), ('locoregional', 1), ('recurrence', 18), ('reason', 12), ('choice', 7), ('scenario', 7), ('foxc2-as1', 7), ('mir-1253/ezh2', 2), ('vital', 26), ('rnas', 28), ('lncrnas', 20), ('unsolved', 2), ('queries', 1), ('tries', 1), ('tumorigenesis', 41), ('stated', 3), ('indicates', 34), ('prognosis', 52), ('gain-', 2), ('loss-of-functional', 1), ('mechanically', 3), ('mir-1253', 1), (\"3'-untranslated\", 4), ('utr', 6), ('ezh2', 14), ('3-utr', 1), ('rescue', 20), ('foxc2-as1/mir-1253/ezh2', 1), ('accelerated', 16), ('troxerutin', 2), ('hepatocarcinoma', 13), ('tx', 7), ('bioflavonoid', 1), ('anti-neoplastic', 2), ('anti-cancer', 26), ('huh-7', 12), ('agarose', 3), ('gel', 7), ('electrophoresis', 8), ('performing', 8), ('immunocytochemistry', 5), ('oxygenase', 11), ('ho', 8), ('-1', 11), ('ikkbeta', 3), ('p65', 41), ('simultaneous', 10), ('oxadiazon', 8), ('aldehyde', 14), ('acylphosphatase', 2), ('striatal', 8), ('precursor', 30), ('herbicides', 8), ('pre-emergence', 1), ('post-emergence', 1), ('herbicide', 16), ('reproductive', 104), ('indications', 8), ('primordium', 1), ('non-cytotoxic', 11), ('aldh2', 9), ('acyp', 3), ('aldehydes', 6), ('alzheimer', 57), ('programmed', 20), ('fgf2-', 1), ('bdnf-dependent', 1), ('towards', 36), ('acyp2', 3), ('differentiative', 2), ('capabilities', 5), ('marco', 13), ('silica-induced', 33), ('scavenger', 21), ('collagenous', 2), ('silicosis', 23), ('polyg', 7), ('e-cadherin', 37), ('alpha-sma', 29), ('efficiently', 17), ('fibrosis-related', 1), ('col1a1', 7), ('col3a1', 3), ('collagen', 73), ('silica-exposed', 4), ('fibrotic', 26), ('5-oxo-hexahydroquinoline', 4), ('p-gp', 32), ('mrp1', 3), ('bcrp', 23), ('multidrug', 16), ('mdr', 6), ('atp-binding', 9), ('cassette', 14), ('p-gp/abcb1', 1), ('resistance-associated', 8), ('mrp1/abcc1', 1), ('bcrp/abcg2', 2), ('helpful', 13), ('overcoming', 7), ('exploiting', 1), ('collateral', 1), ('cs', 16), ('twelve', 7), ('bearing', 10), ('substitutions', 4), ('c4', 9), ('2-pyridyl', 1), ('alkyl', 5), ('carboxylate', 4), ('c3', 1), ('synthesized', 24), ('cytometric', 6), ('determination', 16), ('rhodamine', 2), ('123', 4), ('calcein', 1), ('mitoxantrone', 4), ('accumulations', 1), ('bcrp-overexpressing', 1), ('uterine', 17), ('sarcoma', 2), ('mes-sa/dx5', 1), ('d6', 3), ('d5', 1), ('3-chlorophenyl', 1), ('2,3-dichlorophenyl', 1), ('4-chlorophenyl', 1), ('position', 14), ('core', 16), ('d4', 5), ('3-flourophenyl', 1), ('mrp1-dependent', 1), ('pumps', 2), ('reducing', 74), ('necrosulfonamide', 2), ('sulfur', 18), ('mustard', 16), ('intoxication', 25), ('military', 1), ('ypres', 1), ('ago', 4), ('causal', 5), ('sm', 41), ('exists', 10), ('options', 18), ('co-culture', 11), ('immunocompetent', 4), ('report', 71), ('nsa', 6), ('chosen', 9), ('necroptosis', 26), ('specialized', 4), ('necrotic', 12), ('immense', 1), ('interleukin-8', 16), ('certain', 27), ('nafamostat', 14), ('mesilate', 6), ('obesity-associated', 3), ('fto', 6), ('demethylase', 8), ('protease', 25), ('pancreatitis', 9), ('thermodynamic', 7), ('enthalpy', 1), ('cyp3c', 4), ('p450', 83), ('cyps', 13), ('cyp3s', 2), ('arguably', 1), ('xenobiotic', 28), ('metabolizing', 17), ('cyp3a', 20), ('subfamily', 11), ('subfamilies', 1), ('unique', 24), ('teleost', 1), ('lineage', 5), ('goal', 19), ('17beta-estradiol', 13), ('e2', 58), ('0.001-10', 1), ('beta-naphthoflavone', 12), ('betanf', 6), ('0.005-1', 1), ('prototypical', 6), ('intestine', 22), ('cyp1a', 19), ('vitellogenin', 7), ('vtg', 4), ('dose-dependant', 1), ('cyp3cs', 4), ('cyp3c3', 1), ('cyp3c4', 2), ('cyp3c1', 1), ('0.5', 45), ('inducible', 20), ('planar', 4), ('hydrocarbons', 18), ('steroids', 8), ('cdelta', 4), ('protected', 52), ('cocaine-induced', 8), ('pkcdelta', 22), ('mediates', 53), ('cocaine', 24), ('4-hydroxylnonenal', 1), ('burdens', 3), ('rottlerin', 2), ('depletion', 44), ('erythroid-2-related', 1), ('nrf-2', 20), ('dna-binding', 2), ('rottlerin-treated', 1), ('gamma-glutamyl', 3), ('cysteine', 27), ('ligases', 4), ('gclm', 14), ('gsh/gssg', 2), ('decreases', 50), ('ast', 43), ('signifying', 2), ('post-cocaine', 1), ('bcl-xl', 9), ('cytosolic', 26), ('protecting', 24), ('trans-resveratrol', 1), ('stilbenes', 3), ('carries', 4), ('drug-food', 1), ('xenosensor', 1), ('rsv', 18), ('stilbene', 4), ('phytochemical', 10), ('wine', 2), ('cyp3a4', 37), ('interacts', 14), ('drug/xenobiotic', 1), ('comprehensively', 7), ('trans-', 4), ('cis-resveratrol', 1), ('cis-piceatannol', 1), ('oxyresveratrol', 4), ('pterostilbene', 5), ('pinostilbene', 3), ('b-dihydroresveratrol', 1), ('cis-trismethoxyresveratrol', 1), (\"trans-3,4,5,4'-tetramethoxystilbene\", 1), (\"trans-2,4,3',5'-tetramethoxystilbene\", 1), ('trans-4-methoxystilbene', 1), ('cyp2b6', 6), ('cyp3a4/5', 4), ('cyp2c8/9/19', 1), ('cyp2d6', 32), ('cyp2a6', 13), ('cyp1a2', 32), ('hepatocyte', 89), ('microsomes', 25), ('polymethoxylated', 1), ('prone', 2), ('cis-rsv', 1), ('trans-rsv', 1), ('testosterone', 46), ('6beta-hydroxylation', 2), ('midazolam', 4), ('-hydroxylation', 1), ('non-competitive', 6), ('food-drug', 5), ('substrates', 31), ('triptolide', 17), ('impairs', 33), ('thioredoxin', 10), ('suppressing', 49), ('notch1-mediated', 3), ('pten/akt/txnip', 1), ('tp', 58), ('herb', 9), ('tripterygium', 5), ('wilfordii', 5), ('hook', 4), ('f.', 2), ('twhf', 2), ('multifunction', 1), ('pharmaceutics', 2), ('evidences', 17), ('obvious', 24), ('clinic', 21), ('notch1', 23), ('tp-induced', 12), ('notch', 18), ('nicd', 2), ('pten', 17), ('deleted', 4), ('txnip', 2), ('thioredoxin-interacting', 1), ('trx', 2), ('initiating', 4), ('srebp-2', 16), ('aggravates', 14), ('osteolysis', 4), ('osteoclastogenesis', 7), ('cancer-induced', 4), ('sterol', 11), ('element-binding', 6), ('rankl/camp-response', 1), ('creb', 21), ('cascade', 28), ('participates', 11), ('nfatc1', 1), ('mmps', 12), ('degradative', 2), ('accordingly', 18), ('fatostatin', 1), ('scap', 1), ('srebp', 2), ('cleavage-activating', 1), ('osteolytic', 1), ('fam92a', 5), ('nonsyndromic', 5), ('postaxial', 4), ('polydactyly', 4), ('limb', 17), ('digit', 2), ('anomaly', 2), ('foot', 10), ('pap', 2), ('digits', 1), ('pakistani', 1), ('autosomal', 7), ('recessive', 10), ('papa', 3), ('genomewide', 5), ('genotyping', 4), ('linkage', 8), ('exome', 4), ('sanger', 2), ('sequencing', 63), ('nonsense', 2), ('c.478c', 1), ('p.', 15), ('arg160', 1), ('mapped', 2), ('8q21.13-q24.12', 1), ('segregated', 3), ('e11.5', 1), ('bud', 1), ('progress', 10), ('apical', 9), ('ectodermal', 1), ('ridge', 2), ('cilia', 2), ('patterning', 4), ('fam92a/chibby1', 1), ('ciliogenesis', 1), ('colocalization', 6), ('chibby1', 1), ('base', 12), ('fam92a-/-', 1), ('morphology', 48), ('metatarsal', 2), ('osteomas', 1), ('polysyndactyly', 1), ('deltoid', 1), ('tuberosity', 1), ('humeri', 1), ('ciliopathy', 2), ('loss-of-function', 11), ('american', 6), ('mineral', 14), ('antagonistic', 17), ('formaldehyde', 14), ('fa', 49), ('always', 6), ('unavoidable', 2), ('tea', 7), ('polyphenols', 13), ('zoological', 1), ('mg/m3', 3), ('gsh', 72), ('tnf-alpha', 136), ('obviously', 14), ('raised', 16), ('e', 45), ('nissl', 1), ('illustrated', 16), ('20-500', 1), ('myocardial', 68), ('infarction', 19), ('acutely', 10), ('bisphenols', 27), ('escape', 9), ('devices', 5), ('leach', 3), ('postcardiac', 1), ('wound', 16), ('healing', 24), ('representative', 21), ('replicated', 4), ('di-ethyl', 1), ('hexyl', 2), ('butylbenzyl', 1), ('di-isodecyl', 1), ('di-n-butyl', 5), ('predominated', 1), ('cardiopulmonary', 3), ('bypass', 5), ('machine', 6), ('tolerable', 3), ('limit', 17), ('37-fold', 1), ('bpa+phthalates', 1), ('surgery-induced', 1), ('dilation', 4), ('monocytes', 19), ('ablation', 12), ('erbeta', 28), ('antagonism', 17), ('replacement', 24), ('tri-octyl', 1), ('trimellitate', 1), ('removal', 38), ('dysfunctional', 3), ('m1-type', 1), ('mmp9', 16), ('phagocytic', 8), ('impair', 15), ('cd133', 16), ('abilities', 11), ('self-renew', 2), ('progenies', 1), ('makers', 4), ('isolating', 1), ('studying', 10), ('cd133high', 1), ('self-renewal', 9), ('resistant', 38), ('utilizes', 2), ('dissemination', 4), ('bringing', 2), ('updates', 2), ('modulates', 36), ('summarized', 4), ('cd133-mediated', 1), ('diosbulbin', 4), ('airpotato', 2), ('yam', 3), ('db', 11), ('hepatotoxic', 21), ('month', 12), ('hydroxyproline', 6), ('amounts', 13), ('hyaluronic', 2), ('laminin', 2), ('stellate', 34), ('hscs', 45), ('col1a2', 5), ('fibronectin', 8), ('fn1', 1), ('vim', 5), ('fibroblast-specific', 1), ('fsp1', 2), ('db-treated', 2), ('col1', 5), ('kappab', 9), ('-alpha', 7), ('interleukin', 42), ('il', 25), ('-6', 8), ('molecule-1', 13), ('icam-1', 9), ('contributed', 23), ('db-induced', 1), ('intermittent', 4), ('injections', 12), ('mesocorticolimbic', 2), ('abstinence', 9), ('addictive', 4), ('reaches', 2), ('variation', 16), ('delivery', 34), ('intermittent-access', 1), ('schedule', 8), ('pressed', 1), ('lever', 1), ('slower', 3), ('90', 24), ('mg/kg/injection', 1), ('self-administered', 3), ('pellets', 1), ('tone-light', 1), ('cue', 3), ('reward', 6), ('5s-', 1), ('90s-rats', 1), ('amount', 24), ('cocaine/forced', 1), ('lever-pressing', 1), ('behaviour', 17), ('extinguished', 1), ('6-h', 3), ('thereafter', 3), ('cue-', 1), ('reinstatement', 6), ('5s-rats', 3), ('reward-seeking', 1), ('cue-induced', 2), ('incubation', 33), ('craving', 11), ('extended', 16), ('prelimbic', 1), ('accumbens', 7), ('ventral', 8), ('tegmental', 4), ('rising', 4), ('evoking', 2), ('intensify', 1), ('persist', 4), ('bout', 1), ('sulfasalazine', 3), ('ibd', 16), ('recurrent', 35), ('gastrointestinal', 25), ('tract', 24), ('etiology', 15), ('uc', 30), ('crohn', 2), ('incomplete', 5), ('harmless', 1), ('desirable', 5), ('statins', 6), ('pleiotropic', 2), ('lipid-lowering', 1), ('sim', 4), ('seven', 28), ('colonic', 20), ('mucosal', 17), ('macroscopically', 2), ('microscopically', 2), ('nod-like', 6), ('pyrin', 7), ('domain-1', 1), ('nlrp3', 102), ('super', 5), ('assayed', 13), ('caspase-1', 32), ('cyclooxygenase-2', 22), ('cox2', 7), ('dependant', 1), ('lowering', 4), ('makes', 10), ('chalcone', 12), (\"2-hydroxy-3',5,5'-trimethoxychalcone\", 2), ('dk-139', 7), ('named', 7), ('anti-tumor', 15), ('reticulum-mediated', 1), ('h2ax', 4), ('ser139', 4), ('gamma-h2ax', 6), ('hallmarks', 8), ('dk-139-induced', 4), ('single-cell', 5), ('comet', 21), ('tail', 21), ('p53-null', 1), ('hct116', 22), ('instead', 10), ('caspase-2', 6), ('bh3', 1), ('interacting-domain', 1), ('bid', 7), ('caspase-9', 23), ('n-acetyl', 8), ('nac', 53), ('ros-mediated', 16), ('histamine-4', 2), ('jnj7777120', 2), ('parkinson-like', 1), ('presumed', 4), ('h4r', 7), ('providing', 29), ('validated', 32), ('rotenone-induced', 6), ('h4r-', 1), ('midbrain', 3), ('infusion', 8), ('ventricle', 4), ('rotenone-lesioned', 1), ('apomorphine-induced', 1), ('rotational', 1), ('dopamine', 22), ('body-like', 1), ('neuropathology', 3), ('proof', 3), ('proposes', 1), ('tackle', 2), ('af', 12), ('bpaf', 49), ('fluorinated', 3), ('analog', 17), ('metabolized', 23), ('bpaf-glucuronide', 1), ('bpaf-g', 6), ('believed', 6), ('biologically', 7), ('glucuronidation', 19), ('adipogenesis', 33), ('reporter-gene', 1), ('glucocorticoid', 28), ('3t3l1', 1), ('preadipocytes', 16), ('nile', 2), ('adiponectin', 6), ('cebpalpha', 2), ('agonistic', 11), ('heralpha', 1), ('toxicological', 43), ('warranted', 11), ('better', 74), ('end-elimination', 1), ('prostaglandin', 23), ('down-regulates', 4), ('aromatase', 42), ('obesity-breast', 1), ('connection', 6), ('receptor-positive', 6), ('postmenopausal', 9), ('rate-limiting', 5), ('hypoxia-inducible', 5), ('1alpha', 4), ('hif-1alpha', 31), ('stromal', 20), ('ascs', 3), ('deacetylates', 1), ('inactivates', 1), ('acetyl-hif-1alpha', 4), ('lean', 3), ('utilized', 17), ('sirt1720', 1), ('pge2-mediated', 2), ('p300/cbp-associated', 1), ('pcaf', 2), ('acetylates', 1), ('p300', 14), ('acted', 12), ('ep2', 4), ('ep4', 6), ('atf3', 6), ('repressive', 3), ('bound', 20), ('sirt1-mediated', 1), ('deacetylation', 3), ('generalized', 8), ('hypermobility', 4), ('ghs', 8), ('dynamic', 22), ('plantar', 5), ('kinetic', 31), ('kinematic', 2), ('movement', 9), ('biomechanics', 1), ('sufficient', 21), ('joint', 15), ('gait', 16), ('37', 11), ('22.16', 1), ('2.58', 1), ('aged-matched', 1), ('23.35', 1), ('2.85', 1), ('participant', 8), ('walked', 1), ('barefoot', 1), ('self-selected', 1), ('pace', 1), ('emed-m', 1), ('gmbh', 2), ('munich', 1), ('correlations', 22), ('hs', 10), ('beighton', 1), ('peak', 18), ('pp', 10), ('pressure-time', 2), ('pti', 2), ('ap', 26), ('maximum', 32), ('force', 6), ('mxf', 3), ('mid-foot', 1), ('mf', 2), ('r=', 13), ('0.24', 4), ('p=', 21), ('5th', 6), ('mh5', 5), ('0.33', 2), ('big', 2), ('toe', 2), ('st', 21), ('0.38', 5), ('trend', 28), ('integrals', 1), ('hindfoot', 1), ('hf', 22), ('0.30', 3), ('0.009', 6), ('0.25', 15), ('0.033', 1), ('0.37', 3), ('0.34', 1), ('0.048', 2), ('aps', 11), ('0.042', 1), ('0.40', 4), ('hypermobile', 3), ('0.023', 3), ('0.037', 4), ('mf5', 1), ('0.029', 3), ('sf', 2), ('forefoot', 1), ('load', 11), ('evaluation', 73), ('extremity', 1), ('decision', 3), ('making', 13), ('orthotics', 1), ('rehabilitation', 9), ('protocols', 8), ('intermediate-term', 1), ('star', 18), ('ankle', 4), ('real', 11), ('published', 14), ('arthroplasty', 7), ('taa', 21), ('surgeon', 3), ('1999', 2), ('2013', 12), ('scandinavian', 1), ('prosthesis', 2), ('institution', 7), ('regular', 5), ('intervals', 7), ('physical', 22), ('radiographs', 3), ('orthopaedic', 1), ('aofas', 2), ('ankle-hindfoot', 2), ('implant', 25), ('survivability', 3), ('perioperative', 7), ('periprosthetic', 5), ('fracture', 10), ('taas', 2), ('131', 1), ('81', 9), ('61.5', 1), ('12.3', 2), ('30-88', 1), ('living', 14), ('retained', 13), ('8.8+-4.3', 1), ('2-16.9', 1), ('36.0', 1), ('16.8', 2), ('15.2', 1), ('failures', 2), ('4.9', 3), ('4.5', 1), ('postoperation', 1), ('8.9', 3), ('3.3', 7), ('postoperatively', 4), ('fourteen', 2), ('died', 1), ('implants', 14), ('place', 7), ('true', 8), ('acceptable', 5), ('patient-reported', 1), ('optimal', 18), ('scheme', 6), ('levothyroxine', 5), ('thyroidectomy', 4), ('struggle', 1), ('attain', 1), ('euthyroidism', 2), ('schemes', 7), ('supplant', 1), ('weight-based', 2), ('accuracies', 1), ('learning', 50), ('598', 1), ('attained', 1), ('completion', 2), ('scoping', 1), ('thirteen', 3), ('algorithms', 10), ('10-fold', 5), ('cross-validation', 1), ('12.5', 5), ('microg/day', 1), ('264', 1), ('reviewed', 11), ('implementable', 1), ('poisson', 4), ('proved', 33), ('correctly', 7), ('predicting', 17), ('64.8', 1), ('incorporating', 2), ('best', 33), ('index/weight', 1), ('60.9', 1), ('.031', 1), ('1.6', 3), ('microg/kg/day', 1), ('51.3', 1), ('age/sex/weight', 1), ('27.4', 1), ('readily', 8), ('outperforms', 1), ('estimating', 4), ('hyphae', 2), ('fragments', 4), ('a.', 12), ('fumigatus', 2), ('sensitize', 5), ('particles', 22), ('min-u-sil', 12), ('pm', 17), ('particles/components', 1), ('aspergillus', 3), ('afh', 4), ('mo', 2), ('phorbol', 3), ('12-myristate', 2), ('13-acetate', 2), ('pma', 5), ('-differentiated', 1), ('co-exposure', 23), ('lps-', 2), ('afh-induced', 2), ('afh-', 1), ('caspase-dependent', 16), ('zyvad-fmk', 1), ('releases', 3), ('monocyte-derived', 2), ('mdm', 1), ('pro-il-1beta', 1), ('paclitaxel-induced', 3), ('dysregulation', 42), ('sensitization', 36), ('paclitaxel', 20), ('horn', 4), ('mda7', 8), ('1-', 4), ('3-benzyl-3-methyl-2,3-dihydro-1-benzofuran-6-yl', 1), ('piperidine', 1), ('consecutice', 1), ('intraperitoneally', 26), ('min', 43), ('irf8', 1), ('p2x', 2), ('purinoceptor', 1), ('p2x4', 8), ('isoform', 5), ('calcium/calmodulin-dependent', 1), ('camkiialpha', 1), ('p-creb', 2), ('deltafosb', 1), ('overproduction', 14), ('glutamate', 37), ('subunits', 19), ('glur1', 1), ('nr2b', 17), ('k+-cl-', 1), ('cotransporter', 2), ('mechanical', 26), ('allodynia', 11), ('aforementioned', 7), ('perspective', 7), ('epigenetically', 2), ('represents', 26), ('innovative', 5), ('chemotherapy-induced', 12), ('neuropathy', 15), ('crosstalk', 18), ('hexavalent', 12), ('chromium', 21), ('environments', 9), ('carcinogen', 27), ('grp78', 18), ('p-perk', 1), ('4-phenylbutyric', 2), ('4pba', 1), ('preceded', 5), ('z-vad-fmk', 2), ('3-ma', 7), ('6-12', 2), ('-reduced', 1), ('engulfing', 1), ('apoptosis-dependent', 1), ('keep', 2), ('maybe', 3), ('adaptive', 15), ('d-vitamin', 2), ('8-methoxypsoralen-induced', 1), ('8-methoxypsoralen', 1), ('8-mop', 7), ('ultraviolet', 8), ('puva', 2), ('psoriasis', 12), ('risks', 34), ('8-mop-induced', 3), ('25-hydroxy', 1), ('oh', 10), ('receiving', 18), ('vd-vdr', 2), ('conventional', 23), ('lighting', 1), ('cld', 4), ('deficient', 31), ('vdd', 2), ('sprague-dawley', 37), ('vdr', 14), ('subcellular', 9), ('l02', 15), ('cyp7a1', 24), ('mrp3', 6), ('8-mop-regulated', 1), ('transportation', 6), ('8-mop-mediated', 1), ('convulsant', 11), ('abused', 4), ('5f-ab-pinaca', 4), ('scb', 1), ('cb1r', 31), ('9-tetrahydrocannabinol', 2), ('scbs', 11), ('classic', 11), ('pentylenetetrazol', 2), ('ptz', 17), ('rating', 1), ('elicit', 11), ('potently', 17), ('scb-elicited', 2), ('regimens', 11), ('desensitize', 1), ('cb1rs', 8), ('diazepam', 7), ('ptz-elicited', 1), ('scb-induced', 1), ('repeated', 53), ('subthreshold', 7), ('kindled', 1), ('cross-kindling', 1), ('tolerance', 29), ('cross-tolerance', 2), ('nonselective', 3), ('cyp450s', 1), ('1-aminobenzotriazole', 2), ('potentiated', 18), ('hypothermic', 5), ('eliminated', 12), ('benzodiazepines', 4), ('dramatically', 21), ('subtype-specific', 2), ('rewiring', 1), ('myeloid', 35), ('aml', 28), ('heterogeneous', 12), ('cis-regulatory', 1), ('purified', 16), ('leukemic', 2), ('blast', 4), ('subgroups', 7), ('carrying', 12), ('runx1', 1), ('ftl3-itd', 1), ('ras', 43), ('npm1', 8), ('integrated', 11), ('establishes', 2), ('sets', 15), ('melatonin', 48), ('stemness', 33), ('plc', 5), ('beta-catenin', 55), ('twist', 7), ('cancer-related', 10), ('pineal', 2), ('grand', 2), ('~50', 3), ('sphere', 6), ('erk/p38', 2), ('promise', 5), ('deserves', 3), ('excessive', 31), ('programing', 2), ('osteopenia', 5), ('prenatal', 68), ('caffeine', 30), ('pce', 22), ('mg/100', 2), ('marrow', 23), ('bmscs', 23), ('corticosterone', 7), ('femur', 5), ('ossification', 6), ('center', 15), ('trabecular', 5), ('biomechanical', 1), ('gr', 28), ('ace', 34), ('gamma-carboxyglutamate', 1), ('bglap', 2), ('sialoprotein', 2), ('bsp', 5), ('hypomethylation', 12), ('1250', 1), ('enalapril', 5), ('retardation', 6), ('sustained', 19), ('lactic', 13), ('microrna-744', 1), ('motility', 28), ('arhgap5', 4), ('papillomaviruses', 1), ('integration', 6), ('majority', 19), ('e6', 5), ('e7', 4), ('oncogenes', 6), ('invariably', 1), ('immortalize', 1), ('factor-extracellular', 1), ('glycolytic', 20), ('hpv16', 1), ('stimulating', 10), ('mir-744', 5), ('mir-774/arhgap5', 1), ('triggering', 7), ('acid-induced', 18), ('tetrahydrocurcumin', 2), ('octahydrocurcumin', 2), ('hydrogenated', 2), ('possess', 33), ('superior', 12), ('hepatic-protective', 1), ('acetaminophen-induced', 16), ('keap1-nrf2', 18), ('acetaminophen', 65), ('apap', 91), ('overdose-induced', 2), ('tightly', 7), ('ohc', 9), ('cur', 22), ('apap-induced', 44), ('deterioration', 8), ('miring', 1), ('cat', 38), ('t-aoc', 2), ('enormously', 1), ('nrf2-targeted', 1), ('hepato-protective', 5), ('favorable', 9), ('restoring', 11), ('pro-metastatic', 3), ('cell-induced', 1), ('platelet', 39), ('aggregation', 39), ('arsenic-associated', 6), ('cell-platelet', 1), ('tcpa', 3), ('ultimately', 26), ('freshly', 3), ('platelets', 11), ('attributable', 4), ('reactivity', 8), ('respect', 11), ('thrombin', 10), ('p-selectin', 3), ('gpiib/iiia', 1), ('co-existence', 1), ('extravasation', 1), ('metastasis-related', 3), ('metallo-matrix', 1), ('proteinase-2', 1), ('-9', 13), ('blockers', 9), ('arsenic-contaminated', 2), ('drinking', 61), ('water', 109), ('intravenously', 7), ('cell-injected', 1), ('platelet-activation', 1), ('aspirin', 8), ('eptifibatide', 1), ('clue', 2), ('signatures', 12), ('ochratoxin', 24), ('citrinin', 2), ('ota', 47), ('ctn', 4), ('coexist', 3), ('feed', 19), ('stuff', 1), ('combinative', 3), ('hek', 9), ('co-treatment', 29), ('manifested', 10), ('hek293', 13), ('srna', 1), ('378', 1), ('degs', 39), ('hsa-mir-1-3p', 1), ('hsa-mir-122-5p', 1), ('pdcd10', 5), ('g1', 9), ('ccng1', 1), ('mirna-target', 1), ('account', 11), ('mycotoxin-induced', 1), ('naringenin', 28), ('glioblastoma', 19), ('gbm', 33), ('world', 23), ('citrus', 14), ('exhibits', 36), ('anti-inflammation', 6), ('bladder', 65), ('gastric', 66), ('overt', 5), ('alternation', 4), ('8901', 1), ('8401', 8), ('boyden', 3), ('chamber', 9), ('snail', 23), ('slug', 8), ('nano', 19), ('turmeric', 4), ('copper', 23), ('sulfate', 28), ('transducer', 24), ('tm', 3), ('ntm', 5), ('desferrioxamine', 1), ('dsm', 3), ('serum-urea', 1), ('uric', 17), ('-10', 5), ('c-reactive', 12), ('crp', 20), ('vcam-1', 4), ('kim', 1), ('stat-3', 3), ('-2', 10), ('kim-1', 11), ('cs-induced', 4), ('renotoxicity', 1), ('salvianolic', 4), ('sirt1-enos', 2), ('sa', 31), ('scavenging', 17), ('hydroxyl', 7), ('radicals', 12), ('p-endothelial', 1), ('ex527', 8), ('p-enos', 1), ('glucose-induced', 18), ('carbonic', 9), ('anhydrase', 8), ('butyrylcholinesterase', 8), ('epoxide', 10), ('chalcones', 2), ('epoxides', 3), ('intermediates', 14), ('organic', 59), ('medicinal', 13), ('chemistry', 15), ('spectrum', 34), ('1,3-diphenyl-2-propenone', 1), ('deserve', 4), ('substituted', 11), ('epoxidated', 1), ('isozymes', 6), ('hca', 20), ('ache', 67), ('buche', 3), ('submicromolar', 2), ('constants', 5), ('docked', 2), ('fisetin', 16), ('mda-mb-453', 5), ('her2/neu', 3), ('her2', 14), ('snag', 1), ('faced', 1), ('chemoresistance', 14), ('advanced', 50), ('focussed', 2), ('antiproliferative', 22), ('chemotherapeutic', 26), ('her2/neu-overexpressing', 1), ('depicted', 4), ('proteasomal', 13), ('enolase', 1), ('phosphatidylinositol', 4), ('3-kinase/akt', 2), ('morphogenetic', 8), ('esophageal', 9), ('squamous', 17), ('pluripotency', 6), ('probable', 6), ('bmp', 6), ('escc', 3), ('tumoral', 2), ('margin', 2), ('treatment-naive', 1), ('sizn1', 1), ('ventx', 1), ('dido1', 1), ('i/ii', 2), ('invaded', 1), ('adventitia', 1), ('t3/t4', 1), ('butyrate', 18), ('carcinogens', 12), ('helps', 3), ('chemopreventive', 12), ('interactive', 9), ('xmes', 3), ('hct-116', 8), ('ht-29', 14), ('n-acetyltransferases', 1), ('nat2', 3), ('aldo-keto', 8), ('reductases', 8), ('akr1c1', 1), ('udp-glucuronosyltransferases', 7), ('ugt1a1', 12), ('notable', 10), ('quinone', 18), ('oxidoreductase', 11), ('ugt1a4', 4), ('akr1c3', 17), ('cyp1', 2), ('caco-2', 31), ('differentiation-dependent', 1), ('inducibility', 3), ('xme', 3), ('nats', 1), ('ugts', 19), ('ht29', 1), ('helped', 4), ('expression/activities', 1), ('ugt1', 1), ('a1', 7), ('hdac', 5), ('ppt1', 11), ('repurposing', 3), ('lysosomotropic', 1), ('encouraging', 3), ('dimeric', 4), ('dc661', 3), ('deacidifying', 1), ('hcq', 18), ('photoaffinity', 1), ('palmitoyl-protein', 1), ('thioesterase', 1), ('shared', 9), ('monomeric', 2), ('lys05', 1), ('maintained', 15), ('acidic', 5), ('crispr/cas9', 8), ('editing', 3), ('abrogates', 3), ('correlates', 15), ('significance', 44), ('identifies', 16), ('highlighted', 15), ('issue', 12), ('feature', 14), ('151.', 1), ('allergic', 18), ('33', 15), ('eosinophils', 4), ('eralpha', 79), ('propruritic', 1), ('cutaneous', 26), ('allergy', 6), ('erbeta-selective', 1), ('balb/c', 14), ('propylpyrazoletriol', 2), ('ppt', 6), ('diarylpropionitrile', 2), ('dpn', 6), ('th2', 6), ('il-4', 15), ('il-13', 2), ('agonists', 39), ('il-33', 6), ('eosinophilic', 1), ('eol-1', 2), ('mercury', 19), ('selenium', 28), ('attempted', 9), ('mitigate', 9), ('detrimental', 16), ('mercurial', 1), ('controversial', 13), ('pools', 3), ('organisms', 30), ('quite', 6), ('selenols', 1), ('selenoproteins', 1), ('selenoenzyme', 2), ('reductase', 41), ('trxr', 5), ('integrant', 1), ('functioning', 11), ('hg', 18), ('scope', 5), ('discusses', 2), ('concerning', 9), ('mercurials', 1), ('inorganic', 8), ('extent', 28), ('glutaredoxin', 3), ('hampered', 4), ('compensation', 1), ('txrr', 1), ('puts', 1), ('forward', 8), ('activity/expression', 1), ('refining', 1), ('glycation', 15), ('responsive', 18), ('leukocytes', 8), ('alpha-dycarbonyl', 1), ('derived', 60), ('whose', 19), ('ranging', 13), ('immunoreactivity', 10), ('apoptosis/necrosis', 1), ('phenomena', 5), ('granularity', 2), ('glycation-responsive', 1), ('erythroid-derived', 11), ('-like', 13), ('cuzn-superoxide', 1), ('mn-superoxide', 1), ('gsr', 1), ('glutathione-s-reductase', 1), ('bax-associated', 1), ('bcl-2-associated', 6), ('aif', 9), ('glo-1', 1), ('glyoxalase-1', 1), ('rage', 8), ('casp', 3), ('mg.', 8), ('seems', 15), ('neurobehavioral', 14), ('life', 64), ('larvae', 48), ('alternate', 1), ('consumer', 13), ('goods', 3), ('growing', 16), ('96', 22), ('h-lc50', 2), ('323', 1), ('mg/l', 39), ('308-339', 1), ('0.3', 10), ('3.0', 11), ('postfertilization', 3), ('accompany', 3), ('alpha1-tubulin', 1), ('elavl3', 2), ('gap43', 4), ('mbp', 23), ('syn2a', 2), ('gfap', 12), ('hif-1a', 11), ('1,4-benzoquinone', 6), ('contaminant', 16), ('hematological', 14), ('hypoxia', 29), ('factor-1a', 1), ('1,4-bq', 5), ('lentiviral', 6), ('vector', 10), ('remarkably', 41), ('nox4', 9), ('ld', 1), ('/pyruvic', 1), ('pa', 30), ('glut1', 10), ('ldha', 2), ('pkm2', 18), ('pgk1', 2), ('pdk1', 5), ('pfkl', 1), ('pfkfb3', 8), ('polymerase-1', 2), ('methyl-cpg', 1), ('tk6', 5), ('hq', 16), ('completely', 39), ('hq-treated', 1), ('lymphoblastoid', 3), ('pbs-treated', 1), ('e4f1', 12), ('co-regulators', 1), ('hdac1', 7), ('hdac2', 11), ('acetylated', 3), ('h3ac', 2), ('5-azac', 1), ('dnmts', 10), ('hdacs', 4), ('dox', 85), ('mg132', 4), ('proteasome', 11), ('mbds', 1), ('mbd2', 3), ('neat1/microrna-146b-5p', 1), ('wnt/beta-catenin', 28), ('endometrium', 4), ('intensive', 12), ('post-treated', 1), ('omnibus', 4), ('accession', 4), ('gse29435', 1), ('cytoscape', 2), ('software', 16), ('targetscan', 2), ('miranda', 1), ('hmdd', 1), ('websites', 1), ('enrichment', 28), ('gsea', 7), ('kyoto', 7), ('encyclopedia', 6), ('genomes', 6), ('dual-luciferase', 9), ('propagation', 5), ('testified', 1), ('colony', 30), ('transcript', 39), ('neat1', 29), ('lymphoid', 4), ('lef1', 5), ('eventually', 16), ('hsa_mir-146b-5p', 1), ('involve', 20), ('overexpressed', 26), ('mir-146b-5p', 1), ('neat1/mir-146b-5p', 1), ('suppressive', 16), ('neat1/mir-146b-5p-mediated', 1), ('iubmb', 1), ('71', 9), (':223-234', 1), ('2019.', 7), ('autism', 35), ('asd', 58), ('encompassed', 1), ('nearly', 11), ('births', 3), ('metro', 2), ('vancouver', 2), ('british', 5), ('columbia', 3), ('canada', 7), ('2004', 6), ('2009', 4), ('2014.', 3), ('standardized', 14), ('interview-revised', 2), ('observation', 18), ('monthly', 3), ('no2', 23), ('residence', 3), ('temporally', 2), ('land', 2), ('child', 19), ('sex', 57), ('year', 23), ('birthplace', 1), ('neighborhood-level', 1), ('urbanicity', 1), ('band', 4), ('june', 8), ('2016', 14), ('2018.', 9), ('measures', 37), ('diagnoses', 2), ('formulated', 5), ('132', 1), ('256', 2), ('1307', 1), ('pm2.5-adjusted', 1), ('129', 2), ('439', 1), ('436', 2), ('1276', 1), ('interquartile', 4), ('iqr', 9), ('1.04', 3), ('0.98-1.10', 2), ('1.06', 4), ('0.99-1.12', 1), ('4.8', 3), ('ppb', 6), ('1.07', 3), ('1.01-1.13', 1), ('10.7', 2), ('1.09', 3), ('1.02-1.15', 1), ('1.00-1.13', 1), ('1.03', 3), ('0.90-1.18', 1), ('0.98', 5), ('0.83-1.13', 1), ('1.00', 3), ('0.86-1.16', 1), ('1,2-dichloropropane', 2), ('upregulates', 16), ('activation-induced', 2), ('cytidine', 4), ('deaminase', 5), ('aid', 11), ('cholangiocytes', 8), ('co-cultured', 7), ('1,2-dcp', 8), ('reclassified', 2), ('iarc', 2), ('outbreak', 2), ('cholangiocarcinoma', 4), ('offset-printing', 1), ('1,2-dcp-induced', 3), ('obscure', 2), ('whole-genome', 5), ('mmnk-1', 5), ('co-cultures', 4), ('mmnk-1/thp-1', 1), ('immunostaining', 13), ('sn50', 1), ('tnf-alpha-induced', 15), ('moment', 2), ('consequent', 13), ('omeprazole', 11), ('transporter-mediated', 2), ('hk-2', 23), ('ome', 20), ('prescribed', 16), ('ppi', 12), ('gastroesophageal', 1), ('hyperacidity', 1), ('tubular', 44), ('kidneys', 23), ('concomitantly', 9), ('co-administration', 13), ('cp-induced', 18), ('cation', 6), ('oct2', 10), ('prompt', 2), ('concurrently', 7), ('nf-kappab-dependent', 3), ('oenothein', 9), ('pi3k/akt/nf-kappab', 4), ('wide', 40), ('probed', 4), ('arresting', 3), ('n-acetyl-l-cystein', 1), ('insulin-like', 16), ('igf-1', 22), ('resist', 4), ('3/7', 14), ('p-pi3k', 3), ('p-akt', 24), ('p-nf-kappab', 2), ('compensated', 1), ('robo4', 6), ('variants', 64), ('predispose', 6), ('bicuspid', 2), ('valve', 21), ('thoracic', 6), ('aneurysm', 6), ('bav', 2), ('defect', 13), ('1-2', 4), ('presents', 11), ('ascending', 1), ('ascaa', 1), ('4.', 2), ('bav/ascaa', 2), ('dominant', 16), ('inheritance', 5), ('penetrance', 3), ('predominance', 4), ('causative', 6), ('example', 15), ('smad6', 1), ('=1', 1), ('ascaa5-8', 1), ('impeding', 3), ('segregate', 1), ('probands', 2), ('repertoire', 3), ('suggestive', 4), ('endothelial-to-mesenchymal', 1), ('bav/ascaa-associated', 1), ('azole', 7), ('fungicide', 16), ('tebuconazole', 8), ('triazole', 3), ('fungicides', 4), ('rodent', 28), ('xenobiotic-sensing', 1), ('fungicide-mediated', 1), ('hepg2', 135), ('heparg', 31), ('subtoxic', 7), ('ahr-knockout', 1), ('substantiating', 2), ('inducer', 9), ('propiconazole', 1), ('ahr-downstream', 1), ('assumed', 6), ('ahr-related', 1), ('phosphorus', 9), ('hemodialyis', 1), ('describe', 30), ('hyperphosphatemia', 1), ('dialysis', 3), ('alimentary', 1), ('phosphorous', 10), ('virtually', 2), ('phosphorous-free', 1), ('source', 16), ('wasting', 1), ('hyperphosphatemic', 1), ('53.0', 1), ('10.0', 5), ('weekly', 11), ('bicarbonate', 8), ('open-label', 3), ('instructed', 1), ('replace', 4), ('meals', 1), ('unchanged', 11), ('6.6', 2), ('0.8', 3), ('-1,2', 1), ('1,1', 4), ('0,5', 1), ('0.004', 3), ('-1,7', 1), ('-0,6', 1), ('bioelectrical', 1), ('impedance', 2), ('malnutrition', 5), ('instrument', 1), ('clinicaltrials', 1), ('gov', 1), ('identifier', 3), ('nct03236701', 1), ('fasudil', 10), ('rho-associated', 4), ('coiled', 4), ('coil-forming', 4), ('recovers', 1), ('methylmercury-induced', 1), ('axonal', 15), ('changing', 10), ('neurotoxicant', 2), ('neuropathological', 2), ('mehg-intoxicated', 4), ('survived', 2), ('mehg-induced', 2), ('nerve', 32), ('spinal', 23), ('cord', 28), ('persisted', 6), ('restorative', 5), ('rho', 2), ('supported', 36), ('cotreatment', 9), ('extension/retraction', 2), ('incoordination', 6), ('subacute', 2), ('mehg-mediated', 2), ('neuritic', 1), ('fasudil-induced', 1), ('interleukin-1beta', 27), ('inactivated', 6), ('kappa-light-chain-enhancer', 6), ('arginase-1', 1), ('interleukin-10', 4), ('wdr20', 7), ('shuttling', 4), ('usp12', 9), ('deubiquitinase', 2), ('deubiquitinases', 1), ('usp46', 6), ('closely', 23), ('paralogs', 4), ('suppressors', 2), ('catalytic', 25), ('cofactors', 5), ('uaf1', 2), ('share', 6), ('evolved', 3), ('non-overlapping', 1), ('divergence', 2), ('live', 9), ('epitope-tagged', 1), ('differently', 12), ('dubs', 1), ('site-directed', 3), ('mutagenesis', 3), ('mutants', 21), ('usp12/uaf1/wdr20', 3), ('dynamically', 1), ('shuttles', 1), ('crm1', 1), ('1meil4', 1), ('450mdgaiasgvskfatlslhd468', 1), ('divergently', 1), ('cofactor', 6), ('binding-regulated', 1), ('crm1-dependent', 1), ('tamoxifen-induced', 3), ('tamoxifen', 7), ('tam', 5), ('er+', 14), ('hormone-dependent', 3), ('tam-treatment', 1), ('drawn', 4), ('tam-induced', 1), ('d1', 36), ('coactivators', 3), ('proliferation-activated', 1), ('coactivator-1alpha', 2), ('pgc-1beta', 10), ('mahanine', 7), ('pi3k/akt/mtor', 23), ('glioma', 40), ('gliomas', 3), ('resection', 6), ('availability', 10), ('urgent', 7), ('need', 44), ('look', 2), ('683', 2), ('7.5', 10), ('astrocytes', 49), ('pcdc25c', 1), ('cdc25c', 2), ('pcdc2', 1), ('cdc2', 4), ('mahanine-inhibited', 1), ('p-mtor', 3), ('prove', 6), ('warrants', 5), ('decabromodiphenyl', 2), ('hyperglycemia', 23), ('decabde', 8), ('brominated', 10), ('flame', 29), ('retardant', 12), ('plastic', 9), ('textile', 1), ('clarify', 24), ('dysfuctions', 1), ('nd', 4), ('9.0', 1), ('kcal', 8), ('62.2', 1), ('equivalent', 17), ('l-decabde', 1), ('h-decabde', 1), ('weight/day', 5), ('libitum', 1), ('hfd-fed', 9), ('fasting', 21), ('h-decabde-exposed', 1), ('hfd-feeding', 1), ('tendency', 7), ('remarkable', 11), ('pathway-related', 8), ('ephrin-b1', 9), ('-b2', 7), ('-b4', 8), ('originate', 2), ('amuscular', 1), ('primordial', 4), ('diaphragm', 5), ('newborn', 5), ('infants', 9), ('players', 3), ('harvested', 8), ('gata-4/fgf-10', 1), ('calcitonin', 3), ('gene-related', 3), ('peptide', 39), ('expression/localization', 1), ('ephrin-b2', 1), ('distal', 8), ('carbofuran', 11), ('hampers', 2), ('oligodendrocytes', 12), ('myelination', 5), ('hippocampus', 70), ('oligodendrocyte', 5), ('progenitor', 18), ('opcs', 4), ('neuroepithelium', 1), ('migrate', 1), ('throughout', 24), ('framed', 1), ('sequential', 7), ('axons', 2), ('insulated', 1), ('sheath', 1), ('myelin', 11), ('conduction', 1), ('electric', 4), ('impulses', 2), ('memory', 72), ('neurological', 38), ('deficits', 36), ('carbamate', 3), ('hippocampal', 61), ('neurogenesis', 9), ('dysfunctions', 10), ('nonetheless', 5), ('maturation/differentiation', 1), ('sub-chronic', 5), ('periods', 16), ('brdu', 5), ('incorporation', 9), ('oligodendroglial', 1), ('ultrastructural', 6), ('carbofuran-mediated', 1), ('compaction', 1), ('g-ratio', 1), ('conclusively', 5), ('evi-1', 13), ('oncogene', 8), ('ecotropic', 1), ('site-1', 1), ('prognostic', 34), ('hematopoietic', 13), ('oncoprotein', 3), ('pro-apoptosis', 2), ('transduced', 2), ('8-cetylcoptisine', 2), ('coptisine', 3), ('mitochondria-dependent', 15), ('g0/g1', 17), ('ccop', 6), ('bgc-823', 2), ('cyclins', 1), ('cdks', 2), ('phosphoinositide', 15), ('3-kinase', 18), ('/protein', 1), ('enantioseparation', 1), ('ofloxacin', 7), ('3,4-dihydroxyphenylalanine', 2), ('functionalized', 2), ('nanoparticles-based', 1), ('extraction', 16), ('chiral', 8), ('pharmaceuticals', 3), ('biofluids', 1), ('task', 5), ('enantioseparate', 1), ('trace', 8), ('racemic', 1), ('urine', 61), ('mspe', 3), ('ce', 9), ('polydopa-mnps', 4), ('adsorbents', 3), ('extract', 68), ('spherical', 6), ('130', 4), ('polydopa', 1), ('shell', 1), ('adsorption', 7), ('desorption', 6), ('assistance', 3), ('sonication', 2), ('optimized', 8), ('7.0', 4), ('v/v', 2), ('acoh', 1), ('methanol', 6), ('eluent', 1), ('pressure-assisted', 1), ('field-enhanced', 1), ('pa-fesi', 1), ('enantiomers', 3), ('mspe/pa-fesi', 1), ('linearity', 2), ('0.01-0.06', 1), ('0.29', 6), ('ng/ml', 47), ('feasibility', 11), ('successful', 17), ('spiked', 3), ('samples', 126), ('heparin', 25), ('diclofenac', 27), ('epolamine', 2), ('medicated', 15), ('plaster', 12), ('nonsteroidal', 3), ('nsaid', 2), ('dhep', 11), ('topical', 32), ('localized', 10), ('minor', 22), ('strains', 32), ('sprains', 1), ('contusions', 1), ('epicondylitis', 1), ('knee', 4), ('osteoarthritis', 22), ('glycosaminoglycan', 1), ('nsaids', 2), ('formulation', 13), ('excipient', 3), ('supportive', 8), ('program', 19), ('enhancer', 11), ('pain/inflammation', 1), ('musculoskeletal', 4), ('post-traumatic', 2), ('rheumatic', 2), ('concept', 8), ('bioavailability', 13), ('formulations', 15), ('dissolution', 2), ('permeation', 4), ('testing', 43), ('released', 16), ('marketed', 2), ('benefit/risk', 1), ('180', 13), ('equal', 17), ('placebo', 15), ('breaking', 2), ('rules', 1), ('fmf', 6), ('inherited', 7), ('autoinflammatory', 1), ('attacks', 2), ('painful', 3), ('diffuse', 3), ('serositis', 1), ('amyloidosis', 2), ('il-1beta-mediated', 1), ('appears', 25), ('transmitted', 4), ('mefv', 3), ('symptom', 12), ('genotype-phenotype', 2), ('web-based', 1), ('tools', 13), ('usefully', 1), ('pathogenicity', 6), ('according', 51), ('entire', 4), ('coding', 9), ('sequenced', 1), ('179', 3), ('surveyed', 3), ('predictors', 7), ('recessivity', 1), ('silico', 24), ('describing', 4), ('paradigmatic', 1), ('genetics', 6), ('concepts', 5), ('assessing', 19), ('translated', 1), ('counselling', 2), ('gain-of-function', 5), ('dnmt3a', 14), ('microcephalic', 2), ('dwarfism', 2), ('polycomb-regulated', 1), ('polycomb', 2), ('establishment', 9), ('vertebrate', 10), ('missense', 10), ('hypocellular', 1), ('pwwp', 2), ('abrogate', 4), ('modifications', 31), ('h3k36me2', 3), ('h3k36me3', 2), ('polycomb-associated', 1), ('valleys', 1), ('hypomethylated', 1), ('encompassing', 1), ('methylated', 9), ('h3k27me3', 4), ('h3k4me3', 5), ('bivalent', 1), ('marks', 5), ('dnmt3aw326r', 1), ('pluripotent', 13), ('dnmt3aw326r/+', 1), ('dwarf', 1), ('normally', 4), ('limits', 15), ('polycomb-marked', 1), ('implicate', 10), ('interplay', 19), ('determinant', 4), ('organism', 8), ('alendronate', 2), ('intracerebroventricular', 3), ('streptozotocin', 16), ('abeta', 30), ('bace-1', 3), ('progressive', 35), ('decline', 32), ('precise', 21), ('etiopathology', 1), ('sporadic', 6), ('late-onset', 6), ('app', 15), ('deficit', 7), ('aln', 6), ('modifying', 7), ('supposed', 3), ('pathologies', 11), ('icv', 2), ('stz', 24), ('sad', 1), ('non-cholesterol', 1), ('donepezil', 13), ('preliminary', 9), ('modelling', 6), ('infused', 4), ('1.76', 1), ('spontaneous', 15), ('sab', 1), ('morris', 7), ('maze', 18), ('mwm', 6), ('abeta1-42', 4), ('bace-,1', 1), ('tbars', 9), ('icv-stz', 2), ('imply', 8), ('sad-like', 1), ('perinatal', 15), ('nonylphenol', 8), ('microglia-mediated', 4), ('np', 38), ('pop', 5), ('fetus', 9), ('pops', 12), ('resident', 4), ('defend', 1), ('co-localize', 1), ('tlr4/myd88/nf-kappab', 2), ('cli-095', 1), ('np-induced', 1), ('bv2', 3), ('over-activated', 1), ('bronchoalveolar', 19), ('exacerbation', 9), ('obstructive', 20), ('lactate', 61), ('aspirate', 2), ('aecopd', 9), ('analytical', 7), ('february', 6), ('2015', 13), ('march', 2), ('2017.', 3), ('84', 18), ('42', 12), ('copd', 37), ('anamnesis', 1), ('chest', 6), ('radiography', 1), ('spirometry', 1), ('bronchoscopy', 5), ('serum/bronchiolar', 1), ('8-oxoguanine', 2), ('glycosylase', 6), ('hogg1', 10), ('instability', 9), ('elevate', 2), ('electroplating', 4), ('issues', 5), ('dichromate', 3), ('lcl', 1), ('removing', 3), ('k2cr2o7-containing', 1), ('occupationally', 2), ('monomer', 5), ('2-hydroxyethyl', 2), ('methacrylate', 2), ('hema', 15), ('transcriptionally', 8), ('initiated', 19), ('electrophilic', 6), ('un-polymerized', 1), ('nrf2/are', 19), ('indirectly', 5), ('thiols', 3), ('2mm', 2), ('4h', 1), ('24h', 5), ('trolox', 6), ('6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic', 1), ('bso', 2), ('l-buthioninesulfoximine', 1), ('appear', 13), ('hema-induced', 1), ('hema-containing', 1), ('biomaterials', 2), ('nrf2-are', 4), ('kaempferol', 17), ('arpe-19', 6), ('flavonoid', 31), ('anti-metastasis', 4), ('cancer-cell', 1), ('non-toxic', 11), ('dosages', 11), ('erk1/2-specific', 1), ('cytokeratin', 2), ('canine', 15), ('cytokeratins', 1), ('cks', 5), ('filaments', 1), ('epithelia', 10), ('neoplasms', 3), ('ck', 4), ('routine', 15), ('formalin-fixed', 3), ('paraffin-embedded', 3), ('ffpe', 2), ('unaltered', 2), ('antibody', 28), ('detecting', 17), ('19', 25), ('pancytokeratin', 3), ('ae1/ae3', 2), ('allowed', 12), ('distinction', 4), ('statistical', 23), ('dogs', 10), ('ov-tl', 1), ('12/13', 1), ('fixation', 4), ('authors', 5), ('characterizes', 1), ('prerequisite', 3), ('similarities/differences', 1), ('neoplastic', 7), ('workflow', 2), ('chrysin', 36), ('thioacetamide-induced', 2), ('encephalopathy', 8), ('flavenoid', 1), ('thioacetamide', 7), ('taa-induced', 5), ('falling', 1), ('latency', 16), ('rotarod', 10), ('object', 10), ('ort', 2), ('ammonia', 3), ('toll-4', 1), ('tlr-4', 5), ('astrocyte', 14), ('swelling', 12), ('depicts', 1), ('hyperammonia', 1), ('ameliorating', 10), ('anti-oxidant', 24), ('tlr-4/nf-kappab', 1), ('underestimate', 3), ('clones', 4), ('overexpressing', 17), ('2c19', 4), ('3a4', 11), ('generating', 9), ('hepatoblastoma', 2), ('cyp', 59), ('cyp2c19-overexpressing', 1), ('clone', 13), ('hepg2-2c19', 3), ('c1', 4), ('82', 4), ('pmol', 1), ('min-1', 5), ('mg-1', 1), ('phenotypic', 12), ('stability', 35), ('passages', 2), ('renders', 1), ('suitable', 16), ('benchmarking', 1), ('cyp2c19', 6), ('interested', 2), ('cpa', 12), ('cyp3a4-overexpressing', 1), ('4-hydroxy-cyclophosphamide', 1), ('acrolein', 36), ('cyp3a4-', 1), ('cyp2c19-expressing', 1), ('xtt', 3), ('modest', 9), ('dramatic', 6), ('gammah2ax', 8), ('foci', 5), ('paralleled', 3), ('trypan', 6), ('blue', 17), ('exclusion', 5), ('underestimated', 5), ('quantitate', 1), ('realistically', 1), ('sepsis-induced', 9), ('sepsis', 17), ('silent', 5), ('twenty-four', 5), ('cardiomyocyte', 32), ('autophagosome', 8), ('myocardium', 13), ('creatine', 10), ('kinase-mb', 3), ('ck-mb', 2), ('bmal1', 6), ('per2', 2), ('rev-erba', 1), ('neuropeptide', 6), ('obesogen', 6), ('circadian', 14), ('clock', 6), ('feeding-related', 2), ('npy/agrp-expressing', 1), ('rev-erbalpha', 1), ('bmal1-knockout', 1), ('npy', 6), ('agrp', 2), ('promotor', 4), ('bmal1-ko', 1), ('hormonal', 14), ('freshwater', 4), ('cyanotoxin', 1), ('cylindrospermopsin', 2), ('stage-specific', 2), ('cyn', 4), ('waterborne', 4), ('hepatotoxin', 1), ('renewal', 5), ('regeneration', 28), ('elimination', 16), ('hnf4alpha+', 1), ('immature', 11), ('afp-expressing', 1), ('tumor-promoting', 3), ('anti-proliferative', 21), ('isoliquiritigenin', 3), ('childhood', 10), (\"4,2',4'-trihydroxychalcone\", 1), ('isl', 12), ('20-100', 1), ('confluency', 2), ('15-70', 1), ('10-100', 5), ('depleted', 7), ('stores', 4), ('15-90', 1), ('vehicle-treated', 5), ('isl-mediated', 1), ('externalization', 5), ('phosphatidylserine', 6), ('necrostatin-1', 2), ('12-42', 1), ('isl-treated', 1), ('rip1', 4), ('remained', 26), ('phosphorylated/total', 2), ('native', 8), ('migration/proliferation', 1), ('scratch', 9), ('arrested', 9), ('~10', 2), ('lesser', 7), ('40', 83), ('p-', 3), ('shsy5y', 4), ('necroptotic', 5), ('consequence', 14), ('hypertensive', 16), ('faah', 7), ('civilization', 1), ('vessels', 6), ('urb597', 10), ('amide', 8), ('hydrolase', 11), ('shrs', 2), ('electrical', 24), ('charge', 8), ('density', 44), ('zeta', 6), ('qualitative', 6), ('phospholipids', 7), ('hplc', 14), ('4-hydroxy-2e-hexenal', 1), ('4-hhe', 2), ('gcmsms', 1), ('sialic', 4), ('resorcinol', 14), ('shr', 11), ('phospholipid', 4), ('depend', 9), ('intensifies', 2), ('researches', 8), ('methotrexate', 8), ('folate', 20), ('juvenile', 17), ('mtx', 15), ('lymphoblastic', 6), ('neurovirulent', 1), ('c6', 3), ('astrocyte-like', 1), ('gfap-labeled', 1), ('pro-caspase-3', 1), ('mtx-induced', 4), ('dihydrofolate', 2), ('dhfr', 4), ('supplement', 12), ('gamma-mangostin', 2), ('alleviates', 30), ('3-superoxide-high', 1), ('gamma-man', 6), ('xanthones', 1), ('mangosteen', 6), ('garcinia', 2), ('mangostana', 2), ('lx-2', 20), ('injured', 8), ('alpha-smooth', 13), ('actin', 28), ('deacetylase', 14), ('hmgb1', 22), ('hmgb1-induced', 1), ('hsc', 17), ('ccl4-injured', 1), ('consequently', 28), ('eicosapentaenoic', 4), ('epa', 4), ('docosahexaenoic', 3), ('dha', 14), ('acids', 66), ('paraquat', 69), ('drosophila', 11), ('melanogaster', 6), ('omega-3', 5), ('neurodegeneration', 44), ('pq', 68), (\"1,1'-dimethyl-4-4'-bipyridinium\", 1), ('dichloride', 2), ('citrate', 5), ('h2o2', 40), ('unit', 18), ('fly', 1), ('heads', 4), ('elav', 1), ('vision', 4), ('alpha-spectrin', 1), ('synaptic', 25), ('gamma-secretase', 1), ('amyloid', 37), ('fibrils', 2), ('epa/dha', 1), ('pq-induced', 28), ('reinforcing', 6), ('strain', 16), ('cd-1', 25), ('stimuli', 15), ('sandwich', 3), ('configuration', 2), ('seeding', 3), ('identical', 4), ('3-methylcholanthrene', 3), ('phenobarbital', 17), ('rifampin', 1), ('p-450', 1), ('1a1', 8), ('cyp2b10', 7), ('cyp3a11', 20), ('differ', 10), ('450s', 1), ('hypersensitivity', 13), ('triacylglycerol', 5), ('allergies', 2), ('alcohols', 2), ('fluorescein', 2), ('isothiocyanate', 17), ('fitc', 3), ('chs', 1), ('tributyrin', 6), ('tag', 8), ('butyric', 2), ('triolein', 5), ('adjuvant', 22), ('fitc-chs', 2), ('contains', 15), ('mono-unsaturated', 1), ('dibutyl', 8), ('dbp', 38), ('fitc-presenting', 1), ('cd11c+', 1), ('trafficking', 7), ('draining', 3), ('lymph', 20), ('nodes', 11), ('dc', 8), ('cd86', 4), ('thymic', 4), ('lymphopoietin', 3), ('illustrates', 3), ('tags', 2), ('expected', 18), ('sulphur', 2), ('pathophysiology', 14), ('constitute', 6), ('backbone', 1), ('gaso-transmitter', 1), ('intrarectal', 2), ('0.9', 9), ('na2so3', 1), ('nahso3', 1), ('3:1', 1), ('0.54', 5), ('mmol/kg', 3), ('solution', 35), ('nf-k', 1), ('so2', 17), ('oxaloacetate', 2), ('transaminase', 14), ('attributed', 34), ('so2/glutamate', 1), ('endogenously', 6), ('alternariol', 2), ('pge2/ep2/camp/p-creb', 1), ('aoh', 7), ('mycotoxin', 17), ('contaminates', 3), ('stuffs', 1), ('mechanism/s', 1), ('mug/animal', 1), ('bi-fold', 1), ('hyperplasia', 17), ('camp', 29), ('prostanoid', 3), ('pmk', 2), ('50-500', 2), ('delineated', 3), ('aoh-induced', 1), ('pmks', 1), ('ep2/camp/p-creb', 1), ('mif', 16), ('hundred', 6), ('age-sex', 1), ('matched', 12), ('quantikine', 1), ('immunoassay', 2), ('homocysteine', 14), ('hcy', 7), ('binary', 13), ('24.7', 2), ('08.9', 1), ('18.3', 1), ('6.134', 1), ('cars', 3), ('1.11', 1), ('1.05-1.17', 1), ('hcy/crp/il-6', 2), ('admission', 18), ('66.7', 3), ('28.1', 1), ('8.5', 7), ('17.9', 4), ('6.482', 1), ('1.15', 4), ('1.04-1.19', 1), ('sod1-g93a', 1), ('thimerosal', 7), ('sirt1/dream/pdyn', 1), ('glycine', 10), ('93', 8), ('cu++/zn++', 1), ('sod1-g93', 5), ('amyotrophic', 5), ('sclerosis', 24), ('als', 17), ('stably', 13), ('transfected', 17), ('g93', 1), ('constructs', 6), ('ethylmercury', 1), ('thiosalicylate', 1), ('thimerosal-induced', 2), ('dependent-manner', 2), ('modulator', 10), ('dream', 8), ('participation', 9), ('polyubiquitination', 5), ('counteracted', 12), ('thimerosal-enhanced', 1), ('prodynorphin', 4), ('pdyn', 2), ('mum/24', 1), ('knocking-down', 1), ('thimerosal-reduced', 1), ('neurodetrimental', 1), ('toxicant', 11), ('diesel', 16), ('exhaust', 8), ('beta-adrenoceptors', 1), ('dep', 16), ('extractable', 2), ('dep-eom', 3), ('pahs', 22), ('seem', 7), ('gpcrs', 4), ('betaars', 4), ('par-2', 3), ('inflammation-associated', 5), ('cell-line', 2), ('hmec-1', 5), ('fractionated', 2), ('polarity', 1), ('n-hexane', 1), ('n-hex-eom', 4), ('dichloromethane', 1), ('dcm-eom', 4), ('methanol-eom', 2), ('water-eom', 2), ('2-3', 2), ('cxcl8', 8), ('2-15', 1), ('60-80', 1), ('betaar-inhibitor', 1), ('carazolol', 2), ('n-hex-', 1), ('ca2+-channel', 1), ('skf-96365', 1), ('dcm-eom-induced', 2), ('gene-expression', 1), ('betaar-overexpression', 1), ('par-2-inhibitor', 1), ('enmd-1068', 1), ('betaar', 1), ('extracted', 31), ('am1710', 13), ('morphine', 14), ('1,1-dimethyl-heptyl', 1), ('-1-hydroxy-9-methoxy-benzo', 1), ('chromen-6-one', 1), ('cannabilactone', 1), ('neuropathic', 6), ('rodents', 16), ('producing', 8), ('unwanted', 4), ('behaves', 1), ('broad-spectrum', 10), ('analgesic', 23), ('opioid', 18), ('forskolin-stimulated', 1), ('enduring', 2), ('mcb2', 2), ('hcb2', 1), ('paclitaxel-treated', 1), ('antinociceptive', 13), ('morphine-induced', 3), ('precipitate', 2), ('rendered', 3), ('tolerant', 3), ('freund', 8), ('cfa', 17), ('sciatic', 6), ('ligation', 3), ('psnl', 2), ('prophylactic', 16), ('antiallodynic', 1), ('gabapentin', 1), ('cell-cycle', 4), ('transformed', 6), ('e4', 1), ('participating', 7), ('hq-induced', 6), ('tk6-ht', 4), ('illustrate', 3), ('preliminarily', 3), ('plvx-she4f1', 1), ('plvx-shnc', 1), ('hairpin', 5), ('shrna', 13), ('plasmid', 8), ('plvx-shrna', 1), ('silencing-induced', 1), ('tk6-ht-shnc', 1), ('rb', 4), ('tk6-ht-shrna2', 1), ('tanshinone', 24), ('kras-dependent', 1), ('platinum-based', 4), ('4,5-dimethylthiazol-2-yl', 3), ('-2,5-diphenyltetrazolium', 3), ('bromide', 12), ('count', 17), ('soft-agar', 2), ('colony-formation', 1), ('rvista', 2), ('kras', 16), ('elk1', 5), ('kras-akt', 1), ('stat1/caspase-3', 3), ('fludarabine', 2), ('steroid-induced', 2), ('avascular', 2), ('femoral', 11), ('sanfh', 7), ('glucocorticoids', 11), ('flu', 17), ('stat1', 11), ('flu-treated', 1), ('hematoxylin-eosin', 5), ('phospho-stat1', 1), ('bak', 8), ('lymphoma-extra', 1), ('lymphoma-2', 3), ('dex', 31), ('empty', 4), ('lacunae', 2), ('ganoderic', 4), ('cyclophosphamide-induced', 7), ('gaa', 8), ('-1beta', 12), ('/trx/nf-kb', 1), ('txnip/trx/nf-kb', 1), ('apoptosis-related', 22), ('geraniol', 16), ('lupeol', 13), ('5-year', 9), ('former', 5), ('imperative', 5), ('smmc7721', 1), ('c-jun', 30), ('nh2-terminal', 2), ('anti-liver', 1), ('approaching', 2), ('atomic', 8), ('precision', 6), ('supramolecular', 7), ('assemblies', 8), ('weaker', 7), ('non-covalent', 2), ('bonding', 3), ('van', 3), ('der', 4), ('waals', 1), ('pi', 18), ('c-h', 4), ('self-assemblies', 1), ('host-guest', 1), ('complexes', 25), ('atomically', 3), ('nanoclusters', 2), ('ncs', 8), ('interesting', 10), ('structure-property', 1), ('evolving', 1), ('science', 9), ('reaffirms', 1), ('exploring', 16), ('dissimilar', 4), ('compositional', 1), ('cluster-assembled', 1), ('hybrid', 8), ('possibilities', 3), ('length', 40), ('scales', 2), ('brief', 9), ('discussion', 14), ('aspicule', 1), ('au25', 2), ('distinguish', 6), ('4-', 5), ('tert-butylbenzyl', 1), ('mercaptan', 1), ('bbsh', 1), ('-protected', 2), ('sbb', 1), ('cyclodextrins', 1), ('cd', 135), ('au25sbb18', 1), ('ag29', 3), ('bdt', 4), ('fullerenes', 2), ('c60', 1), ('1-9', 1), ('1,3-benzenedithiolate', 1), ('discussed', 9), ('adducts', 18), ('studied', 95), ('ionization', 7), ('optical', 10), ('absorption', 20), ('spectroscopy', 22), ('sections', 11), ('intercluster', 1), ('polymorphic', 8), ('crystals', 6), ('observable', 3), ('single-crystal', 2), ('x-ray', 13), ('diffraction', 6), ('taking', 10), ('tpp', 2), ('triphenylphosphine', 1), ('packing', 2), ('cubic', 1), ('trigonal', 1), ('lattices', 1), ('plasmonic', 2), ('nanostructures', 3), ('p-mercaptobenzoic', 1), ('p-mba', 5), ('ag44', 2), ('tellurium', 1), ('nanowires', 1), ('te', 2), ('nws', 2), ('crossed-bilayer', 2), ('woven-fabric-like', 1), ('angle', 7), ('layers', 10), ('au102', 1), ('transmission', 23), ('tem', 11), ('geometry', 2), ('nc', 11), ('encapsulate', 3), ('gold', 8), ('nanorods', 3), ('cage-like', 1), ('three-dimensional', 6), ('tomographic', 2), ('reconstructions', 1), ('-cooh', 1), ('aspect', 9), ('advancement', 1), ('close', 18), ('modeling', 26), ('tlr5', 9), ('hyperammonaemia-induced', 1), ('inactivating', 12), ('mediator', 9), ('flagellin', 1), ('hyperammonaemia', 1), ('ha', 29), ('intragastric', 6), ('haematoxylin', 2), ('eosin', 5), ('ihc', 6), ('visualize', 2), ('tunel', 21), ('transam', 1), ('colorimetric', 7), ('kit', 13), ('ha-induced', 6), ('tlr5/nf-kappab', 1), ('tlr5/mapk', 1), ('deepening', 1), ('remove', 2), ('hypothyroid', 3), ('state-linked', 2), ('mirrored', 3), ('compete', 2), ('coenzyme', 10), ('q9', 1), ('q10', 8), ('hypothyroidism', 14), ('hyperthyroidism', 3), ('ubiquinone', 1), ('non-enzymatic', 3), ('inferred', 4), ('emission', 19), ('idea', 2), ('opposite', 27), ('way', 20), ('cytochromes', 3), ('colorectal', 74), ('dissect', 2), ('crc', 80), ('1,439', 1), ('720', 1), ('imputed', 1), ('haplotype', 6), ('consortium', 3), ('genome-wide', 26), ('34,869', 1), ('29,051', 1), ('23,262', 1), ('38,296', 1), ('chd1', 1), ('meta-analysis', 24), ('125,478', 1), ('~100', 2), ('lower-frequency', 1), ('kruppel-like', 4), ('hedgehog', 21), ('hippo-yap', 2), ('heritability', 4), ('polygenic', 3), ('enabling', 2), ('personalized', 2), ('statin-associated', 1), ('myotoxicity', 1), ('ldl-cholesterol', 2), ('tolerated', 3), ('life-threatening', 13), ('myopathy', 2), ('statin-induced', 1), ('co-regulator', 2), ('atorvastatin', 10), ('skm-/-', 2), ('conversion', 13), ('iia', 16), ('iib', 1), ('myofibers', 1), ('switch', 8), ('fibers', 16), ('myotoxic', 1), ('kcnj4', 11), ('adenocarcinoma', 37), ('voltage-gated', 4), ('belongs', 5), ('inward', 1), ('rectifier', 1), ('biologic', 4), ('ladc', 7), ('atlas', 7), ('datasets', 11), ('-mediated', 25), ('technology', 14), ('plate', 8), ('wound-healing', 3), ('transwell', 18), ('sirna-mediated', 4), ('kinase/extracellular', 1), ('p-mek', 2), ('p-erk', 11), ('player', 6), ('valuable', 16), ('protease-activated', 1), ('receptor-1', 4), ('organophosphate-induced', 1), ('epilepticus', 7), ('organophosphates', 5), ('op', 18), ('soldiers', 1), ('civilians', 1), ('weapons', 2), ('war', 7), ('terror', 1), ('manifestations', 7), ('poisoning', 40), ('se', 33), ('seizure-related', 1), ('op-exposed', 1), ('clotting', 1), ('hyperexcitability', 2), ('seizures', 19), ('glutamate-dependent', 1), ('carried', 39), ('ex', 23), ('par-1', 5), ('paraoxon-induced', 2), ('slices', 14), ('paraoxon', 3), ('prothrombin', 3), ('brains', 20), ('paraoxon-treated', 1), ('electrophysiological', 5), ('ca1', 4), ('ca3', 1), ('sch79797', 1), ('altogether', 17), ('pharmacodynamic', 4), ('pregabalin', 11), ('suppositories', 6), ('commercially', 2), ('impossible', 2), ('terminally', 3), ('suppository', 5), ('hospitals', 3), ('bases', 5), ('comprising', 7), ('witepsol', 3), ('h-15', 8), ('s-55', 7), ('e-75', 1), ('pharmacokinetics', 18), ('pharmacodynamics', 2), ('releasing', 6), ('auc0-', 3), ('refrigerated', 1), ('shielding', 1), ('siponimod', 4), ('immune-mediated', 2), ('focal', 20), ('demyelination', 3), ('presentation', 12), ('relapsing-remitting', 1), ('accrual', 2), ('relapses', 1), ('minority', 2), ('beginning', 8), ('achievements', 1), ('relapsing', 3), ('evolution', 4), ('unmet', 1), ('covered', 4), ('covers', 2), ('baf312', 1), ('sphingosine', 6), ('1-phosphate', 2), ('ms.', 4), ('pubmed', 4), ('english', 1), ('keywords', 1), (\"'siponimod\", 1), (\"'baf312\", 1), (\"'multiple\", 1), ('expert', 9), ('opinion', 6), ('gradual', 5), ('adherens', 3), ('toluene', 12), ('diisocyanate-induced', 2), ('cell-cell', 3), ('perpetuation', 1), (\"'ve\", 1), ('diisocyanate', 2), ('tdi', 13), ('vanilloid', 6), ('trpv4', 8), ('ankyrin', 2), ('tdi-induced', 12), ('sensitized', 13), ('gsk', 2), ('2193874', 1), ('hc030031', 4), ('gsk2193874', 3), ('neither', 15), ('blunted', 6), ('neutrophilia', 3), ('proposing', 2), ('isoniazid', 13), ('hydrazine', 4), ('pyridoxal', 2), ('isonicotinoyl', 2), ('hydrazone', 4), ('rifampicin', 25), ('protoporphyrin', 5), ('ix', 8), ('penultimate', 1), ('ferrochelatase', 1), ('fech/fech', 1), ('aminolevulinic', 1), ('alas1/alas1', 1), ('upregulate', 12), ('alas1', 5), ('fech', 6), ('pih', 6), ('isoniazid-vitamin', 1), ('b6', 2), ('conjugate', 11), ('hepg2/c3a', 4), ('coadministered', 1), ('pih-mediated', 1), ('chelation', 6), ('contributing', 15), ('paradoxical', 4), ('emodin', 20), ('anit-induced', 5), ('intrahepatic', 9), ('herb-induced', 1), ('herbal', 13), ('medicines', 7), ('bas', 11), ('anit-treated', 3), ('pro-cholestatic', 2), ('farnesoid', 7), ('emodin-containing', 1), ('herbs', 10), ('polygonum', 3), ('multiflorum', 3), ('semen', 5), ('cassiae', 1), ('aggravate', 8), ('interferes', 6), ('ampk-fxr', 1), ('sc-treated', 1), ('anthraquinones', 1), ('strongest', 9), ('predictive', 23), ('b6c3f1', 4), ('dox-induced', 28), ('somamer-based', 1), ('proteomic', 21), ('1129', 1), ('profiled', 3), ('sal', 16), ('cardio-protectant', 1), ('dexrazoxane', 1), ('dxz', 2), ('=1.2-fold', 1), ('dox-treated', 2), ('sal-treated', 1), ('8-week', 4), ('neurogenic', 6), ('von', 6), ('willebrand', 3), ('vwf', 5), ('legumain', 1), ('mannan-binding', 1), ('lectin', 3), ('addressing', 6), ('clethodim', 9), ('aquatic', 23), ('firstly', 11), ('deformities', 5), ('edema', 44), ('secondly', 2), ('thirdly', 1), ('tlr', 9), ('myd88', 8), ('mug/l', 39), ('il8', 4), ('mock', 2), ('tlr4-kd', 1), ('achr', 1), ('carbachol', 1), ('clethodim-modulated', 1), ('ecosystems', 4), ('sh3px1', 10), ('dnedd4-long', 1), ('neuromuscular', 6), ('nedd4', 1), ('dnedd4', 1), ('hect', 1), ('e3', 8), ('ubiquitin', 11), ('ligase', 12), ('dnedd4s', 2), ('dnedd4lo', 10), ('terminus', 1), ('middle', 18), ('synaptogenesis', 4), ('nms', 6), ('partners', 7), ('sh3', 1), ('px', 2), ('bar', 1), ('ultrastructure', 5), ('presynaptic', 5), ('pro-rich', 1), ('sh3px1-sh3', 1), ('s2', 1), ('periphery', 2), ('post-synaptically', 2), ('pre-synaptically', 1), ('subsynaptic', 1), ('unexpectedly', 6), ('overexpress', 3), ('null', 7), ('neurotransmission', 5), ('compensatory', 14), ('remaining', 11), ('allele', 30), ('post-synaptic-specific', 1), ('infarction-associated', 1), ('thiamethoxam', 3), ('trigonella', 1), ('foenum-graecum', 1), ('seed-derived', 1), ('polysaccharide', 12), ('pesticides', 79), ('today', 3), ('tmx', 5), ('fenugreek', 1), ('seed', 17), ('fwep', 5), ('cardiomyoblastes', 1), ('served', 8), ('regarding', 43), ('noted', 11), ('phosphokinase', 2), ('troponin-t', 2), ('transferase', 11), ('triglyceride', 33), ('defense', 31), ('non-protein', 5), ('thiol', 7), ('carbonyls', 4), ('histo-architecture', 2), ('genotoxicity', 13), ('abts', 2), ('radical-scavenging', 3), ('linoleic', 2), ('genomic', 32), ('nicking', 1), ('tmx-induced', 1), ('hollow', 2), ('s-nitrosothiols', 4), ('nanoparticle', 11), ('polymeric', 8), ('brushes', 3), ('-releasing', 1), ('kind', 7), ('4-vinylphenylboronic', 1), ('brush', 1), ('dual', 17), ('responsiveness', 14), ('endows', 1), ('kill', 3), ('participate', 12), ('necessity', 4), ('diphenhydramine', 1), ('port-a-cath', 1), ('rheumatoid', 15), ('arthritis', 24), ('nano-selenium', 1), ('bisphenol-induced', 1), ('manufacture', 6), ('injurious', 1), ('unveil', 2), ('nse', 7), ('ninety', 1), ('150', 23), ('lasted', 3), ('prostatic', 9), ('measurement', 17), ('internucleosomal', 2), ('receptor-2', 2), ('restoration', 23), ('surpassed', 1), ('laddering', 4), ('offered', 5), ('ovine', 4), ('trophectoderm', 2), ('otr1', 4), ('peri-implantation', 1), ('endocrine-disrupting', 25), ('10-4', 5), ('10-9', 7), ('10-7m', 1), ('10-5', 3), ('cathepsin', 8), ('implantation', 22), ('glucocorticoid-activation', 5), ('glucocorticoid-insulin-like', 1), ('gc-igf1', 3), ('programming', 17), ('dysplasia', 11), ('intrauterine', 17), ('iugr', 7), ('sacrificed', 20), ('nci-h295', 1), ('glucocorticoid-related', 1), ('adrenals', 1), ('steroidal', 4), ('synthetases', 3), ('1200', 1), ('adrenocortical', 2), ('speculated', 4), ('utero', 28), ('hohenbuehelia', 2), ('serotina', 4), ('polysaccharides', 9), ('antineoplastic', 10), ('non-clinical', 1), ('hsp', 11), ('caffeic', 2), ('dimer', 5), ('-epicatechin-3-', 1), (\"3'-o-methyl\", 1), ('-gallic', 1), ('quercetin-acetyl-rutinoside', 1), ('hexoside', 1), ('-epigallocatechin', 1), ('rutin', 2), ('catechin', 2), ('trimer', 2), ('3-caffeoylquinic', 1), ('termination', 4), ('expanded', 4), ('anti-neoplasm', 1), ('ckd2', 1), ('cdk4', 7), ('beta-caryophyllene', 4), ('myelin-associated', 2), ('infiltrates', 2), ('glial', 26), ('bcp', 14), ('oln-93', 1), ('sphingomyelinase', 4), ('smase', 3), ('ppar', 7), ('-gamma', 2), ('nrf2/ho-1/anti-oxidant', 1), ('ppar-gamma', 24), ('0.2', 17), ('10-50', 2), ('imipramine', 2), ('imp', 1), ('fluoxetine', 5), ('flx', 8), ('undertaken', 11), ('antimony', 2), ('sb', 26), ('gdm', 23), ('2093', 1), ('tongji', 2), ('tmchc', 1), ('icp-ms.', 1), ('robust', 16), ('adjustment', 12), ('confounders', 4), ('95th', 2), ('percentile', 7), ('creatinine-corrected', 1), ('cc-sb', 3), ('1.33', 1), ('mug/g', 5), ('0.49', 2), ('logarithmic', 1), ('rr', 7), ('1.29', 5), ('1.57', 3), ('tertile', 22), ('1.92-fold', 1), ('1.42', 2), ('2.60', 1), ('p-value', 5), ('stratification', 15), ('antibiotic-induced', 3), ('mycobacteria', 3), ('gained', 8), ('bedaquiline', 1), ('sirturo', 1), ('kills', 1), ('f1f0', 2), ('nadh', 2), ('dehydrogenases', 2), ('ndh-2', 1), ('ndha', 1), ('bc', 20), ('susceptible', 32), ('antituberculosis', 2), ('classical', 13), ('must', 14), ('maximize', 3), ('subinhibitory', 1), ('uncouplers', 1), ('bactericidal', 2), ('moxifloxacin', 5), ('isoniazid-', 1), ('moxifloxacin-induced', 1), ('mycobacterial', 2), ('dissipated', 3), ('combinations', 10), ('tuberculosis', 6), ('saccharomyces', 3), ('cerevisiae', 4), ('methane', 6), ('beef', 6), ('cattle', 12), ('yeast', 12), ('ch4', 7), ('meta-analytic', 2), ('compilation', 2), ('scientific', 7), ('publications', 2), ('1990', 2), ('meta-analyses', 1), ('pooled', 18), ('dataset', 9), ('category', 7), ('ch4/dmi', 2), ('q', 16), ('i2', 2), ('statistic', 2), ('designs', 1), ('yeasts', 2), ('rumen', 1), ('thiophene', 4), ('2a-e', 1), ('infrared', 5), ('447.28', 1), ('1004.65', 1), ('309.44', 1), ('935.93', 1), ('0.28', 2), ('4.01', 1), ('epilepsy', 18), ('glaucoma', 24), ('duodenal', 3), ('ulcers', 4), ('mountain', 1), ('sickness', 1), ('clopidogrel', 10), ('lipopolysaccharide-induced', 7), ('neutrophil-platelet', 2), ('aggregates', 7), ('endotoxemic', 2), ('endotoxemia', 9), ('platelet-leukocyte', 1), ('platelet-neutrophil', 1), ('thrombocytopenia', 6), ('shedding', 3), ('cd40l', 1), ('cd62p', 1), ('pyrrole', 2), ('tinospora', 3), ('cordifolia', 2), ('designated', 5), ('triple', 17), ('tnbc', 33), ('2-', 12), ('ethyl', 6), ('1h-pyrrole-3,4-dicarboxylate', 1), ('tccp', 7), ('deltapsim', 13), ('mptp', 12), ('cardiolipin', 3), ('fluorometrically', 1), ('caspases', 10), ('annexin-v', 2), ('reverted', 3), ('pifithrin-mu', 1), ('depolarization', 15), ('sub', 3), ('ehrlich', 5), ('ascites', 7), ('eat', 2), ('effectiveness', 31), ('~2', 1), ('fold', 18), ('hepato-renal', 1), ('mitochondrial-mediated', 3), ('ferulic', 8), ('tgf-beta1/smad', 9), ('nox4/ros', 3), ('mfa', 8), ('procollagen', 2), ('pc-iii', 1), ('civ', 1), ('mmp-2/timp-1', 1), ('ginsenosides', 6), ('protopanaxadiol', 1), ('panax', 2), ('ginseng', 2), ('atp-induced', 1), ('yopro-1', 1), ('patch-clamp', 4), ('rd', 2), ('~twofold', 1), ('potentiation', 5), ('ivermectin', 16), ('p2x7', 2), ('hek-293', 5), ('p2x7-deficient', 2), ('bv-2', 7), ('enabled', 2), ('insensitivity', 2), ('atp-', 1), ('atp+', 1), ('ginsenoside-induced', 1), ('homology', 10), ('zfp2x4', 1), ('yielded', 12), ('ginsenoside', 8), ('vestibule', 1), ('ectodomain', 1), ('timp-2', 11), ('discriminatory', 2), ('receiver', 6), ('operating', 6), ('curve', 15), ('specificity', 40), ('emerged', 13), ('bio-sensing', 1), ('raw264.7', 7), ('beat', 1), ('hypoactivity', 4), ('ascribed', 3), ('tnfalpha', 16), ('interferon-gamma', 5), ('bio-compatibility', 1), ('tetrandrine', 4), ('multiforme', 5), ('tet', 25), ('sub-lethal', 3), ('p-egfr', 1), ('tyr1068', 1), ('sos-1', 1), ('grb2', 2), ('ser473', 3), ('thr308', 1), ('nf-kappab-p65', 1), ('n-cadherin', 14), ('p-jnk1/2', 1), ('p-c-jun', 2), ('electrophoretic', 1), ('emsa', 1), ('d-galactosamine-induced', 1), ('fulminant', 2), ('goh', 17), ('oils', 6), ('/d-galactosamine', 1), ('d-galn', 2), ('fhf', 4), ('800', 5), ('lps/d-glan', 1), ('lps/d-galn-induced', 2), ('lps/d-galn', 1), ('artesunate', 12), ('ferroptosis', 30), ('lacks', 6), ('attractively', 1), ('hemisuccinate', 1), ('artemisinin', 3), ('immunomodulating', 1), ('little-known', 1), ('ferritinophagy-', 1), ('endoperoxide', 1), ('ptgs2', 5), ('embodied', 1), ('vitality', 7), ('accumulated', 10), ('peroxides', 5), ('deferoxamine', 4), ('dfo', 6), ('artesunate-induced', 3), ('anti-fibrosis', 4), ('evidently', 4), ('ferritinophagy', 9), ('atg3', 1), ('atg6/beclin1', 1), ('atg12', 1), ('fth1', 1), ('ferritin', 2), ('heavy', 24), ('ncoa4', 1), ('lumen', 5), ('alkalizer-chloroquine', 1), ('ferritinophagy-mediated', 1), ('clues', 8), ('dapagliflozin', 11), ('fructose-streptozotocin-induced', 1), ('challenges', 12), ('dn', 37), ('co-transporter', 1), ('fructose-streptozotocin', 1), ('fr-stz', 3), ('350', 2), ('podocyte', 5), ('ngal', 20), ('cystatin', 3), ('vanin-1', 2), ('nag', 2), ('nephrin', 5), ('interstitial', 24), ('glomerulosclerosis', 9), ('normoalbuminuria', 1), ('reactions', 30), ('presumably', 6), ('diabetes-induced', 3), ('cav3.2', 12), ('t-type', 3), ('bortezomib', 6), ('proteasome-inhibiting', 1), ('myeloma', 1), ('bortezomib-induced', 1), ('bipn', 5), ('afferents', 1), ('administrations', 5), ('2r/s', 1), ('-6-prenylnaringenin', 1), ('ktt-45', 1), ('tta-a2', 1), ('ascorbic', 8), ('cav3.1', 1), ('l4-l6', 1), ('1-21', 1), ('usp5', 4), ('deubiquitinating', 1), ('3-21', 1), ('bortezomib-treated', 1), ('drg-derived', 1), ('nd7/23', 1), ('t-channel-dependent', 1), ('mg-132', 1), ('nociceptor', 1), ('excitation', 16), ('nociceptors', 2), ('activity-dependent', 2), ('jte907', 7), ('treg', 17), ('immunomodulatory', 5), ('immunoregulatory', 1), ('selective/inverse', 1), ('th', 33), ('lineage-specific', 2), ('naive', 6), ('cd4+', 11), ('lymphocytes', 26), ('spleen', 21), ('th0', 2), ('foxp3', 6), ('stat5a', 1), ('dnbs-induced', 1), ('cd4+cd25+foxp3+', 1), ('lamina', 2), ('propria', 1), ('delivered', 8), ('embryo-larval', 3), ('pyrethroids', 10), ('non-target', 9), ('environmentally', 26), ('type-i', 6), ('permethrin', 30), ('bifenthrin', 13), ('type-ii', 1), ('deltamethrin', 17), ('lambda-cyhalothrin', 2), ('esfenvalerate', 1), ('0.0', 4), ('5-h', 1), ('post-fertilization', 14), ('5-d', 1), ('dpf', 21), ('static', 5), ('swimming', 8), ('distance', 12), ('traveled', 6), ('velocity', 2), ('5-dpf', 1), ('nrf2a', 16), ('gst', 14), ('casp-9', 4), ('esterase', 5), ('ces', 8), ('bifenthrin-', 2), ('esfenvalerate-', 2), ('curvature', 3), ('pericardial', 11), ('concentrations-', 2), ('permethrin-', 2), ('0.122', 1), ('lambda-cyhalothrin-', 1), ('0.053', 2), ('fenvalerate-0.037', 1), ('fenvalerate-', 1), ('5.', 3), ('disparity', 1), ('aqueous', 11), ('2-hydroxylase', 2), ('fa2h', 5), ('cancellation', 2), ('pparbeta/delta-mediated', 6), ('ppars', 7), ('pparbeta/delta', 10), ('well-characterized', 2), ('repress', 5), ('express', 9), ('delta9-thc', 40), ('drug-type', 1), ('reasoned', 1), ('bioluminescence', 5), ('arc', 8), ('activity-regulated', 1), ('cytoskeleton-associated', 1), ('neuronal-activity-dependent', 2), ('experience-dependent', 1), ('arc-promoter-driven', 1), ('tg', 34), ('monitor', 11), ('glufosinate', 4), ('methylcarbaryl', 1), ('imidacloprid', 2), ('arc-luc', 4), ('slowly', 4), ('kainic', 2), ('neuroexcitatory', 1), ('convulsive', 2), ('juveniles', 2), ('overexcitation', 1), ('cardiomyoblasts', 2), ('limitation', 5), ('survivors', 12), ('vulnerable', 9), ('adaptations', 5), ('drug-free', 2), ('sub-therapeutic', 2), ('acidification', 7), ('dnmt1', 20), ('epigenetic-based', 2), ('raising', 6), ('preconditioning', 2), ('phenols', 5), ('constrained', 1), ('seldom', 1), ('xenobiotics', 14), ('u.s.-based', 1), ('national', 18), ('nutrition', 13), ('nhanes', 1), ('fitted', 3), ('multivariable', 12), ('quantile', 2), ('sum', 12), ('wqs', 4), ('bayesian', 4), ('kernel', 2), ('bkmr', 2), ('1269', 1), ('38.5', 1), ('58.0', 1), ('abdominal', 27), ('carboxyoctyl', 1), ('mcop', 5), ('2-ethyl-5-carboxypentyl', 1), ('mecpp', 2), ('fourth', 9), ('bmi', 14), ('1.63', 1), ('1.21-2.20', 1), ('1.66', 1), ('1.18-2.34', 1), ('mep', 3), ('heavily', 2), ('weighing', 3), ('60th', 1), ('50th', 2), ('flat', 2), ('recommend', 2), ('interpreting', 1), ('advantages', 2), ('disadvantages', 2), ('thymoquinone', 17), ('ebselen', 2), ('arsenite-induced', 7), ('tq', 20), ('arsenite', 19), ('administrated', 19), ('28', 46), ('lpo', 7), ('nitrite/nitrate', 4), ('oxidant/antioxidant', 3), ('imbalance', 15), ('post-administration', 1), ('as-induced', 2), ('bioactive', 35), ('constituent', 19), ('nigella', 3), ('organoselenium', 2), ('biomethylation', 1), ('neurodevelopmental', 28), ('copy', 6), ('dnm', 2), ('10,927', 1), ('253', 1), ('gene-disruptive', 1), ('lgd', 1), ('reach', 11), ('exome-wide', 1), ('intersecting', 1), ('cnv', 1), ('30/253', 1), ('lr', 1), ('+1.85', 1), ('0.0017', 1), ('dnms', 4), ('overlapping', 8), ('kif1a', 1), ('2q37', 1), ('duplication', 6), ('mapk3', 1), ('16p11.2', 1), ('chd4', 1), ('12p13', 1), ('wdfy4', 1), ('10q11.23', 1), ('cell-specific', 5), ('enrichments', 1), ('d1+', 1), ('d2+', 1), ('spiny', 1), ('striatum', 26), ('at-rvd1', 10), ('paraquat-induced', 12), ('aspirin-triggered', 3), ('resolvin', 3), ('ari', 3), ('ng', 12), ('toxication', 2), ('euthanized', 9), ('post-paraquat', 1), ('collect', 2), ('ly-6g+', 2), ('cd41+', 2), ('ib', 1), ('escalation', 3), ('expansion', 20), ('afuresertib', 11), ('carboplatin', 4), ('platinum-resistant', 5), ('ovarian', 76), ('preclinically', 1), ('restores', 6), ('pan-akt', 1), ('pc', 22), ('proc', 3), ('platinum-refractory', 1), ('pproc', 2), ('3+3', 1), ('50-150', 1), ('mg/day', 10), ('175', 1), ('mg/m2', 2), ('auc5', 1), ('cycles', 8), ('125', 9), ('single-arm', 2), ('mtd', 3), ('tolerability', 7), ('investigator-assessed', 1), ('orr', 7), ('recist', 2), ('version', 8), ('1.1', 5), ('twenty-nine', 1), ('dose-limiting', 2), ('rash', 5), ('=50', 1), ('drug-related', 1), ('nausea', 10), ('diarrhea', 8), ('vomiting', 13), ('alopecia', 10), ('fatigue', 6), ('neutropenia', 5), ('intention', 2), ('32', 10), ('15.9-52.4', 1), ('52', 10), ('31.3-72.2', 1), ('gcig', 1), ('ca125', 1), ('7.1', 2), ('6.3-9.0', 1), ('window', 12), ('ovariectomy', 6), ('et', 23), ('perimenopausal', 1), ('depression', 22), ('fails', 3), ('menopause', 3), ('ovx', 10), ('tryptophan', 6), ('hydroxylase', 10), ('tph2', 4), ('customized', 1), ('rt2', 2), ('profiler', 2), ('reverse-transcription', 1), ('forced', 11), ('swim', 12), ('anxiety-like', 4), ('behaviours', 1), ('ovx-increased', 1), ('sfrs7', 1), ('sfrs16', 1), ('ovx-decreased', 1), ('zrsr2', 1), ('ctnnb1', 7), ('raphe', 2), ('erbeta-specific', 2), ('eralpha-specific', 1), ('paradigm', 6), ('mimicked', 5), ('serotonin', 16), ('timing', 2), ('estrogen-based', 1), ('antidepressants', 3), ('multitissue', 2), ('multiomics', 3), ('disruptions', 6), ('linking', 5), ('edcs', 18), ('debated', 1), ('leveraged', 3), ('edc', 10), ('mg/kg/d', 5), ('no-observed-adverse-effect', 2), ('tens', 1), ('methylomic', 1), ('cross-tissue', 1), ('perturbations', 5), ('tissue-specific', 8), ('prioritized', 4), ('hnf4a', 12), ('srebf1', 3), ('fasn', 8), ('cyp51', 1), ('nfya', 1), ('lastly', 8), ('perturbs', 2), ('offers', 8), ('2a', 8), ('aplastic', 1), ('anemia', 12), ('pp2a', 9), ('hepatocyte-specific', 1), ('ppp2r1a', 2), ('aalpha', 1), ('wildtype', 11), ('progenitors', 4), ('s-phenyl', 1), ('mercapturic', 1), ('exhalation', 1), ('exhaled', 4), ('disclosed', 3), ('b56alpha', 1), ('pp2a-b56alpha', 2), ('ser33-ser37-thr41', 1), ('notion', 6), ('ip', 11), ('post', 23), ('harvest', 2), ('lavage', 15), ('balf', 16), ('w/d', 2), ('erythroid-2', 2), ('oxidoreductase-1', 1), ('oxygenase-1', 25), ('neutrophil', 20), ('percent', 20), ('factor-kappab', 19), ('bleomycin-induced', 9), ('ipf', 5), ('tar', 3), ('tried', 7), ('continuously', 9), ('cigarettes', 3), ('bleomycin', 6), ('11', 30), ('15.', 2), ('reflected', 10), ('percentages', 7), ('cse', 8), ('p-smad2/3', 1), ('collagen-i', 1), ('pleural', 5), ('mesothelial', 1), ('pmcs', 5), ('cse-induced', 5), ('superimposed', 2), ('tgf-beta-smad2/3', 2), ('-akt', 2), ('bleomycin-treated', 1), ('nodular', 4), ('regenerative', 4), ('piperonyl', 6), ('butoxide', 6), ('pbo', 31), ('masses', 3), ('nodules', 7), ('nrh', 8), ('lesion', 24), ('truly', 2), ('nonneoplastic', 1), ('six-week-old', 1), ('icr', 7), ('6,000', 1), ('43', 14), ('complementary', 4), ('frozen', 3), ('clustered', 2), ('delta-notch', 1), ('loaded', 12), ('biopolymeric', 1), ('gum', 5), ('acacia', 5), ('microsphere', 3), ('invitro', 2), ('invivo', 1), ('ga', 47), ('microspheres', 8), ('co-precipitation', 1), ('xrd', 2), ('fesem', 1), ('1h', 4), ('ftir', 5), ('visible', 10), ('spectra', 7), ('dls', 2), ('solubility', 4), ('rendering', 1), ('comfortably', 1), ('encapsulated', 4), ('perturbing', 5), ('delivering', 4), ('in-vivo', 2), ('implicates', 6), ('hinokiflavone', 10), ('focuses', 4), ('hoechst', 4), ('ct26', 2), ('ki-67', 4), ('serological', 7), ('hematoxylin', 3), ('species-mitochondria-mediated', 1), ('smox', 6), ('cerebral', 66), ('ischemia/reperfusion', 8), ('spermine', 1), ('polyamine', 2), ('oxidases', 2), ('ischemic', 19), ('occlusion', 9), ('mcao', 5), ('oxygen-glucose', 3), ('deprivation', 6), ('reoxygenation', 1), ('ogd/r', 6), ('adeno-associated', 5), ('mcao-induced', 2), ('infarct', 3), ('supernatant', 10), ('ischemia', 16), ('aurantium', 4), ('tetrachloride-mediated', 1), ('peel', 4), ('peoca', 6), ('limonene', 1), ('linalool', 1), ('dpph', 6), ('beta-carotene', 1), ('bleaching', 2), ('lps-stimulated', 5), ('raw264,7', 1), ('cu-zn', 1), ('gpx', 12), ('accordance', 4), ('corynoxine', 2), ('hmgb1-dependent', 2), ('come', 2), ('limelight', 1), ('mn-induced', 9), ('high-mobility', 4), ('-dependent', 8), ('dysregulate', 2), ('alpha-synuclein', 27), ('beclin1', 10), ('finding', 25), ('cory', 4), ('b-alone', 1), ('dissociating', 2), ('crocin', 10), ('methylglyoxal-induced', 1), ('dicarbonyl', 3), ('cell-permeant', 1), ('end-products', 2), ('degenerative', 9), ('saffron', 1), ('osteoclasts', 12), ('multinucleated', 1), ('up-', 5), ('bone-related', 1), ('mg-induced', 2), ('tartrate-resistant', 4), ('factor-6', 4), ('traf6', 3), ('akt2', 3), ('kinase-1', 4), ('erk1', 3), ('osteopetrosis-associated', 1), ('ostm1', 2), ('mek/erk/creb', 3), ('atrazine', 2), ('atr', 11), ('artificial', 4), ('hippocampus-dependent', 1), ('postnatal', 46), ('bw', 17), ('/day', 1), ('spatial', 15), ('probe', 11), ('amongst', 4), ('dentate', 3), ('gyrus', 7), ('dg', 4), ('cornu', 1), ('ammonis', 1), ('sub-regions', 1), ('atr-treated', 1), ('members', 32), ('zif268', 1), ('industrialized', 3), ('societies', 1), ('dams', 11), ('consumed', 9), ('400', 21), ('microg', 4), ('bpa/kg/day', 1), ('con', 13), ('15.8', 1), ('pups', 13), ('individually', 22), ('dosed', 4), ('consume', 3), ('periadolescent', 1), ('mpfc', 12), ('p10', 5), ('p90', 3), ('pre-mrna', 2), ('workup', 2), ('parkinsonism', 4), ('positron', 4), ('map-weighted', 2), ('3t', 3), ('nigral', 1), ('hyperintensity', 1), ('nigrostriatal', 2), ('smwi', 5), ('n-3-fluoropropyl-2-beta-carbomethoxy-3-beta-', 1), ('4-iodophenyl', 1), ('nortropane', 1), ('18f-fp-cit', 5), ('pet', 19), ('ethics', 1), ('committee-approved', 1), ('223', 1), ('69.7', 1), ('135', 4), ('performances', 3), ('evaluating', 9), ('equivalence', 1), ('dtcompair', 1), ('package', 4), ('cohen', 1), ('sensitivities', 4), ('94.5', 1), ('sn', 12), ('95.3', 1), ('86.7', 1), ('94.4', 2), ('84.0', 1), ('-0.086', 1), ('-0.104', 1), ('excluding', 1), ('ganglia', 1), ('agreement', 13), ('0.899', 1), ('0.945', 1), ('corilagin', 5), ('carbohydrate', 6), ('anti-diabetic', 16), ('polyphenolic', 8), ('tannins', 2), ('glycated', 3), ('haemoglobin', 2), ('viz', 4), ('bw/day', 5), ('glibenclamide', 4), ('exhibiting', 9), ('antihyperlipidemic', 1), ('analogues', 41), ('foodstuffs', 1), ('bpp', 4), ('preference', 12), ('z', 12), ('fusaric', 4), ('neglected', 7), ('niacin', 1), ('multiprotein', 1), ('scaffold', 6), ('il-beta', 2), ('nrlp3', 3), ('priming', 16), ('spectrophotometry', 5), ('luminometry', 2), ('experimentation', 2), ('programs', 9), ('sheds', 4), ('immunosuppressive', 9), ('subepidermal', 2), ('hyperalgesia', 7), ('stz-induced', 12), ('9.5-', 1), ('peripherin-', 1), ('neurofilament', 2), ('200-immunoreactivity', 1), ('ir', 20), ('senfs', 6), ('cgrp', 3), ('-ir', 3), ('gathered', 2), ('perk1/2', 2), ('perk1/2-ir', 2), ('portion', 8), ('colocalized', 2), ('cgrp-ir', 1), ('intraplantar', 3), ('pl', 29), ('u0126', 5), ('1,4-diamino-2,3-dicyano-1,4-bis', 1), ('2-aminophenylthio', 1), ('butadiene', 4), ('dose-responsive', 1), ('botulinum', 1), ('serotype', 2), ('trpv', 2), ('antagonists', 35), ('cgrp-', 1), ('channel-mediated', 1), ('hyperglycemia-induced', 2), ('pristimerin', 11), ('mapk/nf-kb', 2), ('background/purpose', 1), ('pris', 9), ('triterpenoid', 7), ('nothing', 4), ('cardiotoxic', 9), ('afterwards', 1), ('electrocardiography', 1), ('ecg', 3), ('abnormities', 2), ('pris-treated', 1), ('pro-fibrogenic', 1), ('amelioration', 13), ('factor-erythroid', 5), ('nrf2-dependent', 7), ('gcl', 2), ('mitogen', 3), ('/nuclear', 3), ('kappa-b', 8), ('nf-kb', 25), ('obestatin', 8), ('adropin', 7), ('prader-willi', 2), ('bmi-z', 1), ('paediatric', 1), ('younger', 6), ('pws', 7), ('bmi-z-matched', 1), ('31', 12), ('ghrelin', 14), ('preproghrelin', 2), ('gabaar-coupled', 1), ('cl-/hco3', 4), ('--', 11), ('atpase', 18), ('phenol-induced', 4), ('head-twitching', 1), ('tremor', 7), ('manifests', 2), ('twitching/tremor', 1), ('20-160', 1), ('20-80', 1), ('twitching', 2), ('picrotoxin', 2), ('o-vanadate', 1), ('~55-70', 1), ('atpases', 1), ('phosphoprotein', 1), ('atp-consuming', 1), ('cl-', 2), ('reconstituted', 1), ('pma-induced', 3), ('fibrosarcoma', 4), ('ht-1080', 1), ('kahweol', 4), ('akt/jnk1/2/p38', 2), ('coffee', 7), ('sales', 1), ('beverage', 3), ('phytochemicals', 11), ('ka', 9), ('coffee-specific', 1), ('diterpene', 4), ('anti-tumoric', 1), ('tumoric', 1), ('pma-enhanced', 1), ('analyzing', 7), ('low-concentration', 1), ('elevating', 8), ('phosphatidylinositide', 1), ('phosphorylations', 2), ('chromosome-linked', 2), ('xiap', 8), ('synergism', 4), ('pentachlorophenol', 4), ('copper-1,10-phenanthroline', 2), ('co-occur', 2), ('pcp', 12), ('cu', 32), ('wood', 5), ('preservatives', 1), ('fluids', 4), ('ordinary', 1), ('escherichia', 6), ('coli', 8), ('low-toxic', 2), ('0-1.6', 1), ('pcp/cu', 4), ('molar', 3), ('2:1', 2), ('caspase-3/9', 1), ('glutathione/oxidized', 2), ('hl-7702', 7), ('p-erk-1/2', 1), ('p-jnk', 3), ('2-induced', 1), ('preferentially', 10), ('xiap-ros-apoptosis', 1), ('sensitizing', 6), ('ocular', 28), ('neoplasia', 3), ('ossn', 4), ('ophthalmological', 1), ('surveillance', 4), ('reporting', 11), ('12-month', 1), ('0.53', 3), ('cases/million/year', 3), ('conjunctival', 3), ('intraepithelial', 1), ('0.43', 1), ('eighty-five', 2), ('cent', 2), ('97', 7), ('caucasian', 4), ('67.9', 2), ('+-12.8', 1), ('limbus', 1), ('nasal', 26), ('bulbar', 1), ('conjunctivae', 1), ('visual', 11), ('acuity', 1), ('6/9', 1), ('interferon', 20), ('second-line', 1), ('occasionally', 3), ('subject', 6), ('bias', 7), ('1996.', 1), ('referral', 2), ('olmesartan', 2), ('chemically-induced', 1), ('nrf-2/ho-1', 5), ('at1r', 9), ('olm', 8), ('resemblance', 2), ('intense', 5), ('intra-rectal', 1), ('ml', 9), ('aa-induced', 8), ('machinery', 11), ('caspase3', 11), ('lay', 2), ('behind', 12), ('nfkb', 2), ('multigenerational', 2), ('early-life', 10), ('realm', 1), ('popularized', 1), ('seizure', 19), ('origins', 1), ('dohad', 1), ('fitness', 4), ('f1', 24), ('f0', 14), ('0.024', 3), ('0.12', 3), ('0.6', 12), ('0.4', 9), ('0.006', 7), ('0.15', 5), ('0.02', 15), ('generations', 4), ('fertilization', 10), ('c-fos', 13), ('deleted-in-azoospermia', 1), ('dazl', 2), ('photomotor', 6), ('unexposed', 4), ('cannabinoid-related', 1), ('fecundity', 10), ('ramifications', 1), ('huntingtin', 8), ('huntington', 2), ('hd', 9), ('stimulus', 7), ('gtpase', 2), ('q140/q140', 2), ('knock-in', 2), ('sds-page', 2), ('rac', 1), ('1.5-month-old', 1), ('lysates', 2), ('p85alpha', 2), ('bundling', 1), ('alpha-actinin', 1), ('gtp', 3), ('coordinated', 6), ('transcriptome', 37), ('assembly', 18), ('arillode', 1), ('baccaurea', 2), ('motleyana', 2), ('mull', 1), ('arg', 1), ('rambai', 1), ('underutilized', 1), ('natives', 1), ('indonesia', 2), ('thailand', 1), ('malaya', 1), ('peninsula', 1), ('cultivated', 3), ('java', 2), ('island', 4), ('lim', 1), ('2012', 9), ('edible', 13), ('reddish', 3), ('arillodes', 1), ('sweet', 2), ('acid-sweet', 1), ('tastes', 1), ('nucleotide', 20), ('scarce', 11), ('deposited', 7), ('genbank', 3), ('paired-end', 1), ('illumina', 4), ('assembled', 5), ('contigs', 3), ('trinity', 1), ('filtering', 1), ('37,077', 1), ('contig', 2), ('ranged', 4), ('201-4972', 1), ('n50', 1), ('696', 1), ('annotated', 4), ('swissprot', 1), ('trembl', 1), ('nr', 7), ('nt', 1), ('ncbi', 1), ('databases', 7), ('reads', 1), ('ddbj', 2), ('dra', 1), ('dra007358', 1), ('iadp01000001-iadp01037077', 1), ('accessed', 1), ('//rujakbase.id', 1), ('cyppa', 8), ('melanogenesis', 9), ('gsk3beta/beta-catenin', 4), ('b16f10', 2), ('cyclohexyl-', 1), ('3,5-dimethyl-pyrazol-1-yl', 1), ('-6-methyl-pyrimidin-4-yl', 1), ('-amine', 1), ('small-conductance', 1), ('ca2+-activated', 1), ('k+', 3), ('anti-melanogenic', 3), ('melanin', 8), ('melanocytes', 5), ('nhm', 1), ('likewise', 7), ('tyrosinase', 7), ('tyr', 3), ('melanogenesis-related', 1), ('microphthalmia-associated', 2), ('mitf', 8), ('melanoderm', 1), ('cyppa-treated', 1), ('kinase-3beta', 3), ('beta-catenin/mitf', 1), ('gsk3beta/beta-catenin/mitf', 1), ('dexmedetomidine', 3), ('gsk-3beta/mkp-1/nrf2', 2), ('alpha2', 4), ('adrenergic', 4), ('gsk-3beta', 26), ('alpha2ar', 3), ('l-glutathione', 1), ('wb', 7), ('sb216763', 3), ('antioxidant-related', 3), ('mkp-1', 6), ('2-related', 27), ('anti-apoptosis-related', 2), ('pro-apoptosis-related', 1), ('sb21676', 1), ('atipamezole', 1), ('reversing', 5), ('anti-apoptosis', 2), ('psoralen', 7), ('isopsoralen', 7), ('fructus', 3), ('psoraleae', 2), ('fp', 3), ('undetermined', 4), ('80', 32), ('320', 1), ('160', 6), ('mrp2', 13), ('sult2a1', 6), ('loperamide-induced', 2), ('loperamide', 18), ('over-the-counter', 3), ('antidiarrheal', 1), ('supratherapeutic', 1), ('gavaged', 3), ('hydrochloride', 8), ('fragmented', 4), ('provoked', 8), ('explanation', 6), ('overdose', 23), ('multicolorimetric', 2), ('listeria', 4), ('monocytogenes', 8), ('etching', 2), ('food-borne', 4), ('sensing', 16), ('tmb2+', 2), ('apt-mnp', 1), ('igy-bsa-mno2', 1), ('oxidase-like', 1), ('nano-artificial', 1), ('oxidize', 1), ('tmb', 11), ('generate', 19), ('longitudinal', 17), ('resonances', 1), ('106', 4), ('cfu', 3), ('ml-1', 5), ('vivid', 1), ('color', 5), ('colorful', 1), ('rainbow', 1), ('glance', 1), ('recoveries', 2), ('97.4', 1), ('101.3', 1), ('pre-enrichment', 1), ('perception', 4), ('instrumental', 1), ('on-site', 1), ('treadmill', 4), ('exercise', 18), ('postural', 5), ('compromising', 3), ('autophagy-lysosome', 2), ('e.g', 18), ('paradigms', 1), ('7-8', 1), ('non-lesioned', 1), ('categories', 6), ('exclusively', 6), ('regularity', 2), ('unforced', 1), ('walk', 1), ('automated', 1), ('catwalk', 1), ('xt', 1), ('irregular', 5), ('stride', 1), ('diagonal', 1), ('three-paw', 1), ('immuno-reactivity', 1), ('robustly', 3), ('platycodin', 11), ('db/db', 7), ('platycodi', 1), ('radix', 5), ('platycodon', 2), ('grandiflorum', 1), ('anti-obesity', 2), ('anti-obese', 1), ('design/methods', 1), ('gain', 34), ('thermogenic', 4), ('pd-treated', 1), ('3t3-l1', 12), ('adipose-derived', 7), ('hamscs', 2), ('obesity-related', 4), ('ccaat/enhancer', 1), ('c/ebpalpha', 6), ('uncoupled', 2), ('pcg1alpha', 1), ('bat-associated', 1), ('ampkalpha', 9), ('ampk-associated', 1), ('pgc1alpha', 1), ('nullified', 1), ('anti-adipogenic', 1), ('hsp70', 30), ('formaldehyde-induced', 5), ('pneumonia', 4), ('shock', 31), ('atp-dependent', 1), ('chaperone', 5), ('fa-induced', 4), ('mumol/l', 15), ('gli2', 7), ('annexin-apc/7aad', 1), ('double-labeled', 1), ('ly', 9), ('294002', 1), ('pi3k-akt', 5), ('needed', 32), ('adenylyl', 4), ('imidazole', 3), ('miconazole', 8), ('nine', 19), ('trans-membrane', 1), ('tmac', 5), ('synthesize', 2), ('isoform-selective', 1), ('imidazoles', 2), ('ac1', 2), ('intact', 11), ('crude', 13), ('stimulators', 2), ('ensuing', 1), ('ac9', 5), ('gdp-beta-s', 1), ('ac2', 1), ('clotrimazole', 3), ('acs', 1), ('saturation', 8), ('vmax', 3), ('km', 5), ('isoproterenol', 5), ('calcineurin', 2), ('fk506', 3), ('forskolin', 2), ('cooh-terminal', 1), ('autoinhibition', 1), ('isoform-specific', 2), ('ca2+/calcineurin', 1), ('achievable', 2), ('phenylated', 1), ('chains', 3), ('exploration', 14), ('exploit', 1), ('acea', 10), ('excitotoxicity', 8), ('perspectives', 4), ('plaques', 3), ('neurofibrillary', 1), ('tangles', 1), ('tau', 37), ('hyperphosphorylation', 7), ('presumptive', 1), ('-selective', 1), (\"arachidonyl-2'-chloroethylamide\", 1), ('neuro-2a', 3), ('stz-triggered', 1), ('claudins', 1), ('nonspecific', 4), ('hyper-reactivity', 1), ('allergen', 9), ('alpha/beta-unsaturated', 1), ('room', 7), ('irritant', 5), ('tobacco', 11), ('cooking', 4), ('uncontrolled', 2), ('asthma-like', 1), ('rads', 6), ('ovalbumin', 2), ('ova', 6), ('ppm/10', 1), ('hyper-responsiveness', 1), ('56', 7), ('57.', 1), ('antioxidant-associated', 1), ('sham', 5), ('cldns', 1), ('hops', 7), ('popular', 12), ('tend', 3), ('take', 9), ('alternatives', 7), ('relieve', 6), ('menopausal', 1), ('spent', 8), ('beer', 1), ('brewing', 1), ('prenylated', 8), ('flavonoids', 42), ('xanthohumol', 7), ('xh', 5), ('isoxanthohumol', 3), ('8-prenylnaringenin', 3), ('8-pn', 8), ('6-prenylnaringenin', 1), ('6-pn', 3), ('glucuronic', 2), ('hop', 4), ('phytoestrogens', 1), ('electrophile', 3), ('detoxification', 26), ('h-quinone', 1), ('s-transferase', 9), ('alkylates', 3), ('antiobesity', 1), ('xh-rich', 1), ('1a1/2', 1), ('1b1', 8), ('2c8', 3), ('2c9', 9), ('phytoconstituents', 1), ('erk-nfkappab', 1), ('jak1/2-stat3', 1), ('cpla2', 3), ('jak1', 2), ('jak2', 2), ('portulaca', 2), ('oleracea', 3), ('arising', 4), ('trauma', 6), ('leaves', 5), ('po', 11), ('possesses', 19), ('50-200', 2), ('dexa', 6), ('subsequentially', 1), ('wet/dry', 2), ('wbc', 4), ('tgf', 4), ('-beta', 2), ('broncho', 1), ('paving', 1), ('rational', 4), ('lung-related', 1), ('triptonide', 8), ('tumorigenicity', 11), ('shh-gli1', 3), ('inadequate', 2), ('bottleneck', 1), ('anti-lung', 3), ('5-10', 2), ('spheres', 2), ('sphere-forming', 1), ('gli1', 8), ('repressing', 5), ('sonic', 6), ('shh', 18), ('ptch1', 1), ('smo', 11), ('syncytiotrophoblasts', 3), ('arise', 6), ('cytotrophoblasts', 2), ('aea', 20), ('aea-mediated', 2), ('explants', 9), ('bewo', 17), ('trophoblasts', 18), ('hcgalpha', 1), ('syncytin-1', 1), ('0-10', 2), ('3-24', 1), ('coordinately', 1), ('hcgss', 1), ('syncytin-2', 1), ('mycoestrogens', 1), ('perfluorinated', 2), ('aea-treated', 1), ('mycoestrogen', 1), ('zearalenone', 22), ('glyburide', 1), ('labeled', 3), ('bodipy', 1), ('co-treated', 4), ('am630', 7), ('8-br-camp', 1), ('forskolin-induced', 1), ('cb2-camp', 1), ('exposure-induced', 4), ('integrin', 14), ('beta1', 9), ('associates', 4), ('interpreted', 2), ('quickly', 7), ('s134', 1), ('d137', 1), ('e229', 1), ('autodock', 4), ('vina', 3), ('native-page', 1), ('tumorigenic', 4), ('give', 13), ('rise', 19), ('concerns', 17), ('farnesol', 2), ('steatotic', 4), ('isoprenoid', 2), ('foh', 8), ('loading', 5), ('hepatocyte-like', 1), ('oleic', 2), ('oa', 34), ('oa-induced', 3), ('~25', 3), ('arrays', 6), ('lipid-metabolizing', 2), ('foh-mediated', 1), ('oa-loaded', 1), ('hydroxyacyl-coa', 1), ('dehydrogenase/3-ketoacyl-coa', 1), ('thiolase/enoyl-coa', 1), ('hydratase', 1), ('acyltransferase', 2), ('lost', 7), ('gw6471', 2), ('drug-metabolizing', 4), ('1a2', 10), ('2b6', 3), ('pparalpha-mediated', 1), ('visceral', 9), ('dss', 16), ('visceromotor', 2), ('distention', 1), ('crd', 2), ('cb', 2), ('synthesizing', 1), ('worsened', 4), ('5-ht4', 2), ('n-acyl-phosphatidylethanolamine-specific', 1), ('nape-pld', 3), ('somatostatin', 3), ('corticotrophs', 2), ('pasireotide', 7), ('shrinkage', 4), ('term', 10), ('date', 14), ('pasireotide-mediated', 1), ('cytostatic', 3), ('acth-secreting', 4), ('corticotroph', 1), ('att-20', 3), ('sst5', 2), ('sst2', 1), ('-12.1', 2), ('phospho-erk1/2', 3), ('-36.4', 1), ('20.5', 2), ('3.6', 10), ('-10.5', 2), ('7.7', 1), ('-13.9', 1), ('10.9', 1), ('-26.8', 1), ('bim23206', 2), ('bim23120', 2), ('octreotide', 3), ('-13.3', 1), ('9.1', 1), ('-8.4', 2), ('28.6', 4), ('-51.4', 1), ('15.9', 2), ('implication', 12), ('sst5-mediated', 1), ('piperlongumine', 4), ('anthracyclines', 4), ('assumes', 2), ('cbr1', 10), ('biotransformation', 16), ('undesirable', 9), ('chemosensitizing', 2), ('piper', 2), ('longum', 2), ('alkaloid', 13), ('tracked', 2), ('fraction', 17), ('lc-ms', 6), ('doxorubicinol', 2), ('doxol', 1), ('structure-based', 5), ('saikosaponin', 4), ('pscs', 12), ('ssd', 19), ('bupleurum', 1), ('falcatum', 1), ('dibutyltin', 1), ('2.0', 16), ('gavage', 18), ('ecm', 21), ('mmps/timps', 1), ('tgf-beta1/smads', 2), ('concluded', 23), ('trioxide-induced', 2), ('anti-angiogenesis', 7), ('triple-negative', 11), ('subtype', 8), ('her-2', 2), ('poorer', 6), ('hematogenous', 1), ('spreads', 2), ('cancerous', 5), ('restrained', 5), ('zeste', 4), ('il-6/stat3', 1), ('irinotecan', 7), ('rucaparib', 5), ('combinatorial', 6), ('par', 7), ('dna-damaging', 5), ('sulforhodamine', 3), ('synergy', 2), ('olaparib', 12), ('microsatellite', 4), ('mss', 5), ('unstable', 4), ('msi', 6), ('isogenic', 3), ('facs', 6), ('exerting', 4), ('late-stage', 3), ('g2-m', 3), ('early-stage', 7), ('ki67', 6), ('rps6kb1', 1), ('kml001', 6), ('salvage', 8), ('refractory', 11), ('biliary', 14), ('meta-arsenite', 1), ('naaso2', 5), ('telomerase', 7), ('telomere', 1), ('btc', 4), ('gemcitabine-based', 2), ('forty-four', 1), ('ps', 9), ('0-2', 1), ('eligible', 6), ('bimonthly', 1), ('ct.', 1), ('0.5-10.0', 1), ('6.8', 1), ('52.3', 1), ('40.9', 1), ('dropped', 4), ('2.3', 6), ('completed', 13), ('kept', 3), ('47.6', 2), ('grade-3', 1), ('aes', 9), ('grade-4', 1), ('11/44', 1), ('10/44', 1), ('22.7', 1), ('discontinued', 2), ('13.6', 1), ('qtc', 3), ('prolongation', 2), ('enough', 3), ('gemcitabine', 6), ('well-tolerable', 1), ('immunotherapy', 22), ('crpc', 7), ('castration-sensitive', 2), ('cspc', 4), ('pd-l1', 18), ('cd3/cd8', 1), ('pd-l1/2', 1), ('rna-seq', 20), ('395', 1), ('immune-related', 8), ('cd276', 2), ('pvr', 1), ('nectin2', 1), ('immunostimulatory', 1), ('epithelial-to-mesenchymal', 8), ('-related', 4), ('unsupervised', 6), ('checkpoint', 16), ('pvr/nectin2/cd226/tigit', 1), ('azoxystrobin', 2), ('delays', 5), ('sexual', 13), ('strobilurin', 1), ('2-4', 3), ('20.0', 5), ('intersex', 2), ('disappeared', 3), ('retarded', 3), ('gonadal', 7), ('cyp19a', 6), ('cyp19b', 3), ('hsd3b', 4), ('hsd17b', 1), ('vtg1', 6), ('vtg2', 1), ('reared', 2), ('azo-free', 1), ('leiomyoma', 8), ('membrane-associated', 2), ('eralpha36', 9), ('nongenomic', 7), ('fibroids', 5), ('hormonally', 2), ('ht-utlm', 5), ('fibroid', 2), ('g0-g1', 1), ('mum-200', 1), ('sos1', 1), ('mapkp44/42/erk1/2', 1), ('pegfr', 2), ('mapkp44/42', 1), ('psrc', 2), ('coimmunoprecipitation', 1), ('sieralpha36', 2), ('beings', 5), ('indeed', 10), ('transposons', 1), ('cdh1', 6), ('sfn', 1), ('tnfrsf10c', 1), ('implied', 6), ('thbs4', 1), ('creb5', 1), ('col5a3', 1), ('ontology', 15), ('self-fertilizing', 2), ('kryptolebias', 2), ('marmoratus', 5), ('gnrh', 8), ('mangrove', 1), ('killifish', 1), ('k.', 5), ('gnrh1', 5), ('sequences', 11), ('gnrh2', 2), ('chicken', 7), ('gnrh-ii', 1), ('gnrh3', 5), ('salmon', 1), ('cloning', 1), ('deduced', 3), ('medaka', 1), ('preoptic', 1), ('gnrh1-immunoreactive', 1), ('gnrh1-ir', 1), ('luteinizing', 10), ('tegmentum', 1), ('gnrh2-ir', 1), ('telencephalic', 2), ('gnrh3-ir', 2), ('lh-ir', 1), ('neuromodulators', 1), ('18f-sodium', 1), ('sacroiliitis', 8), ('axial', 1), ('spondyloarthritis', 2), ('sacroiliac', 1), ('sij', 5), ('18f-naf', 4), ('pet/ct', 9), ('spa', 3), ('idrcb', 1), ('2012-a00568-35', 1), ('clinicaltrials.gov', 4), ('nct', 1), ('02869100', 1), ('single-center', 3), ('asas', 3), ('ny', 1), ('ap-view', 1), ('radiograph', 1), ('readers', 2), ('sijs', 2), ('sparcc', 5), ('scoring', 8), ('erosion', 4), ('metaplasia', 3), ('backfill', 1), ('ankylosis', 1), ('scored', 3), ('slice-by-slice', 1), ('inspired', 3), ('pet-activity', 3), ('standardised', 1), ('suvmax', 18), ('mris', 2), ('18.7', 1), ('18.2', 1), ('+-8.7', 1), ('1.78', 1), ('inter-reader', 1), ('reliability', 2), ('icc=', 1), ('0.56', 1), ('ic-95', 2), ('0.76', 1), ('icc=0.70-0.90', 1), ('0.96', 4), ('r=0.61', 1), ('p=0.001', 3), ('r=0.56', 1), ('p=0.004', 1), ('87.0', 1), ('43.5', 1), ('65.2', 1), ('regresses', 1), ('virtue', 3), ('antiapoptotic', 15), ('hes', 10), ('flavanone', 3), ('glycoside', 4), ('predominant', 9), ('ch', 4), ('iso', 10), ('iso-control', 1), ('p.o.+enalapril', 1), ('p.o.', 2), ('s.c.', 6), ('hemodynamics', 5), ('alleviation', 9), ('coronarin', 2), ('though', 12), ('jnk1/2', 3), ('southeast', 3), ('asian', 8), ('countries', 18), ('taiwan', 3), ('anti-bacterial', 1), ('nasopharyngeal', 9), ('caspase-8', 12), ('-3.', 2), ('cd-treated', 6), ('torsina', 2), ('heterologous', 1), ('lumenal', 2), ('linc', 1), ('dyt1', 1), ('dystonia', 1), ('in-frame', 1), ('glutamic', 3), ('codon', 3), ('aaa+', 1), ('tora', 11), ('envelope/endoplasmic', 1), ('membrane-spanning', 1), ('lap1', 3), ('lull1', 1), ('ill-defined', 1), ('budding', 2), ('torsins', 1), ('interrogate', 5), ('envelope-embedded', 1), ('spindle', 16), ('pole', 3), ('bodies', 12), ('spbs', 2), ('oligomerization', 2), ('sun', 1), ('sad1', 1), ('unc-84', 1), ('-domain', 1), ('mps3', 2), ('physically', 4), ('sun1/2', 1), ('spb', 1), ('atpase-stimulating', 1), ('tora-deltae', 3), ('pom152', 2), ('biochemically', 4), ('tora-nucleoporin', 1), ('avenues', 5), ('envelope', 2), ('herniations', 1), ('steato-hepatitic', 1), ('fibrosing', 1), ('inadequacy', 1), ('co-administered', 6), ('fast', 3), ('ffd', 3), ('chow', 6), ('fth', 3), ('sth', 2), ('hep3b', 15), ('palmitic', 8), ('transferred', 10), ('featured', 4), ('ff', 4), ('tgf-ss', 1), ('complemented', 2), ('anti-nafld', 1), ('anti-fibrotic', 15), ('bamboo', 2), ('stems', 3), ('phyllostachys', 2), ('henosis', 1), ('phenylhydrazine-induced', 2), ('hepatoprotective', 19), ('pn3', 8), ('nqo1-are', 1), ('nf-e2-related', 2), ('nqo-1', 7), ('arachidonic', 8), ('iron-induced', 3), ('chlorogenic', 1), ('p-coumaric', 4), ('iron-mediated', 1), ('phenylhydrazine', 1), ('mice-a', 1), ('overload-induced', 1), ('immunopathology', 2), ('coronavirus', 14), ('spike', 5), ('coronaviruses', 4), ('syndrome-related', 2), ('sars-cov', 6), ('east', 12), ('mers-cov', 14), ('virus-cell', 1), ('th1-prone', 1), ('tmprss2-knockout', 1), ('dpp4', 2), ('hdpp4-tg', 2), ('tmprss2-ko', 2), ('tmprss2-deficient', 1), ('kinetics', 19), ('weakened', 7), ('chemokine', 13), ('intranasal', 5), ('infected', 16), ('immunopathology.importance', 1), ('antiviral', 34), ('pandemic', 2), ('belonging', 4), ('cleaves', 2), ('infections', 24), ('nano-tio2', 9), ('obscuration', 1), ('nano-titanium', 1), ('sunblock', 1), ('chief', 2), ('route', 14), (\"8-hydroxy-2'-deoxyguanosine\", 1), ('appearance', 2), ('immunoglobulin', 12), ('hypersensitive', 2), ('neutralizing', 5), ('injure', 3), ('stress-induced', 14), ('repositioning', 6), ('salicylanilide', 4), ('anthelmintic', 5), ('already', 14), ('agencies', 1), ('costs', 4), ('steady', 3), ('increment', 5), ('immunosuppressed', 4), ('efficacious', 5), ('supports', 11), ('search', 9), ('anti-adenovirus', 3), ('niclosanide', 1), ('oxyclozanide', 2), ('rafoxanide', 2), ('hadv', 1), ('endosome', 1), ('whilst', 5), ('e1a', 1), ('community-acquired', 1), ('kamir', 8), ('st-elevation', 3), ('grace', 5), ('stemi', 5), ('guidelines', 10), ('inherent', 5), ('compatible', 3), ('korea', 5), ('1093', 1), ('48.2', 2), ('hs-crp', 7), ('pro-b-type', 2), ('natriuretic', 5), ('nt-probnp', 1), ('power', 11), ('receiver-operating', 1), ('roc', 8), ('auc', 23), ('0.802', 6), ('0.721', 2), ('mace', 9), ('0.683', 5), ('0.656', 1), ('1.019', 2), ('1.015-1.024', 2), ('1.052', 1), ('1.000-1.104', 1), ('0.018', 2), ('nt-pro', 6), ('bnp', 11), ('1.142', 1), ('1.004-1.280', 1), ('0.021', 4), ('1.012', 1), ('1.003-1.021', 1), ('0.020', 2), ('1.136', 1), ('1.104-1.168', 1), ('0.890', 1), ('5.982', 1), ('0.873', 1), ('3.721', 1), ('0.871', 1), ('2.187', 1), ('0.047', 2), ('0.940', 1), ('6.177', 1), ('0.771', 2), ('6.818', 1), ('0.712', 1), ('2.022', 1), ('0.031', 3), ('0.720', 1), ('2.974', 1), ('0.789', 1), ('6.900', 1), ('above-mentioned', 1), ('receptor-alpha', 9), ('nongenotoxic', 3), ('insecticide', 26), ('pathologists', 2), ('2500', 1), ('5000', 2), ('treatment-related', 4), ('2-year', 3), ('moa', 20), ('investigative', 4), ('cyp4a', 8), ('cyp2b', 6), ('mitogenic', 4), ('permethrin-induced', 3), ('plausible', 9), ('interspersed', 2), ('elements', 25), ('sines', 4), ('normalization', 3), ('lobe', 3), ('validate', 12), ('rodent-specific', 2), ('tle', 12), ('genorm', 3), ('normfinder', 2), ('ranked', 6), ('hprt1', 2), ('ywhaz', 1), ('gusb', 1), ('b2m', 1), ('skewed', 1), ('normalize', 5), ('implementing', 3), ('-notably', 1), ('element-', 1), ('aggravating', 3), ('keshan', 3), ('congestive', 1), ('0.25-1', 1), ('cardiomyocytes', 50), ('cleaved-caspase', 1), ('3.', 7), ('lc3-ii', 11), ('3-methyladenine', 5), ('lowered', 12), ('exacerbate', 10), ('subchronic', 14), ('depression-like', 6), ('high-sucrose', 6), ('high-sucrose/high-fat', 2), ('normal-diet', 1), ('c-nd', 1), ('np-l-nd', 1), ('np-m-nd', 1), ('np-h-nd', 1), ('hshfd', 6), ('c-hshfd', 1), ('np-l-hshfd', 1), ('np-m-hshfd', 1), ('np-h-hshfd', 2), ('anxiety', 19), ('np-h', 1), ('arms', 8), ('disordered', 5), ('cristae', 2), ('curvatures', 1), ('postsynaptic', 2), ('cleft', 3), ('width', 5), ('hshfd-only', 1), ('np-only', 1), ('dissimilarities', 2), ('polyhexamethyleneguanidine', 2), ('phmg-p', 34), ('biocide', 2), ('guanidine', 10), ('charges', 1), ('cationic', 5), ('property', 20), ('anionic', 6), ('phmg-p.', 6), ('phmg-p-induced', 12), ('diacetate', 5), ('propidium', 4), ('iodine', 11), ('poly-l-glutamic', 1), ('disrupts', 23), ('memantine', 21), ('thalamocortical', 6), ('hyper-glutamatergic', 1), ('xc', 1), ('sup/', 1), ('deficiencies', 3), ('/glutamate', 1), ('nmdar', 21), ('impairments', 26), ('mem', 10), ('mk801', 5), ('xc-', 1), ('sxc', 8), ('metabotropic', 1), ('mglurs', 1), ('gaba', 10), ('mediodorsal', 1), ('thalamic', 1), ('mdtn', 4), ('dual-probe', 1), ('microdialysis', 1), ('ultra-high-pressure', 1), ('unaffected', 9), ('glutamatergic', 27), ('gabaergic', 16), ('disinhibition', 1), ('weakly', 5), ('ii-mglur', 1), ('iii-mglur', 1), ('exporting', 1), ('astroglial', 1), ('demonstrations', 2), ('hyperactivation', 5), ('sxc/ii-mglur', 1), ('sxc/ii-mglur/iii-mglur', 1), ('vasoconstrictor', 7), ('elastic', 5), ('stiffness', 10), ('vasodilatory', 1), ('stiffer', 1), ('arteries', 15), ('vasoconstrictors', 3), ('eln+/-', 6), ('implicating', 7), ('end-organ', 3), ('tone', 5), ('circulations', 1), ('elastin', 1), ('haploinsufficient', 3), ('eln+/+', 5), ('mcas', 3), ('vasoconstriction', 3), ('ang', 43), ('~40', 1), ('losartan', 9), ('at1rs', 1), ('gastrocnemius', 3), ('noradrenaline', 1), ('mca', 2), ('triptolide-associated', 1), ('inability', 6), ('eliminate', 2), ('tp-lps', 5), ('250', 21), ('intragastrically', 11), ('testify', 1), ('detoxicate', 1), ('pathogen', 6), ('fmk', 2), ('necrostatin', 1), ('nec-1', 2), ('storage', 14), ('crocus', 2), ('sativus', 2), ('safranal', 7), ('cysteine/lysine', 1), ('safranal-evoked', 1), ('nociception', 6), ('contracted', 1), ('strips', 3), ('trpa1-dependent', 1), ('behaving', 1), ('gsk1016790a', 1), ('evoke', 3), ('petasites', 1), ('parthenolide', 1), ('agonism', 4), ('isoflurane', 18), ('anesthetic', 5), ('anesthesia-induced', 1), ('synchronized', 3), ('chemotaxis', 10), ('adult-stage', 1), ('adult-worms', 1), ('c31c9.2', 2), ('f26h9.5', 2), ('y62e10', 4), ('a.13', 4), ('l-serine', 6), ('phosphoserine', 2), ('glycerophosphorylcholine', 1), ('gpc', 3), ('5.13', 1), ('1.44', 3), ('7.65', 1), ('0.81', 3), ('52.9', 1), ('58.7', 1), ('61.1', 1), ('anesthesia', 5), ('gpc-treated', 1), ('5.22', 1), ('1.19', 3), ('4.90', 1), ('0.702', 1), ('supplied', 1), ('deteriorated', 3), ('78.1', 2), ('75.5', 1), ('0.465', 1), ('corresponds', 1), ('influenced', 18), ('solutes', 5), ('pool', 6), ('7a1', 1), ('p-cresyl', 2), ('na+-taurocholate', 1), ('cotransporting', 1), ('taurocholic', 2), ('tca', 17), ('anion-transporting', 2), ('oatp1b1', 15), ('transporter-overexpressing', 2), ('kynurenic', 2), ('glucuronide', 20), ('hippuric', 2), ('indoxyl', 6), ('oatp1b3', 8), ('sulfate-exposed', 1), ('pa-1', 4), ('gynaecology', 1), ('0-200', 3), ('ao/etbr', 3), ('bad', 7), ('quercetin-treated', 1), ('mir-145-5p', 12), ('smoke-related', 1), ('klf5', 15), ('cs-mediated', 1), ('hbecs', 5), ('non-smokers', 1), ('p53-mediated', 3), ('pre-inflammatory', 1), ('interleukins', 2), ('cse-stimulated', 1), ('conferred', 4), ('traits', 11), ('large-scale', 7), ('wgs', 3), ('grouped', 4), ('variant-set', 4), ('gene-based', 1), ('aggregate', 5), ('skat', 1), ('originally', 2), ('pedigree', 3), ('computationally', 2), ('powerful', 7), ('tractable', 3), ('smmat', 1), ('relatedness', 2), ('institute', 5), ('trans-omics', 1), ('topmed', 2), ('smmats', 2), ('covariates', 9), ('needs', 15), ('fit', 6), ('simulation', 17), ('fibrinogen', 4), ('23,763', 1), ('commons', 1), ('cloud-based', 1), ('computing', 3), ('platform', 18), ('glun2b-containing', 6), ('short-', 3), ('se-induced', 2), ('forty-eight', 2), ('pilocarpine', 2), ('12-18', 2), ('licl', 5), ('meq/kg', 1), ('i.p.', 7), ('fifteen', 1), ('minutes', 5), ('nacl', 3), ('non-selective', 7), ('noncompetitive', 7), ('ket', 3), ('ci-1041', 3), ('cp-101,606', 3), ('glun1/glun2b', 1), ('diheteromers', 1), ('removed', 7), ('fluoro-jade', 1), ('iba1/ed1', 1), ('immunolabeling', 1), ('terminate', 1), ('licl-pilocarpine-induced', 1), ('iba1+/ed1+', 2), ('double-labeling', 2), ('amygdala', 4), ('mepv', 1), ('stopping', 1), ('epileptic', 9), ('k2', 10), ('pth', 14), ('ovariectomized', 3), ('solutions', 3), ('osteoblastogenesis', 2), ('osteoporotic', 5), ('calvarial', 5), ('bilateral', 11), ('spf', 2), ('vk', 5), ('everyday', 3), ('1-34', 1), ('marrow-derived', 5), ('k2+pth', 1), ('observe', 12), ('gamma-carboxylated', 1), ('osteocalcin', 7), ('gla-oc', 2), ('micro-ct', 5), ('immunofluorescent', 2), ('labeling', 18), ('femurs', 2), ('ocn', 3), ('runx2', 27), ('bmp2', 20), ('microrna-532-5p', 2), ('promotion', 16), ('hmgb3/wnt/beta-catenin', 1), ('mir-532-5p', 14), ('b3', 1), ('hmgb3', 6), (\"3'-utr\", 5), ('oncogenic', 17), ('mir-532-5p/hmgb3', 2), ('aconitum', 5), ('alkaloids', 9), ('influencing', 11), ('aconitine', 7), ('ac', 17), ('mesaconitine', 1), ('diterpenoid', 3), ('aconite', 1), ('high-performance', 9), ('penetrated', 1), ('pericardium', 3), ('tbx5', 4), ('gata4', 11), ('nkx2.5', 5), ('12-24', 2), ('dda', 1), ('retinoic', 20), ('rar', 10), ('molluscs', 3), ('retinoid', 13), ('disruptive', 6), ('anthropogenic', 6), ('mollusc', 5), ('rars', 3), ('respond', 11), ('phylogenetically', 1), ('monomers', 3), ('rxr', 15), ('retinoid-dependent', 2), ('isomers', 7), ('unresponsive', 1), ('organochloride', 1), ('repressions', 1), ('rar/rxr', 2), ('retinoids', 1), ('rxr-specific', 1), ('corroborate', 2), ('heterodimers', 1), ('biding', 1), ('rosacea', 6), ('manage', 9), ('variable', 8), ('facts', 1), ('really', 1), ('oxymetazoline', 1), ('rosacea-related', 1), ('erythema', 2), ('metronidazole', 1), ('procedural', 1), ('pulsed', 1), ('radiofrequency', 1), ('ultrasound', 12), ('monotherapies', 2), ('modalities', 8), ('tailored', 6), ('n-acetylcysteine', 19), ('fenitrothion-induced', 1), ('existence', 12), ('fenitrothion', 16), ('fnt', 13), ('soil', 15), ('nephrotoxic', 8), ('fnt-induced', 4), ('thirty-two', 2), ('xenobiotic-metabolizing', 3), ('enzymes-cytochrome', 1), ('gsta4-4', 1), ('hepatopathy', 4), ('follicular', 17), ('follicle', 20), ('348', 1), ('infertile', 2), ('89', 2), ('pcos', 16), ('145', 9), ('fallopian', 1), ('obstruction', 9), ('114', 1), ('inductively', 3), ('icp-ms', 1), ('steroidogenesis-related', 1), ('retrievable', 1), ('1.785', 1), ('high-quality', 5), ('-6.360', 1), ('.050', 1), ('r', 59), ('0.275', 1), ('.010', 1), ('0.250', 2), ('.022', 1), ('granulosa', 30), ('overexposed', 1), ('cyp19a1', 16), ('copper-induced', 4), ('steroidogenesis', 19), ('ep1', 4), ('2,3,7,8-tetrachlorodibenzo-p-dioxin-induced', 1), ('neonatal', 30), ('hydronephrosis', 7), ('dioxin-induced', 2), ('ep3', 1), ('ono-ae3-208', 1), ('ono', 1), ('pnd', 23), ('13.', 1), ('expose', 3), ('urinalysis', 2), ('ep1+/+', 1), ('ep1-/-', 1), ('fact', 10), ('ep2+/+', 1), ('ep2-/-groups', 1), ('88.9', 2), ('ep3+/+', 1), ('ep3-/-', 1), ('ono-treated', 1), ('tcdd-induced', 1), ('microrna-29a', 1), ('end-stage', 5), ('morbidities', 1), ('discovering', 2), ('paramount', 2), ('tubulointerstitial', 5), ('high-glucose-stressed', 1), ('mesangial', 14), ('mir-29a', 4), ('sufficiently', 6), ('receptor-gamma', 7), ('profibrogenic', 3), ('cytomegalovirus', 7), ('us28', 5), ('hcmv', 2), ('compartment', 8), ('hcmv-encoded', 1), ('gpcr', 8), ('latent', 8), ('pus28', 3), ('trans', 3), ('complements', 2), ('us28delta', 3), ('lytic', 2), ('represses', 10), ('miep', 5), ('continual', 1), ('pus28-mediated', 1), ('fos', 14), ('ap-1', 26), ('miep-driven', 1), ('replication', 18), ('gas-phase', 3), ('passive', 7), ('sampling', 4), ('hocs', 2), ('unidentified', 2), ('samplers', 1), ('isolate', 7), ('bioassays', 2), ('urban', 5), ('residential', 5), ('polycyclic', 16), ('retardants', 17), ('sampler', 1), ('bioassay-derived', 1), ('equivalents', 3), ('bap-eqbio', 2), ('hoc', 3), ('downtown', 1), ('cleveland', 1), ('rural/residential', 1), ('city', 2), ('2-ring', 1), ('alkyl/substituted', 1), ('organophosphate', 20), ('ethylhexyl', 1), ('diphenyl', 18), ('literature-derived', 1), ('equivalency', 1), ('iefs', 2), ('augmentation', 4), ('unmonitored', 1), ('environ', 1), ('toxicol', 1), ('chem', 1), ('2019', 14), ('38:748-759', 1), ('setac', 1), ('ecbs', 3), ('ecb', 4), ('embryogenesis', 7), ('fasd', 10), ('pax6a', 1), ('risk-taking/anxiety-like', 1), ('tank', 1), ('dive', 2), ('dysmorphogenesis', 2), ('jzl195', 1), ('magl', 1), ('risk-taking', 1), ('fasd-like', 1), ('topics', 8), ('modifiable', 4), ('providers', 6), ('service', 6), ('visits', 3), ('affordable', 1), ('implementation', 9), ('internet', 1), ('adolescents', 12), ('13-26', 1), ('guided', 3), ('formative', 2), ('fisher', 3), ('information-motivation-behavioral', 1), ('skills', 2), ('provider', 8), ('past', 8), ('discussions', 6), ('sexually', 4), ('hiv', 19), ('half', 22), ('talked', 1), ('confidentiality', 2), ('4/4', 1), ('aor', 3), ('1.85-2.00', 1), ('1.50', 2), ('checklist', 1), ('1.78-1.96', 1), ('youth', 2), ('attitudes', 1), ('discussing', 1), ('3/3', 2), ('explanations', 1), ('questionnaires', 8), ('steady-state', 5), ('monobutyl', 3), ('single-dose', 3), ('humanized-liver', 5), ('plasticizer', 13), ('replaced', 6), ('kinds', 5), ('diisononyl', 9), ('dosimetry', 2), ('simplified', 1), ('hl-mice', 4), ('absorbed', 4), ('converted', 4), ('0-7', 1), ('humanized', 2), ('hl-mouse', 2), ('curves', 8), ('virtual', 10), ('allometric', 1), ('scaling', 1), ('consideration', 9), ('interspecies', 4), ('1.2', 7), ('exceeding', 3), ('japanese', 6), ('authorities', 1), ('in-depth', 6), ('validity', 2), ('assumptions', 1), ('biomonitoring', 1), ('line-specific', 2), ('rtks', 1), ('contain', 14), ('autophosphorylation', 4), ('recruit', 2), ('sh2', 1), ('phosphotyrosine-binding', 1), ('ptb', 6), ('recognize', 4), ('phosphotyrosine-containing', 1), ('motifs', 3), ('slims', 2), ('polyspecific', 1), ('slim', 1), ('vice', 1), ('versa', 1), ('competition', 6), ('rtk', 1), ('rule-based', 1), ('ligand-induced', 2), ('sh2/ptb', 1), ('domain-containing', 3), ('igf1r', 6), ('parameterized', 1), ('site-specific', 4), ('affinities', 15), ('restructuration', 2), ('redundancy', 4), ('rule-derived', 1), ('equations', 2), ('numerical', 3), ('approximation', 8), ('ranking', 2), ('kd', 4), ('unable', 6), ('recapitulate', 4), ('pairs', 5), ('recruited', 10), ('anti-correlated', 1), ('fashions', 1), ('depends', 12), ('pairwise', 1), ('connectivity', 4), ('abundances', 4), ('competitors', 2), ('microrna-873', 1), ('kras-driven', 1), ('proto-oncogenes', 3), ('pdac', 8), ('aberrantly', 7), ('uncovered', 5), ('mir-873', 8), ('recapitulated', 4), ('mir-873-based', 1), ('magnetoresistance', 1), ('gallium', 1), ('arsenide', 1), ('wells', 3), ('magnetoresistances', 1), ('nlmrs', 5), ('topological', 2), ('weyl', 1), ('fermions', 1), ('chirality', 1), ('non-weyl', 1), ('gaas', 1), ('semiconducting-like', 1), ('metallic', 2), ('tesla', 1), ('temperatures', 6), ('fields', 6), ('resembling', 2), ('attribute', 2), ('phenomenological', 1), ('three-resistor', 1), ('showcase', 1), ('unusual', 5), ('tuning', 2), ('electronic', 17), ('disorder/defect', 1), ('nano-engineering', 1), ('antifungal', 9), ('sporothrix', 4), ('jiangxi', 2), ('sporotrichosis', 1), ('subcutaneous', 17), ('mycosis', 1), ('traumatic', 2), ('inoculation', 3), ('globosa', 3), ('schenckii', 2), ('multilocus', 1), ('rdna', 2), ('ef1alpha', 1), ('transcribed', 2), ('spacer', 1), ('calmodulin', 1), ('factor-1alpha', 2), ('itraconazole', 1), ('terbinafine', 1), ('posaconazole', 1), ('amphotericin', 4), ('voriconazole', 7), ('fluconazole', 3), ('5-fluorocytosine', 1), ('mics', 2), ('co-occurrence', 2), ('routes', 3), ('mir-125a-3p', 8), ('fyn/stat3', 1), ('ectopic', 5), ('nih/3t3', 2), ('mrc-5', 5), ('fyn', 4), ('effector', 11), ('p-stat3', 6), ('opposed', 5), ('tgf-beta1-treated', 1), ('mir-125a-3p/fyn/stat3', 1), ('tetrahydrocannabinol', 8), ('hot', 6), ('debate', 2), ('legalization', 2), ('preterm', 19), ('restriction', 9), ('miscarriage', 2), ('ecs', 3), ('10-40', 1), ('degrading', 1), ('n-arachidonoylphosphatidylethanolamine-specific', 1), ('re-establish', 1), ('users', 11), ('disturb', 9), ('delicate', 1), ('foetal', 6), ('sirt6', 11), ('peroxide-induced', 3), ('bach1', 16), ('rgcs', 14), ('insults', 3), ('stress-damaged', 1), ('h2o2-treated', 2), ('promotional', 1), ('btb', 4), ('cnc', 3), ('sirt6-mediated', 1), ('leptin', 8), ('fetuses/pups', 1), ('lactational', 5), ('relationships', 14), ('sv/129', 1), ('mppara', 4), ('ppara-null', 2), ('pparalpha-humanized', 1), ('hppara', 2), ('killed', 4), ('2-day-old', 1), ('21-day-old', 1), ('weaning', 8), ('neurologic', 5), ('screens', 5), ('perturbation', 4), ('linuron', 12), ('amplifies', 2), ('sigma', 3), ('inositol-requiring', 3), ('enzyme-1alpha', 1), ('ire1alpha', 5), ('x-box', 2), ('xbp1', 2), ('astrocyte-specific', 1), ('shrna-', 1), ('crispr/cas9-driven', 1), ('atac-seq', 1), ('chip-seq', 5), ('ire1alpha-xbp1', 1), ('encephalomyelitis', 2), ('eae', 1), ('multidisciplinary', 4), ('frenolicin', 2), ('peroxiredoxin', 2), ('ros/4e-bp1-mediated', 1), ('prx1', 3), ('grx3', 3), ('pyranonaphthoquinone', 1), ('fb', 3), ('covalent', 5), ('active-site', 1), ('fb-targeted', 1), ('peroxisome-bound', 1), ('tuberous', 2), ('mtorc1/4e-bp1', 1), ('structure-activity', 6), ('4e-bp1', 4), ('prx1/grx3', 1), ('ros-based', 1), ('copi-mediated', 1), ('egfrviii', 10), ('non-ligand-dependent', 1), ('golgi', 5), ('syntaxin-6', 1), ('copi', 1), ('xenotransplantation', 2), ('searching', 1), ('entry', 10), ('arsenic-induced', 10), ('brca1', 12), ('-positive', 6), ('foods', 11), ('contaminated', 8), ('naasiii', 3), ('eralpha-positive', 3), ('ccnd1', 10), ('folr1', 2), ('methylenetetrahydrofolate', 3), ('mthfr', 20), ('polii', 1), ('naasiii-preconditioned', 1), ('mcf7naasiii', 1), ('pads', 1), ('asiii', 1), ('hampering', 3), ('autism/neuroprotection-linked', 1), ('adnp/nap', 1), ('excitatory', 4), ('synapse', 5), ('adnp', 9), ('autism-like', 5), ('phenotypically', 2), ('intellectual', 5), ('disabilities', 4), ('speech', 3), ('impediments', 1), ('snippet', 1), ('nap', 4), ('penetration', 2), ('pertinent', 2), ('olfactory', 7), ('strength', 20), ('brain/body', 1), ('breaching', 1), ('improvements', 8), ('diffusion', 3), ('tensor', 1), ('dti', 2), ('slc17a7', 1), ('vglut1', 2), ('explaining', 3), ('tie', 1), ('synapses', 2), (\"autism/alzheimer's/schizophrenia-linked\", 1), ('cp201', 1), ('uk', 5), ('biobank', 6), ('77,052', 1), ('378,169', 1), ('hip', 21), ('64', 6), ('doubling', 1), ('loci', 18), ('fine-mapped', 1), ('integrating', 5), ('trait', 5), ('eqtl', 2), ('fine-mapping', 3), ('rare-disease', 1), ('animal-model', 1), ('tgfb1', 1), ('ctsk', 2), ('il11', 1), ('noncardiac', 5), ('intermediate-to-high', 3), ('aged', 29), ('=60', 1), ('july', 7), ('erasmus', 1), ('university', 4), ('rotterdam', 1), ('netherlands', 2), ('high-sensitivity', 1), ('l-1', 10), ('14-49', 1), ('50-149', 1), ('=150', 1), ('angina', 2), ('revascularization', 1), ('cerebrovascular', 5), ('accident', 1), ('all-cause', 10), ('kaplan-meier', 5), ('estimates', 7), ('3085', 1), ('1678', 1), ('54.4', 1), ('one-year', 3), ('5.8', 1), ('3.4', 5), ('6.1', 1), ('10.4', 1), ('40.6', 2), ('1.32', 5), ('0.85-2.06', 1), ('2.53', 1), ('1.42-4.53', 1), ('10.24', 1), ('5.91-17.75', 1), ('14.6', 4), ('1.25', 6), ('0.98-1.60', 1), ('2.39', 1), ('1.72-3.32', 1), ('3.79', 1), ('2.60-5.54', 1), ('graded', 5), ('orlistat', 16), ('hepatoma', 16), ('undefined', 3), ('cdk1', 2), ('cdk2', 5), ('orlistat-induced', 2), ('acot8', 1), ('fabp1', 3), ('cpt1', 5), ('cpt2', 2), ('peroxisomal', 1), ('deoxynivalenol', 16), ('aflatoxin', 5), ('zen', 5), ('afb1', 11), ('untargeted', 5), ('gc-ms.', 1), ('gc-ms', 5), ('6.7', 5), ('deconvoluted', 1), ('aligned', 4), ('dial', 1), ('metamapp', 1), ('caspase-utilized', 1), ('seriously', 3), ('threonine', 6), ('pyruvate', 25), ('ceramide', 12), ('playing', 8), ('updated', 6), ('vasodilator', 3), ('albeit', 3), ('hypoxic', 13), ('normoxic', 2), ('ductus', 1), ('arteriosus', 2), ('constriction', 2), ('exaggerated', 4), ('mir22hg', 11), ('notch2', 7), ('n=43', 1), ('n=21', 1), ('ges-1', 4), ('mkn-45', 5), ('ags', 13), ('sgc-7901', 2), ('pcdna3', 1), ('pcdna3-mir22hg', 1), ('cck-8', 15), ('hey1', 1), ('facies', 2), ('macrocephaly', 1), ('chd8', 3), ('decade', 1), ('submicroscopic', 1), ('deletions', 3), ('14q11.2', 1), ('dysmorphic', 1), ('widely-spaced', 1), ('eyes', 15), ('nose', 2), ('bridge', 2), ('philtrum', 1), ('cupid', 1), ('bow', 1), ('upper', 11), ('lip', 2), ('auricular', 2), ('anomalies', 2), ('constituted', 2), ('anomaly-intellectual', 1), ('supt16h', 1), ('original', 4), ('document', 2), ('integrate', 1), ('sleep', 16), ('problems', 20), ('confirms', 7), ('suggestion', 2), ('syndromic', 1), ('haploinsufficiency', 2), ('puerarin', 18), ('familiar', 1), ('tradition', 1), ('calorimetric', 1), ('statically', 1), ('quenched', 1), ('hindered', 2), ('path', 5), ('interacted', 7), ('enzymatically', 3), ('deltah', 1), ('deltas', 1), ('spontaneously', 8), ('deltag', 2), ('catch', 2), ('attentions', 2), ('ica', 9), ('o3fa', 4), ('filtered', 4), ('ncd', 1), ('high-cholesterol', 1), ('hcd', 4), ('gp91', 2), ('atherogenic', 1), ('mir-138-5p', 11), ('mncl2', 4), ('manganism', 1), ('mirna-138-5p', 1), ('axon', 4), ('retard', 2), ('ex-527', 13), ('sirt1-specific', 1), ('srt1720', 2), ('pyelonephritis/urosepsis', 5), ('empirical', 3), ('descriptive', 1), ('tertiaryteaching', 1), ('hospital', 33), ('centre', 7), ('records', 5), ('uti', 14), ('complicated', 12), ('bacteriuria', 3), ('asymptomatic', 4), ('2nd', 4), ('10th', 2), ('2014', 11), ('regimen', 8), ('stay', 14), ('los', 8), ('compliance', 14), ('etg', 2), ('appropriateness', 2), ('univariate', 4), ('chi-square', 4), ('sas', 3), ('295', 1), ('152', 3), ('73', 5), ('piperacillin/tazobactam', 2), ('tazocin', 1), ('43.4', 1), ('49', 11), ('40.2', 1), ('85.5', 1), ('0.0074', 1), ('41.3', 2), ('89.8', 1), ('0.0312', 1), ('comorbidities', 7), ('clinicians', 4), ('subdural', 2), ('haematoma', 2), ('apixaban', 2), ('68-year-old', 1), ('man', 5), ('emergency', 5), ('department', 6), ('back', 11), ('long-haul', 1), ('flight', 2), ('embolus', 1), ('dissection', 1), ('discharged', 7), ('analgesia', 16), ('worsening', 5), ('weakness', 4), ('coordination', 5), ('managed', 4), ('conservatively', 1), ('taurine', 15), ('as2o3-induced', 5), ('pparalpha-autophagy', 1), ('as2o3', 16), ('supplemented', 11), ('autophagy-dependent', 1), ('proliferator', 4), ('droplet', 10), ('pparalpha/autophagy', 1), ('vsmcs', 5), ('vsmc', 4), ('eeds', 2), ('abolish', 1), ('expectancy', 2), ('potentials', 12), ('ng/l-mug/l', 1), ('rle', 4), ('e2+bpa', 1), ('e2+np', 1), ('ranges', 4), ('slopes', 1), ('logarithm', 1), ('lnet50', 1), ('-10.1', 1), ('kcal/mol', 5), ('eralpha-lbd', 1), ('-8.0', 1), ('-6.8', 1), ('pair-wise', 1), ('p-score', 2), ('5504', 2), ('pembrolizumab', 7), ('0.95', 5), ('0.87', 3), ('0.79-0.95', 1), ('3-5', 2), ('toxicity-related', 1), ('glyphosate', 52), ('based-herbicide', 1), ('blood-brain', 9), ('glyphosate-based', 1), ('gbh', 3), ('battery', 10), ('y-maze', 1), ('tasks', 2), ('discrimination', 1), ('step-through-latency', 1), ('scrutiny', 1), ('aki', 67), ('cre', 5), ('bun', 11), ('attracting', 1), ('six-week', 2), ('csp', 1), ('gen', 3), ('create', 4), ('puromycin', 1), ('pur', 1), ('mir-3473', 1), ('mir-143-3p', 1), ('mir-122-5p', 1), ('earlier', 9), ('type-specific', 1), ('soman', 9), ('carbamates', 8), ('physostigmine', 2), ('pyridostigmine', 7), ('reversibly', 3), ('muscles', 1), ('adamantine', 1), ('fasciculations', 1), ('behavioural', 5), ('poisoned', 3), ('atropine', 6), ('oxime', 10), ('hi-6', 6), ('antidotal', 7), ('antidotes', 4), ('dose-finding', 1), ('0-72', 1), ('time-finding', 1), ('0-1440', 1), ('im', 13), ('post-exposure', 13), ('0.75', 5), ('inhibitions', 1), ('phrenic', 1), ('nerve-diaphragm', 1), ('preparation', 9), ('prs', 5), ('6.33', 1), ('7.23', 1), ('atropine/hi-6', 1), ('atropine/hi-6/diazepam', 2), ('10.11', 1), ('atr/hi-6-treated', 1), ('36', 12), ('antagonised', 1), ('soman-induced', 1), ('fastest', 2), ('assured', 1), ('unpretreated', 1), ('assures', 1), ('longer-lasting', 1), ('narrow', 5), ('antidote', 8), ('ache-protecting', 1), ('receptor-blocking', 1), ('cadmium', 56), ('hormone-related', 3), ('gynecologic', 2), ('ovcar3', 14), ('skov3', 1), ('cdcl2', 11), ('0-', 3), ('pre-incubated', 2), ('182,780.', 1), ('foxo3a', 15), ('182,780', 3), ('cdcl2-induced', 1), ('p-erk1/2', 6), ('intensified', 4), ('er-dependent', 5), ('deregulates', 2), ('noteworthy', 3), ('contraceptives', 8), ('multistudy', 1), ('pks', 2), ('levonorgestrel', 1), ('lng', 8), ('-containing', 3), ('cocs', 4), ('reanalyzed', 1), ('ethinyl', 2), ('ee', 34), ('zero-order', 1), ('k0', 1), ('two-compartment', 1), ('pk', 7), ('weights', 9), ('bsa', 11), ('habitus', 1), ('metrics', 4), ('cmax', 9), ('auctau', 2), ('cmin', 1), ('=.17', 1), ('=.056', 1), ('cl', 3), ('appreciable', 2), ('v1', 2), ('=.001', 1), ('v2', 3), ('=.009', 1), ('=.006', 1), ('trough', 1), ('lng/ee', 1), ('unlikely', 2), ('contraceptive', 5), ('lng-containing', 1), ('comt', 19), ('catechol-o-methyltransferase', 5), (\"'gate-keeper\", 2), ('bca', 23), ('estradiol-treated', 1), ('carcinoma-derived', 1), ('mutagenic', 7), ('depurinating', 1), ('illustrating', 1), ('17ss-estradiol', 1), ('phytoestrogen', 1), ('genistein', 26), ('promoters', 7), ('membrane-bound', 2), ('mb', 20), ('mb-comt', 1), ('chip', 5), ('dnmt3b', 5), ('sulforaphane', 23), ('cruciferous', 2), ('estrogen-induced', 3), ('eralpha-cyclin', 2), ('d-cdk4/6-prb', 3), ('1-100', 4), ('sk-br-3', 1), ('bps-induced', 2), ('phospho-retinoblastoma', 1), ('p-rb', 1), ('e2f', 2), ('a2', 14), ('methylpiperidino', 1), ('pyrazole', 3), ('cdk6', 1), ('0332991', 1), ('eralpha-dependent', 4), ('d-cdk4/6', 1), ('hospital-based', 4), ('cadmium-polluted', 4), ('inhabitants', 2), ('itai-itai', 1), ('overlooked', 3), ('institutes', 2), ('akita', 3), ('prefecture', 1), ('definite', 2), ('odate', 1), ('kosaka', 1), ('town', 3), ('ss2-microglobulin', 2), ('over-accumulation', 1), ('cr.', 1), ('fulfilled', 2), ('57', 4), ('10.5', 3), ('registration', 10), ('2010', 6), ('rosai', 1), ('1117', 1), ('december', 10), ('caries', 10), ('preschool', 3), ('cotinine', 15), ('pack-years', 4), ('405', 1), ('3-6', 1), ('preschools', 1), ('2006.', 2), ('habits', 2), ('parent-administered', 1), ('decayed', 5), ('filled', 2), ('teeth', 10), ('first-void', 1), ('morning', 1), ('31.1', 1), ('29.5', 1), ('5.55', 1), ('2.17-14.22', 1), ('2.00', 1), ('1.12-3.58', 1), ('2.92', 1), ('1.23-6.96', 1), ('1.75', 2), ('0.96-3.20', 1), ('ors', 3), ('3.10', 1), ('1.71-5.63', 1), ('0.012', 3), ('2.02', 1), ('1.10-3.70', 1), ('0.10', 4), ('carboxylesterases', 4), ('perfluorooctanoic', 12), ('catalyze', 5), ('pfoa', 56), ('fluorochemical', 1), ('ncrl', 1), ('ces1', 3), ('ces1d', 1), ('1e', 2), ('1f', 2), ('2c', 1), ('2e', 2), ('1.5-', 1), ('ces1c', 2), ('2b', 4), ('cyp4a14', 1), ('pfoa-treated', 1), ('pparalpha-dependent', 1), ('ces2', 1), ('erythrocyte', 6), ('sedimentation', 2), ('osteomyelitis', 2), ('persons', 4), ('esr', 9), ('differentiating', 7), ('om', 6), ('soft', 7), ('sti', 3), ('102', 3), ('nondiabetic', 3), ('admitted', 9), ('single-photon', 1), ('cutoffs', 2), ('45.5', 1), ('mm/h', 1), ('3.45', 1), ('mg/dl', 6), ('cutoff', 1), ('79', 3), ('61', 9), ('happening', 2), ('sense', 4), ('predictable', 2), ('transporting', 5), ('comprehends', 1), ('stimuli-responsive', 1), ('multi-responsiveness', 1), ('exploitation', 1), ('multi-stimuli', 1), ('nanogels', 1), ('micelles', 1), ('near', 7), ('surroundings', 2), ('manipulate', 2), ('custom-designed', 1), ('merkel', 6), ('polyomavirus', 2), ('antigens', 14), ('fbw7', 7), ('beta-trcp', 4), ('mcpyv', 6), ('accounts', 2), ('mcc', 10), ('oncoproteins', 2), ('lt-t', 4), ('large-t', 2), ('lsd', 4), ('sequester', 1), ('stabilize', 1), ('e.', 18), ('well-defined', 2), ('phospho-degrons', 1), ('phospho-degron', 1), ('fail', 3), ('accomplished', 3), ('olympiad', 3), ('physician', 2), ('germline', 13), ('brca', 2), ('her2-negative', 2), ('tpc', 6), ('brca2', 1), ('brcam', 2), ('-negative', 1), ('mbc', 5), ('planned', 6), ('nct02000622', 1), ('=2', 4), ('tablets', 1), ('predeclared', 1), ('capecitabine', 1), ('vinorelbine', 1), ('eribulin', 1), ('205', 4), ('maturity', 1), ('19.3', 2), ('0.90', 5), ('0.66-1.23', 1), ('0.513', 2), ('25.3', 2), ('26.3', 1), ('prespecified', 1), ('0.51', 2), ('0.29-0.90', 1), ('yes', 2), ('second/third-line', 1), ('1.13', 2), ('0.79-1.64', 1), ('0.93', 2), ('0.62-1.43', 1), ('0.86', 6), ('0.55-1.36', 1), ('platinum', 8), ('0.83', 11), ('0.49-1.45', 1), ('0.91', 6), ('0.64-1.33', 1), ('manageable', 1), ('meaningful', 4), ('please', 1), ('see', 31), ('online', 5), ('video', 2), ('porcine', 23), ('enteroid', 3), ('iscs', 3), ('piglets', 6), ('moloney', 1), ('insertion', 3), ('bmi1', 2), ('crypt', 2), ('isolation', 9), ('cultivation', 2), ('crypts', 1), ('budded', 1), ('morphologies', 1), ('leucine-rich-repeat-containing', 1), ('lgr5', 1), ('enteroids', 2), ('sensitively', 4), ('non-mutagenic', 1), ('molecular-level', 2), ('uncertain', 5), ('previously-published', 1), ('transcriptomic-based', 1), ('relate', 4), ('postulate', 1), ('genomic/epigenomic', 1), ('cross-study', 1), ('372', 1), ('substantiates', 1), ('cytotoxicity/cell', 1), ('geographic', 3), ('opioid-involved', 7), ('crash', 8), ('maryland', 3), ('2006-2017.', 1), ('opioids', 7), ('fatalities', 3), ('crashes', 5), ('county', 1), ('examiner', 1), ('2006-2017', 1), ('fatally', 1), ('8.3', 1), ('2006', 8), ('14.1', 3), ('-1.9', 1), ('follow', 4), ('broader', 7), ('scene', 1), ('rural', 7), ('counties', 1), ('irrespective', 4), ('g/dl', 3), ('supraphysiological', 2), ('vesicle-enriched', 1), ('oocyte', 16), ('2000', 7), ('000', 3), ('ev-enriched', 2), ('ev-mir-27b-3p', 1), ('fc', 9), ('0.58', 3), ('.04', 2), ('fadd', 2), ('1.22', 2), ('.01', 2), ('1.59', 2), ('.06', 3), ('1.73', 1), ('mir-27b-3p', 1), ('0.65', 5), ('lithium', 9), ('minimize', 4), ('olanzapine', 19), ('oxidative-inflammatory', 1), ('olz', 6), ('second-generation', 3), ('antipsychotic', 10), ('oxidative-inflammation', 1), ('mood', 4), ('olz-induced', 2), ('oxi-inflammatory', 1), ('methodology', 7), ('264.7', 3), ('olz-exposed', 1), ('olz-supplemented', 1), ('methodological', 3), ('fat/high', 1), ('tauopathy', 4), ('cognition', 8), ('neuro-protective', 1), ('hfhcd', 4), ('subdivided', 3), ('non-treated', 2), ('hole', 3), ('board', 1), ('p-tau', 6), ('hfhcd-induced', 1), ('phosphorylate', 2), ('munc18-2', 4), ('munc18-1', 5), ('munc18-3', 2), ('hemostasis', 7), ('degranulation', 5), ('snare', 1), ('munc18', 2), ('uncoordinated', 1), ('granule', 6), ('em', 1), ('design-based', 1), ('stereology', 1), ('ablates', 1), ('dense', 5), ('granules', 2), ('exocytic', 1), ('munc18-2-deficient', 1), ('defective', 8), ('thrombus', 6), ('shear', 1), ('megakaryocyte-specific', 1), ('hemostatic', 4), ('venous', 10), ('bleeding', 24), ('zyxin', 2), ('zyx', 7), ('recurrence-free', 1), ('nupr1', 1), ('cst5', 1), ('isobaric', 1), ('absolute', 10), ('quantitation', 4), ('cd26/dpp4-inhibitor', 2), ('vildagliptin', 6), ('macrophage-mediated', 1), ('nk', 38), ('cd26/dipeptidyl', 1), ('peptidase', 5), ('cd26/dpp4', 3), ('lewis', 3), ('llc', 2), ('h460', 4), ('cd1/nude', 1), ('immunohistochemically', 4), ('f4/80+', 2), ('nkp46+', 1), ('vildagliptin-treated', 2), ('clodronate', 1), ('il-15-/-', 1), ('tumor-suppressing', 1), ('tumor-infiltrating', 3), ('necrosis-related', 1), ('apoptosis-inducing', 6), ('trail', 15), ('intra-cellular', 2), ('trail-treated', 1), ('vildagliptin-mediated', 1), ('antagonizing', 3), ('surfactant-activated', 1), ('trail-mediated', 5), ('particles-caused', 1), ('threatening', 3), ('vd', 9), ('toxins', 16), ('particles-induced', 4), ('intratracheal', 6), ('intramuscular', 2), ('tgfbeta1', 7), ('autophagy-related', 10), ('antifine', 1), ('blood-neural', 1), ('hucb-nscs', 2), ('53', 8), ('s100b', 1), ('oct4', 2), ('gdf3', 1), ('sox1', 1), ('pax6', 1), ('ngn1', 2), ('bfgf', 1), ('junction-associated', 1), ('claudin', 4), ('abnormality', 2), ('coal', 4), ('pitch', 2), ('extract-induced', 1), ('inflammation-related', 15), ('inflammsome', 1), ('2.4', 4), ('ctpe', 12), ('numbered', 1), ('passage', 5), ('passaged', 1), ('dmso', 13), ('time-pcr', 2), ('ctpe-stimulated', 1), ('lot', 2), ('morphologically', 3), ('activation-related', 1), ('ctpe-induced', 1), ('spreading', 6), ('sessile', 1), ('communities', 11), ('emergent', 5), ('emerges', 1), ('distantly', 1), ('pseudomonas', 6), ('fluorescens', 2), ('pf0-1', 2), ('pedobacter', 2), ('v48', 2), ('hard', 5), ('agar', 4), ('permissive', 2), ('monoculture', 1), ('coculture', 3), ('reproducible', 4), ('nonhomogenous', 1), ('high-nutrient', 1), ('low-nutrient', 1), ('two-species', 2), ('inhabit.importance', 1), ('wealth', 2), ('microbial', 19), ('dynamics', 28), ('ecological', 9), ('community', 15), ('priori', 2), ('holistic', 2), ('connect', 3), ('interspecific', 1), ('microbiome', 17), ('plant-root', 1), ('rationally', 2), ('mdr1a/1b', 2), ('bcrp1', 4), ('phip/dss-induced', 1), ('2-amino-1-methyl-6-phenylimidazo', 5), ('4,5-b', 4), ('pyridine', 5), ('phip', 29), ('high-temperature', 2), ('phip-induced', 5), ('bcrp1-/-', 2), ('mrp2-/-', 2), ('mrp3-/-', 1), ('mdr1a/b-/-', 1), ('dextran', 14), ('dss-induced', 10), ('sinusoidal', 11), ('pre-carcinogenic', 1), ('n2-oh-phip', 1), ('phip-5-sulphate', 1), ('17-fold', 1), ('two-', 1), ('four-fold', 1), ('perhaps', 3), ('counterintuitively', 1), ('chlorpromazine', 5), ('yap', 28), ('obstacle', 4), ('cscs', 11), ('cpz', 5), ('anti-breast', 4), ('anti-csc', 1), ('mammosphere', 2), ('aldh', 4), ('stemness-related', 2), ('mcf7/adr', 1), ('chemotherapies', 2), ('yes-associated', 3), ('hippo', 12), ('stem-like', 5), ('basal-like', 3), ('repurposed', 3), ('dimethylfumarate', 2), ('dmf', 11), ('ccl4-induced', 13), ('twice', 15), ('tsb', 1), ('col', 5), ('necroinflammation', 1), ('blunting', 2), ('denoted', 1), ('serve', 33), ('buparlisib', 8), ('daunorubicin', 9), ('1c3', 2), ('pan-class', 1), ('carbonyl-reducing', 2), ('catalyse', 1), ('akr1a1', 2), ('akr1b1', 2), ('akr1b10', 6), ('akr7a2', 19), ('superfamily', 7), ('short-chain', 8), ('dehydrogenase/reductase', 4), ('9.5', 2), ('constant', 9), ('14.0', 1), ('mixed-type', 2), ('0.6.', 1), ('hct', 1), ('116', 1), ('flexible', 6), ('occupies', 1), ('trifluoromethyl', 1), ('tyr55', 1), ('pi3k-independent', 1), ('ros-dependent', 10), ('2,3,5-tris', 2), ('glutathion-s-yl', 3), ('tghq', 10), ('nephroncarcinogenic', 1), ('retains', 3), ('hl-60', 12), ('tghq-mediated', 2), ('intriguingly', 8), ('gsk3beta-dependent', 1), ('discounted', 1), ('tghq-induced', 2), ('ser40', 1), ('up-regulate', 4), ('post-translational', 4), ('ho1', 6), ('actually', 3), ('engagement', 3), ('extension', 3), ('necessarily', 1), ('delve', 1), ('solely', 4), ('chromosomal', 11), ('rearrangement', 4), ('fusions', 3), ('ccnh-c5orf30', 2), ('trmt11-grik2', 2), ('mtor-tp53bp1', 1), ('tmem135-ccdc67', 1), ('kdm4-ac011523.2', 1), ('lrrc59-flj60017', 1), ('node', 9), ('pd2+', 10), ('-initiated', 1), ('formic', 3), ('decomposition', 6), ('formate', 4), ('hcooh', 1), ('hydrogen-storage', 1), ('decomposes', 1), ('co2', 5), ('333', 2), ('no3', 2), ('pd0', 2), ('-bound', 1), ('/co2', 1), ('theory', 8), ('dft', 2), ('rotation', 2), ('beta-hydride', 1), ('energies', 4), ('electronics', 2), ('geometries', 2), ('reductive', 4), ('appraisement', 1), ('disinfection', 2), ('by-products', 7), ('dbps', 6), ('allium', 4), ('cepa', 4), ('chlorinated', 8), ('concentrated', 6), ('genotoxic', 24), ('potable', 1), ('aberration', 2), ('trichloroacetic', 2), ('tcaa', 5), ('trichloromethane', 2), ('tcm', 9), ('tribromomethane', 2), ('tbm', 5), ('methanesulfonate', 1), ('ems', 1), ('tap', 2), ('tip', 4), ('sticky', 1), ('chromosomes', 2), ('vagrant', 1), ('c-anaphase', 1), ('multipolarity', 1), ('aberrations', 5), ('anaphase-telophase', 1), ('noticed', 11), ('roots', 3), ('ascorbate', 6), ('guaiacol', 2), ('dnas', 1), ('spectrophotometric', 5), ('spectrofluorometric', 1), ('calf', 1), ('thymus', 3), ('ct-', 1), ('non-traditional', 2), ('intercalation', 2), ('mrtf-a', 7), ('rpe', 4), ('subretinal', 6), ('macular', 5), ('myocardin-related', 1), ('rpe-1', 5), ('connective', 4), ('ctgf', 8), ('paxillin', 2), ('immunoblot', 4), ('pro-matrix', 1), ('ccg-1423', 4), ('tgf-beta2', 2), ('pro-mmp-2', 1), ('photocoagulation', 1), ('pink1/parkin-mediated', 2), ('neuroprotection', 19), ('carnosic', 4), ('homologue', 2), ('pink1', 20), ('/parkin-mediated', 1), ('ca', 25), ('rosemary', 2), ('6-hydroxydopamine', 6), ('6-ohda', 22), ('co-localization', 4), ('parkin', 28), ('mitotracker', 2), ('fm', 1), ('ubiquitinated', 3), ('6-ohda-inhibited', 1), ('vacuoles', 2), ('sirna-transfected', 2), ('mitophagy-related', 1), ('apoptotic-related', 2), ('condensation', 6), ('all-trans', 6), ('atra', 18), ('dermatologic', 1), ('hypercholesterolemia', 15), ('7a', 1), ('alongside', 5), ('lentiviral-mediated', 1), ('atra-induced', 1), ('gene-knockdown', 1), ('hnf4alpha', 12), ('proximal', 23), ('atra-mediated', 3), ('c-jun/c-fos', 1), ('pull-down', 5), ('sequence-specific', 1), ('mir-543', 10), ('inhibites', 1), ('trpm7', 13), ('cc', 14), ('69', 11), ('clinicopathological', 2), ('figo', 1), ('mir-543-mediated', 1), ('p13k/akt', 1), ('p38/mapk', 1), ('mir-543/trpm7', 1), ('apelin-13', 9), ('adipocytokine', 1), ('fructose', 27), ('hyperuricemia', 6), ('600', 12), ('apj', 2), ('2-week', 1), ('perfluorooctanoate', 5), ('nafld', 44), ('one-third', 4), ('unhealthy', 2), ('preexisting', 3), ('low-fat', 1), ('1mg/kg/d', 1), ('lobular', 1), ('47', 13), ('carefully', 5), ('fe3o4', 8), ('pda', 4), ('probe-based', 1), ('amplification', 10), ('biosensing', 2), ('i.', 6), ('immunomagnetic', 1), ('technology-assisted', 1), ('troponin-i', 1), ('ctni', 6), ('au', 2), ('film', 2), ('aunps', 3), ('polydopamine', 2), ('platforms', 3), ('immobilizing', 1), ('cab', 2), ('attaching', 1), ('dab', 1), ('matrixes', 1), ('pda-dab', 1), ('specially', 1), ('immobilized', 2), ('introducing', 3), ('ab2', 1), ('multi-walled', 3), ('nanotube-pda-agnps', 1), ('mwcnts-pda-agnps/ab2', 1), ('residual', 9), ('occupied', 5), ('amplified', 8), ('3.75', 1), ('320-folds', 1), ('pda-based', 1), ('chrysin-induced', 1), ('sorafenib', 7), ('background/aim', 1), ('hcc', 86), ('super-family', 1), ('abcg2', 5), ('chrysin-mediated', 2), ('violet', 5), ('blockage', 19), ('mek1', 5), ('chrysin-synergized', 1), ('rutaceae', 1), ('cae', 6), ('27', 13), ('polymethoxyflavone', 2), ('nobiletin', 1), ('silymarin', 7), ('histopathologically', 7), ('ffa', 1), ('peroxisome-proliferator-activated', 1), ('1c', 3), ('srebp-1c', 3), ('cae-treated', 1), ('bde-47', 23), ('polybrominated', 8), ('ethers', 7), ('pbdes', 5), (\"2,2',4,4'-tertrabromodiphenyl\", 1), ('choriocarcinoma', 5), ('cyp11a1', 5), ('3beta-hsd', 3), ('depolarized', 2), ('mfn2', 4), ('tspo', 5), ('atad3', 2), ('fis1', 1), ('drp1', 7), ('disturbed', 9), ('demethylation', 9), ('opa1', 8), ('vdac2', 1), ('unveiled', 4), ('nad-dependent', 1), ('-transformed', 15), ('sirtuin-3', 1), ('pink', 2), ('passage-matched', 1), ('-cr', 1), ('p-p62ser349', 2), ('cyanide', 5), ('m-chlorophenyl', 1), ('cccp', 1), ('gpr173', 14), ('phoenixin', 2), ('saturated', 9), ('palmitate', 7), ('p38-mediated', 1), ('hypothalamic-pituitary-gonadal', 2), ('ovaries', 9), ('pnx', 1), ('estrous', 2), ('nutrients', 4), ('2-24', 1), ('pnx-induction', 1), ('crispr-cas9', 8), ('huh7', 4), ('knockouts', 3), ('hits', 4), ('systematically', 18), ('ancestry', 3), ('gwas', 10), ('36,614', 1), ('155,150', 1), ('88', 8), ('diabetes-associated', 2), ('5.0', 8), ('115', 5), ('twenty-eight', 3), ('disequilibrium', 2), ('r2', 17), ('unreported', 1), ('maf', 1), ('mafjpn', 1), ('mafeur', 1), ('gp2', 1), ('glp1r', 1), ('transethnic', 1), ('comparisons', 6), ('ethnically', 1), ('coagulation', 10), ('rivaroxaban', 5), ('+rivaroxaban', 1), ('parameter', 3), ('concludes', 1), ('heptachlor-induced', 5), ('-beta1-mediated', 1), ('heptachlor', 2), ('0.01-10', 4), ('glutathione-s-hydroxylase', 1), ('tgf-beta1-mediated', 5), ('smad', 9), ('smad-2', 1), ('smad-3', 1), ('m-rna', 1), ('insulinopenia/hyperglycemia', 2), ('forebrain', 11), ('convergent', 2), ('facets', 1), ('cb1r-ko', 6), ('sham-injected', 3), ('milder', 5), ('~11', 1), ('leaner', 1), ('resting', 5), ('deoxyglucose', 2), ('~20', 3), ('frontocortical', 1), ('depolarization-induced', 1), ('dissipative', 1), ('14c', 1), ('-u-glucose', 1), ('beverages', 3), ('etiologic', 2), ('rich', 7), ('sugar', 3), ('archetypal', 2), ('food-contaminating', 2), ('hfhs', 5), ('diethylhexylphthalate', 1), ('2,3,7,8-tetrachlorodibenzo-p-dioxine', 1), ('153.', 2), ('jejunum', 12), ('depots', 1), ('week-old', 2), ('principally', 2), ('oppose', 4), ('extends', 3), ('cocktail', 2), ('low-dosed', 1), ('tissue-specificity', 1), ('dots', 4), ('canned', 5), ('yellow', 18), ('croaker', 5), ('foodborne', 12), ('insufficiently', 3), ('cds', 13), ('1.8-5.8', 1), ('9.7', 2), ('wavelength', 1), ('340', 5), ('redshift', 1), ('elemental', 2), ('76.42', 1), ('6.49', 2), ('16.7', 3), ('10.', 1), ('quenching', 3), ('cu2+', 1), ('fe3+', 1), ('interior', 1), ('hexokinase', 2), ('atrial', 6), ('distensibility', 2), ('ventricular', 28), ('stenosis', 11), ('la', 21), ('lad', 14), ('las', 7), ('lv', 4), ('transthoracic', 3), ('doppler', 2), ('prospectively', 8), ('area-length', 1), ('four-', 1), ('two-chamber', 1), ('views', 2), ('mitral', 4), ('volmax', 2), ('closure', 4), ('volmin', 2), ('/volmin', 1), ('4-2', 1), ('dedicated', 1), ('hospitalization', 3), ('vol/m2', 3), ('pasp', 1), ('charlson', 3), ('transaortic', 1), ('pyroptotic', 5), ('forceful', 2), ('unravel', 5), ('ly294002', 12), ('subvert', 1), ('inhibitive', 3), ('pyroptosis', 27), ('il-18', 14), ('conductivity', 1), ('lc3ii', 4), ('foxo4', 1), ('one-carbon', 4), ('b-vitamin', 1), ('catalyzes', 4), ('10-methylenetetrahydrofolate', 1), ('5-methyltetrahydrofolate', 1), ('polymorphism', 33), ('677', 1), ('-15', 1), ('north', 3), ('pd-like', 2), ('three-month-old', 1), ('mthfr+/-', 4), ('safflower', 6), ('127', 2), ('www.goldcopd.org', 1), ('2011', 5), ('63', 9), ('infusions', 1), ('dissolved', 5), ('28-day', 6), ('spss', 1), ('22.0', 1), ('p=0.496', 1), ('p=0.075', 1), ('dyspnoea', 1), ('shorten', 2), ('p=0.006', 2), ('ventilation', 6), ('chictr-ipr-17014176', 1), ('her2-cb2r', 3), ('heteromers', 3), ('her2-positive', 3), ('-targeted', 2), ('heteromerization', 1), ('cb2r', 11), ('her2-her2', 1), ('homodimers', 1), ('c-cbl', 1), ('cardio', 1), ('dox-mediated', 2), ('4-hydroxynonenal-protein', 1), ('hne', 15), ('spironolactone', 9), ('podocytes', 7), ('lining', 5), ('bowman', 1), ('capsule', 5), ('filtration', 5), ('proteinuria', 1), ('automatic', 4), ('analyzer', 3), ('ace1', 2), ('ace2', 14), ('aldosterone', 3), ('histochemical', 2), ('anti-nphs2', 1), ('anti-wt1', 1), ('anti-beclin1', 1), ('anti-lc3b', 1), ('spironolacton', 1), ('podocyte-specific', 1), ('wt1', 6), ('nphs2', 1), ('rennin', 1), ('raas', 2), ('fkbp5', 12), ('akt/phlpp', 1), ('neurotoxin', 5), ('mpp', 1), ('pten-induced', 1), ('presently', 2), ('fk506-binding', 1), ('fkbp51', 1), ('phosphorylates', 2), ('pink1-deficient', 1), ('473', 1), ('murine-cultured', 1), ('shrna-mediated', 1), ('leucine-rich', 5), ('repeat', 21), ('phlpp', 5), ('rescues', 5), ('dead', 2), ('k219m', 1), ('testable', 1), ('pink1-fkbp5', 1), ('badges', 2), ('badge', 3), ('reproduce', 3), ('manuscript', 3), ('disclosure', 1), ('https', 14), ('//cos.io/our-services/open-science-badges/', 1), ('daphnetin', 2), ('insult', 5), ('nf-e2', 1), ('p45-related', 3), ('daph', 8), ('coumarin', 15), ('antagonized', 8), ('steatosis-induced', 1), ('potentiate', 4), ('oxidation-related', 1), ('lipogenesis-related', 1), ('mitochondrial-related', 2), ('hyperglycemic', 2), ('neonate', 1), ('predisposition', 3), ('neonates', 2), ('eutrophic', 3), ('villous', 5), ('decidua', 1), ('ppar-alpha', 4), ('ppargc-1beta', 1), ('perfluorooctane', 13), ('sulfonate', 14), ('pfos', 52), ('continuing', 2), ('discharges', 2), ('legacies', 1), ('0.2-200', 1), ('nmol/l', 3), ('nonmonotonic', 2), ('peaked', 1), ('osteopontin', 4), ('osteonectin', 1), ('7.', 1), ('dkk1', 13), ('ligand/osteoprotegerin', 1), ('ccaat/enhancer-binding', 2), ('protein-alpha', 1), ('597', 1), ('log2', 1), ('0.3.', 1), ('biodiesel', 8), ('emissions', 14), ('biodiesels', 1), ('fuel', 4), ('additives', 5), ('triacetin/biodiesel', 3), ('phbecs', 4), ('coconut', 3), ('triacetin', 2), ('casp3', 3), ('b50', 1), ('b90', 1), ('substitution', 6), ('lps-activated', 7), ('microglia-effect', 1), ('non-psychoactive', 3), ('deep', 17), ('ingenuity', 4), ('mir-21', 6), ('rb/e2f', 1), ('notch-dll1', 1), ('lps-upregulated', 1), ('dll1', 1), ('nrf2-driven', 2), ('nrf2-mediated', 8), ('redox-dependent', 1), ('mox-like', 1), ('surveillant', 1), ('cross-talk', 4), ('methamphetamine', 24), ('creb/bdnf', 3), ('akt/gsk3', 3), ('neuro-stimulant', 1), ('ambiguous', 4), ('methamphetamine-induced', 5), ('epm', 1), ('oft', 1), ('fst', 3), ('tst', 1), ('gsk3', 2), ('interleukine-1', 1), ('malicious', 1), ('mediation', 4), ('quinone-induced', 1), ('works', 4), ('pro-survival', 4), ('contrarily', 3), ('pro-death', 1), ('pcb29-pq', 10), ('pcb29-pq-induced', 4), ('arose', 2), ('calpain', 7), ('location', 12), ('irrelevance', 1), ('autophagy-to-apoptosis', 1), ('pcb29-pq-treated', 1), ('agonistic/antagonistic', 2), ('veterinary', 12), ('livestock', 2), ('farmed', 1), ('oecd', 8), ('wildlife', 1), ('official', 3), ('cooperation', 2), ('vm7luc4e2', 1), ('cefuroxime', 1), ('cymiazole', 1), ('trenbolone', 1), ('zeranol', 2), ('phoxim', 1), ('altrenogest', 1), ('nandrolone', 1), ('anti-', 1), ('ligustrazin', 5), ('mir-193a', 6), ('ros-related', 1), ('pro-fibrotic', 4), ('microrna-193', 1), ('hh', 20), ('ceclin1', 1), ('myosin-like', 1), ('smoothened', 3), ('glioma-associated', 2), ('oncogene-1', 1), ('gli-1', 1), ('ggli-1', 1), ('mothers', 9), ('dpp', 2), ('homologue-2', 1), ('smad2', 1), ('2p45-related', 1), ('factor-2', 3), ('p-smad2', 3), ('oxidised', 1), ('rla8-a', 1), ('quadruple', 2), ('ppar-alpha/gamma/delta', 1), ('subcategory', 1), ('cirrhosis', 13), ('rla8', 7), ('balanced', 4), ('-alpha/gamma/delta', 1), ('methionine/choline-deficient', 1), ('lipoperoxide', 1), ('morphologic', 3), ('pathologic', 11), ('ballooning', 2), ('fiber', 8), (\"5'amp-activated\", 1), ('kinase-acetyl-coa', 1), ('lipogenic', 1), ('nash-induced', 1), ('worthy', 1), ('eye', 13), ('korean', 5), ('23,376', 1), ('2012.', 1), ('adjusting', 10), ('sociodemographic', 2), ('1.64', 2), ('1.39', 2), ('1.02', 5), ('1.89', 1), ('0.039', 3), ('1.51', 2), ('0.59', 2), ('0.283', 1), ('1.05', 2), ('0.84', 4), ('1.58', 4), ('0.389', 1), ('confounding', 1), ('1.18', 2), ('1.69', 1), ('1.12', 3), ('2.24', 1), ('pelargonidin', 11), ('pel', 15), ('cams', 2), ('adhesion/transendothelial', 1), ('hyperpermeability', 5), ('endorsing', 1), ('usefulness', 4), ('mori', 6), ('ramulus', 4), ('chin.ph', 2), ('-the', 2), ('dried', 3), ('twigs', 2), ('morus', 4), ('alba', 5), ('l./part', 1), ('glycosides', 5), ('anti-hyperuricemic', 1), ('l.-is', 1), ('antirheumatic', 2), ('finds', 1), ('xanthine', 7), ('xo', 7), ('ec', 10), ('1.1.3.22', 1), ('hyperuricemy', 1), ('gout', 8), ('anti-hyperuremic', 1), ('allopurinol', 1), ('purine', 2), ('promissing', 1), ('coumarins', 3), ('antiplatelet', 17), ('dad', 3), ('q-tof', 1), ('separating', 1), ('multi-herbal', 1), ('/esi-q-tof-ms/ms', 2), ('pharmacologically', 5), ('glycosides-including', 1), ('time-in', 1), ('project', 6), ('moriramulosid', 2), ('umbelliferone-6-beta-d-apiofuranosyl-', 1), ('-beta-d-glucopyranoside', 1), ('6-', 3), ('6-o-', 1), ('6-deoxy-alpha-l-mannopyranosyl', 1), ('-beta-d-glucopyranosyl', 1), ('-2h-1-benzopyran-1-one', 1), ('scopolin', 1), ('alpha-lipoic', 8), ('upm', 8), ('upm-induced', 1), ('ala', 11), ('turbinate', 1), ('ares', 2), ('upm-exposed', 1), ('rhinitis', 5), ('multi-target', 4), ('chelator', 7), ('m30', 5), ('implanted', 7), ('osmotic', 6), ('cyclophosphamide-treated', 1), ('tnfrsf19', 1), ('ercc2', 1), ('lama5', 1), ('ctsl', 2), ('per1', 1), ('high-throughput', 21), ('fast-growing', 1), ('aneuploidy', 4), ('hydraulic', 1), ('fracturing', 1), ('meiosis', 6), ('eliciting', 1), ('thiocyanomethylthio', 1), ('benzothiazole', 1), ('tcmtb', 1), ('double-strand', 6), ('break', 4), ('dsb', 2), ('p53/cep-1-dependent', 1), ('diakinesis', 1), ('segregation', 1), ('germline-specific', 1), ('antinociception', 10), ('modern', 3), ('2013.', 1), ('res', 32), ('res-induced', 5), ('paw', 15), ('carrageenan', 5), ('mug/paw', 3), ('swiss', 14), ('right', 20), ('hind', 2), ('naloxone', 2), ('clocinnamox', 1), ('muor', 3), ('naltrindole', 1), ('nor-binaltorfimine', 1), ('deltaor', 1), ('kor', 1), ('intermediate-dose', 1), ('bestatin', 1), ('involved-enzymes', 1), ('mafp', 1), ('amidase', 1), ('jzl184', 1), ('2-arachidonoylglycerol', 5), ('involved-enzyme', 1), ('vdm11', 1), ('reuptake', 6), ('probiotic', 2), ('bacillus', 2), ('subtilis', 6), ('cw14', 6), ('ota-induced', 3), ('microvilli', 1), ('up-regulating', 7), ('tbbpa', 26), ('th-sensitive', 1), ('characterised', 6), ('embryo-larvae', 4), (\"2,2',4,4'-tetrabromodiphenyl\", 1), ('tetrabromobisphenol', 4), ('fertilisation', 2), ('suite', 3), ('hypothalamic-pituitary-thyroid', 4), ('hpt', 8), ('mount', 3), ('hybridisation', 2), ('wish', 4), ('96-h', 2), ('96h-lc50', 1), ('oedemas', 1), ('swollen', 3), ('craniofacial', 17), ('curved', 1), ('deiodinases', 3), ('dio1', 4), ('ttr', 7), ('paired', 13), ('pax8', 4), ('ugt1ab', 9), ('dio3b', 1), ('varying', 18), ('thrb', 1), ('conjugation', 7), ('production/', 1), ('pronephric', 1), ('ducts', 1), ('appearing', 1), ('trs', 1), ('ths', 10), ('bfrs', 1), ('windows', 4), ('50-year-old', 2), ('woman', 4), ('inferoposterior', 1), ('percutaneous', 2), ('pci', 2), ('circumflex', 1), ('rca', 4), ('uncomplicated', 1), ('sinusitis.three', 1), ('non-stemi', 1), ('nstemi', 3), ('angiogram', 4), ('anterior', 13), ('descending', 2), ('wire', 2), ('liberal', 1), ('intracoronary', 1), ('fractional', 3), ('reserve', 1), ('0.71', 1), ('stent', 6), ('readmitted', 2), ('patent', 1), ('stents', 6), ('figure', 4), ('1a', 13), ('felt', 3), ('therapy.heartjnl', 1), ('105/12/960/f1f1f1figure', 1), ('nitrates', 3), ('cmr', 2), ('arrest.the', 1), ('out-of-hospital', 2), ('fibrillation', 3), ('vf', 2), ('resuscitated', 1), ('implantable', 7), ('cardioverter', 3), ('defibrillator', 1), ('icd', 7), ('persistently', 12), ('1.78x109', 1), ('0.02-0.5x109', 1), ('antinuclear', 1), ('antibodies', 12), ('antineutrophil', 1), ('anca', 1), ('disease.prinzmetal', 1), ('angina.loeffler', 1), ('endocarditis.coronary', 1), ('vasculitis', 3), ('non-isotopic', 3), ('predictor', 2), ('psychological', 6), ('conventionally', 2), ('isotopes', 1), ('inconvenient', 1), ('radioactivity', 1), ('radio-isotope-labeled', 1), ('jwh-015', 2), ('jwh-210', 2), ('rcs-4', 2), ('jwh-250', 2), ('biosensor', 2), ('isotopic', 3), ('9.52', 1), ('10-13', 1), ('6.54', 1), ('10-12', 2), ('1.56', 1), ('10-11', 5), ('2.75', 1), ('6.80', 1), ('x10-11', 1), ('immunotoxicant', 1), ('tbbpa-induced', 4), ('akt/mapk', 1), ('cl-20/tnt', 8), ('cocrystal', 2), ('reaxff', 3), ('md', 8), ('sensitivity-decrease', 3), ('high-energetic', 1), ('cl-20', 3), ('thermolysis', 3), ('varxmd', 1), ('tnt', 6), ('n-no2', 2), ('c-n', 2), ('scission', 1), ('ring-opening', 2), ('oxygen-abstraction', 1), ('slowed', 2), ('beta-cl-20', 1), ('confined', 2), ('surrounding', 8), ('ring', 11), ('accounting', 1), ('nitro', 1), ('hydrogen-abstraction', 1), ('chain-like', 1), ('exothermal', 1), ('tuned', 1), ('energetic', 1), ('cl-20-based', 1), ('cocrystals', 1), ('aloin', 10), ('p-stat-1', 1), ('anthraquinone', 2), ('aloe', 3), ('anti-oxidative', 9), ('cyclooxygenase', 8), ('-activated', 3), ('lps-treated', 3), ('nf-kappab-luciferase', 2), ('preferential', 4), ('inos/no', 2), ('cox-2/pge2', 1), ('stat-1', 1), ('siho-1rna-transfection', 1), ('stress-associated', 3), ('organophosphorus', 18), ('malathion', 11), ('malathion-induced', 3), ('gibco', 1), ('gha', 3), ('reagent', 2), ('wst-1', 2), ('reader', 2), ('productions', 2), ('cycle-related', 2), ('e1', 2), ('cdk1/cdc2', 1), ('caspase-9/caspase-3', 1), ('10-25', 3), ('stresses', 4), ('glutathion', 1), ('malathion-evoked', 1), ('malathion-activated', 1), ('gamma-tocotrienol', 3), ('ndufb8', 4), ('sdhb', 4), ('tocotrienols', 4), ('t3s', 3), ('bioenergetic', 2), ('gamma-t3', 5), ('oxphos', 6), ('uqcrc2', 1), ('atp5f1a', 1), ('k63-linked', 3), ('kpf', 4), ('endotoxin-induced', 2), ('tgf-beta-activated', 2), ('tak1', 8), ('lps-mediated', 1), ('irak1', 1), ('corroborations', 1), ('medicinally', 1), ('pyrazoles', 2), ('determinations', 2), ('validations', 1), ('getting', 1), ('deals', 1), ('precursors', 1), ('4-fluorophenyl', 2), ('-6-isopropyl-2-', 2), ('methylsulfonyl', 1), ('pyrimidine-5-carbohydrazides', 1), ('3a-m', 2), ('methyl-4-', 1), ('sulfonyl', 1), ('pyrimidine-5-carboxylate', 1), ('acetophenone', 2), ('vilsmeier-haack', 1), ('8-10', 1), ('hrs', 6), ('gave', 4), ('carbaldehyde', 1), ('4a-m', 4), ('phosphoinositide-3-kinase', 1), ('hrbc', 1), ('admet', 2), ('ae', 11), ('fabp10', 1), ('egfp', 2), ('sudan', 4), ('black', 9), ('dock', 1), ('blackened', 1), ('nf-kappab-p53', 1), ('inflammation-apoptosis', 1), ('lifelines', 2), ('c14:0', 2), ('c15:0', 4), ('c17:0', 1), ('trans-c16:1', 1), ('n-7', 9), ('trans-c18:1', 8), ('cla', 6), ('hardly', 3), ('enrich', 1), ('portfolio', 2), ('769', 1), ('ffq', 1), ('25th-75th', 1), ('intakes', 3), ('322', 1), ('209-447', 1), ('8.4-17.4', 1), ('std.beta', 4), ('0.286', 1), ('0.111', 1), ('0.292', 1), ('0.115', 1), ('0.272', 1), ('0.103', 1), ('0.269', 1), ('0.099', 1), ('0.128', 1), ('0.143', 1), ('fragile', 2), ('histidine', 2), ('triad', 2), ('fhit', 9), ('october', 4), ('non-hepatoma', 2), ('hepatitis', 17), ('a/hepatitis', 1), ('b/hepatitis', 1), ('methylation-specific', 2), ('msp', 4), ('accuracy', 15), ('51.8', 1), ('25.0', 1), ('10.550', 1), ('2.313~48.116', 1), ('8.239', 1), ('2.386~28.455', 1), ('aminophylline', 3), ('photoilluminated', 2), ('riboflavin', 3), ('macromolecular', 7), ('benzopyrene', 1), ('rf', 1), ('b2', 1), ('photosensitizer', 1), ('photophysical', 1), ('photochemical', 1), ('phosphodiesterase', 2), ('bronchodilator', 1), ('haemolytic', 1), ('proteolytic', 5), ('unravelled', 1), ('scavengers', 1), ('am-rf', 1), ('characteristically', 2), ('derives', 1), ('anticipate', 1), ('photodynamic', 1), ('realised', 1), ('aminorex', 3), ('4-mar', 6), (\"4,4'-dmar\", 7), ('3,4-dmar', 4), (\"4,4'-dimethylaminorex\", 1), ('illicit', 2), ('market', 5), ('psychostimulant', 5), ('4-methylaminorex', 1), ('amphetamine-like', 1), ('1960ies', 1), ('withdrawn', 5), ('3,4-dimethylaminorex', 1), ('direx', 1), ('norepinephrine', 2), ('ne', 5), ('da', 31), ('potencies', 4), ('transporter-transfected', 1), ('3,4-methlyenedioxymethamphetaime', 1), ('mdma', 13), ('serotonergic', 5), ('amphetamine', 5), ('releasers', 1), ('dat', 3), ('endotoxemia-induced', 1), ('etm', 1), ('-challenged', 1), ('6-phosphofructo-2-kinase', 1), ('pfk-2', 1), ('/fructose-2,6-bisphosphatase', 1), ('indispensable', 9), ('etm-induced', 1), ('lps-challenged', 2), ('3pyridinyl', 1), ('-1-', 1), ('4-pyridinyl', 1), ('-2-propen-1-one', 1), ('3po', 4), ('echocardiographic', 5), ('hl-1', 1), ('gr-c/ebpalpha-sirt1', 2), ('mg/kg.d', 4), ('gd', 13), ('9-20.', 2), ('pw', 4), ('pw28', 4), ('kleiner', 1), ('ccaat', 1), ('factor-sterol', 1), ('srebp1c', 6), ('pw12', 1), ('h3k14ac', 3), ('h3k27ac', 8), ('pce-induced', 1), ('atp-sensitive', 2), ('k-channel', 1), ('anticonvulsant', 9), ('cbr', 2), ('cbrs', 2), ('tri-phosphate', 1), ('-sensitive', 1), ('collaborate', 1), ('clonic', 1), ('threshold', 9), ('cst', 5), ('naval', 1), ('nmri', 5), ('cromakalim', 3), ('opener', 1), ('am-251', 4), ('am-630', 3), ('55,212-2', 10), ('appraised', 2), ('subeffective', 1), ('single-treated', 1), ('accomplishes', 1), ('methylation-regulated', 1), ('zfp57', 5), ('rct', 7), ('trimesters', 3), ('epifasstt', 1), ('imprinted', 10), ('epigenome-wide', 2), ('epic', 2), ('850,000', 1), ('86', 7), ('top-ranked', 2), ('dmr', 4), ('imprint', 1), ('pyrosequencing', 4), ('gains', 2), ('afast', 1), ('strengthen', 3), ('www.isrctn.com', 1), ('isrctn19917787', 1), ('laxiflora', 4), ('fipronil', 18), ('fpn', 9), ('insects', 10), ('abrogating', 2), ('tl', 1), ('fourty', 1), ('neuroprotectant', 1), ('25.8', 3), ('30.9', 1), ('41.2', 1), ('40.54', 1), ('30.35', 1), ('fpn-induced', 2), ('kinase/signal', 1), ('jak/stat', 2), ('sw480', 21), ('transcriptase-polymerase', 2), ('shuttled', 2), ('egf-induced', 1), ('diethylnitrosamine', 2), ('den', 6), ('hesperidin/day', 1), ('afp', 2), ('den-induced', 1), ('cdk-2', 2), ('preserved', 6), ('antioxidation', 4), ('stroke', 29), ('amph', 11), ('adversely', 6), ('determines', 3), ('normothermic', 1), ('environmentally-induced', 1), ('eih', 5), ('fold-change', 2), ('organ-specific', 4), ('alb', 1), ('fbg', 2), ('f2', 7), ('spink1', 1), ('bronchi/lungs', 1), ('f3', 3), ('cyp4b1', 1), ('np4', 1), ('ratnp-3b', 1), ('cesl1', 1), ('slc22a8', 1), ('mir-122', 9), ('muscle/heart-enriched', 1), ('cd14', 1), ('vcan', 1), ('t-cells', 2), ('50-70', 1), ('exception', 4), ('ccr5', 2), ('chst12', 1), ('leaving', 3), ('b-cells', 1), ('b-lymphoblasts', 1), ('cd19', 1), ('cd180', 1), ('tk1', 1), ('ahsa1', 1), ('=500', 1), ('stip1', 1), ('ackr3', 2), ('ccr2', 1), ('pld1', 2), ('modify', 7), ('high-dimensional', 1), ('xenobiotic-induced', 2), ('introduce', 2), ('machine-learning', 1), ('toxicogenomic', 3), ('discrete', 1), ('others', 20), ('transitions', 1), ('cachexia', 5), ('whole-body', 9), ('gdf15', 1), ('broadly', 3), ('rho-kinase', 2), ('peptide-modified', 1), ('perfusion', 11), ('cirrhotic', 11), ('rock', 3), ('rock-inhibitor', 1), ('y-27632', 1), ('y27', 4), ('mannose-6-phosphate-receptors', 1), ('decompensated', 1), ('platelet-derived', 2), ('pdgfrbeta', 2), ('hsa', 15), ('pdgfrbeta-recognizing', 1), ('peptides', 9), ('lx2', 2), ('bdl', 2), ('i.v', 4), ('y27ppbhsa', 4), ('0.5/1', 1), ('b.w', 3), ('moesin', 2), ('myosin', 6), ('mlc', 2), ('mesenteric', 6), ('ppbhsa', 1), ('hplc/ms', 1), ('relax', 2), ('y27ppbhsa-treated', 2), ('output', 11), ('double-immunostainings', 1), ('acta2', 2), ('olesoxime', 6), ('islets', 22), ('transplantation', 12), ('c-peptide', 2), ('bax/bcl2', 4), ('stressful', 3), ('functionality', 6), ('mining', 12), ('basin', 2), ('san', 2), ('jorge', 2), ('river', 2), ('colombia', 3), ('contamination', 9), ('wastes', 4), ('bocas', 1), ('ure', 1), ('mina', 1), ('el', 2), ('alacran', 1), ('torno', 1), ('rojo', 1), ('micronucleus', 8), ('cytome', 1), ('bmcyt', 2), ('exfoliated', 2), ('buccal', 2), ('representing', 4), ('stage-dependent', 1), ('pharmaceutical', 11), ('affective', 2), ('inadvertently', 1), ('watersheds', 1), ('axes', 4), ('build', 3), ('life-stage-dependent', 1), ('breeding', 4), ('contributions', 10), ('developmentally', 5), ('flx-exposed', 2), ('sexes', 5), ('mated', 4), ('descended', 2), ('bred', 1), ('revealing', 7), ('life-stage', 1), ('maternally', 4), ('methyltransferases', 5), ('post-transcriptional', 2), ('unfertilized', 1), ('eggs', 7), ('dnmt3', 1), ('paralogues', 1), ('mir-740', 1), ('mir-26', 1), ('mir-30d', 1), ('mir-92a', 4), ('mir-103', 1), ('mirna-30d', 1), ('mirna-92a', 1), ('separated', 6), ('flx-females', 1), ('food/herb-drug', 5), ('antioxygen', 1), ('scattered', 1), ('effluxing', 1), ('illuminate', 3), ('tangeretin', 10), ('sinensetin', 3), ('isosinensetin', 2), ('sciadopitysin', 1), ('oroxylin', 10), ('mdr1-mdckiicells', 1), ('p-gp-mediated', 1), ('taxol', 1), ('digoxin', 2), ('auc0-t', 2), ('extents', 2), ('19.84', 1), ('81.51', 1), ('pharmacophore', 8), ('flavonoid-containing', 3), ('bisphenol-a', 12), ('mitosis', 5), ('retinoid-signalling', 1), ('9-16', 1), ('post-natal', 3), ('30.', 1), ('all-trans-retinoic', 3), ('adh1', 9), ('aox1', 3), ('rxrbeta', 2), ('bivariate', 1), ('rargamma', 3), ('rxrgamma', 2), ('mutational', 3), ('crlm', 3), ('worse', 8), ('defining', 5), ('hepatectomy', 3), ('multi-centric', 1), ('tbs', 7), ('clinico-pathological', 1), ('784', 1), ('oxaliplatin-', 1), ('irinotecan-based', 3), ('34', 7), ('kras/nras/braf', 1), ('kras/nras', 1), ('=6', 2), ('delta-tbs', 3), ('prognostically', 1), ('multi-faceted', 2), ('ch223191-induced', 2), ('circumstances', 3), ('2-methyl-2', 1), ('h-pyrazole-3-carboxylic', 1), ('2-methyl-4-', 1), ('o-tolylazo-phenyl', 1), ('-amide', 1), ('ch223191', 11), ('6-formylindolo', 6), ('3,2-', 1), ('carbazole', 6), ('ficz', 18), ('hepg2-xre-luc', 2), ('p4501a1', 3), ('buthionine-', 1), ('-sulfoximine', 1), ('n-acetyl-l-cysteine', 12), ('microsomal', 19), ('mitochondrial-dependent', 2), ('1.48', 3), ('ahr-induced', 1), ('oxidants', 2), ('reversibility', 2), ('randall', 3), ('stone', 9), ('anchors', 2), ('papillary', 14), ('pits', 7), ('encountered', 11), ('ureteroscopy', 2), ('stones', 9), ('overgrowing', 2), ('rp', 3), ('dislodged', 2), ('digital', 7), ('muct', 3), ('endoscopic', 4), ('procedures', 13), ('rpas', 1), ('fashion', 8), ('videos', 1), ('urologists', 1), ('muct-confirmed', 1), ('rpa', 5), ('formers', 2), ('oxalate', 2), ('7.6', 3), ('manipulation', 7), ('dislodgement', 1), ('attached', 2), ('pit', 3), ('routinely', 3), ('depth', 4), ('302', 1), ('172', 4), ('shallow', 2), ('pulling', 1), ('away', 2), ('piece', 2), ('papilla', 1), ('undersurface', 1), ('attachment', 10), ('pkr', 12), ('c16', 2), ('conditioning', 5), ('otherwise', 5), ('hsc-stimulated', 1), ('pkr-inhibited', 1), ('acid-stimulated', 1), ('n-acetyl-p-benzoquinoneimine', 2), ('paracetamol', 13), ('n-acetyl-para', 1), ('antipyretic', 2), ('cytochrome-p450', 1), ('napqi', 11), ('bioactivation', 30), ('concentration-time', 2), ('cyp3a4-mediated', 4), ('receptor-beta', 2), ('afflicts', 2), ('20-36', 1), ('lipotoxic', 1), ('fr-beta', 10), ('goals', 3), ('methionine', 4), ('choline', 11), ('mcd', 6), ('mc+', 1), ('fr-beta-targeted', 1), ('etarfolatide', 2), ('mc', 8), ('-fed', 2), ('fastspect', 2), ('control-fed', 2), ('categorized', 4), ('harnessed', 1), ('endosulfan-induced', 5), ('etiopathogenesis', 1), ('dieldrin', 9), ('endosulfan', 24), ('n27', 1), ('autophagosomes', 10), ('delta', 5), ('precedes', 2), ('wortmannin', 2), ('crispr/cas9-based', 1), ('mesencephalic', 1), ('dictate', 2), ('pesticide-induced', 3), ('sirtuin-1', 3), ('cadmium-induced', 5), ('xbp-1s', 5), ('damaging', 7), ('caspase-1-dependent', 1), ('cd-induced', 23), ('pyroptosis-related', 1), ('or/and', 3), ('yvad', 1), ('caspase-1-', 1), ('nlrp3-inflammasome-dependent', 1), ('branches', 2), ('ire-1alpha', 1), ('ire-1alpha/xbp-1s', 3), ('branch', 2), ('stf-083010', 1), ('xbp-1', 1), ('sirt-1', 3), ('co-overexpression', 1), ('deacetylating', 1), ('mir-219a-5p', 6), ('tp53bp2', 4), ('i/r', 17), ('hypovolemic', 1), ('age-dependent', 3), ('agomir-mir-219a-5p', 1), ('toa', 1), ('osi', 1), ('h2o2-induced', 10), ('aml-12', 2), ('nctc1469', 1), ('tp53', 18), ('age-related', 9), ('tp53-dependent', 1), ('bde-100', 3), ('bde-153', 3), ('patient-derived', 8), ('persistence', 9), ('pbde', 5), ('congeners', 4), ('missing', 5), ('bioactivities', 2), ('binding/activity', 1), ('nonbiased', 1), ('estrogen-dependent', 1), ('mcf-7aroere', 2), ('pdx', 2), ('erralpha', 1), ('er-regulated', 1), ('cyp1b1', 25), ('agonist/antagonist', 1), ('apoptosis/cell', 1), ('dmh-cbd', 8), ('a2a', 8), ('immunological', 9), ('dimethyl-heptyl-cannabidiol', 1), ('lc50', 4), ('58', 6), ('provokes', 6), ('ikbalpha', 2), ('8-', 2), ('3-chlorostyryl', 1), ('csc', 7), ('intimately', 1), ('thymidine', 2), ('phosphorylase', 2), ('hsp90', 8), ('salinomycin', 6), ('polyether', 1), ('ionophore', 1), ('pyrimidine', 2), ('nucleoside', 4), ('prognoses', 1), ('17-aag', 2), ('salinomycin-induced', 2), ('mkk3/6-p38', 1), ('enforced', 4), ('mkk6e', 1), ('mkk6', 1), ('rosiglitazone', 16), ('gamma-dependent', 1), ('anti-fibritic', 1), ('sprague-dawly', 2), ('euthanised', 1), ('28.', 3), ('distilled', 9), ('nominated', 2), ('rsg', 3), ('gw', 3), ('gw9662', 10), ('pao2', 1), ('wet-to-dry', 2), ('upregulateing', 1), ('maneb-induced', 6), ('maneb', 9), ('oxidase-regulated', 1), ('dpi', 6), ('ferroptotic', 1), ('myristate', 2), ('maneb-treated', 6), ('inquiry', 1), ('gpx4', 5), ('hepcidin-ferroportin', 1), ('hepcidin', 14), ('ferroportin', 5), ('sequestration', 2), ('ferroportin-expressing', 1), ('restricted', 6), ('erythropoiesis', 2), ('manipulating', 1), ('overview', 2), ('scenarios', 6), ('patellar', 1), ('dislocations', 1), ('arthroscopic', 1), ('mpfl', 1), ('redislocations', 1), ('orphan', 1), ('stallion', 1), ('testes', 15), ('stallions', 1), ('postinjection', 1), ('steroidogenic', 13), ('nr0b2', 1), ('nr4a1', 3), ('nr5a1', 3), ('nr5a2', 3), ('depressed', 7), ('nfkbia', 2), ('nr0b1', 1), ('nr2f1', 1), ('nr2f2', 1), ('nr3c1', 1), ('cyp17a1', 8), ('dhcr24', 1), ('gsta3', 1), ('hsd3b2', 2), ('hsd17b3', 1), ('lhcgr', 3), ('leydig', 9), ('-7', 6), ('regorefenib', 1), ('extrinsic/intrinsic', 2), ('mapk/nf-kappab-modulated', 1), ('regorafenib', 7), ('tsgh', 2), ('8301', 2), ('progression-associated', 4), ('140', 3), ('mul', 3), ('cyclin-d1', 3), ('caliper', 1), ('qnz', 2), ('mapk/', 1), ('nf-kappab-modulated', 1), ('stem-cell-like', 1), (\"3,3',4',7-tetrahydroxyflavone\", 1), ('faraway', 1), ('favoring', 6), ('claiming', 1), ('translationally', 1), ('anti-metastatic', 3), ('h1299', 14), ('cd44', 6), ('colonies', 3), ('solid-state', 3), ('anaerobic', 4), ('digestion', 5), ('wheat', 6), ('s/i', 5), ('pilot-scale', 2), ('fungal', 11), ('ssad', 4), ('bed', 3), ('reactor', 4), ('substrate/inoculum', 1), ('start-up', 3), ('productivity', 3), ('vfa', 2), ('reactors', 2), ('vfa/alkalinity', 1), ('ghac_eq/gcaco3', 2), ('g/l', 2), ('5.5.', 1), ('wet', 3), ('submitted', 6), ('non-sterile', 1), ('digested', 2), ('2.8-2.9.', 1), ('batch', 1), ('biodegradability', 2), ('254', 2), ('215', 1), ('nml/g', 1), ('suboptimal', 1), ('161', 2), ('171', 1), ('nml/gtsinitial', 1), ('60-days', 1), ('anti-muscarinic', 9), ('rectal', 12), ('constipation', 7), ('sci', 2), ('relates', 3), ('symptomatology', 2), ('anti-muscarinics', 1), ('solifenacin', 2), ('tolterodine', 2), ('adrenoceptor', 1), ('mirabegron', 3), ('wanted', 2), ('anorectal', 3), ('manometry', 4), ('neurogastroenterology', 1), ('london', 2), ('thirty-five', 1), ('supraconal', 1), ('anal', 2), ('rectoanal', 1), ('reflex', 2), ('rair', 3), ('overactive', 3), ('started', 5), ('identically', 1), ('pre-and', 1), ('non-sci', 1), ('squeeze', 1), ('cough', 4), ('pressures', 2), ('amplitude', 2), ('sphincter', 4), ('relaxation', 2), ('wexner', 3), ('incontinence', 1), ('rectum', 2), ('cftr', 17), ('endoglin', 2), ('eng', 12), ('modifier', 7), ('cystic', 7), ('cf', 33), ('pathobiology', 2), ('non-cf', 1), ('cftrinh', 1), ('-172', 1), ('fivefold', 1), ('homogenates', 3), ('threefold', 3), ('twofold', 2), ('tripled', 1), ('triorganotin', 5), ('trialkyltins', 1), ('triaryltins', 1), ('ligand-binding', 3), ('tributyltin', 12), ('triphenyltin', 11), ('bottom-up', 1), ('maldi-tof/tof', 1), ('ms/ms', 1), ('pdquest', 2), ('triorganotins', 2), ('rxr/rar', 1), ('heterodimer', 4), ('epigenotoxic', 2), ('acrylamide', 15), ('agency', 3), ('well-recognized', 2), ('0.0875', 1), ('0.175', 1), ('0.35', 3), ('0.70', 3), ('nontarget', 3), ('n7-', 2), ('2-carbamoyl-2-hydroxyethyl', 2), ('guanine', 3), ('n3-', 1), ('trimethylation', 3), ('h4k20me3', 1), ('mark', 2), ('microtissues', 9), ('3d', 26), ('contractile', 1), ('microtissue', 2), ('hesc', 1), ('-derived', 5), ('cms', 4), ('sarcomeric', 1), ('cardiac-specific', 1), ('transdifferentiated', 1), ('manifesting', 2), ('plasticizers', 10), ('polyvinyl', 2), ('pvc', 1), ('ppargamma-deficient', 1), ('vct', 2), ('syncytiotrophoblast', 4), ('vcts', 2), ('activity/hcg', 1), ('lipidomics', 1), ('placentas', 8), ('hcg', 1), ('u-shaped', 6), ('//doi.org/10.1289/ehp3730', 1), ('mir-126', 3), ('mir-190a', 5), ('egfl7', 2), ('tp53inp1', 2), ('phlpp1', 2), ('microrna-126', 1), ('bp-induced', 4), ('sodium-induced', 4), ('kinase-1-', 1), ('cascades', 10), ('represented', 5), ('protein-1alpha', 2), ('receptor-gamma-coactivator', 1), ('alleviations', 2), ('peroxynitrite', 3), ('picture', 4), ('inexplicably', 1), ('dysregulates', 2), ('asd-related', 3), ('hippocampi', 5), ('prenatally', 1), ('auts2', 1), ('foxp2', 1), ('interactome', 2), ('functions/disorders', 1), ('reanalysis', 1), ('bpa-responsive', 1), ('asd-linked', 1), ('dysregulating', 3), ('auriculasin', 11), ('sensitizes', 8), ('dr5-dependent', 1), ('chemotherapeutics', 2), ('factor-related', 1), ('rc-58t/h/sa', 2), ('rwpe-1', 3), ('tumor-specific', 1), ('endo', 3), ('caspases-9', 1), ('-10.', 1), ('dr5', 8), ('chop', 12), ('chimeric', 4), ('ac-trail-induced', 1), ('trail-resistant', 1), ('anthracycline', 4), ('c-13', 1), ('govern', 3), ('ac16', 6), ('suspected', 8), ('addressed', 8), ('zr-75-1', 1), ('hmf3a', 1), (\"p'-ddt\", 25), ('methoxychlor', 3), ('benzophenone-2', 1), ('4-phenylphenol', 1), ('n-butylparaben', 1), ('aromatase-induced', 1), ('inadvertent', 1), (\"'phenolic\", 1), ('estrogen-sensitive', 1), ('94,437', 1), ('iqck', 1), ('adam10', 8), ('adamts1', 1), ('wwox', 1), ('-by-familial-proxy', 1), ('leukocyte', 3), ('hla', 1), ('hla-dr15', 1), ('early-onset', 4), ('up-regulates', 2), ('metallothionein', 5), ('glyphosate-induced', 5), ('glyphosate-treated', 2), ('gly', 4), ('gly+qe', 1), ('b.w./day', 5), ('gamma-gt', 1), ('mt', 10), ('histoarchitecture', 1), ('ultralow', 4), ('dextromethorphan', 11), ('sepsis-like', 1), ('wildly', 2), ('antitussive', 1), ('subpicomolar', 3), ('neuron-glial', 1), ('subpico-', 1), ('lipopolysaccharide/d-galactosamine', 2), ('lps/galn', 2), ('mug/600', 1), ('lps/galn-injected', 1), ('kupffer', 4), ('oxidase-generated', 2), ('iros', 1), ('septic', 14), ('hexahelicene', 2), ('carbohelicenes', 1), ('helical-shaped', 1), ('helicene', 7), ('imidazolium', 1), ('1-butyl-3-', 1), ('2-methyl', 1), ('helicenyl', 1), ('-imidazolium', 1), ('2.1-fold', 1), ('bisphenol-s', 1), ('gerbils', 5), ('prostates', 4), ('biometric', 1), ('morphometric', 7), ('glandular', 1), ('ddt', 20), ('dichlorodiphenyltrichloroethane', 5), ('316', 1), ('daughters', 4), ('ddts', 2), ('midlife', 1), ('dmrs', 3), (\"p'-dde\", 15), ('ccdc85a', 1), ('zfpm2', 1), ('pubertal', 7), ('life-long', 1), (\"3,3',4,4',5-pentachlorobiphenyl\", 2), ('stress-sensitive', 2), ('redox-modulating', 1), ('circulatory', 4), ('alpha-tocopherol', 5), ('liposoluble', 1), ('nitroprusside', 2), ('gstp1', 2), ('gpx1a', 3), ('geriatric', 5), ('cga', 5), ('belgian', 1), ('oncology', 4), ('kortrijk', 1), ('cutdown-annoyed-guilty-eye-opener', 1), ('cage', 4), ('test-screening', 1), ('audit-c', 3), ('193', 2), ('77.7', 1), ('6.3', 3), ('30.0', 1), ('21.7', 1), ('entered', 4), ('geriatric-8', 1), ('polypharmacy', 1), ('feasible', 10), ('implement', 2), ('sclerosing', 3), ('cholangitis', 6), ('3,5-diethoxycarbonyl-1,4-dihydrocollidine', 2), ('nrf2-ko', 1), ('nrf2-/-', 6), ('hyperactivated', 1), ('hkeap1-/-', 1), ('oval', 7), ('hkeap1-/', 3), ('suffered', 4), ('abcc2-4', 1), ('nrf2-/', 2), ('anthocyanins', 9), ('bilberry', 4), ('nephroprotective', 4), ('ml/kg', 7), ('.the', 2), ('anthocyanins/kg', 1), ('seventh', 4), ('nephrotoxicant', 1), ('pro-oxidative', 2), ('gssg', 3), ('noticeable', 3), ('pod', 6), ('beta2-microglobulin', 1), ('kim1/tim1', 1), ('defence', 3), ('parenchyma', 3), ('periglomerular', 1), ('dilatation', 4), ('tubules', 10), ('ccl4-intoxicated', 1), ('neutralization', 4), ('cyproheptadine', 2), ('appetite', 9), ('cy', 8), ('stimulant', 3), ('caloric/nutritional', 1), ('prisma', 1), ('standards', 2), ('39', 4), ('malignant/progressive', 1), ('sedation', 2), ('demographics', 1), ('helping', 1), ('underweight', 1), ('augments', 4), ('phycotoxin', 4), ('13-desmethylspirolide', 2), ('13-spx-c', 7), ('dinoflagellates', 1), ('accumulate', 8), ('shellfish', 7), ('13-spx-c-contaminated', 1), ('seafood', 3), ('codex', 1), ('alimentarius', 1), ('consumers', 3), ('s9', 10), ('13-spx-c.', 2), ('cyp1a2-silensomes', 1), ('first-pass', 2), ('sirt1-related', 1), ('a2ar/camp/pka', 2), ('tch', 8), ('investigates', 8), ('20.', 4), ('gd20', 6), ('0-100', 5), ('ldl-c', 11), ('tch/hdl-c', 2), ('ldl-c/hdl-c.', 1), ('srebf2', 1), ('hmgcr', 10), ('hmgcs1', 1), ('a2ar', 2), ('monophosphate', 3), ('sirtuin1', 6), ('pka', 8), ('cgs-21680', 1), ('lysine-specific', 2), ('lsd1/kdm1a', 2), ('mono-', 5), ('di-methylated', 1), ('h3k4', 2), ('lsd1-mediated', 1), ('c-myc-induced', 1), ('lsd1', 7), ('e-boxes', 2), ('stomach', 5), ('immunocompromised', 4), ('globe', 2), ('t-cell', 8), ('reactivate', 1), ('develops', 2), ('anti-cytomegalovirus', 1), ('prophylaxis', 6), ('ganciclovir', 1), ('valganciclovir', 1), ('foscarnet', 1), ('cidofovir', 1), ('letermovir', 2), ('terminase', 1), ('placebo-controlled', 3), ('transplant', 2), ('reactivations', 1), ('reactivation', 12), ('diagnostics-guided', 1), ('pre-emptive', 1), ('orv', 1), ('hetil', 1), ('363-369.', 1), ('galactose', 8), ('inborn', 1), ('errors', 3), ('extremely', 9), ('pdh', 9), ('seahorse', 1), ('xf24', 1), ('fingerprints', 2), ('aerobic', 14), ('squares', 1), ('discriminant', 3), ('glutaminolytic', 2), ('branched-chain', 1), ('discriminating', 1), ('fingerprinting', 2), ('chlorpyrifos', 47), ('mir-181/sirt1/pgc-1alpha/nrf2', 2), ('cpf', 79), ('mir-181', 6), ('has-mir-181-5p', 1), ('sirt1/pgc-1alpha/nrf2', 3), ('deeper', 2), ('mitoq', 11), ('attack', 3), ('repairing', 2), ('fertility', 7), (\"'have\", 1), ('1.3', 7), ('2.6', 3), ('.2mg/kg', 1), ('spermatogenesis', 36), ('blood-testis', 1), ('microstructure', 3), ('sperm', 28), ('drp-1and', 1), ('outstanding', 2), ('sertoli', 19), ('eif4e', 7), ('precancer', 1), ('mucus', 14), ('cocarcinogen', 1), ('serial', 1), ('nicotine-induced', 6), ('akt/mtor', 8), ('hpv-immortalized', 1), ('4ebp1/eif4e', 3), ('eif4e-4ebp1', 1), ('phospho-4ebp1', 1), ('70.', 1), ('chose', 2), ('diminishes', 2), ('eif4e-specific', 1), ('decelerating', 1), ('g0/g1-s', 1), ('4ebp1', 1), ('dissociation', 7), ('erythropoietin', 3), ('excitotoxic', 2), ('epo', 12), ('placed', 7), ('rhepo', 3), ('monosodium', 3), ('msg', 5), ('iu/kg', 1), ('epo-mediated', 1), ('epor', 2), ('betacr', 2), ('mucin', 13), ('goblet', 7), ('ls174t', 1), ('pas', 7), ('secretory', 5), ('extractive', 2), ('ionization-mass', 1), ('eesi-ms', 1), ('vocs', 2), ('gases', 2), ('exam', 1), ('cytology', 1), ('antiinflammatory', 1), ('tedlar', 1), ('bag', 1), ('orotic', 1), ('tetrahydrobiopterin', 2), ('n-phenylacetylglutamine', 1), ('9000', 1), ('pb', 40), ('5,6-benzoflavone', 1), ('bnf', 2), ('pb-bnf-induced', 4), ('pb-bnf', 2), ('cyp2b1/2', 1), ('cyp2c6', 2), ('cyp3a1', 1), ('cyp3a2', 2), ('cyp2c11', 2), ('mi', 5), ('chlorpheniramine', 2), ('piroxicam', 2), ('lansoprazole', 2), ('phenacetin', 1), ('promutagens', 1), ('astragaloside', 2), ('autophagy-associated', 3), ('iv-mediated', 1), ('suberoylanilide', 2), ('hydroxamic', 2), ('saha', 3), ('sevoflurane', 17), ('gestation', 23), ('progressively', 3), ('q-pcr', 2), ('platform-crossing', 1), ('quadrant', 2), ('traveling', 1), ('non-sensitizers', 3), ('cd54', 7), ('h-clat', 2), ('irritants', 2), ('false-positive', 4), ('danger', 2), ('leucine-rich-containing', 1), ('2,4-dinitrochlorobenzene', 3), ('dncb', 8), ('sensitizer', 3), ('octanoic', 1), ('non-sensitizer', 4), ('salicylic', 2), ('cd54-only', 1), ('depressive', 12), ('daytime', 1), ('kangbuk', 1), ('samsung', 1), ('82,078', 1), ('full-time', 1), ('t-tests', 2), ('multigroup', 1), ('paths', 3), ('latanoprost', 10), ('corneal', 30), ('clarity', 1), ('1-year', 1), ('quantitatively', 2), ('scheimpflug', 2), ('open-angle', 3), ('densitometry', 5), ('pentacam', 2), ('oculus', 1), ('1st', 6), ('3rd', 4), ('12th', 3), ('12-mm', 1), ('cornea', 3), ('concentric', 1), ('radial', 4), ('zones', 4), ('t-test', 2), ('33.3', 2), ('totally', 3), ('59.48', 1), ('10.1', 1), ('1st-month', 1), ('began', 2), ('2-6', 1), ('transparency', 1), ('butylated', 4), ('hydroxyanisole', 3), ('colitis-associated', 6), ('bha', 2), ('azoxymethane/dextran', 1), ('mkp-1-/-', 3), ('nitrotyrosine', 2), ('p53bp1', 1), ('6-o-alpha-maltosyl-beta-cyclodextrin', 2), ('niemann-pick', 2), ('npc', 7), ('hepatomegaly', 2), ('g2-beta-cd', 10), ('injectable', 3), ('npc1', 5), ('hamster', 3), ('cho', 2), ('viscosity', 3), ('2.9', 3), ('hepatocytomegaly', 1), ('transaminases', 4), ('cerebroventricular', 1), ('21.4', 1), ('mumol/kg', 1), ('purkinje', 3), ('cerebellum', 4), ('4-hydroxynonenal-', 1), ('4-hydroxynonenal', 4), ('end-product', 2), ('michael', 2), ('nucleophilic', 4), ('sulfhydryl', 5), ('4.5-fold', 2), ('akr1c', 1), ('1.5-fold', 2), ('rnai', 4), ('knocking', 10), ('hne-induced', 1), ('7-hydroxycoumain', 1), ('hepatoprotection', 2), ('chalconoid', 1), ('prenylflavonoids', 1), ('sdr21c1', 1), ('assorted', 1), ('underpinning', 4), ('daun', 5), ('daunorubicinol', 2), ('daunol', 1), ('hop-derived', 1), ('xn', 3), ('cbr1-mediated', 2), ('2,3-hexanedione', 2), ('turned', 5), ('somewhat', 2), ('ic50-values', 1), ('3.71', 1), ('0.26', 3), ('cbr1-driven', 1), ('de-', 1), ('p44/42', 5), ('prime', 3), ('phenylethyl', 13), ('hyperpigmentation', 3), ('luciferase-reporter', 1), ('elisas', 2), ('mapks', 18), ('cell-free', 2), ('tyrosinase-related', 1), ('melanogenic', 1), ('trp-1', 1), ('-luciferase', 2), ('cre-binding', 1), ('mek1/2', 2), ('resorcinol-induced', 1), ('antenna', 2), ('arrangement', 3), ('algal', 4), ('photosystem-i-lhci', 1), ('supercomplex', 2), ('oxygenic', 1), ('photosynthesis', 4), ('photosystems', 1), ('psi', 10), ('psii', 4), ('light-driven', 1), ('converter', 1), ('alga', 5), ('chlamydomonas', 1), ('reinhardtii', 1), ('light-harvesting', 1), ('lhci', 2), ('antennae', 3), ('forming', 11), ('psi-lhci', 2), ('crpsi-lhci', 3), ('solved', 1), ('cryo-electron', 1), ('lhcis', 1), ('supercomplexes', 1), ('populated', 2), ('chlorophylls', 2), ('harvesting', 1), ('egfr-dependent', 2), ('flavoring', 10), ('2,3-butanedione', 4), ('butter', 1), ('bronchiolitis', 2), ('obliterans', 2), ('bo', 5), ('contexts', 3), ('chemotactic', 1), ('da-induced', 5), ('cinc-1', 1), ('nci-h292', 1), ('ag1478', 3), ('tapi-1', 1), ('c-myc-', 1), ('sp1-mediated', 1), ('htert', 8), ('cpt', 12), ('quinoline', 2), ('camptotheca', 1), ('acuminate', 1), ('topoisomerase', 3), ('cpt-induced', 8), ('htert-targeting', 1), ('n-acetyl-cysteine', 3), ('sp1', 6), ('c-myc/ros/sp1', 1), ('stinging', 4), ('itch', 5), ('cosmetics', 1), ('understudied', 1), ('rhe', 2), ('keratinocyte', 19), ('publically', 1), ('toxicogenomics', 4), ('damage-associated', 3), ('hspa1a', 2), ('ddit3', 2), ('il1a', 2), ('hmgb2', 1), ('artn', 1), ('chemokines', 9), ('trans-epidermal', 1), ('filaggrins', 1), ('flg', 1), ('flg2', 1), ('corneodesmosin', 1), ('cdsn', 1), ('carbendazim', 7), ('submerged', 1), ('preservation', 3), ('films', 10), ('mutagenicity', 4), ('monolayer', 6), ('ic25', 1), ('vitrocell', 2), ('cloud', 1), ('alpha-tubulin', 2), ('endocrine-related', 2), ('normoxia', 1), ('guideline', 2), ('455.', 1), ('17-beta-estradiol', 3), ('1.31', 2), ('degraded', 3), ('eralpha-mediated', 2), ('factor-1', 7), ('radiative', 6), ('budgets', 1), ('mat', 6), ('irradiance', 6), ('tidal', 6), ('microphytobenthic', 1), ('photosynthetic', 6), ('mats', 1), ('immersion', 6), ('emersion', 7), ('sediment', 4), ('net', 6), ('budget', 3), ('microsensor', 1), ('scalar', 1), ('coastal', 1), ('reflectance', 1), ('upward', 1), ('downward', 3), ('photon', 3), ('m-2', 1), ('400-700', 1), ('irradiances', 1), ('warming', 2), ('non-photochemical', 1), ('producers', 4), ('temperature-dependent', 1), ('gallic', 6), ('ald', 3), ('anti-ald', 1), ('ethanol-stimulated', 1), ('receptor-interacting', 5), ('rip3', 2), ('ethanol-incubated', 1), ('requisite', 3), ('imazalil', 2), ('imz', 6), ('tc', 19), ('hdl-c', 5), ('virilization', 1), ('trp751', 1), ('running', 6), ('zika', 5), ('ifn', 13), ('ifns', 6), ('flaviviridae', 1), ('well-described', 1), ('zikv', 7), ('attracted', 7), ('outbreaks', 3), ('begun', 1), ('uses', 9), ('evade', 4), ('flaviviruses', 1), ('infect', 2), ('raises', 6), ('intriguing', 1), ('evasion', 1), ('ge11-pda-pt', 4), ('uspios', 7), ('nano-formulation', 3), ('relief', 2), ('mri/pai-guided', 1), ('radio-chemotherapy', 3), ('radio-chemo', 3), ('synergetic', 4), ('h2s', 27), ('cisplatin-loaded', 3), ('dopamine-coated', 1), ('ge11', 1), ('peptide-conjugated', 2), ('multi-functional', 1), ('theranostic', 1), ('acrylic', 1), ('acid-coated', 1), ('ultra-small', 1), ('paa', 3), ('imaging/photoacoustic', 1), ('mri/pai', 1), ('thick', 1), ('coating', 4), ('complexing', 1), ('carboxylic', 3), ('thin', 2), ('encapsulation', 4), ('functionalization', 3), ('endowed', 2), ('photo-thermal', 1), ('impede', 3), ('egfr-positive', 2), ('hypothermia', 16), ('probes', 5), ('relieved', 9), ('evaluations', 6), ('997', 1), ('660', 2), ('initiative', 3), ('spot', 2), ('in-person', 1), ('multinomial', 1), ('sigmadehp', 1), ('4th', 4), ('3.29', 1), ('1.80-6.03', 1), ('monoethyl', 1), ('mono-hydroxybutyl', 1), ('mono-hydroxyisobutyl', 1), ('2.32', 1), ('kg', 4), ('0.93-3.72', 1), ('ephrin', 3), ('glpg1790', 8), ('anti-tumour', 1), ('gscs', 2), ('repopulate', 1), ('erythropoietin-producing', 3), ('eph', 4), ('tumourigenicity', 1), ('ephrin-a1-mediated', 1), ('tyr588', 1), ('ser897', 1), ('epha2', 1), ('b2-mediated', 1), ('epha3', 1), ('ephb4', 13), ('anti-glioma', 3), ('down-modulated', 1), ('nestin', 6), ('octamer-binding', 1), ('3/4', 1), ('oct3/4', 1), ('cd90', 1), ('cd105', 1), ('fibrillary', 4), ('pro-neural/neuronal', 1), ('betaiii', 1), ('tubulin', 7), ('neurofilaments', 1), ('tumour', 29), ('rt', 2), ('u251', 2), ('t98g', 3), ('temozolomide', 2), ('tmz', 2), ('u87mg', 4), ('orthotopic', 4), ('cscs-5', 1), ('disease-free', 1), ('dfs', 1), ('radio-', 1), ('gics', 1), ('radio', 1), ('chemo', 1), ('antiglioma', 1), ('naphthalene', 2), ('1,4-naphthoquinone', 4), ('butane-1-sulfinyl', 1), ('-1,4-naphthoquinone', 2), ('bsq', 7), ('octane-1-sulfinyl', 1), ('osq', 7), ('p-p38', 4), ('p-extracellular', 1), ('p-protein', 1), ('p-signal', 1), ('transcription-3', 2), ('hif1alpha', 5), ('tension', 5), ('nephropathies', 1), ('pro-oxidation', 1), ('transformative', 1), ('tgfbeta', 6), ('0.125', 2), ('mum-0.5', 1), ('tumourigenesis', 1), ('canaliculi', 3), ('hepatocellular-cholestatic', 1), ('erythromycin', 2), ('co-added', 1), ('tvx', 7), ('carboxy-dichlorofluorescein', 1), ('multi-drug', 1), ('dilatated', 1), ('phenylvalerate', 1), ('acetylthiocholine', 3), ('phenyl', 4), ('valerate', 1), ('pv', 9), ('pvase', 4), ('nte', 1), ('organophosphorus-induced', 1), ('bche', 8), ('hbche', 2), ('cholinesterase', 8), ('best-fitting', 2), ('atch', 2), ('non-activated', 1), ('asn289', 1), ('situated', 1), ('pv-site', 3), ('acethylcholine', 1), ('ach', 2), ('pockets', 3), ('crystallized', 1), ('hydrolysis', 9), ('sua', 11), ('mets', 10), ('13,057', 1), ('check-up', 1), ('systolic', 5), ('cis', 5), ('quartiles', 2), ('1.055', 1), ('0.936', 1), ('1.190', 1), ('0.927', 1), ('0.818', 1), ('1.050', 1), ('0.807', 1), ('0.707', 1), ('0.922', 2), ('1.000', 1), ('0.843', 1), ('1.186', 1), ('0.744', 2), ('0.615', 1), ('0.900', 1), ('0.684', 1), ('0.557', 1), ('0.840', 1), ('fully-adjusted', 1), ('one-standard', 1), ('0.944', 1), ('0.906', 1), ('0.982', 1), ('p=0.005', 1), ('0.851', 1), ('0.801', 1), ('0.905', 1), ('naringin', 13), ('glucocorticoid-induced', 2), ('osteonecrosis', 6), ('akt/bad', 4), ('gionfh', 6), ('gcs', 10), ('metabolism-related', 2), ('naringin-treated', 1), ('methylprednisolone', 3), ('mps', 1), ('edu', 2), ('osteocytes', 2), ('deoxynucleotidyl', 3), ('nick', 3), ('v-fitc-pi', 1), ('osteocyte', 3), ('50-year', 1), ('diet-heart', 1), ('holding', 1), ('fats', 1), ('raise', 6), ('harsh', 2), ('generates', 6), ('co', 10), ('refinement', 1), ('dipalmitoyl', 1), ('phosphatidylcholine', 2), ('dppc', 2), ('solvent', 4), ('evaporated', 1), ('emulsified', 1), ('hmg-coa', 1), ('7alpha-hydroxylase', 3), ('steps', 3), ('deacidification', 1), ('deodorization', 1), ('glycerol-derived', 1), ('glycidyl', 3), ('monochloropropandiol', 1), ('mcpd', 2), ('virgin', 4), ('vco', 1), ('creates', 1), ('eif2s3', 9), ('x-linked', 3), ('hypopituitarism', 2), ('heterotrimeric', 1), ('gtp-binding', 1), ('eif2', 1), ('ternary', 4), ('initiator', 2), ('methionyl-trna', 1), ('recruits', 2), ('40s', 2), ('selection', 11), ('initiates', 4), ('eif2gamma', 3), ('microcephaly', 1), ('mehmo', 2), ('circumferences', 1), ('gh', 5), ('tsh', 4), ('eif2s3-knockdown', 1), ('hemizygous', 1), ('p.pro432ser', 2), ('boys', 4), ('langerhans', 1), ('activity/cell', 1), ('relaxed', 2), ('stringency', 1), ('interpretation', 12), ('hypothalamo-pituitary', 1), ('expanding', 2), ('beyond', 10), ('hypoglycaemia', 1), ('fund', 1), ('gosh', 1), ('mrf', 1), ('brc', 1), ('mrc/wellcome', 1), ('trust', 2), ('nigms', 1), ('funded', 2), ('vasculature', 7), ('faster', 6), ('vascularized', 9), ('hasc', 2), ('vascularization', 1), ('vasculature-related', 2), ('collageniv', 1), ('cd140b', 1), ('cd144', 1), ('lipolysis', 5), ('prochloraz', 7), ('mancozeb', 2), ('butylparaben', 1), ('15-deoxy-delta12,14-prostaglandin', 1), ('bis-', 1), ('thoroughly', 5), ('ercc6l2', 7), ('rs591486', 9), ('greek', 1), ('shares', 4), ('155', 3), ('genotyped', 7), ('2.15', 1), ('1.04-4.46', 1), ('over-dominant', 1), ('1.91', 2), ('1.01-3.60', 1), ('g/a', 1), ('g/g', 1), ('indication', 5), ('rx-3117', 5), ('fluorocyclopentenyl', 1), ('cytosine', 5), ('antimetabolite', 1), ('gemcitabine-resistant', 1), ('700', 4), ('days/week', 2), ('describes', 7), ('pharmacokinetic/pharmacodynamic', 1), ('investigational', 2), ('uridine-cytidine', 1), ('uck2', 1), ('eryptosis', 2), ('repellent', 2), ('n-diethyl-3-methylbenzamide', 2), ('deet', 8), ('nucleated', 2), ('rbcs', 6), ('organelles', 5), ('termed', 4), ('rbc', 3), ('accompanying', 2), ('hematocrit', 4), ('1-5', 1), ('-0.1', 1), ('eryptotic', 2), ('cytometer', 1), ('annexin-v-fitc', 3), ('scatter', 1), ('fsc', 2), ('fluo-3/am', 1), (\"2',7'-dichlorodihydrofluorescein\", 1), ('h2dcfda', 1), ('fluo3', 2), ('deet-induced', 1), ('casein', 1), ('domain-like', 4), ('deet-mediated', 1), ('elicits', 10), ('suicidal', 2), ('asymmetry', 2), ('africans', 4), ('thromboembolic', 9), ('anticoagulant', 9), ('africa', 6), ('interindividual', 5), ('host-environment', 1), ('pharmacogenetics-informed', 1), ('pharmacogenetics', 3), ('african', 7), ('january', 9), ('343', 2), ('botswana', 1), ('ethiopia', 1), ('egypt', 1), ('ghana', 1), ('kenya', 1), ('south', 1), ('tanzania', 1), ('mozambique', 1), ('apoe', 8), ('calu', 1), ('ggcx', 1), ('ephx1', 2), ('egyptians', 1), ('asp36tyr', 1), ('funding', 3), ('commitments', 1), ('ensure', 5), ('lessons', 1), ('inform', 1), ('hematology', 1), ('cardiology', 1), ('specialties', 3), ('surgically', 7), ('astigmatism', 4), ('canines', 3), ('sutured', 1), ('dorsonasal', 5), ('dorsotemporal', 6), ('incisions', 5), ('sia', 5), ('phacoemulsification', 2), ('client-owned', 1), ('segment', 4), ('pre-operatively', 1), ('post-operatively', 5), ('refractive', 1), ('112', 1), ('60-132', 1), ('post-operative', 7), ('pre-operative', 1), ('2.01', 1), ('1.24', 3), ('3.05', 1), ('radius', 4), ('2.04', 1), ('3.06', 1), ('1.27', 2), ('prompts', 1), ('incision', 1), ('taiwanin', 5), ('arecoline', 11), ('4-nitroquinoline-1-oxide-induced', 1), ('hinders', 1), ('receptor/pi3k', 1), ('ossc', 1), ('mucosa', 15), ('podophyllotoxin', 1), ('taiwania', 1), ('cryptomerioides', 1), ('hayata', 1), ('hinder', 3), ('t28', 2), ('non-tumor', 1), ('n28', 1), ('oscc', 9), ('p-pi3k/p-akt', 1), ('emphasize', 4), ('arecoline-induced', 1), ('exenatide', 11), ('adriamycin-induced', 5), ('adriamycin', 12), ('adr', 12), ('ischaemia-reperfusion', 1), ('adr-induced', 3), ('ck-mb/ldh', 2), ('v+/pi+', 1), ('mitotic', 25), ('mad2-cdc20', 1), ('jnk-mediated', 2), ('microtubule', 4), ('polymerization', 6), ('mad2', 4), ('cdc20', 1), ('p21-mediated', 1), ('z-lehd-fmk', 2), ('decodes', 1), ('i-mediated', 1), ('thiram-induced', 2), ('tibial', 3), ('dyschondroplasia', 1), ('tetramethyl', 3), ('thiuram', 1), ('thiram', 4), ('dithiocarbamate', 4), ('seeds', 8), ('storing', 1), ('thiram-contaminated', 1), ('dyschondrolplasia', 1), ('td', 7), ('avian', 1), ('chickens', 2), ('shrinking', 1), ('chondrocyte', 4), ('columns', 1), ('375', 1), ('266', 1), ('kegg', 10), ('mitophagy-animal', 1), ('broilers', 9), ('mia', 11), ('yields', 3), ('schizophrenia-', 1), ('asd-like', 1), ('seh', 7), ('oxylipin', 1), ('epoxy', 4), ('ephx2', 2), ('cell-derived', 11), ('neurospheres', 5), ('22q11.2', 2), ('postmortem', 1), ('brodmann', 1), ('1-trifluoromethoxyphenyl-3-', 1), ('1-propionylpiperidin-4-yl', 1), ('tppu', 2), ('p56', 1), ('parvalbumin', 2), ('e5', 1), ('diagnostics', 2), ('academic', 5), ('laboratories', 1), ('ngs', 6), ('analytic', 2), ('throughput', 3), ('cost-effectiveness', 1), ('broad-based', 2), ('meet', 5), ('minnesota', 1), ('ordered', 3), ('informatically', 1), ('clinically-ordered', 1), ('counselors', 2), ('2509', 1), ('august', 3), ('till', 4), ('vus', 3), ('.002', 1), ('dermatology', 1), ('ophthalmology', 1), ('deletion/duplication', 2), ('implemented', 4), ('panels', 4), ('aggregating', 1), ('ordering', 1), ('custom', 3), ('patient-specific', 1), ('polymyxin', 2), ('alpha-amanitin', 8), ('amanita', 1), ('phalloides', 2), ('mushrooms', 1), ('mushroom', 1), ('rnapii', 2), ('polb', 4), ('reverts', 2), ('guarantee', 1), ('alpha-amanitin-intoxicated', 1), ('organic-anion-transporting', 1), ('1b3', 2), ('na', 3), ('-taurocholate', 1), ('mp', 3), ('attempt', 6), ('revert', 2), ('alpha-amanitin-induced', 2), ('infiltrate', 1), ('bpf', 21), ('analogue', 12), ('commercial', 19), ('arom', 3), ('neuroendocrine-related', 1), ('kiss1', 11), ('kiss1r', 1), ('lhbeta', 2), ('fshbeta', 1), ('adrenocorticotropic', 1), ('follicle-stimulating', 6), ('accepted', 2), ('reconsidered', 1), ('periodontal', 17), ('ligament', 6), ('pdlscs', 5), ('periodontitis', 1), ('hpdlscs', 1), ('highglucose', 1), ('reactiveoxygen', 1), ('osterix', 6), ('alizarin', 2), ('red-s', 1), ('mineralized', 1), ('nodule', 2), ('quinolines', 4), ('catalyzed', 8), ('n-methyltransferases', 2), ('hydroxylation', 7), ('polyaromatic', 1), ('awareness', 4), ('aox', 1), ('nmt', 1), ('n-heterocycles', 3), ('estrogen-responsive', 2), ('overexpresses', 1), ('aoxs', 1), ('nmts', 2), ('aox/nmts', 1), ('n-methylated', 1), ('hydroxylated', 6), ('chromatography-mass', 8), ('biotransformations', 1), ('metabolization', 2), ('estrogenicity', 1), ('maps', 2), ('intrinsically', 3), ('ews/fli', 9), ('dependencies', 1), ('oncogenesis', 5), ('pathognomic', 1), ('ewing', 1), ('amino-terminal', 1), ('ews', 4), ('coordinates', 2), ('carboxy-terminal', 1), ('fli', 1), ('ets', 3), ('orchestrating', 1), ('repetitive', 7), ('ggaa-microsatellites', 1), ('overarching', 2), ('executing', 1), ('attempts', 10), ('daf', 1), ('nonfunctional', 1), ('context-dependent', 2), ('anchorage-independent', 2), ('structure-function', 2), ('requirements', 7), ('ews/fli-mediated', 1), ('4-methylpyrazole', 2), ('4mp', 11), ('-90', 2), ('oxidant', 6), ('overdoses', 1), ('insulator', 1), ('nanostructured', 2), ('nanotube', 2), ('insulating', 2), ('graphene-based', 1), ('high-speed', 1), ('promises', 1), ('vapor', 12), ('few-layer', 1), ('sio2', 8), ('feedstock', 1), ('annealing', 1), ('sp2', 1), ('nanographene', 1), ('flakes', 1), ('carbon-based', 3), ('pave', 4), ('economical', 1), ('catalyst-free', 1), ('silicon-processing', 1), ('surfaces', 4), ('quartz', 2), ('sapphire', 1), ('muc2', 2), ('muc5ac', 16), ('muc5b', 4), ('caco-2/ht29-mtx', 2), ('afm1', 7), ('zea', 40), ('tj', 10), ('mannose', 1), ('febrile', 12), ('mannose-binding', 1), ('mbl', 5), ('fn', 7), ('relations', 2), ('mbl-serum', 1), ('polymorphisms', 39), ('-550h/l', 2), ('-221x/y', 2), ('mbl-deficient', 1), ('22.5', 4), ('mbl-sufficient', 1), ('0.796', 1), ('microg/ml', 10), ('0.92', 3), ('jejunostomy', 8), ('placement', 5), ('minimally', 2), ('oesophagectomy', 4), ('unnecessary', 2), ('adequate', 7), ('jejunostomy-related', 4), ('oesophageal', 1), ('ivor', 1), ('mie', 4), ('reconstruction', 8), ('2007', 3), ('anastomotic', 1), ('188', 4), ('7.4', 2), ('0.73', 3), ('0.68', 2), ('0.999', 2), ('0.591', 1), ('phenothiazine', 2), ('chromophore', 1), ('methylene', 12), ('cn', 14), ('un-sedated', 1), ('clarifying', 1), ('sixty-nine', 1), ('awake', 1), ('kcn', 2), ('hydroxocobalamin', 1), ('hyco', 2), ('coma', 1), ('reaching', 6), ('urethane-anesthetized', 1), ('sublethal', 1), ('mg/kg/min', 1), ('mb-treated', 1), ('hyperlactacidemia', 1), ('pyruvate/lactate', 1), ('ratio-a', 1), ('nad/nadh', 2), ('ratio-and', 1), ('looking', 3), ('cyclically', 1), ('re-oxidize', 1), ('ahr2', 12), ('ahr1a', 7), ('ahr1b', 7), ('fin', 14), ('tcdd-dependent', 3), ('hematopoiesis', 3), ('malformations', 10), ('ahrs', 1), ('ahr1', 2), ('tcdd-resistant', 1), ('endometrioid', 2), ('non-recurrent', 1), ('ten-year', 1), ('archival', 1), ('msi-h', 5), ('mismatch', 5), ('3.9', 4), ('1.1-14.7', 1), ('4.4', 2), ('1.1-17.0', 1), ('decision-making', 2), ('low-risk', 1), ('p-cresol', 19), ('urothelial', 8), ('tsgh8301', 3), ('25-100', 1), ('pc-treated', 1), ('migrated', 1), ('invasion/migration', 1), ('y27632', 1), ('everolimus', 1), ('air/liquid', 1), ('repeatedly', 4), ('flows', 2), ('vapors', 1), ('outflow', 2), ('inverted', 6), ('cyp2f1', 1), ('unconverted', 1), ('by-product', 2), ('pure', 4), ('permits', 1), ('cy2s1', 1), ('catalysts', 1), ('smn2', 3), ('smn', 6), ('stabilizers', 1), ('correct', 6), ('sma', 8), ('infant', 3), ('versatile', 1), ('smn2-gfp', 1), ('z-fa-fmk', 3), ('protease-mediated', 1), ('exon', 5), ('7-deleted', 1), ('capn1', 1), ('capn7', 1), ('ctsb', 2), ('mitochondriopathy', 1), ('e64d', 1), ('pass', 1), ('stabilizing', 3), ('cuticular', 2), ('choosiness', 1), ('mating', 6), ('fecund', 5), ('mate', 2), ('assessable', 1), ('ornaments', 2), ('reliably', 2), ('cricket', 1), ('teleogryllus', 1), ('oceanicus', 2), ('chc', 5), ('t.', 2), ('chcs', 1), ('pc1', 2), ('proxy', 1), ('sire', 1), ('lifelong', 4), ('gender-specific', 1), ('l-cd', 1), ('h-cd', 4), ('conception', 1), ('sacrifice', 1), ('weaned', 9), ('anp', 4), ('profibrotic', 4), ('hfd/h-cd-exposed', 1), ('3-nt', 1), ('rearing', 8), ('laying', 2), ('housing', 11), ('medullary', 4), ('pneumatic', 3), ('attributes', 1), ('73-wk', 1), ('lohmann', 1), ('lsl', 1), ('lite', 1), ('hens1', 1), ('pullets', 2), ('birds', 6), ('lsl-lite', 1), ('aviary', 3), ('cages', 3), ('a-a', 3), ('c-c', 2), ('a-e', 1), ('c-e', 3), ('housed', 5), ('pullets/cage', 3), ('allowance', 2), ('290', 3), ('cm2/pullet', 4), ('756', 1), ('pullets/enclosure', 1), ('285', 1), ('754', 2), ('58.4', 1), ('66.0', 1), ('482', 1), ('multi-tier', 1), ('cm2/hen', 1), ('litter', 5), ('birds/cage', 1), ('750', 2), ('cm2/bird', 1), ('perches', 1), ('nest', 2), ('bbs', 2), ('tbw', 4), ('ash', 4), ('tibia', 3), ('humerus', 3), ('keel', 2), ('hens', 3), ('heavier', 5), ('0.60', 1), ('hyaluronan', 5), ('reperfusion', 8), ('-rich', 1), ('has2', 7), ('has1', 1), ('post-i/r', 5), ('severely', 5), ('has1-deficient', 1), ('19f', 1), ('perfluorcarbon-labeled', 1), ('mac-2/galectin-3', 1), ('fluorescence-activated', 1), ('sorting', 1), ('cd45+cd11b+ly6g-cd64+f4/80+cells', 1), ('ly6chigh', 1), ('ly6clow', 1), ('infarcted', 4), ('border', 1), ('contract', 1), ('gels', 2), ('ha/cd44', 1), ('talk', 2), ('monocyte/macrophages', 1), ('postinfarct', 1), ('rg1', 18), ('relieving', 5), ('clp', 1), ('dcfda', 1), ('factor-', 1), ('tnf-', 2), ('interleukin-', 1), ('il-', 1), ('unrevealing', 1), ('epimagnolin', 8), ('p38/nf-kappab', 1), ('pma-stimulated', 3), ('lignan', 2), ('flower', 5), ('buds', 4), ('magnolia', 4), ('fargesii', 2), ('traditionally', 3), ('headache', 5), ('congestion', 2), ('fargesin', 1), ('phorbol-12-myristate-13-acetate', 2), ('p38/nf-kb', 1), ('directs', 2), ('lrp1', 8), ('dyshomeostasis', 2), ('parenchymal', 1), ('amyloid-beta', 2), ('receptor-related', 1), ('mvecs', 2), ('microrna-200b-3p', 2), ('-200c-3p', 3), ('-205-5p', 2), ('24-h', 6), ('48-h', 2), ('postexposure', 3), ('antagomirs', 1), ('microrna-205-5p', 1), ('-200b-3p', 1), ('marginally', 3), ('thromboembolism', 2), ('medline', 2), ('embase', 4), ('cochrane', 3), ('register', 2), ('igaku', 1), ('chuo', 1), ('zasshi', 1), ('ichushi', 1), ('1947', 1), ('flurbiprofen', 13), ('dipyridamole', 1), ('salicylate', 1), ('studies.conclusion', 1), ('methicillin-sensitive', 2), ('methicillin-resistant', 2), ('staphylococcus', 12), ('aureus', 17), ('nostrils', 2), ('shelter', 6), ('mssa', 1), ('mrsa', 6), ('staphylococcal', 4), ('441', 3), ('216/441', 1), ('7/441', 1), ('4/9', 1), ('3/9', 1), ('summer', 4), ('winter', 4), ('001', 1), ('enterotoxin', 4), ('sea', 6), ('seb', 9), ('seg', 1), ('sei', 1), ('sen', 1), ('seo', 1), ('seu', 1), ('sea-seb', 1), ('seg-sei-sem-sen-seo-seu', 1), ('isolates', 14), ('poisoning-associated', 1), ('enterotoxins', 1), ('owners', 2), ('sccmec', 1), ('vii', 3), ('sec-seg-sei-sel-sem-sen-seo-seu', 1), ('seb-sek-seq', 1), ('microbiological', 2), ('ca-mrsa', 2), ('st59', 1), ('health-associated', 1), ('poisoning-related', 1), ('shelters', 1), ('cities', 1), ('mir-192', 7), ('idiosyncratic', 4), ('forty', 8), ('whatever', 1), ('non-significant', 3), ('sdr', 2), ('dhrs11', 11), ('acetohexamide', 4), ('nadp+-dependent', 1), ('beta-hydroxysteroid', 3), ('orthologs', 1), ('rhar', 3), ('cdna', 1), ('abundantly', 5), ('tolbutamide', 3), ('rhar-specific', 1), ('alpha-dicarbonyl', 1), ('ketones', 6), ('acetylbenzenes', 1), ('acetylpyridines', 1), ('competitively', 6), ('non-steroidal', 3), ('sulindac', 2), ('aliphatic', 5), ('insensitive', 1), ('thr163', 1), ('val200', 1), ('leu', 6), ('dhrs11s', 1), ('mir-221', 23), ('lens', 10), ('e2f3', 7), ('regarded', 9), ('cataract', 3), ('sra01/04', 6), ('pcdna3.1-sirt1', 1), ('pcdna3.1-e2f3', 1), ('pcdna3.1', 1), ('opacities', 2), ('grades', 1), ('marine', 8), ('biotoxin', 1), ('okadaic', 4), ('hepatopancreas', 2), ('oa-contaminated', 1), ('diarrhetic', 2), ('tjps', 4), ('concentration-', 7), ('zonula', 4), ('occludens', 1), ('zo', 5), ('human-relevant', 3), ('f-actin', 1), ('tjp', 1), ('food-relevant', 1), ('oa-dependent', 1), ('update', 3), ('eular', 3), ('recommendations', 12), ('01/2007-12/2017', 1), ('questions', 6), ('opinions', 1), ('flares', 3), ('gc', 34), ('minimised', 1), ('prednisone', 7), ('azathioprine', 3), ('mycophenolate', 1), ('expedite', 1), ('tapering/discontinuation', 1), ('flaring', 1), ('extrarenal', 1), ('add-on', 1), ('belimumab', 1), ('rituximab', 1), ('rtx', 1), ('organ-threatening', 1), ('haematological', 1), ('antiphospholipid', 4), ('preventative', 3), ('evidence-base', 1), ('expert-opinion', 1), ('partitioning', 1), ('t2a-1', 7), ('cry2a', 3), ('metabolisms', 4), ('non-bt', 2), ('inserted', 1), ('lepidoptera', 1), ('mh63', 5), ('parts', 6), ('assimilated', 1), ('1:1:1.', 1), ('proteomics', 12), ('allocation', 1), ('subtyping', 1), ('erythroleukemia', 1), ('ael', 3), ('myelodysplasia', 1), ('159', 6), ('non-ael', 1), ('kmt2a', 1), ('mutated/rearranged', 1), ('ddx41', 1), ('nup98', 1), ('rearranged', 2), ('hoxb9', 1), ('flt3', 1), ('rb1', 2), ('targetable', 1), ('alk', 4), ('ntrk1', 1), ('leukemogenesis', 2), ('trk', 1), ('landscape', 6), ('biallelic', 5), ('rfc1', 4), ('ataxia', 10), ('cerebellar', 6), ('proprioceptive', 1), ('vestibular', 3), ('areflexia', 2), ('canvas', 2), ('non-parametric', 1), ('aaggg', 2), ('neuronopathy', 1), ('alusx3', 1), ('aaaag', 1), ('0.7', 5), ('europeans', 1), ('implies', 5), ('didymin', 11), ('insulin-resistant', 5), ('isosakuranetin', 1), ('7-o-rutinoside', 1), ('alpha-glucosidase', 8), ('ptp1b', 22), ('aldose', 1), ('rlar', 4), ('hrar', 4), ('proximity', 9), ('irs', 1), ('895', 1), ('synthasekinase-3', 1), ('gsk-3', 1), ('phosphoenolpyruvate', 4), ('carboxykinase', 4), ('6-phosphatase', 2), ('gluconeogenesis', 11), ('target-oriented', 1), ('atdc', 12), ('ataxia-telangiectasia', 1), ('complementing', 1), ('dishevelled', 1), ('dvl2', 2), ('wnt/dvl2/beta-catenin', 1), ('thrombocytopenic', 2), ('purpura', 2), ('strokes', 3), ('ttp', 11), ('microangiopathy', 1), ('adamts13', 4), ('disintegrin', 2), ('metalloprotease', 2), ('thrombospondin', 2), ('repeats', 1), ('suffering', 11), ('plasmatic', 2), ('anti-adamts13', 1), ('igg', 11), ('upschaw-schulman', 1), ('uss', 2), ('fresh', 3), ('rs1558139', 8), ('rs2108622', 7), ('searched', 4), ('examining', 8), ('random', 5), ('giving', 4), ('0.71-0.96', 1), ('0.71-0.98', 1), ('1.07-1.44', 1), ('1.08-1.45', 1), ('0.85-1.13', 1), ('0.86-1.24', 1), ('0.72-1.14', 1), ('vinyl', 6), ('hydrogel', 3), ('crosslinked', 1), ('pva', 5), ('deliver', 5), ('hydrogels', 6), ('crosslinking', 6), ('densities', 4), ('fourier', 4), ('transform', 5), ('crosslinker', 1), ('higuchi', 1), ('korsmeyer-peppas', 1), ('phosphate-induced', 3), ('tlr-p38', 2), ('guanidine-based', 1), ('disinfectant', 4), ('aerosolized', 2), ('complain', 2), ('intratracheally', 2), ('sloughing', 2), ('tethered', 1), ('calu-3', 5), ('sp600125', 6), ('tlr2-', 1), ('6-silenced', 1), ('tlr6', 1), ('tpc1', 1), ('tpc-1', 1), ('adding', 9), ('nutraceuticals', 3), ('piperine', 3), ('naturex', 1), ('a.c.e.f', 1), ('e-acetate', 1), ('basf', 1), ('pro-caspase3', 2), ('extra', 3), ('oleacein', 6), ('substrate-inhibitor', 1), ('catechol-containing', 1), ('-catalyzed', 2), ('o-methylation', 1), ('phenolics', 4), ('evoo', 4), ('dihydroxy-phenol', 1), ('comt-driven', 1), ('docking/molecular', 1), ('mechanical/molecular', 1), ('mechanics', 1), ('onto', 6), ('catechol-binding', 1), ('positions', 5), ('s-adenosyl-l-methionine', 2), ('meta-methylation', 1), ('o5', 1), ('benzenediol', 1), ('moiety', 6), ('catechol', 4), ('o-alkylated', 1), ('val158met', 1), ('dihydroxy-phenols', 1), ('adds', 1), ('secoiridoids', 1), ('epididymo-orchitis', 7), ('encephalitis', 5), ('complicating', 2), ('anti-pd-1', 4), ('nivolumab', 1), ('epididymitis', 2), ('orchitis', 2), ('headaches', 3), ('mental', 10), ('lumbar', 2), ('puncture', 1), ('meningoencephalitis', 2), ('etiologies', 3), ('metagenomic', 1), ('5-week', 1), ('taper', 1), ('aware', 1), ('anti-programmed', 2), ('therapy.for', 1), ('diagnosis.if', 1), ('corticosteroids', 5), ('eversense', 2), ('xl', 2), ('cgm', 7), ('t1d', 9), ('single-centre', 1), ('180-day', 1), ('canadian', 1), ('mard', 2), ('15/15', 2), ('springs', 2), ('instruments', 1), ('grid', 2), ('sensor', 7), ('arm', 7), ('in-clinic', 1), ('device', 5), ('insertion/removal', 2), ('thirty-six', 1), ('adolescent/6', 1), ('female/23', 1), ('kg/m2', 2), ('9.4', 1), ('7163', 1), ('82.9', 1), ('78.4', 1), ('-86.1', 1), ('83.6', 1), ('80.4', 1), ('-85.7', 1), ('83.4', 1), ('79.7', 1), ('-85.5', 1), ('98.4', 1), ('device-related', 1), ('s-transferases', 4), ('combustion', 4), ('bioactivated', 3), ('monooxygenases', 3), ('oxidized', 16), ('macromolecules', 4), ('conjugative', 1), ('bioactivating', 1), ('chemoproteomics', 1), ('gsta2', 2), ('m4', 8), ('m6', 2), ('p1', 13), ('gsta4', 1), ('expression-independent', 1), ('alluding', 1), ('ace/', 1), ('dinp', 15), ('c57/bl6', 1), ('sbp', 2), ('aorta', 5), ('angiotensin-ii', 1), ('acei', 1), ('expand', 3), ('elucidates', 1), ('aquisition', 1), ('piceatannol', 20), ('molt-4', 5), ('grapes', 1), ('p62/sqstm1', 1), ('nuclei', 7), ('molt4', 1), ('enzalutamide-resistant', 7), ('enzalutamide', 18), ('administration-approved', 2), ('deregulated', 3), ('hes1', 2), ('bhlh', 1), ('mr49f', 1), ('c4-2r', 2), ('adam', 1), ('metallopeptidase', 3), ('exclusive', 3), ('pf-03084014', 2), ('resensitized', 1), ('22rv1', 1), ('erratum', 1), ('nickel', 8), ('workplace', 2), ('corrects', 1), ('doi', 2), ('10.1155/2018/3812795.', 1), ('cinobufagin', 9), ('p73', 4), ('na+/k+-atpase', 1), ('aurora', 2), ('aurka', 5), ('33342', 2), ('signaling-associated', 1), ('ribonucleoprotein', 1), ('minute', 4), ('micromol/l', 1), ('phorbol-12-myristate-13-acetate-induced', 1), ('aurka-dependent', 1), ('polyvinylchloride-based', 1), ('discrepancies', 1), ('vae', 11), ('ain-93g', 2), ('iu/g', 2), ('1,000', 1), ('retinol', 4), ('seminiferous', 8), ('oxytocin-dependent', 2), ('reopening', 2), ('epoch', 1), ('expressly', 1), ('circuit', 5), ('exuberant', 1), ('constraints', 1), ('imposed', 1), ('matures1', 1), ('adapt', 1), ('reopen', 1), ('priority', 1), ('neuroscience2', 1), ('oxytocin-mediated', 1), ('+/-', 5), ('-3,4-methylendioxymethamphetamine', 1), ('reopens', 1), ('metaplastic', 1), ('mdma-induced', 4), ('terminals', 2), ('injury3', 1), ('delta-9-tetrahydrocannabinol', 6), ('neuro-hyperactivity', 6), ('pentylenetetrazole', 3), ('gabra1-/-', 3), ('1:1', 5), ('1:5', 1), ('1:10', 1), ('1:1.', 1), ('brought', 5), ('light-induced', 1), ('dampened', 1), ('side-effect', 1), ('complimentary', 1), ('dysregulations', 2), ('genesis', 1), ('err', 1), ('pregnan', 1), ('safer', 4), ('nrs', 17), ('bpc', 8), ('bpe', 3), ('lacked', 3), ('substitutes', 2), ('habituation', 4), ('aversive', 2), ('uniform', 1), ('12-week', 4), ('pretested', 3), ('lp', 4), ('hp', 5), ('performers', 1), ('ni', 4), ('step-through', 1), ('sh', 5), ('non-pretested', 1), ('pretest', 1), ('boost', 3), ('retesting', 2), ('depended', 4), ('ee-related', 1), ('coping', 3), ('fearful', 1), ('situations', 4), ('pre-housing', 1), ('oxidized/reduced', 1), ('gssg/gsh', 1), ('cyt', 5), ('t-regulatory', 2), ('gansu', 2), ('u.', 1), ('inconclusive', 3), ('direction', 3), ('magnitude', 6), ('village', 1), ('non-heating', 1), ('heating', 2), ('seasons', 1), ('1-hydroxypyrene', 1), ('1-ohp', 3), ('il-35', 1), ('interleukin-12', 1), ('il-12alpha', 2), ('epstein-barr-virus-induced', 1), ('ebi3', 2), ('8-hydroxy-2-deoxyguanosine', 1), ('8-ohdg', 4), ('17.4', 2), ('mol-cr', 1), ('5.01', 1), ('12.7', 2), ('30.3', 2), ('mg-cr', 1), ('northwest', 1), ('tinnitus', 5), ('ototoxic', 1), ('phantom', 5), ('sound', 2), ('tcs', 3), ('cisplatin-based', 1), ('762', 1), ('dichotomized', 1), ('moderate/severe', 1), ('154', 1), ('608', 1), ('snp', 11), ('imputation', 1), ('noise', 8), ('over-representation', 1), ('auditory', 8), ('cisit', 4), ('mg/m2-treated', 1), ('580', 1), ('402-828', 1), ('2.61-fold', 1), ('0.0001', 12), ('0.25-12', 1), ('khz', 3), ('vertigo', 1), ('6.47', 1), ('crowd', 1), ('8.22', 1), ('otos', 4), ('rs7606353', 1), ('eqtls', 1), ('hei-oc1', 5), ('neuro-otological', 1), ('cochlear', 6), ('wall', 8), ('otoprotective', 1), ('polycarbonate', 4), ('manufacturing', 5), ('1957.', 1), ('hgns', 3), ('hescs', 3), ('outgrowth', 9), ('synaptophysin', 2), ('psd-95', 2), ('alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic', 1), ('ampar', 1), ('rns', 2), ('nnos', 3), ('3-nitrotyrosine', 1), ('hesc-based', 1), ('asia', 4), ('genotype-predicted', 7), ('contrasting', 3), ('drink', 3), ('kadoorie', 2), ('512', 1), ('715', 1), ('2008', 2), ('jan', 2), ('ischaemic', 3), ('intracerebral', 3), ('haemorrhage', 3), ('registries', 3), ('498', 2), ('aldh2-rs671', 1), ('adh1b-rs1229984', 1), ('associating', 2), ('self-reported', 4), ('epidemiology', 6), ('epidemiology-ie', 1), ('mendelian', 1), ('randomisation', 1), ('897/210', 1), ('spirits', 1), ('6245/302', 1), ('510', 1), ('n=14', 1), ('930', 1), ('n=3496', 1), ('n=2958', 1), ('drinks', 2), ('non-drinkers', 1), ('drinkers', 3), ('week-ie', 1), ('zero', 4), ('log-linear', 1), ('280', 3), ('36-1', 1), ('0001', 3), ('13-1', 1), ('p=0', 2), ('78-1', 1), ('usual', 4), ('drank', 2), ('apparently', 5), ('non-causal', 1), ('uniformly', 2), ('ministry', 3), ('charitable', 1), ('foundation', 5), ('glaxosmithkline', 1), ('council', 2), ('wellcome', 1), ('mitochondrially', 1), ('nad+', 8), ('droplets', 2), ('dissipating', 1), ('undetectable', 4), ('underexpression', 1), ('abamectin', 2), ('species-mediated', 2), ('mgc803', 4), ('aba', 8), ('utterly', 2), ('g0/g1-phase', 1), ('cataracts', 2), ('retinopathy', 2), ('uveitis', 3), ('topically', 2), ('polyol', 2), ('peroxidant', 1), ('insoluble', 2), ('psychosocial', 13), ('completing', 2), ('three-month', 1), ('health-related', 5), ('pcs', 3), ('mcs', 15), ('591', 1), ('26.2', 1), ('73.8', 2), ('64+-9', 1), ('62+-9', 1), ('p=0.045', 1), ('39.5+-8.1', 1), ('43.9+-7.8', 1), ('46.6+-10.8', 1), ('49.4+-9.8', 1), ('p=0.003', 1), ('6.4+-4.0', 1), ('5.2+-4.0', 1), ('4.7+-3.5', 1), ('3.6+-3.3', 1), ('2.1+-0.9', 1), ('1.7+-0.7', 1), ('mmol/l', 8), ('1.4+-0.4', 1), ('1.1+-0.3', 1), ('+1.1+-10.1', 1), ('-2.1+-9.7', 1), ('p=0.002', 1), ('6.3+-7.5', 1), ('3.0+-8.1', 1), ('p53-independent', 1), ('histones', 2), ('tsa-induced', 2), ('caspase-10/3', 2), ('h3/h4', 1), ('q.', 1), ('vorinostat', 1), ('tsa/vorinostat-', 1), ('h3k9ac', 10), ('pne', 10), ('subcutaneously', 4), ('p450arom', 5), ('kgn', 8), ('nachralpha6', 1), ('alpha9', 1), ('non-specific', 2), ('vecuronium', 1), ('calcifies', 1), ('high-phosphate', 2), ('thromboembolisms', 1), ('valvular', 4), ('accelerates', 9), ('calcification', 20), ('warfarin-induced', 3), ('havics', 10), ('high-inorganic', 1), ('valves', 9), ('calcific', 1), ('regurgitation', 2), ('non-as', 2), ('3.2', 5), ('calcigenic', 1), ('dorsomorphin', 1), ('ketoconazole', 22), ('coumestrol', 3), ('sn-50', 1), ('havic', 5), ('pxr-bmp2-alp', 3), ('ccaat-displacement', 1), ('protein/cut', 1), ('homeobox', 2), ('cux1', 9), ('er-alpha', 6), ('muscadine', 2), ('grape', 3), ('mske', 6), ('tnbcs', 4), ('l', 10), ('expression/activity', 2), ('tissue/cell', 1), ('er-positive', 2), ('cbioportal', 1), ('blot/zymography', 1), ('mda-mb-468', 2), ('z-fy-cho', 1), ('non-tumorigenic', 7), ('mcf10a', 1), ('4-hydoxytamoxifen', 1), ('snail-cat', 1), ('antihypertensive', 7), ('2j2', 2), ('azelnidipine', 6), ('manidipine', 5), ('dihydropyridine', 1), ('angiotensin-converting', 5), ('cyp2j2', 9), ('amlodipine', 2), ('barnidipine', 2), ('benidipine', 2), ('cilnidipine', 2), ('efonidipine', 2), ('felodipine', 4), ('nicardipine', 2), ('nifedipine', 2), ('nilvadipine', 2), ('nisoldipine', 2), ('nitrendipine', 2), ('telmisartan', 4), ('delapril', 2), ('quinapril', 2), ('luciferin-2j2/4f12', 1), ('o-dealkylase', 1), ('0.116-9.19', 1), ('0.0294', 1), ('preincubation', 8), ('metabolism-dependent', 1), ('20-min', 1), ('kinact/ki', 1), ('105', 2), ('l/mmol/min', 1), ('azelnidipine-mediated', 1), ('mechanism-based', 6), ('inactivator', 4), ('mycoplasmal', 2), ('lipopeptide', 1), ('mycoplasma', 1), ('pneumoniae', 4), ('mycoplasma-derived', 1), ('macrophage-activating', 1), ('lipopeptide-2', 1), ('malp-2', 1), ('excretes', 1), ('system-stimulating', 1), ('confers', 13), ('rna-mediated', 3), ('sulforaphane-induced', 2), ('malp-2-induced', 3), ('malp-2-triggered', 1), ('snpp', 1), ('monoxide-releasing', 1), ('corm-2', 1), ('diminishing', 6), ('methabolit', 1), ('gim-1', 9), ('monobutyl-phthalate', 1), ('geltrex', 1), ('10mum', 1), ('0,05mum', 1), ('ohdg', 1), ('spaces', 1), ('mpb', 1), ('voluntary', 6), ('reward-predictive', 2), ('edibles', 1), ('thc-containing', 1), ('thc-gelatin', 1), ('pavlovian', 2), ('male-specific', 2), ('cb1r-expressing', 1), ('vglut-1', 1), ('vta', 7), ('sex-dependent', 6), ('rooms', 1), ('gram', 4), ('caudal', 10), ('msc', 4), ('grafting', 1), ('il-1ss', 1), ('pmn', 1), ('gsh-px', 6), ('msc-treated', 1), ('nh3', 9), ('irritating', 3), ('odor', 5), ('poultry', 4), ('houses', 1), ('nh3-caused', 2), ('broiler', 9), ('spleens', 3), ('mir-133a', 1), ('mir-6615', 2), ('helper', 1), ('th1', 5), ('loc101747543', 2), ('decapentaplegic', 2), ('smad7', 2), ('hsps', 2), ('th1/th2', 1), ('immunotoxic', 6), ('husbandry', 3), ('survivin', 20), ('wilms', 1), ('leukemia-associated', 1), ('laas', 1), ('bm', 7), ('blasts', 4), ('0.017', 2), ('favorable-prognosis', 1), ('cytogenetics', 1), ('0.035', 3), ('flt3-itd', 1), ('0.026', 2), ('27.9', 1), ('0.049', 1), ('inferior', 4), ('wbcs', 1), ('cytogenetic', 1), ('mrd', 1), ('pbt', 4), ('eco-toxicological', 1), ('qsa/', 3), ('ecotoxicological', 1), ('chlorella', 3), ('vulgaris', 3), ('acetochlor', 2), ('acetamiprid', 15), ('boscalid', 3), ('gibberellic', 2), ('ioxynil', 2), ('diclofop', 3), ('2,4,5-t.', 2), ('structure-activity/', 1), ('qsarins-chem', 1), ('module', 2), ('qsarins', 2), ('qstr', 1), ('algae', 2), ('bioaccumulation', 1), ('catalyzing', 2), ('27.', 1), ('discrepancy', 1), ('adipose-specific', 3), ('ezh2-selective', 1), ('gsk126', 4), ('adipocyte-specific', 1), ('crossing', 1), ('floxed', 1), ('adiponectin-cre', 1), ('vldl', 1), ('littermate', 1), ('glucose-stimulated', 1), ('lipoprotein-dependent', 4), ('abcc11', 3), ('axillary', 2), ('osmidrosis', 2), ('snps', 19), ('ao', 9), ('219', 1), ('matrix-assisted', 4), ('technologies', 6), ('rs1256061', 3), ('rs17822931', 3), ('rs16945916', 3), ('rs62058521', 3), ('81.1', 1), ('63.2', 2), ('96.3', 1), ('armpit', 1), ('28.0', 1), ('antu-induced', 5), ('alpha-naphthylthiourea', 1), ('antu', 5), ('rodenticide', 2), ('pe', 14), ('effusion', 4), ('ggt', 2), ('electrocardiographic', 1), ('oxido-nitrosative', 2), ('rv', 2), ('diacerein', 5), ('glycerol-induced', 2), ('rhabdomyolysis', 1), ('glycerol-treated', 2), ('serine/threonine-protein', 1), ('ripk3', 7), ('pseudokinase', 1), ('mlkl', 7), ('anti-necroptotic', 1), ('polydatin', 8), ('doxorubicin-resistant', 6), ('osteosarcoma', 28), ('tug1', 8), ('doxorubicin-resistance', 1), ('carcinomas', 6), ('50-250', 1), ('dose-', 6), ('tug1/akt', 1), ('stress-mediated', 6), ('sirt1/hif-1alpha', 2), ('107', 2), ('cm-dil-labeled', 1), ('cleaved-caspase-12', 1), ('cypermethrin', 7), ('non-classical', 3), ('tm4', 3), ('cck8', 3), ('icelligence', 1), ('rtca-icelligence', 1), ('t-mediated', 1), ('inhibin', 1), ('inh', 3), ('abp', 1), ('transferrin', 2), ('androgen-mediated', 1), ('extracellular-regulated', 2), ('kinase1/2', 1), ('androgen-induced', 1), ('creb-regulated', 1), ('egr1', 3), ('cyp-induced', 3), ('sustainability', 6), ('recycling', 17), ('wastewater', 6), ('manure', 2), ('crops', 6), ('criticality', 1), ('answer', 2), ('sustainable', 2), ('greenhouse', 1), ('ghg', 3), ('simulating', 2), ('supply', 3), ('2000-2050.', 1), ('recycled', 2), ('originates', 2), ('constitutes', 4), ('grow', 3), ('exponentially', 1), ('contradicts', 1), ('friendliness', 1), ('1-mediated', 2), ('hmgb1-tlr4-nlrp3-gsdmd', 1), ('pcd', 2), ('intrinsic/extrinsic', 1), ('-generation', 1), ('seek', 1), ('gasdermin', 1), ('gsdmd', 1), ('tlr2', 1), ('tlr9', 6), ('pcbs-induced', 1), ('thp1', 3), ('epidemiologic', 5), ('ops', 10), ('op-induced', 4), ('parathion', 1), ('diazinon', 1), ('oxon', 5), ('phosphorothioate', 2), ('reagents', 4), ('pdgf', 1), ('diethyl', 6), ('dithiophosphate', 1), ('thiophosphate', 1), ('eserine', 1), ('non-cholinergic', 1), ('muscarinic', 5), (\"2,2',4,4\", 2), ('pentain', 2), ('bde-99', 10), ('spawned', 1), ('clean', 4), ('thyroxine', 4), ('t4', 23), ('transthyretin', 3), ('uridine', 4), ('glucuronosyl', 2), ('deio2', 1), ('hypothalamic-pituitary-thyroid-liver', 1), ('hptl', 1), ('non-coding', 9), ('incurable', 1), ('silicon', 1), ('tracheal', 5), ('intubation', 12), ('coefficient', 6), ('682', 1), ('382', 1), ('seventy-three', 2), ('cerna', 3), ('shape', 5), ('exosome', 6), ('fgf-2', 5), ('upa', 7), ('urokinase', 2), ('tpa', 7), ('dilated', 4), ('csa', 10), ('4-pba', 2), ('ubiquitin-proteasome', 2), ('pba', 7), ('myocytes', 3), ('stained', 4), ('ups', 5), ('averted', 1), ('atrogin-1', 1), ('uchl1', 1), ('uchl5', 1), ('mediators-p53', 1), ('muscle-cross', 1), ('sectional', 2), ('wastage', 2), ('disturbing', 4), ('kinetochore', 2), ('centriole', 2), ('2,2-bis-', 1), ('4-hydroxyphenyl', 1), ('propane', 1), ('estrogens', 5), ('hurp', 1), ('ends', 2), ('microtubules', 3), ('kif2a', 1), ('minus', 1), ('tpx2', 1), ('mislocalization', 1), ('multipolar', 1), ('overduplication', 1), ('disengagement', 1), ('er-independent', 3), ('endovascular', 7), ('expresses', 3), ('cd59', 7), ('complement-dependent', 2), ('extravillous', 1), ('evts', 2), ('invade', 2), ('decidual', 1), ('spiral', 1), ('complement', 16), ('cdc', 2), ('intensely', 3), ('evt-like', 1), ('swan71', 3), ('cd59-silencing', 1), ('sw_cd59sh', 2), ('non-silencing', 1), ('sw_ctrsh', 2), ('aryl-phosphorus-containing', 1), ('p53-dependent', 9), ('phosphorus-containing', 1), ('aryl-pfrs', 6), ('ecosystem', 3), ('2-ethylhexyldiphenyl', 1), ('ehdpp', 3), ('mdpp', 4), ('bdp', 3), ('isodecyl', 1), ('idpp', 2), ('cresyl', 1), ('cdp', 4), ('high-content', 1), ('hcs', 5), ('97.94', 1), ('546.85', 1), ('phase-reducing', 1), ('fluorophore', 1), ('firefly', 1), ('luminescence', 1), ('p53-transfected', 1), ('aryl-pfrs-induced', 2), ('p53/p21/gadd45beta-', 1), ('p53/p21/mdm2-mediated', 1), ('p53/bax', 1), ('pfrs-induced', 1), ('licochalcone', 10), ('jnk/p38', 2), ('antiasthmatic', 1), ('antimalignancy', 1), ('kinase-related', 1), ('cleaved-poly', 1), ('jnk-in-8', 1), ('abolishes', 1), ('antisense', 6), ('oligonucleotide', 5), ('basic', 7), ('ibds', 1), ('summarizes', 4), ('pre-clinical', 4), ('oligonucleotide-based', 1), ('immunnotoxicity', 1), ('semichronic', 1), ('ramos', 1), ('vacuole', 3), ('vmp1', 4), ('abated', 3), ('groundwork', 2), ('mutually', 1), ('continue', 3), ('locally', 8), ('neuroestrogens', 1), ('ligand-independent', 3), ('factor-dependent', 1), ('phosphoinositde-3', 1), ('neuroestrogen', 2), ('igf-1-dependent', 1), ('comorbidity', 8), ('first-time', 10), ('dui', 10), ('offenders', 17), ('compares', 3), ('screener', 1), ('computerized', 3), ('composite', 9), ('interview', 1), ('cidi', 1), ('kessler', 1), ('ustun', 1), ('3.7', 3), ('past-year', 1), ('1.9', 4), ('pervasive', 2), ('predicts', 6), ('re-offense', 1), ('first-offenders', 1), ('allocate', 1), ('1,3-butadiene', 9), ('strain-', 1), ('susceptibly', 2), ('collaborative', 4), ('635', 1), ('1,3-butadiene-induced', 1), ('n-7-', 1), ('2,3,4-trihydroxybut-1-yl', 1), ('-guanine', 1), ('thb-gua', 1), ('line-1', 1), ('sine', 1), ('retrotransposons', 1), ('deriving', 1), ('chemical-specific', 1), ('ignored', 1), ('mapping', 3), ('interstrain', 1), ('quantify', 7), ('nanotube-', 1), ('asbestos-induced', 1), ('nanotubes', 5), ('cnts', 6), ('nanoscale', 3), ('tube-shaped', 1), ('asbestos', 3), ('16hbe14o-', 1), ('single-walled', 1), ('swcnts', 1), ('multiwalled', 3), ('mwcnts', 9), ('chrysotile', 2), ('amosite', 2), ('crocidolite', 1), ('hydroxy', 2), ('cytosines', 1), ('tandem-mass', 1), ('adenines', 1), ('elisa-like', 1), ('gene-specific', 5), ('cytosine-phosphate-guanine', 1), ('cdkn1a', 3), ('traf2', 13), ('bisulfite', 3), ('mwcnt-exposed', 1), ('swcnt', 3), ('mwcnt', 2), ('nanolayers', 1), ('tin-chalcogenide', 1), ('nanosheet/conductive', 1), ('thermoelectric', 4), ('exfoliation', 2), ('snse0.97te0.03', 8), ('nanosheets', 7), ('ball-milling', 1), ('hydrothermal', 5), ('practical', 5), ('~300', 1), ('nanosize', 1), ('3,4-ethylenedioxythiophene', 1), ('pedot', 5), ('pss', 4), ('nano-coating', 1), ('pedot-coated', 3), ('nanosheet/pedot', 1), ('merit', 2), ('zt', 2), ('~61', 1), ('inorganic/organic', 1), ('composite-based', 1), ('thermoelectrics', 1), ('bictegravir', 2), ('nano-drug', 1), ('hiv-1', 4), ('bic', 25), ('integrase', 2), ('strand', 6), ('insti', 1), ('tablet', 1), ('siv', 1), ('adherence', 5), ('lactic-co-glycolic', 2), ('oil-in-water', 1), ('emulsion', 3), ('47.9', 1), ('6.9', 1), ('lc-ms/ms', 7), ('hiv-1nlx', 1), ('hiv-1ada', 1), ('tzm-bl', 2), ('pbmcs', 12), ('nanoencapsulation', 1), ('cc50', 1), ('2.25', 1), ('820.4', 1), ('lowers', 1), ('0.604', 1), ('0.0038', 1), ('215,789', 1), ('523.33', 1), ('drug-release', 1), ('dysfunction-induced', 1), ('fas/fasl', 1), ('flucloxacillin', 1), ('oligodeoxynucleotide', 1), ('odn', 7), ('fas', 25), ('killer', 4), ('nkt', 7), ('mpt', 3), ('flux-induced', 2), ('gld/gld', 1), ('-deficient', 1), ('cyclophilin', 1), ('d-knockout', 1), ('fas/fas', 2), ('ligand-mediated', 1), ('gefitinib', 18), ('epithermal', 1), ('receptor-tyrosine', 1), ('definitively', 1), ('gefitinib-resistant', 2), ('h1650', 6), ('h1650gr', 5), ('azd9291-resistant', 1), ('h1975ar', 3), ('ic50s', 1), ('50.0', 1), ('31.0', 1), ('10.3', 1), ('a549gr', 6), ('adopting', 1), ('park2', 2), ('eopd', 1), ('hundreds', 2), ('evidence-including', 1), ('modeling-and', 1), ('p.v224a', 1), ('structure-guided', 2), ('designer', 1), ('p.w403a', 1), ('p.f146a', 1), ('hyperactive', 2), ('coherent', 2), ('classify', 3), ('genotype-specific', 2), ('hypoplastic', 1), ('bipotent', 2), ('alveoli', 1), ('nitrofen/bisdiamine', 4), ('accurately', 7), ('gavage-fed', 1), ('8.5.', 1), ('facial', 5), ('nanoct', 1), ('11.5', 1), ('16.5', 1), ('canalicular', 5), ('17.5', 4), ('weight/body', 1), ('morphometry', 1), ('immaturity', 1), ('thickened', 3), ('walls', 3), ('id2', 1), ('pdpn', 1), ('hopx', 1), ('pro-spc', 1), ('muc1', 2), ('pdpn+', 1), ('pufas-rich', 1), ('pyrenoidosa', 6), ('spirulina', 2), ('platensis', 5), ('hypoglycemic', 2), ('microalgae', 1), ('ultra-high', 3), ('quadrupole', 1), ('time-of-flight', 4), ('cp55', 2), ('sp55', 2), ('polyunsaturated', 3), ('diversity', 6), ('16s', 4), ('rrna', 6), ('ruminococcus', 7), ('parasutterella', 4), ('erysipelotrichacea', 2), ('lactobacillus', 3), ('turicibacter', 4), ('blautia', 1), ('oscillibacter', 2), ('alloprevotella', 1), ('uniquely', 2), ('mir-30', 13), ('emphysema', 1), ('cd-upregulated', 1), ('e-', 1), ('cadherin', 2), ('zeb1', 8), ('mir-30e', 8), ('relieves', 5), ('glut12', 14), ('facilitative', 2), ('glut4', 20), ('insulin-sensitive', 1), ('radio-labelled', 1), ('sugars', 4), ('alpha-methyl-d-glucose', 1), ('alphamg', 2), ('peri-nuclear', 1), ('araloside', 8), ('fibroblast-like', 5), ('synoviocytes', 5), ('aralia', 2), ('taibaiensis', 2), ('saponins', 2), ('rheumatism', 1), ('saponin', 1), ('bark', 3), ('caspase-3/7', 7), ('mh7a', 10), ('curbed', 1), ('bay11-7082', 1), ('pdtc', 1), ('lespedeza', 2), ('bicolor', 3), ('pterocarpans', 1), ('6ar,11ar', 2), ('-6a,11a-dihydrolespedezol', 3), ('-2-isoprenyl-6a,11a-dihydrolespedezol', 1), ('6ar,11ar,3', 2), ('a3', 6), ('stilbenoid', 1), ('1,2-diketone', 1), ('fragment', 2), ('bicoloketone', 1), ('pterocarpen', 1), ('lespedezol', 1), ('multistage', 1), ('polyamide', 1), ('circular', 7), ('dichroism', 3), ('ecd', 1), ('experimentally', 6), ('tddft', 1), ('ferric', 2), ('htb-19', 1), ('kyse-30', 1), ('hepg-2', 1), ('6.0-19.1', 1), ('possessed', 4), ('methoxylated', 3), ('tetramethoxystilbene', 3), ('tms', 18), (\"2,3',4,5'-tetramethoxy-trans-stilbene\", 1), ('37.5', 2), ('14.8', 1), ('289-fold', 1), ('5-fold', 2), ('1.4-fold', 2), ('organochlorine', 11), ('organophosphorous', 3), ('probable-role', 1), ('ocps', 5), ('opps', 2), ('alpha-hch', 1), ('beta-hch', 1), ('gamma-hch', 1), ('2,4', 1), ('dde', 10), ('4,4', 1), ('2,4ddt', 1), ('4,4ddt', 1), ('tac', 14), ('arylesterase', 2), ('paraoxonase-1', 8), ('pon-1', 3), ('mgmt', 1), ('0.002', 4), ('south-east', 1), ('iran', 1), ('leonurine', 2), ('myocarditis', 13), ('le', 10), ('herba', 2), ('leonuri', 1), ('preventable', 3), ('ikappabalpha', 6), ('p-ikappabalpha', 3), ('p-p65', 3), ('translocalization', 1), ('lps-injured', 1), ('reversion', 2), ('fructose-fed', 1), ('ingested', 3), ('hyperinsulinemia', 5), ('mets-like', 3), ('fructose-induced', 2), ('cotreated', 3), ('everted', 1), ('sacs', 1), ('counterbalanced', 1), ('unbalance', 1), ('normalizing', 4), ('reduced/oxidized', 1), ('preserve', 1), ('multispecies', 1), ('theca', 7), ('tbt', 29), ('organotin', 8), ('catalyst', 2), ('non-steroidogenic', 1), ('luteinization', 1), ('sheep', 4), ('cow', 2), ('pig', 9), ('rxralpha', 7), ('knocked', 2), ('abca1', 11), ('plantamajoside', 2), ('isoproterenol-induced', 2), ('akt/', 1), ('pms', 8), ('plantaginis', 1), ('injury-related', 1), ('iso-induced', 5), ('myh7', 2), ('anatomical', 3), ('col3', 1), ('p-gsk3beta', 2), ('akt/gsk-3beta', 5), ('t356m', 1), ('hdat', 9), ('recreational', 5), ('t356', 6), ('slc6a3', 1), ('0.01-1000', 1), ('methylphenidate', 3), ('bupropion', 3), ('amphetamine-type', 1), ('stimulants', 1), ('4-fluoroamphetamine', 1), ('4-fa', 1), ('ssri', 1), ('citalopram', 2), ('arylcyclohexylamines', 1), ('methoxetamine', 1), ('mxe', 2), ('3-45', 1), ('phthalate-treated', 1), ('mehp-treated', 8), ('insulin-induced', 2), ('glucose/lipid', 1), ('fgfr', 2), ('betaklotho', 2), ('actively', 3), ('fgfr3', 3), ('fgfr4', 1), ('fgf21/fgfr', 2), ('/akt', 3), ('lc-ms-based', 1), ('metabonomics', 7), ('aristolochiaceae', 1), ('aristolochia', 2), ('fangchi', 1), ('caulis', 1), ('aristolochiae', 1), ('manshuriensis', 1), ('aai-induced', 5), ('tricarboxylic', 5), ('spermatogenic', 3), ('spermatogonial', 1), ('transgenerational', 5), ('epimutations', 2), ('generational', 3), ('ancestral', 1), ('phosphonomethyl', 1), ('roundup', 4), ('conflicting', 1), ('rigorous', 2), ('gestating', 1), ('grand-offspring', 1), ('great-grand-offspring', 1), ('tracer', 2), ('18f-fdopa', 6), ('pheochromocytoma', 7), ('cut-off', 8), ('glands', 5), ('18f-dopa', 2), ('inter-individual', 4), ('contralateral', 5), ('intra-individual', 3), ('november', 4), ('pet/ct-scan', 1), ('adrenalectomy', 1), ('earl', 1), ('pheochromocytomas', 2), ('245', 1), ('0.865', 1), ('2.6-50', 1), ('1.1-6.6', 1), ('4.1', 8), ('0.951', 1), ('0.992', 1), ('0.995.', 1), ('distinguishes', 1), ('replenishment', 1), ('tissue-resident', 3), ('lxralpha', 8), ('self-renewing', 1), ('quiescent', 2), ('lxralpha-expressing', 1), ('home-based', 4), (\"'exergaming\", 2), ('6-min', 2), ('walking', 4), ('single-blinded', 1), ('randomised', 4), ('technology-driven', 1), ('qol', 10), ('androgen-deprivation', 1), ('adt', 3), ('assessor-blinded', 1), ('65', 5), ('exergaming', 4), ('denmark', 1), ('6mwt', 3), ('leg', 1), ('extensor', 1), ('lep', 2), ('lean-', 1), ('fat-mass', 1), ('organisation', 1), ('30-item', 1), ('eortc', 1), ('qlq-c30', 1), ('fact-p', 1), ('fact-f', 1), ('21.5', 1), ('3.2-39.9', 1), ('0.227', 2), ('0.100', 1), ('0.092', 1), ('0.084', 1), ('0.113', 1), ('0.614', 1), ('0.147', 1), ('training', 13), ('fiber-modified', 3), ('hadv-5', 4), ('vectors', 10), ('transduce', 4), ('f35-eg', 2), ('f11p-eg', 3), ('hadv-35', 1), ('hadv-11p', 2), ('pseudotyped', 2), ('hr-eg', 2), ('cr-eg', 2), ('rgd', 1), ('hi', 1), ('loop', 9), ('c-terminus', 2), ('jurkat', 24), ('multiplicity', 1), ('moi', 3), ('vp/cell', 2), ('cd34+', 1), ('superiority', 1), ('adenoviral', 1), ('cd8+', 5), ('uninfected', 2), ('cd4/cd8', 1), ('ef1a', 1), ('transgene', 1), ('immunocellular', 1), ('long-wave', 1), ('uva', 1), ('filter', 6), ('avobenzone', 16), ('obesogenic', 7), ('sunscreen', 2), ('nheks', 5), ('genome-scale', 6), ('273', 1), ('274', 2), ('obesogens', 1), ('hbm-mscs', 6), ('avobenzone-induced', 1), ('adipogenesis-promoting', 1), ('ppargamma-independent', 1), ('ii-induced', 3), ('c-jun/hif-1alpha', 2), ('translocator', 2), ('arnt', 1), ('halogenated', 2), ('ahr-/-', 7), ('fenofibrate', 7), ('age-matched', 1), ('ng/kg/min', 1), ('endothelin', 3), ('ventricles', 3), ('gpr30-egfr', 3), ('30-epidermal', 1), ('subcultures', 1), ('ul', 3), ('/extracellular', 1), ('/c-fos', 1), ('proliferate', 2), ('mapk/erk/c-fos', 1), ('microrna-200c-3p', 1), ('reck', 5), ('mircorna-200c-3p', 1), ('mir-200c-3p', 5), ('chloride-pilocarpine', 1), ('modeled', 4), ('sirna-negative', 1), ('reck-sirna', 1), ('indexes', 7), ('p-pi3k/t-pi3k', 1), ('p-akt/t-akt', 1), ('hhq-4', 7), ('derivate', 1), ('glucose-deprived', 4), ('down-regulator', 2), ('glucose-regulated', 8), ('78', 12), ('er-transmembrane', 1), ('upr', 7), ('premise', 1), ('quinolone', 1), ('2-hexyl-3-methyl-4', 1), ('-quinolinone', 1), ('2-deoxy-d-glucose', 1), ('2-dg', 3), ('-stressed', 1), ('hhq-4-mediated', 2), ('stressing', 1), ('perk/eif2alpha/atf4', 1), ('ire1/xbp1', 1), ('intricate', 2), ('microenvironments', 2), ('honokiol', 6), ('officinalis', 4), ('microemulsion', 3), ('record', 4), ('e2-related', 5), ('embryo-developmental', 1), ('ahu377+valsartan', 1), ('lcz696', 22), ('valsartan', 8), ('pathophysiologic', 2), ('neprilysin', 5), ('ahu377', 1), ('at1', 8), ('at2', 6), ('1-7', 5), ('receptor/mas', 1), ('masr', 7), ('sixteen-week-old', 1), ('wistar-kyoto', 2), ('wky', 5), ('12-hour', 2), ('dark', 10), ('tail-cuff', 1), ('lcz696+shr', 1), ('effectors', 5), ('cardiac-protective', 2), ('hypotensive', 3), ('uppsala', 2), ('seniors', 2), ('pivus', 2), ('2001', 2), ('eighteen', 4), ('stockholm', 1), ('convention', 1), ('992', 1), ('497', 1), ('50.1', 1), ('2004.', 1), ('814', 1), ('82.1', 1), ('412', 1), ('50.7', 1), ('158', 1), ('ages', 10), ('hexa-chloro-', 1), ('octa-chloro-substituted', 1), ('206', 4), ('1-sd', 1), ('log-transformed', 2), ('1.55', 1), ('1.26-1.91', 1), ('189', 4), ('170', 3), ('209', 3), ('1.47', 2), ('1.19-1.81', 1), ('1.08-1.55', 1), ('1.02-1.52', 1), ('1.04-1.60', 1), ('noncardiovascular', 1), ('dichlorodiphenyldichloroethylene', 4), ('toxicant-associated', 2), ('tash', 2), ('pcb-exposed', 2), ('hepato-toxicological', 1), ('serpine1', 3), ('breakdown', 2), ('pro-androgenic', 1), ('anti-estrogenic', 10), ('pcb-mediated', 1), ('boxa2r-pcr', 2), ('cocci', 2), ('repetitive-pcr', 1), ('rep-pcr', 1), ('well-established', 2), ('rep', 1), ('eric', 1), ('gtg', 1), ('boxa1r', 1), ('boxa2r', 1), ('primers', 7), ('discriminate', 3), ('lactococcus', 2), ('lactis', 3), ('leuconostoc', 1), ('mesenteroides', 1), ('thermophilus', 1), ('subspeciate', 1), ('cremoris', 1), ('lab', 4), ('fermented', 1), ('occasional', 1), ('spoilage', 1), ('simplicity', 2), ('microbiologists', 1), ('australian', 4), ('retail', 1), ('28th', 1), ('ers-related', 3), ('self-assembled', 1), ('dual-drug', 2), ('core-shell', 3), ('metal-free', 3), ('alternating', 3), ('polyester', 2), ('directed', 6), ('biocompatible', 5), ('biodegradable', 3), ('nanomaterial', 3), ('triethyl', 1), ('borane', 1), ('et3b', 1), ('/bis', 1), ('triphenylphosphoranylidene', 1), ('ppncl', 1), ('pair', 5), ('non-metallic', 1), ('tert-butyl', 2), ('tbge', 1), ('phthalic', 4), ('anhydride', 3), ('tbge-alt-pa', 1), ('mnvia', 1), ('copolymerization', 1), ('rocop', 1), ('hemocompatible', 1), ('fabrication', 3), ('nanodrug', 1), ('ndfs', 5), ('amorphous', 2), ('entrapment', 1), ('colorimetry', 1), ('dsc', 3), ('paca-2', 4), ('anomalous', 1), ('polyesters', 1), ('engineering', 4), ('amitraz', 8), ('bts-27271', 2), ('formamidine', 1), ('isoenzymes', 4), ('keap1/nrf2', 1), ('unspecific', 1), ('nrf2-pathway', 1), ('cleistocalyx', 2), ('operculatus', 3), ('endotoxic', 5), ('nrf2/ho-1', 16), ('tropical', 6), ('eco', 7), (\"2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone\", 1), ('dmc', 3), ('ziyuglycoside', 8), ('caspases-dependent', 1), ('caspases-independent', 3), ('sanguisorba', 1), ('phosphorylated-p53', 1), ('prolong', 2), ('trans-ferulic', 2), ('mitigates', 5), ('bioenergetics', 8), ('drp-1', 6), ('conceived', 2), ('streptozocin-induced', 1), ('fa,100', 1), ('preserving', 2), ('intracerebral-ventricular', 1), ('streptozocin', 2), ('fission', 16), ('cytochrome-c', 3), ('mitofusin2', 1), ('propensity', 3), ('prolonging', 2), ('n-ethylpentylone', 2), ('nep', 20), ('cathinone', 2), ('presenting', 8), ('dose-effect', 1), ('re-challenge', 1), ('anxiolytic-like', 2), ('sio2-induced', 2), ('millions', 2), ('mg/ml', 16), ('mfn1', 1), ('fis', 1), ('drp', 1), ('dust', 10), ('deoxynivalenol-induced', 1), ('contaminate', 1), ('cereals', 2), ('flora', 4), ('don-induced', 9), ('c57bl6/j', 1), ('genera', 2), ('parabacteroides', 1), ('enterobacter', 2), ('odoribacter', 1), ('lachnospiracea', 1), ('incertae', 1), ('sedis', 1), ('picrust', 1), ('ways', 4), ('gene-editing', 1), ('low-grade', 1), ('triphenyl', 7), ('tphp', 26), ('144', 3), ('shotgun', 1), ('input', 2), ('phagosome', 2), ('ascertain', 3), ('retinoschisin', 1), ('opsins', 1), ('crystallins', 1), ('broaden', 2), ('hypereosinophilia', 2), ('hypereosinophilic', 1), ('mild-severity', 1), ('fip1l1-platelet-derived', 1), ('pdgfralpha', 1), ('5-year-old', 1), ('girl', 1), ('country', 1), ('constitutional', 1), ('multifocal', 2), ('complaints', 1), ('unexplained', 1), ('striking', 3), ('serology', 2), ('strongyloides', 1), ('stercoralis', 1), ('fip1l1-pdgfra', 2), ('imatinib', 3), ('sustainability-inspired', 1), ('recyclable', 3), ('rechargeable', 2), ('batteries', 1), ('nonrenewable', 1), ('massive', 4), ('end-of-life', 4), ('recyclability', 1), ('electrode', 7), ('na3v2', 2), ('po4', 2), ('aluminum', 4), ('foil', 1), ('collector', 1), ('high-power', 1), ('correspondence', 3), ('enables', 7), ('~99.1', 1), ('solid-component', 1), ('98.0', 1), ('closed-loop', 1), ('reutilization', 1), ('li-rads', 4), ('hepatobiliary', 6), ('hypointensity', 6), ('lr-3', 4), ('lr-4', 2), ('10-19', 6), ('hyperenhancement', 2), ('aphe', 6), ('dual-institution', 1), ('consecutively', 1), ('92/109', 1), ('0.00001', 2), ('67/80', 1), ('moderately', 6), ('44/60', 1), ('64/75', 1), ('76/80', 1), ('washout', 2), ('80/80', 1), ('99', 11), ('79/80', 1), ('virus-infected', 2), ('hcv', 11), ('ngen', 7), ('hcvcp', 4), ('infection-induced', 1), ('xbp1s', 2), ('hcv-infected', 1), ('hcvcp-infected', 1), ('tunicamycin-treated', 1), ('huh-7.5.1', 1), ('hcvcp-induced', 2), ('hcvcp-stimulated', 1), ('hcv-induced', 1), ('glutaminase', 6), ('inhibition-resistant', 1), ('managing', 7), ('warburg', 3), ('glutamine', 4), ('cb-839', 5), ('cb-839-sensitive', 1), ('-resistant', 2), ('gls', 1), ('cb-839-resistant', 4), ('mobilized', 1), ('acetyl-coa', 9), ('monocyte', 8), ('chemoattractant', 7), ('dicf', 5), ('deprived', 2), ('mg/kg/12', 1), ('g/kg/day', 1), ('mcp', 5), ('g/kg', 6), ('mcp-1', 5), ('cr-1', 1), ('transcriptome-wide', 5), ('high-grade', 2), ('serous', 2), ('splice', 8), ('hgsoc', 4), ('hgsoc-relevant', 1), ('2,169', 1), ('largest', 10), ('13,037', 1), ('40,941', 1), ('lrrc46', 1), ('19q21.32', 1), ('chmp4c', 2), ('8q21', 1), ('prc1', 2), ('15q26', 1), ('allele-specific', 1), ('0.0024', 1), ('essentiality', 1), ('haus6', 1), ('kansl1', 1), ('myc', 7), ('jnk/erk/ap-1', 1), ('zak', 5), ('entity', 1), ('flavonol', 1), ('sterile-alpha', 1), ('leucine', 4), ('zipper', 3), ('map3k', 2), ('map4k', 1), ('mst1/2', 1), ('lats1/2', 2), ('turning', 1), ('jnk/erk', 1), ('-epigallocatechin-3-gallate', 2), ('skn-1', 5), ('antagonize', 4), ('nematode', 2), ('ortholog', 1), ('gst-4', 1), ('skn-1-mediated', 1), ('egcg-treated', 1), ('skn-1-regulated', 1), ('mustard-induced', 1), ('warfare', 4), ('blisters', 1), ('sm-induced', 3), ('blistering', 2), ('ulceration', 2), ('acetylsalicylic', 1), ('ibuprofen', 6), ('indomethacin', 5), ('cox-2-specific', 1), ('celecoxib', 16), ('parecoxib', 1), ('cox-independent', 1), ('tofacitinib', 4), ('nhek', 1), ('surrogate', 4), ('multiplex', 3), ('janus', 7), ('sometimes', 4), ('c3a/c3ar', 1), ('unconventionally', 1), ('glomerulonephritis', 1), ('c3a', 7), ('c3ar', 4), ('parallels', 2), ('epithelial-mesenchymal-transition', 2), ('c3ara', 2), ('ketoglutarate', 1), ('pro-osteogenic', 1), ('mtor/s6k1/s6', 2), ('alpha-ketoglutarate', 3), ('akg', 9), ('krebs', 1), ('anabolic', 2), ('disodium', 1), ('dihydrate', 1), ('hfob', 2), ('mc3t3-e1', 2), ('s6k1', 2), ('akg-promoted', 1), ('gpr99', 3), ('ketoglutaric', 1), ('salts', 3), ('angptl4-ceramide-protein', 1), ('czeta', 2), ('hypertriglyceridemia', 4), ('angptl4', 2), ('angiopoietin-like', 1), ('dexamethasone-induced', 3), ('ceramide-mediated', 1), ('isotope-labeling', 1), ('lipogenesis', 8), ('angptl4-null', 1), ('angptl4-/-', 2), ('myriocin', 1), ('rate-controlling', 1), ('sptlc1', 1), ('/sptlc2', 1), ('virus-expressing', 1), ('sptlc2', 1), ('pkczeta', 2), ('ceramides', 2), ('2-acetyl-1,3-cyclopentanedione', 1), ('acpd', 1), ('ppp2ca', 1), ('angptl4-ceramide-pkczeta', 1), ('outlook', 2), ('micronutrients', 2), ('chlorophyll', 5), ('cu-based', 1), ('agrochemicals', 4), ('excessively', 2), ('phytotoxicity', 1), ('carbohydrates', 3), ('remediation', 2), ('soils', 2), ('palmitoylethanolamide', 6), ('inflammation-induced', 4), ('vivo-a', 1), ('pea', 15), ('fluorescein-labeled', 2), ('dextrans', 3), ('fd10', 1), ('fd4', 1), ('ifngamma', 4), ('3-kinases', 1), ('mek/erk', 2), ('resections', 1), ('ppardelta', 1), ('g-coupled', 3), ('gpr55', 7), ('gpr119', 1), ('claudins-1', 1), ('-5', 1), ('aquaporin', 3), ('controlled-trial', 1), ('lactulose', 2), ('mannitol', 2), ('claudin-5', 1), ('fall', 3), ('neutral', 5), ('endopeptidase', 2), ('thiorphan', 4), ('sialorphin', 8), ('pentapeptide', 1), ('ahnpr', 2), ('qanpr', 2), ('qhapr', 2), ('qhnar', 2), ('n-acetylated', 1), ('c-amidated', 2), ('sw620', 10), ('ls180', 3), ('hsf', 2), ('n-acetylation', 1), ('c-amidation', 1), ('crc-cell', 1), ('peptide-anp', 1), ('melphalan-mel', 1), ('ser2448', 1), ('p70s6k', 2), ('insufficiency', 3), ('3-30', 1), ('cb1r/cb2r', 1), ('vegfa', 8), ('flt-1', 1), ('tudca', 1), ('atp-coupling', 1), ('background/aims', 3), ('trpm4', 4), ('ato-induced', 8), ('isometric', 2), ('multiwire', 1), ('myograph', 1), ('9-phenanthrol', 4), ('viability/', 1), ('ato-mediated', 2), ('acetylcholine-induced', 1), ('endothelium-dependent', 2), ('relaxations', 3), ('sestrin2', 4), ('stress-inducible', 2), ('sesn2', 23), ('formerly', 1), ('iron-rich', 1), ('aggregation-induced', 2), ('electrochemiluminescence', 2), ('tetraphenylethylene', 2), ('nanocrystals', 2), ('ecl', 9), ('emitters', 2), ('nir', 4), ('tpe', 4), ('semiconductor', 1), ('recombination', 6), ('nonradiative', 1), ('impressively', 1), ('enormous', 1), ('red-shifted', 2), ('678', 3), ('blue-light', 1), ('photoluminescence', 2), ('440', 1), ('autofluorescence', 1), ('realize', 1), ('expands', 1), ('nanomaterials', 7), ('sarcopenia', 7), ('sarcopenic', 6), ('resectable', 1), ('133', 2), ('scans', 4), ('=38.5', 1), ('cm2/m2', 2), ('=52.4', 1), ('=25kg/m2', 1), ('0.016', 1), ('non-sarcopenic', 1), ('neoadjuvant', 4), ('0.038', 2), ('amphiregulin-mediated', 1), ('t47d', 2), ('bpaf-induced', 5), ('er-rtk', 3), ('areg', 3), ('human-induced', 2), ('societal', 2), ('myocardia', 1), ('animal-based', 1), ('hipsc-cms', 10), ('transients', 2), ('contractility', 9), ('solute', 8), ('ethanol-treated', 2), ('filament-based', 1), ('glaucocalyxin', 14), ('tgf-beta1/smad2/3', 2), ('unsatisfactory', 2), ('ent-kauranoid', 1), ('mg-63', 8), ('143b', 2), ('emt-associated', 1), ('low-metastatic', 1), ('u2os', 3), ('tgf-beta-induced', 1), ('2/3', 1), ('transplanted', 4), ('c/ebpbeta-related', 1), ('meth', 44), ('ccaat-enhancer', 1), ('c/ebpbeta', 8), ('meth-induced', 16), ('ddit4', 9), ('trib3', 4), ('tribbles', 1), ('pseudo', 1), ('alpha-syn', 26), ('ddit4-mediated', 1), ('trib3-mediated', 1), ('ribonucleic', 1), ('tsc2', 5), ('meth-caused', 2), ('lv-shc/ebpbeta', 1), ('lentivirus', 2), ('stereotaxic', 2), ('positioning', 4), ('p-tsc2/tsc2', 1), ('cyto', 2), ('apoptogenic', 1), ('ddit4/tsc2/mtor', 1), ('trib3/parkin/alpha-syn-related', 1), ('meth-triggered', 1), ('multicellular', 4), ('upgraded', 1), ('3-dimensional', 1), ('phh', 6), ('kcs', 1), ('microarray-technology', 1), ('median-dose', 1), ('chain-', 1), ('median-', 1), ('fcgammar', 1), ('-coding', 1), ('lps/apap', 2), ('co-exposures', 2), ('kc-phagocytosis', 1), ('unbalanced', 1), ('ramipril', 2), ('rhoa/rock', 2), ('pathway-regulated', 1), ('nephropathy-associated', 1), ('glomerulus', 2), ('20-hete/ppars', 1), ('reno-therapeutic', 1), ('11.1', 1), ('proliferators-activated', 1), ('20-hydroxyeicosatetraenoic', 1), ('20-hete', 2), ('cyp4a-20-hete', 3), ('nrk-52e', 2), ('het0016', 1), ('nanoparticle-based', 1), ('s100p', 6), ('surface-enhanced', 2), ('raman', 5), ('point-of-care', 2), ('poc', 2), ('handheld', 2), ('noninvasive', 7), ('salivary', 2), ('s100', 2), ('calcium-binding', 2), ('saliva', 4), ('sers', 3), ('-based', 7), ('oligonucleotides', 1), ('malachite', 1), ('dna-conjugated', 1), ('format', 2), ('vertical', 3), ('vfc', 2), ('sers-based', 2), ('vfcs', 1), ('gs28', 5), ('nitroprusside-induced', 1), ('s-nitro-n-acetylpenicillamine', 1), ('sigs28', 1), ('-transfected', 2), ('photodegraded', 1), ('sierk1', 1), ('cotransfection', 2), ('pan-caspase', 1), ('procaspase-3', 2), ('siatg5', 1), ('sierk1-cotransfected', 1), ('inductive', 2), ('snp-induced', 1), ('p38mapk-p53-fas', 1), ('s-allyl', 4), ('bagatelle', 1), ('distinctive', 2), ('p38mapk-p53', 1), ('fas-fasl-fadd', 1), ('perturbed', 2), ('cycling', 5), ('normalized', 10), ('p38mapk-p53-disc-caspase', 1), ('inr', 10), ('uni-', 1), ('multi-variate', 1), ('rs35410204', 1), ('tenfold', 1), ('rs866236', 1), ('homozygotes', 1), ('2.9-fold', 1), ('trichloroethylene-sensitized', 2), ('trichloroethylene', 4), ('nos', 6), ('e-selectin', 4), ('tce+tempol', 3), ('vacuolar', 3), ('lysed', 1), ('degenerated', 1), ('vcam-1and', 2), ('titanium', 14), ('tio2-nps', 11), ('aesthetic', 1), ('toothpaste', 3), (\"n't\", 3), ('mucous', 1), ('mouth', 2), ('pdl', 6), ('tio2-nps-induced', 1), ('stimulatory', 4), ('overproduced', 1), ('nlrp3/caspase-1', 4), ('/caspase-1/il-1beta', 1), ('mcc950', 5), ('vx-765', 2), ('ac-yvad-cho', 2), ('hyperresponsiveness', 1), ('neutrophil-dominated', 1), ('th2/th17', 2), ('tdi-asthmatic', 1), ('tdi-exposed', 2), ('asthmatics', 1), ('anthraquinone-type', 1), ('assesses', 1), ('2-methyl-1,3,6-trihydroxy-9,10-anthraquinone', 1), ('mtaq', 5), ('postprandial', 2), ('functioned', 5), ('41.88', 1), ('substrate-1,3-phosphoinositide-dependent', 1), ('ethanol-exposed', 1), ('pee', 18), ('elucidating', 6), ('24.', 1), ('ldl-c/hdl-c', 1), ('conversed', 1), ('bi', 16), ('pee-induced', 1), ('cumulus', 2), ('luteinized', 1), ('hcgc', 4), ('antral', 4), ('follicles', 10), ('biosynthetic', 3), ('ppargamma-dependent', 1), ('brazilian', 1), ('spherocytosis', 2), ('unmetabolized', 1), ('umfa', 3), ('tetrahydrofolate', 2), ('ifng', 2), ('tnfa', 4), ('hs-u', 5), ('non-users', 2), ('hs-nu', 5), ('supplemental', 5), ('consuming', 1), ('leucocyte', 2), ('5-methyl-tetrahydrofolate', 1), ('5-methyl-thf', 1), ('thf', 1), ('n=42', 1), ('p=0.044', 1), ('n=12', 1), ('intrapatient', 2), ('erythematosquamous', 1), ('papers', 3), ('baths', 1), ('galenic', 1), ('lanette', 2), ('vax', 2), ('thirty', 5), ('genders', 3), ('investigator', 1), ('pasi', 2), ('sensors', 7), ('multiprobe', 1), ('adapter', 1), ('mpa5', 1), ('courage', 1), ('khazaka', 1), ('cologne', 1), ('hydration', 2), ('transepidermal', 1), ('psoriatic', 2), ('mir-19b', 6), ('sirt1/nrf2', 3), ('apap-mediated', 2), ('lo2', 3), ('apap-evoked', 1), (\"mirna-3'utr\", 1), ('carbenoxolone', 3), ('ubc9', 4), ('cbx', 5), ('2a4', 1), ('slc2a4', 5), ('/glut4', 1), ('vat', 2), ('sat', 2), ('soleus', 4), ('srebp1', 5), ('srebp1-binding', 1), ('ubiquitin-modifier', 1), ('conjugating', 1), ('hypercorticosteronemia', 1), ('decay', 4), ('slc2a4/glut4', 1), ('reinforces', 1), ('11betahsd1', 1), ('prodigiosin', 6), ('tripyrrole', 1), ('impressive', 1), ('prodigiosin-induced', 4), ('pd184352', 2), ('prodigiosin-mediated', 1), ('prodigiosin-inhibited', 2), ('jnks', 1), ('aeruginosa-derived', 1), ('pyocyanin', 10), ('aeruginosa', 4), ('blue-pigmented', 1), ('virulence', 2), ('pyocyanin-treated', 1), ('explant', 3), ('sclc', 9), ('die', 2), ('survive', 3), ('survivorship', 7), ('tnm', 1), ('staging', 1), ('curative-', 1), ('non-curative-intent', 1), ('microarrays', 2), ('harbored', 4), ('cd3-positive', 1), ('tumor-suppressive', 1), ('individualized', 2), ('immunotherapies', 1), ('sex-specific', 15), ('restrict', 1), ('monoallelic', 4), ('cd-sex', 1), ('regressed', 1), ('74', 4), ('log-cd', 1), ('attainment', 1), ('study-', 1), ('strata', 4), ('hampshire', 1), ('nhbcs', 1), ('text', 30), ('rhode', 1), ('richs', 1), ('fixed-effects', 1), ('distal-less', 1), ('h19', 24), ('necdin', 1), ('mage', 2), ('ndn', 3), ('carboxypeptidase', 1), ('a4', 1), ('cpa4', 1), ('grb10', 1), ('integrin-linked', 1), ('ilk', 3), ('cd-associated', 1), ('z-scores', 2), ('//doi.org/10.1289/ehp4264', 1), ('habenula', 2), ('daergic', 1), ('hypofunction', 1), ('5-htergic', 1), ('drn', 6), ('lhb', 10), ('immunohisochemistry', 1), ('mk-801', 9), ('firing', 3), ('mk-801-treated', 2), ('sucrose', 2), ('schizophrenia-like', 2), ('electrolytically', 1), ('lesioned', 2), ('d1r', 3), ('lhb-lesioned', 1), ('activation-mediated', 2), ('nanoparticle-induced', 1), ('localisation', 4), ('sinps', 18), ('nad+-dependent', 1), ('sinp', 1), ('sinp-triggered', 1), ('sinp-mediated', 1), ('sinp-exposed', 1), ('sinp-induced', 1), ('antagonise', 1), ('cadmium-transformed', 1), ('reactome', 2), ('2357', 1), ('1083', 1), ('1274', 1), ('ecm-receptor', 1), ('syndecan', 1), ('satb1', 1), ('eya2', 1), ('kpna7', 1), ('.0027', 1), ('pitx2', 1), ('.0007', 2), ('pdlim4', 1), ('.0020', 1), ('fabp5', 1), ('gliosis', 3), ('telencephalon', 2), ('mesencephalon', 1), ('d-l', 1), ('hcy/50', 1), ('mantle', 1), ('placenta-findings', 1), ('toll', 4), ('tlr7/9', 3), ('nutrient', 6), ('sex-dependence', 1), ('polyoxyethylated', 3), ('solubilising', 4), ('cremophor', 1), ('rh', 15), ('poloxamer', 3), ('tween', 1), ('ranitidine', 2), ('ussing', 1), ('non-polyoxyethylated', 1), ('span', 2), ('non-sex-dependent', 1), ('retract', 1), (\"'one\", 1), ('fits', 1), ('pharmacotherapy', 3), ('chlordecone', 2), ('french', 3), ('west', 7), ('indies', 1), ('banana', 1), ('borer', 1), ('pest', 4), ('persists', 1), ('meiotic', 3), ('breaks', 9), ('puberty', 6), ('atretic', 4), ('rcbtb2', 1), ('rbpms', 1), ('signaling-', 1), ('maturation-associated', 1), ('h2aub', 1), ('h4ac', 2), ('trim28', 12), ('imprinting', 1), ('packaging', 7), ('aids', 2), ('retrovirus', 1), ('packaged', 3), ('assembling', 1), ('fidelity', 3), ('vrna', 3), (\"'packaging\", 1), ('joined', 1), ('conformers', 1), ('dimerization', 4), ('gag', 1), ('assembles', 1), ('obscured', 2), ('nucleates', 1), ('n-methyltransferase', 3), ('disease-associated', 1), ('becoming', 3), ('etiological', 3), ('nafld-associated', 1), ('stelic', 1), ('steatohepatitis-derived', 1), ('choline-', 1), ('folate-deficient', 2), ('cfd', 2), ('gnmt', 7), ('inbred', 1), ('nafld-like', 1), ('nafld-derived', 1), ('18f', 3), ('pbr111', 3), ('diisopropylfluorophosphate', 2), ('electroencephalographic', 1), ('posited', 2), ('biometrics', 1), ('preclude', 1), ('histopathologic', 6), ('dfp', 3), ('2-pralidoxime', 1), ('moderate-to-severe', 4), ('suv', 5), ('corroborated', 3), ('regional', 8), ('spatiotemporally', 1), ('mono-methylchrysenes', 4), ('comprise', 2), ('chrysene', 6), ('ahr-regulated', 2), ('chrysenes', 3), ('yeast-based', 1), ('4-methylchrysene', 1), ('5-methylchrysene', 1), ('methylchrysenes', 1), ('pcr-based', 1), ('unsubstituted', 1), ('wiley', 1), ('periodicals', 1), ('inc.', 1), ('principles', 1), ('voted', 1), ('apl', 5), ('obstetric', 4), ('lda', 3), ('non-pregnant', 2), ('unprovoked', 2), ('vka', 2), ('normalised', 2), ('2-3.', 1), ('3-4', 4), ('bleeding/thrombosis', 1), ('positivity', 3), ('prednisolone', 4), ('trimester', 5), ('b-induced', 1), ('coq10', 16), ('scavenges', 1), ('uvb', 4), ('irradiation', 9), ('post-uvb', 1), ('p-pka', 3), ('uvb-induced', 2), ('pka-erk', 1), ('financing', 1), ('barranquilla', 1), ('centers', 9), ('1,887', 1), ('21,699', 1), ('1,880', 1), ('69.2', 1), ('favors', 1), ('analgesics', 5), ('sparing', 3), ('nociceptive', 2), ('permeant', 1), ('pore-dilated', 1), ('amplitudes', 3), ('trpv2', 1), ('trpm8', 1), ('state-selectivity', 1), ('free-living', 1), ('beluga', 3), ('whales', 4), ('delphinapterus', 2), ('leucas', 2), ('arctic', 1), ('climate', 1), ('scarcity', 1), ('gauge', 1), ('resilience', 2), ('pertaining', 1), ('eastern', 5), ('beaufort', 1), ('myoglobin', 3), ('averaged', 2), ('77.9', 1), ('g-1', 1), ('haematocrit', 1), ('half-girth', 1), ('whale', 2), ('~27', 1), ('26.0', 1), ('35.7', 1), ('15.6', 1), ('17.7', 1), ('conservative', 3), ('assumption', 2), ('underwater', 1), ('equates', 1), ('extremes', 2), ('14.3', 2), ('prey', 2), ('predators', 2), ('ice', 1), ('entrapments', 1), ('foraging', 2), ('acquisition', 5), ('morin', 8), ('hepatorenal', 1), ('administrating', 1), ('8.', 1), ('aquaporin-2', 1), ('aqp-2', 2), ('boletus', 2), ('t2dm', 16), ('orbital', 1), ('plexus', 2), ('canthus', 1), ('dissected', 2), ('malonaldehyde', 1), ('mir-187-3p', 9), ('ischemia-reperfusion-induced', 1), ('p2x7r', 12), ('ischemia-reperfusion', 2), ('mirs', 5), ('purinergic', 1), ('ir-induced', 2), ('5-min', 1), ('arch', 2), ('pwt', 5), ('pwl', 5), ('intrathecal', 1), ('mir-187-3p/p2x7r', 2), ('bioinformatic', 5), ('mimic-187', 3), ('inhibitor-187', 3), ('a-438079', 2), ('comparably', 1), ('ir-injured', 1), ('bzatp', 2), ('sham-operated', 1), ('immunoreactivities', 1), ('il-1beta-neutralizing', 1), ('expectedly', 1), ('aniline', 9), ('h295r', 15), ('cosmetic', 3), ('dyes', 1), ('rubber', 2), ('adhesives', 1), ('municipal', 1), ('byproducts', 1), ('3,4-dichloroaniline', 1), ('3,4-dca', 1), ('1-naphthylamine', 1), ('1-npa', 1), (\"4,4'-methylenedianiline\", 1), (\"4,4'-mda\", 1), ('cyp17', 3), ('e2/t', 1), ('androgenicity', 1), ('anti-androgenicity', 1), ('warrant', 4), ('intra-', 4), ('extraosseous', 8), ('palliatively', 2), ('resonance-guided', 2), ('high-intensity-focused', 2), ('intraosseous', 5), ('mrghifu', 3), ('intraprocedural', 1), ('prfs', 1), ('thermometry', 1), ('gadolinium-enhanced', 1), ('gd-t1w', 4), ('appearances', 1), ('responders', 2), ('nonresponders', 1), ('nonenhancement', 3), ('worst-pain', 1), ('0.027', 4), ('0.013', 3), ('67', 9), ('informative', 1), ('homodimerization', 6), ('nac1', 11), ('accumbens-associated', 1), ('repressor', 1), ('nacc1', 1), ('met7', 1), ('leu90', 1), ('1-130', 1), ('hts', 4), ('nic3', 1), ('leu-90', 1), ('nic3-mediated', 1), ('bevacizumab', 6), ('benzbromarone', 2), ('pre-existing', 4), ('performs', 1), ('dili', 13), ('reformation', 4), ('reappeared', 1), ('bbr', 6), ('reformed', 1), ('3a', 10), ('lithocholic', 17), ('delta-tocotrienol', 7), ('c-3', 2), ('3-ketocholanoic', 3), ('cyp3a-catalyzed', 2), ('3-oxidation', 8), ('catalysis', 2), ('cyp3a5', 4), ('1/', 2), ('3/', 1), ('alpha-tocotrienol', 2), ('tocotrienol-rich', 2), ('isomer-dependent', 1), ('oscar', 1), ('tracp5', 1), ('methylglyoxal-treated', 2), ('diabetes-related', 3), ('imbalanced', 3), ('phosphoglycerate', 2), ('micro-computed', 1), ('senescence', 28), ('phgdh', 5), ('bmsc', 2), ('imiquimod', 2), ('receptor-regulated', 3), ('imq', 11), ('monohydroxylated', 1), ('7-hydroxyflavone', 1), ('solvent-', 1), ('beta-naphthoflavone-treated', 1), ('cyp1a1/cyp1a2', 1), ('knock-out', 8), ('style-related', 1), ('inevitable', 4), ('/heme', 4), ('physiologic', 3), ('adnexal', 3), ('preadolescent', 3), ('nonphysiologic', 2), ('entities', 2), ('centralized', 1), ('notes', 1), ('dates', 1), ('cyst', 4), ('wilcoxon', 1), ('kruskal-wallis', 1), ('categorical', 1), ('8-18', 2), ('409', 2), ('documentation', 2), ('321', 2), ('59.6', 1), ('149', 1), ('nonsimple', 1), ('one-hundred', 2), ('fifty-nine', 1), ('5.3', 2), ('69.8', 1), ('111', 4), ('62.8', 1), ('paratubal', 2), ('separability', 1), ('rsna', 1), ('paederia', 2), ('foetida', 3), ('cure', 2), ('edible-plant', 1), ('methanolic', 3), ('mepl', 2), ('tumor-suppressor', 2), ('beta-sitosterol', 1), ('cellular-viability', 1), ('cellular-migration', 1), ('il1-beta', 2), ('machineries', 1), ('provoking', 2), ('large-cell', 2), ('paranasal', 2), ('curative', 4), ('40-year-old', 1), ('eroded', 1), ('frontal', 9), ('lobes', 3), ('processed', 4), ('immunohistological', 1), ('staged', 1), ('ct4bn0m0', 1), ('detected.we', 1), ('wnt/beta-catenin-signaling', 2), ('filter-feeding', 1), ('dsp', 2), ('beta-catenin-dependent', 1), ('wnt-signaling', 1), ('oa-mediated', 1), ('redistribution', 2), ('live-cell', 1), ('chromobody', 1), ('hypophosphorylated', 1), ('wnt-target', 1), ('diallyl', 2), ('trisulfide', 2), ('drp1-mediated', 2), ('dats', 6), ('high-glucose', 8), ('deoxyuridine', 1), ('jc-1', 1), ('monophosphate-activated', 1), ('activation-inhibited', 1), ('ampk-dependent', 2), ('ir780-loaded', 1), ('folate-targeted', 1), ('image-guided', 3), ('modality', 4), ('light-triggered', 1), ('ir780', 2), ('iodide', 11), ('liposomes', 2), ('fa-ir780-np', 7), ('stereomicroscope', 2), ('delineation', 1), ('margins', 1), ('eradicated', 1), ('enfuvirtide', 2), ('raltegravir', 2), ('antiretroviral', 2), ('crossover', 1), ('volunteers', 9), ('hiv-infected', 2), ('scarcely', 1), ('antiretrovirals', 1), ('t20', 2), ('ral', 2), ('twenty-six', 1), ('t20/90mg', 1), ('ral/400mg', 1), ('12h', 1), ('4-week', 2), ('end-points', 1), ('high-density-lipoprotein', 1), ('hdl', 4), ('-cholesterol', 2), ('low-density-lipoprotein', 1), ('ldl', 3), ('content-mtdna-in', 1), ('end-point', 2), ('t20-administration', 1), ('ral-administration', 1), ('presuming', 1), ('dnt', 8), ('tier', 1), ('proposal', 1), ('hyper-', 1), ('3-300', 1), ('sudden', 4), ('6-propyl-2-thiouracil', 1), ('ptu', 1), ('morpholino', 4), ('mct8', 3), ('spawning', 2), ('tetrac', 1), ('morphants', 1), ('th-active', 1), ('superdiffusive', 2), ('motion', 2), ('pgse-', 1), ('thanks', 2), ('governing', 1), ('agarose-carbomer', 1), ('magic', 1), ('spinning', 1), ('hr-mas', 1), ('superdiffusion', 1), ('smallest', 1), ('mesh', 1), ('90-120', 1), ('rationalized', 1), ('heavy-tailed', 1), ('distributions', 1), ('displacements', 1), ('levy', 1), ('flights', 1), ('waiting', 1), ('nanoscopic', 3), ('modulations', 3), ('nmr-based', 1), ('metabonomic', 2), ('metabolomics', 15), ('7-15', 1), ('glucometabolic', 2), ('pklr', 1), ('agreed', 2), ('glucokinase', 2), ('gck', 2), ('high-intensity', 2), ('inspiratory', 11), ('cardiorespiratory', 1), ('imtg=14', 1), ('cg=11', 1), ('repetitions', 1), ('progressing', 1), ('19.0cmh2o', 1), ('0.4-37.5', 1), ('imtg', 2), ('102+-25.7cmh2o', 1), ('cg', 1), ('83+-19.2', 1), ('p=0.046', 1), ('33.5', 1), ('nct03082404', 1), ('cardiogenesis', 3), ('epigallocatechin', 2), ('gallate', 5), ('anti-estrogen', 2), ('neutralize', 2), ('4000', 4), ('hand2', 3), ('esr2b', 1), ('acetyltransferase', 1), ('kat6a', 1), ('sinergy', 1), ('neutralized', 2), ('lying', 1), ('prostate-specific', 5), ('bounce', 12), ('stereotactic', 2), ('sbrt', 2), ('low-', 2), ('intermediate-risk', 1), ('time-dose-fraction', 2), ('nadir', 13), ('failure-free', 1), ('bffs', 3), ('gy/five', 3), ('qw', 3), ('tg-1', 2), ('tg-2', 1), ('tg-3', 1), ('gy/two', 1), ('tg-4', 2), ('excluded', 4), ('287', 1), ('28.9', 1), ('19.6', 1), ('7.2', 1), ('2.7', 2), ('0.26-0.97', 1), ('0.04-0.24', 1), ('0.09-0.93', 1), ('probability', 4), ('0.08-1.74', 1), ('1.77', 2), ('0.28-11.07', 1), ('misinterpreted', 1), ('nr3b3', 1), ('xenoestrogen', 1), ('cell-based', 10), ('purposely', 1), ('ec50s', 1), ('ones', 5), ('kds', 1), ('crystallographic', 1), ('lbd', 1), ('alkylphenol', 1), ('naphthol', 1), ('characterizations', 2), ('rigidifying', 1), ('contrasts', 2), ('helix', 1), ('h12', 1), ('owes', 1), ('insecticidal', 2), ('ed', 1), ('ddt/dde', 1), ('eds', 1), ('muscle-specific', 1), ('nonhormonal', 1), ('ddx', 7), ('ry-binding', 2), ('ryr1-signaling', 1), ('hek293t', 5), ('hek-ryr1', 1), ('0.1-10', 1), ('ca2+-efflux', 1), ('ryr', 1), ('ca2+-transient', 1), ('electrically', 2), ('fatigability', 2), ('ca2+-dynamics', 1), ('ryr1-expressing', 1), ('andrographolide', 15), ('smoke-induced', 3), ('hotair', 3), ('hbe', 10), ('mirtazapine', 5), ('john', 2), ('cunningham', 2), ('virus-related', 2), ('immunodeficiency', 5), ('leukoencephalopathy', 2), ('pml', 3), ('name', 2), ('jc', 3), ('predilection', 1), ('infecting', 1), ('replicates', 2), ('vigorously', 1), ('lysis', 1), ('culminating', 1), ('5ht2a', 1), ('arabic', 1), ('favorably', 2), ('gw788388', 4), ('smad3', 12), ('neighboring', 2), ('apap-treated', 2), ('occupancies', 1), ('blues', 5), ('nonequilibrium', 2), ('monte', 2), ('carlo', 2), ('plethora', 2), ('metabolite-formation', 1), ('orientations', 1), ('spacious', 1), ('i-helix', 1), ('n3', 1), ('n1', 1), ('n7', 1), ('c8', 1), ('preferably', 1), ('oriented', 1), ('paraxanthine', 1), ('forcing', 1), ('theophylline', 1), ('trimethyluretic', 1), ('hepatoctyes', 1), ('mannan/beta-glucans', 2), ('deoxyniyalenol-induced', 1), ('ipec-j2', 2), ('biomacromolecules', 2), ('bycw', 7), ('oxidizing', 1), ('cancer-associated', 7), ('cancer-stromal', 4), ('erks', 1), ('kras-mutant', 1), ('pccs', 2), ('beta-galactosidase', 5), ('co-transplantation', 1), ('pcc', 1), ('organoid', 2), ('psc', 2), ('splenic', 15), ('transgenetic', 1), ('hmpccs', 1), ('inhibition-induced', 1), ('lac-megantic', 7), ('train', 3), ('derailment', 1), ('tragedy', 4), ('townships', 3), ('quebec', 2), ('derailed', 1), ('disaster', 2), ('conflagration', 1), ('explosions', 1), ('buildings', 1), ('evacuation', 1), ('unparalleled', 2), ('spill', 1), ('notwithstanding', 1), ('citizens', 2), ('suffer', 2), ('catastrophe', 4), ('tailor', 1), ('well-being', 3), ('811', 1), ('elsewhere', 1), ('7,926', 1), ('ie', 8), ('insecurity', 1), ('anxiolytic', 2), ('gambling', 1), ('posttraumatic', 1), ('six-digit', 1), ('postal', 1), ('capturing', 2), ('subjective', 3), ('chi-squares', 1), ('episode', 3), ('less-exposed', 1), ('2015.', 7), ('aftermath', 1), ('organizations', 2), ('responding', 2), ('large-scaling', 1), ('disasters', 1), ('advocate', 1), ('community-based', 2), ('mir-224-3p', 8), ('fip200', 3), ('ischemic/reperfusion', 1), ('n2a', 1), ('ogd', 1), ('fak', 9), ('family-interacting', 1), ('bangladeshi', 3), ('bangladesh', 1), ('396', 2), ('heals', 1), ('infiniummethylationepic', 1), ('svs', 1), ('arsenical', 1), ('cpgs', 8), ('creatinine-adjusted', 1), ('sixteen', 2), ('abr', 1), ('cg01912040', 1), ('cg10003262', 1), ('221', 1), ('non-cpg', 1), ('islands', 4), ('shores', 1), ('annotating', 1), ('replicable', 1), ('//doi.org/10.1289/ehp3849', 1), ('rhob', 6), ('gtpases', 1), ('multiple-reaction', 1), ('mrm', 1), ('imr90', 2), ('12-h', 1), ('gm00637', 1), ('arsenite-elicited', 1), ('angle-closure', 2), ('resting-state', 2), ('pacg', 8), ('fmri', 2), ('data-driven', 1), ('graph', 1), ('fcd', 9), ('forty-five', 1), ('53.28+-10.79', 1), ('males/28', 2), ('well-matched', 1), ('52.67+-11.01', 1), ('years,18', 1), ('finished', 1), ('rnflt', 2), ('intraocular', 1), ('iop', 2), ('cup', 6), ('disc', 5), ('a-c/d', 2), ('v-c/d', 1), ('between-group', 1), ('short-range', 5), ('long-range', 6), ('voxel', 1), ('ifg', 1), ('/insula/parahippocampal', 1), ('ifg/insula', 2), ('corrected', 4), ('occipital/cuneus/precuneus/superior', 2), ('parietal/postcentral', 2), ('hc', 19), ('ifg/insula/parahippocampal', 1), ('iminyl', 3), ('iminoxyl', 2), ('acceptors', 4), ('pph3', 1), ('afforded', 4), ('homolytic', 1), ('n-o', 1), ('spin', 1), ('exocyclic', 1), ('protumorigenic', 4), ('steadily', 1), ('dcis', 8), ('ninety-one', 1), ('nos2', 8), ('arg-1', 2), ('cd206', 2), ('microg/l', 3), ('cd206+', 1), ('accelerator', 1), ('renin/angiotensin', 1), ('4-oxo-2', 1), ('-nonenal', 2), ('4-hydroxy-2', 1), ('n-terminus', 3), ('asp1', 1), ('arg2', 2), ('his6', 3), ('ros-derived', 2), ('peroxidation-derived', 1), ('ea.hy926', 8), ('one-', 1), ('pyruvamide', 1), ('-ang', 2), ('asca', 1), ('cuso4', 1), ('silfac', 1), ('isotope', 2), ('13c18', 1), ('-linoleic', 1), ('13c9', 2), ('-thiadiazabicyclo-one-glutathione', 1), ('adduct', 9), ('-hne', 1), ('iis', 1), ('let-7b', 10), ('glioma.quantitative', 1), ('clinicopatholoigcal', 1), ('plotted', 2), ('log', 8), ('ration', 2), ('.027', 1), ('karnofsky', 1), ('kps', 1), ('.018', 1), ('2.415', 1), ('1.531-3.808', 1), ('.let-7b', 1), ('oxide-based', 1), ('sp2-hybridized', 1), ('hexagonal', 1), ('go-based', 3), ('adsorbent', 1), ('emphasized', 1), ('outlined', 2), ('thrilling', 1), ('beta-ionone', 3), ('hepatocarcinogenesis', 6), ('neoplasias', 1), ('betai', 5), ('gst-p', 1), ('preneoplastic', 1), ('ppnls', 2), ('evolve', 1), ('nafld/rh', 1), ('schisandrin', 6), ('sch', 11), ('schisandra', 1), ('chinensis', 1), ('collaboratively', 1), ('pathway-act-network', 1), ('4440', 1), ('1878', 1), ('2562', 1), ('4243', 1), ('2584', 1), ('1659', 1), ('b-treated', 1), ('oxidation-reduction', 2), ('programed', 1), ('ligand-1', 2), ('grandiflorus', 1), ('jacq', 1), ('dc.', 1), ('nci-h1975', 2), ('enhancive', 1), ('interleukin-2', 1), ('d-treated', 1), ('d-induced', 1), ('d-mediated', 1), ('d-triggered', 1), ('hemolytic', 3), ('flavin', 3), ('oxidase-induced', 2), ('biphasic', 6), ('impart', 2), ('oxidative-associated', 1), ('paradoxically', 3), ('pro-oxidant', 1), ('bcde', 5), ('ornithine', 1), ('decarboxylase', 3), ('odc', 1), ('res-elicited', 1), ('function/dysfunction', 1), ('obtaining', 1), ('cardio-protective', 1), ('cardio-protection', 1), ('mir-143', 6), ('-exposing', 1), ('beas-cr', 1), ('il-6/hif-1alpha', 1), ('mir-143/il-6/hif-1alpha', 1), ('zip9', 7), ('slc39a9', 1), ('vinclozolin', 9), (\"3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide\", 1), ('antiandrogenic', 4), ('nar', 1), ('androgen-responsive', 1), ('antiandrogens', 2), ('nonclassical', 1), ('mars', 1), ('zip', 1), ('slc39a', 1), ('mar', 2), ('testosterone-dependent', 1), ('nar-', 1), ('pc3-zip9', 2), ('single-point', 1), ('displaced', 1), ('-testosterone', 2), ('antiandrogen', 2), ('co-treatments', 2), ('testosterone-induced', 1), ('mapkinase', 1), ('hesperetin', 9), ('cisplatin-treated', 3), ('scr', 3), ('mda/mpo', 1), ('sod/gsh', 1), ('protectant', 2), ('nearby', 1), ('nha-sv40lt', 3), ('ccne1', 2), ('mmp2', 5), ('plaur', 1), ('anti-proliferation', 11), ('h292', 2), ('non-transformed', 1), ('thiazolyl', 2), ('tetrazolium', 2), ('tenascin-c', 1), ('timp-1', 4), ('transepithelial', 5), ('stat', 5), ('phospho-nf-kappab', 1), ('phospho-stat3', 2), ('irfs', 1), ('interferons', 2), ('ifn-stimulated', 3), ('isgs', 4), ('irf7', 9), ('irf', 1), ('virus-1', 1), ('hiv-1tg', 1), ('irf7-mutant', 3), ('293ft', 2), ('irf7-regulated', 1), ('irf7-delta7', 4), ('irf7-delta11', 1), ('chrna3', 1), ('chrna9', 1), ('modestly', 2), ('ifn-beta', 2), ('retinoic-acid-inducible', 1), ('rig-i', 1), ('melanoma-differentiation-associated', 1), ('mda5', 1), ('isg3', 1), ('isg15', 3), ('ifit1', 2), ('oas1', 4), ('graphical', 2), ('c-induced', 2), ('dsrna', 6), ('irf3', 4), ('ifnar', 1), ('isgf3', 1), ('stat2', 1), ('irf9', 2), ('c-stimulated', 1), ('tachyarrhythmias', 1), ('laminopathies', 2), ('tachyarrhythmia', 1), ('lmna', 3), ('cardioverter-defibrillator', 1), ('839', 1), ('nationwide', 2), ('cardiomyopathies', 1), ('ltvta', 6), ('defibrillator-treated', 1), ('hemodynamically', 2), ('fine-gray', 1), ('reclassification', 1), ('medians', 1), ('444', 1), ('derivation', 3), ('38.2', 1), ('15.0', 2), ('1.0-7.2', 1), ('5.1', 1), ('2.0-9.3', 1), ('nonmissense', 1), ('atrioventricular', 2), ('nonsustained', 1), ('tachycardia', 1), ('ejection', 2), ('//lmna-risk-vta.fr', 1), ('c-index', 2), ('0.776', 1), ('0.711-0.842', 1), ('calibration', 2), ('slope', 2), ('0.827.', 1), ('0.800', 1), ('0.642-0.959', 1), ('1.082', 1), ('0.643-1.522', 1), ('=7', 1), ('96.2', 1), ('28.8', 1), ('guidelines-based', 1), ('defibrillators', 1), ('url', 1), ('//www.clinicaltrials.gov', 1), ('nct03058185', 1), ('cryogels', 6), ('fabricated', 2), ('hypercholesterolemic', 2), ('cnbr', 1), ('immobilization', 2), ('compatibility', 3), ('-hp', 3), ('2.95', 1), ('4.91', 1), ('26.7', 1), ('mg/g', 5), ('cryogel', 2), ('1.67', 1), ('bare', 1), ('adsorption-desorption', 1), ('reusable', 1), ('ldl-c.', 1), ('cynaroside', 6), ('remitted', 3), ('keratinocyte-specific', 2), ('il-6ralpha', 6), ('dermatitis', 9), ('il6radeltaker', 4), ('jp-8', 1), ('jet', 2), ('bkc', 1), ('acetone', 2), ('cd11b+cd45+', 1), ('gammadelta', 1), ('il-22', 3), ('intra-clot', 2), ('microbubble-enhanced', 2), ('catheter-directed', 2), ('thrombolysis', 7), ('microbubbles', 3), ('vessel-obstructing', 1), ('cdt', 5), ('imut', 4), ('dvt', 6), ('1-mhz', 1), ('air-backed', 1), ('100-mus-pulse-length', 1), ('100-hz-pulse-repetition', 1), ('mpa', 13), ('forty-three', 1), ('historical', 1), ('5.23', 1), ('10.00', 1), ('2.69', 1), ('3.82', 1), ('1.68', 1), ('iu', 2), ('4.99', 1), ('2.26', 2), ('procedure-related', 1), ('m100907', 6), ('bd', 9), ('1047', 5), ('pharmacotherapies', 2), ('devastating', 5), ('public-health', 1), ('5-ht2a', 2), ('sigma1', 2), ('swiss-webster', 1), ('telemetric', 1), ('electroencephalography', 1), ('meth-elicited', 3), ('bd1047', 1), ('di-', 6), ('-phthalate', 1), ('ppargamma/pten/akt', 4), ('embryotoxicity', 4), ('h9-hescs', 2), ('cell-microelectronic', 1), ('rtca', 1), ('quantigene', 1), ('plex', 1), ('qgp', 1), ('itraq-based', 2), ('fcm', 2), ('pre-treated', 1), ('h9-hesc', 1), ('165.78', 1), ('qpg', 1), ('toxicoproteomic', 1), ('tubule', 15), ('2,3,5-tris-', 1), ('nephrocarcinogenic', 1), ('reciprocally', 1), ('par-associated', 2), ('356', 1), ('par-modified', 1), ('annotations', 1), ('ii-i', 1), ('tfii-i', 4), ('trpc3', 2), ('alpha/beta-tfii-i', 1), ('translesion', 3), ('par-dependent', 1), ('rela/p65', 1), ('humidifier', 5), ('disinfectants', 1), ('g1/s', 3), ('ros/atm/p53', 1), ('fas-mediated', 6), ('fas/cd95', 1), ('cell-mediated', 1), ('nontoxic', 1), ('fas-induced', 2), ('dispensable', 1), ('fas-resistant', 1), ('musings', 1), ('ketogenic', 6), ('semistarvation', 1), ('eucaloric', 1), ('fat-based', 1), ('ketonemia', 2), ('equation', 5), ('hunger', 1), ('carbohydrate-free', 1), ('dieting', 1), ('24-hour', 2), ('thermic', 1), ('amounting', 1), ('magnolol', 15), ('enzyme-regulatory', 1), ('hces', 3), ('hydrolytic', 3), ('ester-bearing', 1), ('well-investigated', 1), ('hce1-mediated', 2), ('hce2', 4), ('substrate-dependent', 1), ('hce1', 7), ('carboxylesterase', 3), ('deciphering', 2), ('avoiding', 2), ('trans-3,4,5,4', 2), ('-tetramethoxystilbene', 2), ('connected', 6), ('non-genotoxic', 3), ('dmu-212', 1), ('n-nitrosodiethylamine/phenobarbital-induced', 1), ('pb-induced', 3), ('cyp2c29', 2), ('cyp2c55', 6), ('mki67', 1), ('foxm1', 3), ('mcl1', 17), ('tcpobop', 1), ('aml12', 2), ('car-independent', 1), ('endobiotic', 2), ('burn', 4), ('inhalational', 3), ('burns', 2), ('johns', 1), ('hopkins', 1), ('bayview', 1), ('intubated', 7), ('amphetamines', 4), ('barbiturates', 2), ('methadone', 1), ('codeine/morphine', 1), ('icu', 3), ('mann-whitney', 1), ('u', 11), ('sub-group', 5), ('binomial', 1), ('50/115', 1), ('forty-two', 2), ('thirty-one', 1), ('62', 5), ('26/50', 1), ('7/50', 1), ('0.022', 2), ('lengths', 4), ('6.4', 3), ('2.5-16.3', 1), ('1.2-5.1', 1), ('poses', 5), ('titrated', 3), ('centella', 2), ('asiatica', 2), ('astaxanthin', 5), ('anhydride-induced', 1), ('teca', 10), ('ointment', 2), ('ad-like', 6), ('hos', 1), ('hr-1', 1), ('mug/cm2', 13), ('dorsum', 1), ('cyclocxygenase', 1), ('pa-induced', 2), ('teca+ast', 2), ('reatments', 1), ('epsilon', 3), ('l-type', 3), ('proteomes', 1), ('ionic', 1), ('alpha1c', 1), ('na+-k+-atpase', 3), ('cn-induced', 2), ('alpha1', 1), ('pkcepsilon', 4), ('myristoylated', 1), ('myocyte', 2), ('fluxes', 3), ('demand', 5), ('preserves', 2), ('translates', 1), ('cardiogenic', 1), ('creating', 3), ('disconnect', 1), ('mir-381', 14), ('ets1', 4), ('mir', 2), ('-381', 1), ('/akt/mammalian', 1), ('meglumine', 5), ('diatrizoate', 3), ('doubles', 1), ('cin', 4), ('intra-peritoneal', 1), ('non-diabetic', 1), ('diabetic/sulforaphane', 1), ('diabetic/cin', 1), ('diabetic/cin/sulforaphane', 1), ('liraglutide', 16), ('glucagon-like', 4), ('glp-1', 7), ('v-fitc/propidium', 1), ('peroxidationand', 1), ('chemo-', 1), ('neurotropic', 1), ('cerebrum', 2), ('leukocytosis', 1), ('lymphocytosis', 1), ('il-2', 8), ('immunoglobulins', 1), ('igm', 5), ('radical', 12), ('8-hydroxy', 1), ('2-deoxyguanosine', 1), ('8oh2dg', 1), ('saikosaponins-d-induced', 1), ('saikosaponins-d', 1), ('bupleuri', 2), ('ssd-induced', 5), ('stem/progenitor', 1), ('npcs', 10), ('axin', 4), ('apc', 2), ('val16ala-sod2', 2), ('cyto-genotoxicity', 1), ('superoxide-hydrogen', 4), ('s-hp', 2), ('rs4880', 1), ('sod-snp', 1), ('cyto-genotoxic', 1), ('pb-concentrations', 1), ('sod2-genotypes', 1), ('quantity', 5), ('aa-pbmcs', 1), ('seemed', 5), ('cell-mortality', 1), ('carbonylation', 6), ('cyto-genoprotective', 1), ('v-allele', 1), ('hp-release', 1), ('tricetin', 6), ('6-ohda-induced', 4), ('mitochondria-mediated', 6), ('6-ohda-pd', 1), ('exploratory', 6), ('room-temperature', 2), ('crystallography', 3), ('relies', 4), ('template', 4), ('bank', 2), ('cryogenic', 1), ('conformations', 2), ('p31', 4), ('amenable', 2), ('co-crystallized', 1), ('hache', 4), ('9-aminoacridine', 1), ('gorge', 2), ('aricept', 1), ('e2020', 1), ('bw284c51', 2), ('p3121', 1), ('proceed', 1), ('reactivators', 4), ('temperature-related', 1), ('informed', 5), ('-potential', 1), ('anthocyanidin', 1), ('berries', 2), ('strawberries', 1), ('blueberries', 1), ('radishes', 1), ('jb6', 5), ('p+', 4), ('hepg2-c8', 1), ('are-luciferase', 1), ('shnrf2', 1), ('tpa-induced', 3), ('h/quinone', 1), ('phenanthrene', 11), ('isomer', 9), ('anthracene', 10), ('car-/-', 2), ('car-related', 1), ('gstm3', 1), ('phenanthrene-exposed', 1), ('grilled', 1), ('lamb', 1), ('phenanthrene-induced', 1), ('pahs-contaminated', 1), ('silicotic', 4), ('pneumoconiosis', 2), ('autopsy', 1), ('gli', 1), ('patch-1', 1), ('silica-inhalation', 1), ('gli3', 2), ('ac-sdkp', 3), ('tetrapeptide', 1), ('anti-silicotic', 1), ('captopril', 4), ('geraniin', 8), ('fak/src', 2), ('antihyperglycaemic', 1), ('anti-migration', 2), ('scc-9', 2), ('scc-14', 2), ('mapk/erk1/2', 1), ('fgb', 2), ('f5', 2), ('f7', 2), ('f12', 2), ('gp1ba', 4), ('gpiiia', 2), ('cyp11b2', 2), ('pon1', 11), ('pon2', 2), ('hifla', 1), ('lta', 2), ('alox5ap', 2), ('nos3', 1), ('pde4d', 3), ('hif1a', 2), ('cci', 3), ('interrelation', 1), ('t/t', 1), ('83c', 1), ('gb', 7), ('or=6.22', 1), ('ci=1.86-20.79', 1), ('p=0.0036', 1), ('dd', 1), ('rs1799752', 1), ('cardioembolic', 1), ('or=2.67', 1), ('ci=1.23-5.8', 1), ('p=0.02', 2), ('or=7.14', 1), ('ci=1.72-29.69', 1), ('p=0.0057', 1), ('brachiocephalic', 1), ('rs2243093', 1), ('-5t/c', 1), ('or=3.39', 1), ('ci=1.12-10.25', 1), ('p=0.03', 2), ('or=4.44', 1), ('ci=1.27-15.54', 1), ('p=0.023', 1), ('ilcs', 1), ('35-day-old', 1), ('8bromo-camp', 2), ('22r-oh-cholesterol', 1), ('pregnenolone', 3), ('androstenedione', 2), ('dihydrotestosterone', 3), ('3beta-hydroxysteroid', 4), ('6.31', 1), ('srd5a1', 2), ('akr1c14', 2), ('apob', 5), ('142', 1), ('ewha-severance', 2), ('c.13013g', 1), ('c.1853c', 4), ('c.1594c', 1), ('c.293c', 4), ('c.7545c', 1), ('g.4798t', 1), ('g.6406g', 1), ('g.10413t', 1), ('c.388t', 1), ('c.526c', 1), ('g.6399c', 1), ('c.1075a', 1), ('2.9-25.5', 1), ('88.3', 1), ('2.3-17.9', 1), ('84.3', 1), ('auroc', 1), ('iiib/iv', 2), ('non-squamous', 2), ('innovations', 1), ('erlotinib/bevacizumab', 1), ('cisplatin/gemcitabine/bevacizumab', 1), ('pgb', 5), ('104', 1), ('eb-arm', 1), ('pgb-arm', 1), ('=0.353', 1), ('0.189-', 1), ('0.658', 1), ('log-rank', 2), ('p=0.0007', 1), ('hr=0.276', 1), ('0.115-', 1), ('0.659', 1), ('p=0.0021', 1), ('helical', 6), ('i-125', 5), ('transcatheter', 3), ('chemoembolization', 2), ('iodine-125', 1), ('tace', 5), ('mpvtt', 4), ('transhepatic', 1), ('6-8', 2), ('42.3', 1), ('84.6', 2), ('34.6', 1), ('46.2', 3), ('6.2-15.2', 1), ('nrf2-', 1), ('nitrergic-mediated', 1), ('non-motor', 1), ('pd-induced', 1), ('dysmotility', 2), ('1-methyl', 1), ('4-phenyl', 2), ('1,2,3,6-tetrahydropyridine', 1), ('parkinsonian', 3), ('l-methyl-4-phenylpyridinium', 1), ('emptying', 2), ('nitrergic', 2), ('mptp-induced', 5), ('bh4', 1), ('enteric', 5), ('mpp+-induced', 5), ('l-name', 10), ('w', 2), ('-nitro-l-arginine', 1), ('ester', 11), ('nrf2/bh4/nnos', 1), ('galectin-3', 11), ('83', 3), ('anti-tpo', 2), ('hdl-cholesterol', 1), ('ft4', 2), ('ft3', 2), ('anti-tg', 2), ('2.89', 1), ('1.17-10.79', 1), ('1.95', 1), ('1.15-6.11', 1), ('believe', 2), ('beta-tubulin', 2), ('self', 1), ('potentia', 1), ('rencell', 1), ('100mumol/l', 2), ('sox2/brdu', 1), ('nestin/brdu', 1), ('methyflashtm', 1), ('peotein', 1), ('immunfluorescence', 1), ('brdu/sox2', 1), ('pq-exposed', 5), ('brdu/nestin', 1), ('50,100mumol/l', 1), ('pq-treated', 2), ('inhibite', 1), ('gata6', 6), ('229', 1), ('2.0-3.0', 1), ('single-nucleotide', 2), ('nng', 3), ('tt', 9), ('rs13273672', 4), ('rs10454095', 4), ('5.0-', 1), ('1.6-15.7', 1), ('3.1-fold', 1), ('1.1-8.7', 1), ('experiencing', 1), ('22.2', 1), ('8.7-fold', 1), ('1.7-46.1', 1), ('40.0.', 1), ('favipiravir', 5), ('bourbon', 2), ('brbv', 5), ('tick-borne', 1), ('orthomyxoviridae', 1), ('vaccines', 1), ('st.', 1), ('louis', 1), ('brbv-stl', 5), ('tropism', 2), ('brbv-induced', 1), ('ifnar1-/-', 2), ('congenic', 1), ('brbv-stl-induced', 1), ('beta-2-himachalen-6-ol', 2), ('4t1', 6), ('cells-induced', 1), ('sesquiterpene', 1), ('lebanese', 1), ('carrot', 1), ('umbels', 1), ('6-thioguanine', 1), ('ic90', 1), ('sub-g1', 1), ('annexin/pi', 1), ('tumor/inflammation', 1), ('colony-forming', 4), ('oxidative-stress-induced', 5), ('/antioxidant', 1), ('inhibition-mediated', 1), ('h2o2-exposed', 1), ('bach1/nrf2/are', 1), ('receptor-binding', 2), ('so-called', 1), ('nextgen', 4), ('tritium-labeled', 1), ('bpap', 2), ('bpb', 4), ('bpz', 4), ('3.3-73', 1), ('bpm', 3), ('doubtful', 1), ('raralpha', 3), ('rarbeta', 1), ('roralpha', 1), ('rorbeta', 1), ('rorgamma', 1), ('lxrbeta', 1), ('distinctly', 4), ('consequential', 1), ('endocrine-disruption', 1), ('bs', 7), ('scaffold-free', 1), ('htert-hscs', 1), ('bs-triggered', 1), ('concordant', 1), ('multitude', 4), ('2.5um', 1), ('han', 4), ('emphysematous', 2), ('exacerbateed', 1), ('exosome-derived', 2), ('endometritis', 7), ('exosomes', 31), ('extractions', 2), ('competence', 2), ('ivf', 4), ('30-150', 1), ('cd63', 5), ('cd9', 1), ('118', 4), ('co-incubated', 2), ('21.84+3.17', 1), ('32.37+2.69', 1), ('clonidine', 13), ('tramadol', 4), ('bupivacaine', 10), ('epidural', 1), ('adjuvants', 1), ('shot', 2), ('entitled', 2), ('asa', 3), ('2-12', 1), ('infra-umbilical', 1), ('surgeries', 2), ('0.5ml/kg', 1), ('mcg/kg', 2), ('student', 4), ('requirement', 6), ('avermectins', 1), ('anti-parasitic', 1), ('glutamate-gated', 1), ('invertebrate', 1), ('non-neural', 1), ('2-8', 1), ('glyr', 4), ('acc', 4), ('z-guggulsterone', 1), ('ivermectin-induced', 1), ('glyr-dependent', 1), ('fxr-dependent', 1), ('docetaxel', 4), ('arrests', 1), ('dedifferentiated', 2), ('liposarcoma', 3), ('ls', 3), ('chemotherapy-resistant', 2), ('ddls', 5), ('pdox', 4), ('orthotopically', 1), ('inguinal', 1), ('gem', 3), ('doc', 3), ('pazopanib', 1), ('paz', 1), ('yondelis', 1), ('yon', 2), ('0.184', 2), ('diastereoisomer-specific', 2), ('hexabromocyclododecane', 2), ('hbcd', 11), ('bfr', 3), ('diastereoisomer', 3), ('diastereoisomers', 6), ('alpha-', 4), ('beta-', 1), ('gamma-hbcd', 4), ('beta-hbcd', 3), ('alpha-hbcd', 3), ('structure-selective', 1), ('mdd', 2), ('illness', 4), ('multilevel', 1), ('sphingolipids', 1), ('hydrolyzing', 1), ('s-asm', 4), ('unmedicated', 2), ('3-weeks', 1), ('psychometric', 1), ('inventories', 1), ('asm', 1), ('clinician-evaluated', 1), ('self-rated', 1), ('ham-d', 1), ('madrs', 1), ('bdi-ii', 1), ('contrariwise', 1), ('pathomechanisms', 1), ('mono-methylindoles', 2), ('mmi', 6), ('ahr-cyp1a', 2), ('2-methylindole', 2), ('absent', 4), ('ahr-knock-out', 1), ('mmis', 2), ('23.8', 3), ('11.4', 2), ('4-methylindole', 1), ('6-methylindole', 1), ('7-methylindole', 1), ('az-ahr', 1), ('2-hydroxyphenyl', 1), ('acetamide', 2), ('na-2', 6), ('dominating', 1), ('hydroxyphenyl', 1), ('anti-arthritic', 1), ('anti-glioblastoma', 1), ('mebendazole', 3), ('agp01', 8), ('mbz', 18), ('ethidium', 2), ('acridine', 1), ('orange', 4), ('0.5mum', 1), ('individuals1', 1), ('variants2-4', 1), ('variants5-10', 1), ('implicated11-14', 1), ('ca2', 1), ('ddhd1', 1), ('nsun2', 1), ('rarb', 1), ('rogdi', 1), ('slc1a1', 1), ('ush2a', 1), ('fev', 2), ('refine', 1), ('illuminating', 1), ('lactone', 8), ('paraoxonase', 1), ('hydrolysing', 2), ('rpon1', 7), ('lactones', 4), ('alpha-angelica', 3), ('gamma-butyrolactone', 1), ('gamma-hexalactone', 1), ('gamma-heptalactone', 1), ('gamma-octaclactone', 1), ('gamma-furanone', 2), ('gamma-valerolactone', 1), ('gamma-decalactone', 2), ('subtrates', 1), ('1-6', 1), ('well-recognised', 1), ('irf-dependent', 1), ('irf1', 6), ('il-12', 12), ('lmp2', 2), ('co-ip', 3), ('isre', 1), ('adp-ribosyl', 1), ('ation', 1), ('irf1-mediated', 3), ('isres', 2), ('irf1-related', 1), ('anergy', 1), ('non-invasive', 3), ('preimplantation', 4), ('utilization', 4), ('intracytoplasmic', 1), ('icsi', 1), ('pgd', 2), ('royan', 1), ('g-2tm', 1), ('fluorometric', 4), ('chemiluminecence', 1), ('30.7', 2), ('pmol/embryo/hour', 2), ('22.60', 1), ('0.19', 1), ('nmol/mul', 2), ('24.74', 1), ('hemangioma', 8), ('hyper-proliferation', 2), ('mir-655', 1), ('telangiectasia', 1), ('timp2', 3), ('igfbp7', 8), ('multicentre', 2), ('metalloproteinases-2', 1), ('factor-binding', 1), ('soon', 2), ('icus', 1), ('169-315', 1), ('post-collapse', 1), ('kdigo', 2), ('eleven', 2), ('0.80-6.62', 1), ('2/1000', 5), ('0.17', 4), ('0.05-0.59', 1), ('-severe', 1), ('0.84-0.95', 1), ('0.39', 4), ('84-100', 1), ('61-82', 1), ('98', 2), ('92-100', 1), ('0.63-0.84', 1), ('uo', 2), ('0.78-0.94', 1), ('opioid-sparing', 1), ('epidemic', 11), ('formalin', 5), ('win55,212-2', 8), ('gp1a', 4), ('sub-additive', 1), ('varies', 2), ('hold', 7), ('cancer-testis', 2), ('pitfalls', 1), ('immune-privileged', 1), ('imparts', 2), ('ideal', 1), ('spa17', 1), ('protein-17', 1), ('sp-17', 4), ('igf2bp3', 1), ('factor-ii', 1), ('mrna-binding', 1), ('imp-3', 4), ('follistatin-like', 1), ('tmeff1', 4), ('molecularly', 1), ('crisp', 2), ('2.06', 1), ('perinuclear', 3), ('52.93', 1), ('96.51', 1), ('quetiapine', 8), ('bidirectional', 2), ('atypical', 3), ('quetiapine-induced', 5), ('quetiapine-treated', 1), ('21-day', 1), ('opposing', 2), ('281', 2), ('jwh-133', 2), ('1241', 2), ('630', 1), ('bidirectionally', 1), ('ohcs', 1), ('azadirachtin', 2), ('exercised', 1), ('equilibrium', 5), ('aza', 4), ('azadirachta', 1), ('indica', 1), ('hyperplastic', 2), ('uterus', 4), ('actinomycin', 2), ('cystine/glutamate', 3), ('xct', 4), ('cd133+', 3), ('metastasizes', 1), ('hccs', 1), ('lcscs', 5), ('gaining', 1), ('organized', 2), ('non-target-based', 1), ('alpha-fetoprotein', 1), ('+/cluster', 1), ('133+', 1), ('actd', 5), ('actd-induced', 1), ('tumor-specificity', 1), ('lcsc', 1), ('fa2n-4', 1), ('spheroid-forming', 1), ('spheroid', 7), ('actd-mediated', 1), ('destabilization', 3), ('ppd', 8), ('lmwha', 4), ('/tlr4/nf-kappab', 1), ('acd', 2), ('allergens', 10), ('damps', 3), ('p-phenylenediamine', 2), ('co-operation', 1), ('dncb-induced', 1), ('sensitizers', 4), ('synthases', 3), ('nctc2544', 2), ('nf-kappabeta', 3), ('lmwha-effects', 1), ('executed', 2), ('sustain', 1), ('allergen-dependent', 1), ('lmwha/tlr4/', 1), ('immune-cell', 2), ('dss-treated', 2), ('semipurified', 1), ('ain-93', 1), ('colitic', 2), ('cpf-exposed', 7), ('igf1-related', 1), ('foetus', 1), ('g/kg.d', 1), ('9-20', 2), ('gd9-20', 1), ('lipoprotein-cholesterol', 4), ('scarb1', 1), ('ldlr', 8), ('abcg1', 2), ('mehp-induced', 3), ('substrate-1/protein', 1), ('b/fork-head', 1), ('irs-1/akt/foxo1', 1), ('pepck', 1), ('glucose-6-phosphatase', 2), ('g6pc', 2), ('irs-1/akt/glycogen', 1), ('gys', 1), ('rbp4', 3), ('resistance-inducing', 1), ('regularly', 4), ('interspaced', 1), ('palindromic', 1), ('repeats-cas9', 1), ('caution', 6), ('involvements', 1), ('disturbance', 6), ('mir-124', 4), ('starbase', 1), ('rip', 1), ('anti-mir-124', 1), ('decidualized', 3), ('trophoblastic', 6), ('spheroids', 8), ('jeg-3', 16), ('ere-luc', 1), ('receptivity', 2), ('harmed', 1), ('lif', 1), ('alphavbeta3', 1), ('mmp2/mmp9', 1), ('timp1/pai-1', 1), ('rhynchophyllin', 2), ('tourette', 5), ('jak2/stat3', 7), ('ts', 9), ('5-ht2a/2c', 1), ('5-dimethoxy-4-iodophenyl', 1), ('-2-aminopropane', 1), ('doi-induced', 1), ('/signal', 2), ('nodding', 1), ('p-jak2', 1), ('p-nf-kappabp65', 1), ('overfeeding', 5), ('microgliosis', 2), ('long-lasting', 4), ('overfed', 3), ('primed', 1), ('hyper-responsive', 1), ('hypothesised', 1), ('minocycline', 5), ('21-42', 1), ('normalise', 1), ('manipulated', 2), ('sizes', 4), ('suckled', 1), ('litters', 1), ('neonatally', 1), ('3-week', 1), ('renoprotection', 2), ('glt', 9), ('fructose-enriched', 1), ('ada', 2), ('/xanthine', 1), ('/uric', 1), ('ua', 2), ('allotted', 1), ('rats/group', 1), ('w/v', 3), ('glucose-6-phosphate', 2), ('sodium-potassium-atpase', 1), ('ada/xo/ua', 3), ('fed-induced', 1), ('depletion-driven', 1), ('glutathionedepletion', 1), (\"'master-regulator\", 1), ('xenobiotics/endobiotics', 1), ('defends', 1), ('imposes', 1), ('ddis', 2), ('pxr-platform', 1), ('pre-assessed', 1), ('judiciously', 1), ('pioglitazone', 8), ('thiazolidinediones', 1), ('tzds', 1), ('mdr1', 4), ('inflict', 1), ('carotid', 4), ('cas', 21), ('wished', 2), ('2016.', 6), ('cad', 2), ('1h-nmr', 3), ('spectroscopy-based', 1), ('60.2', 1), ('5.9', 2), ('63.3', 1), ('6.0', 5), ('0.050', 1), ('vip', 2), ('cd71+', 6), ('hpv-e6', 4), ('aggressiveness', 4), ('radioresistance', 1), ('subpopulation', 9), ('cell-surface', 1), ('hpv-negative', 2), ('c33a', 2), ('cd71+subpopulation', 1), ('hpv-e6-overexpressing', 3), ('cd71', 3), ('hpv-positive', 1), ('cd55', 2), ('enriches', 1), ('cd71+cells', 1), ('reviews', 3), ('hong', 2), ('kong', 2), ('6000', 1), ('poisons', 2), ('poison', 1), ('psychiatric-related', 1), ('decontamination', 3), ('zopiclone', 1), ('tricyclic', 3), ('antipsychotics', 5), ('valproic', 7), ('tips', 1), ('microcarcinomas', 2), ('neck', 10), ('indolent', 1), ('subclinical', 1), ('nodal', 5), ('pmc', 4), ('pn1b', 6), ('pn0', 3), ('410', 1), ('nanostring', 1), ('248', 1), ('tcga', 10), ('landscapes', 1), ('tert', 1), ('n1b', 1), ('forest', 1), ('learning-based', 1), ('classifier', 2), ('0.72', 3), ('rnaseq', 2), ('bioinformatics-driven', 1), ('hdacis', 2), ('roxyl-zr', 5), ('n=5', 1), ('n=3', 9), (\"5-bromo-2'-deoxyuridine\", 1), ('mice/group', 2), ('n=4', 1), ('nickend', 1), ('hdaci', 2), ('roxyl-zr-enhanced', 1), ('jak1-stat3', 1), ('hdac-cyclin-dependent', 1), ('conjugates', 6), ('k3', 2), ('menadione', 12), ('1,2-dimethylhydrazine', 1), ('ineffective', 2), ('crl-1790', 1), ('cdh2', 3), ('topflash/fopflash', 1), ('tcf7l2', 1), ('bcl9l', 1), ('ep300', 1), ('subg0', 1), ('g0', 1), ('bakuchiol', 2), ('oestrogen/testosterone-induced', 1), ('androgens', 5), ('bph', 10), ('psoralea', 1), ('corylifolia', 1), ('long-termed', 1), ('wpmy-1', 3), ('bph-1', 4), ('oestrodial/testosterone-induced', 1), ('e2/t-induced', 1), ('periglanular', 1), ('pge2-induced', 1), ('ba-stimulated', 2), ('ere', 4), ('silence', 4), ('ba-induced', 1), ('iron-uptake', 2), ('osteoclastic', 1), ('fe-s', 1), ('transferrin-bound', 1), ('warfarin-exposed', 1), ('resembles', 2), ('embryopathy', 2), ('developmental-time', 1), ('crosses', 3), ('hemorrhages', 2), ('15.13', 1), ('75.68', 1), ('378.43', 1), ('eleuthero-embryos', 1), ('mimicking', 6), ('766', 1), ('564', 1), ('202', 3), ('overrepresented', 1), ('vasculogenesis', 1), ('phototransduction', 1), ('eradication', 4), ('season', 1), ('urge', 3), ('species-specific', 2), ('anticoagulants', 2), ('biopsies', 12), ('era', 1), ('imaging-targeted', 1), ('suspicious', 2), ('multiparametric', 2), ('mpmri', 2), ('sbs', 5), ('undebated', 1), ('suspicion', 3), ('multicenter', 2), ('665', 1), ('4.0ng/ml', 1), ('pi-rads', 2), ('=3', 2), ('1:1:1', 1), ('tb', 12), ('mri-trus', 1), ('fus-tb', 3), ('cog-tb', 3), ('in-bore', 1), ('cspca', 6), ('gleason', 2), ('=3+4', 1), ('insignificant', 1), ('cispca', 2), ('mcnemar', 1), ('6.0-22', 1), ('11-25', 1), ('missed', 2), ('2/152', 1), ('omitted', 1), ('mri-targeted', 1), ('triptolide-induced', 3), ('ingredients', 6), ('lc/ms-based', 1), ('ppara-/-', 1), ('notch-nrf2', 1), ('heathy', 1), ('cholinesterases-catalyzed', 1), ('enzyme-catalyzed', 1), ('chromogenic', 1), ('invisible', 4), ('thiocholine', 1), ('benzoylthiocholine', 1), ('butyrylthiocholine', 1), ('aryl-acylamides', 1), ('o-nitro', 1), ('trifluoro', 1), ('acetaminide', 1), ('acetamido', 2), ('-n', 2), ('n-trimethylanilinium', 2), ('butyrylcholine', 2), ('bimolecular', 1), ('kcat/km', 1), ('invisible/visible', 1), ('b/a', 1), ('golicnik', 1), ('cholinesterases', 4), ('michaelian', 1), ('non-michaelian', 1), ('reevaluation', 1), ('replacing', 2), ('libraries', 5), ('6-hydroxydopamine-induced', 1), ('imr-32', 1), ('diminution', 3), ('phosphatidic', 1), ('diacylglycerol', 1), ('governs', 1), ('benzoquinone', 6), ('catalytically', 1), ('ptpn2', 7), ('nonreceptor', 1), ('immune/inflammatory', 1), ('arises', 3), ('hematotoxic', 2), ('well-understood', 1), ('topoisomerases', 1), ('reacting', 3), ('cell-signaling', 1), ('jak', 2), ('inact', 1), ('645', 1), ('irreversibly', 3), ('stat1-regulated', 1), ('covalently', 3), ('modifies', 3), ('acetabular', 4), ('computer-assisted', 2), ('tha', 2), ('c-arm', 1), ('fluoroscopy', 1), ('daa', 6), ('imageless', 4), ('surgeons', 2), ('anteversion', 3), ('inclination', 3), ('intraoperatively', 2), ('anteroposterior', 1), ('radiographic', 3), ('bland-altman', 2), ('abs', 2), ('4.2', 3), ('4.0', 1), ('64/69', 1), ('67/69', 1), ('pairings', 2), ('fell', 1), ('94', 2), ('65/69', 1), ('69/69', 1), ('agreeable', 1), ('definitive', 4), ('binders', 1), ('tracing', 1), ('screenings', 2), ('kinases-2', 1), ('cdk2s', 2), ('forty-nine', 2), ('cdk2-atp', 1), ('10ns', 1), ('calculation', 2), ('pic50', 1), ('exhaustive', 1), ('ligand-protein', 1), ('protein-ligand', 1), ('incorporates', 1), ('flexibility', 5), ('cha', 1), ('in-house', 3), ('eluforsen', 13), ('p.phe508del', 3), ('conductance', 2), ('phenylalanine', 3), ('508', 1), ('evaluates', 7), ('single-stranded', 1), ('33-nucleotide', 1), ('p.phe508del-cftr', 1), ('short-circuit', 1), ('oro-tracheal', 1), ('f508del-cftr', 1), ('cftr-mediated', 2), ('sweat', 1), ('npd', 2), ('p.phe508del-cftr-mediated', 1), ('2,3', 4), (\"4,4',5-pentachlorobiphenyl\", 2), ('m2-dependent', 1), ('pcb118', 7), ('smmc-7721', 2), ('pcb118-induced', 2), ('pkm2-dependent', 1), ('ahr/nadph', 1), ('rare-earth', 8), ('carbonates', 4), ('earth', 1), ('hydroxycarbonates', 2), ('carbonates-with', 1), ('re2', 1), ('co3', 1), ('2-3h2o', 1), ('generic', 1), ('tengerite-type', 2), ('peculiar', 1), ('morphology-and', 1), ('reco3oh', 1), ('law', 1), ('lanthanides', 2), ('neodymium', 1), ('erbium', 1), ('lighter', 1), ('rare-earths', 1), ('nrf2/gsh', 1), ('ngn', 8), ('c15h12o5', 1), ('mitochondria-related', 3), ('10-80', 1), ('mg-triggered', 1), ('mg-treated', 1), ('nrf2/gsh-dependent', 1), ('cepharanthine', 2), ('cep', 12), ('bisbenzylisoquinoline', 1), ('firmly', 1), ('t-all', 12), ('anti-t-all', 1), ('viabilities', 2), ('6.', 1), ('mcl-1', 8), ('cylcin', 1), ('relapsed', 2), ('prmt3', 9), ('arginine', 3), ('prmt', 1), ('cytosine-cytosine-adenosine-adenosine-thymidine-enhancer-binding', 1), ('poly-adenosine', 1), ('diphosphate-ribose', 1), ('phospho-p53', 1), ('prmt4', 5), ('house', 9), ('institute-organ', 1), ('corti', 2), ('faah1', 5), ('prmts', 1), ('keratinocyte-derived', 1), ('il-36gamma', 6), ('hydroquinone-induced', 3), ('leukoderma', 5), ('vitiligo', 1), ('rhododendrol', 1), ('4-tertiary', 1), ('4-tbp', 1), ('dermatological', 2), ('heks', 4), ('sub-cytotoxic', 3), ('pathway-based', 1), ('il-17', 9), ('cytokine-induced', 1), ('gse53751', 1), ('hq-', 1), ('il-17a-treated', 1), ('il36g', 1), ('il-17a', 5), ('hems', 1), ('dct', 3), ('tyrp1', 1), ('autocrinally', 2), ('cxcl8/il-8', 1), ('paracrinally', 1), ('inspiration', 2), ('breath-hold', 2), ('239', 2), ('left-sided', 2), ('dosimetric', 1), ('coverage', 4), ('lsbcp', 3), ('dibh', 7), ('imrt', 2), ('contest', 1), ('suitability', 1), ('comply', 2), ('varian', 1), ('rpm', 1), ('gating', 1), ('tangential', 1), ('inverse-planned', 1), ('beams', 1), ('42.4', 2), ('gy/16', 1), ('gy/25', 1), ('gy/5', 1), ('planning', 3), ('mhd', 4), ('0.94', 2), ('13.82', 1), ('fractionation', 5), ('0.85', 3), ('0.0005', 3), ('20.78', 1), ('12.45', 1), ('0.88', 2), ('0.52', 3), ('17.68', 1), ('10.63', 1), ('0.0002', 1), ('v20', 1), ('0.13', 1), ('0.09', 2), ('v95', 1), ('96.1', 1), ('84.5', 1), ('239/280', 1), ('unselected', 3), ('receives', 1), ('vast', 5), ('cucurbitacin', 2), ('egfr-mapk', 2), ('cuiia', 7), ('tetracyclic', 1), ('harboring', 5), ('inconsistently', 1), ('raf1', 2), ('egfr-mitogen-activated', 1), ('cylclinb1', 1), ('shifted', 1), ('stabilized', 2), ('person-centered', 5), ('diabetes-a', 1), ('self-determination-young', 1), ('gsd-y', 5), ('reflection', 2), ('glycaemic', 3), ('self-perceived', 3), ('conflicts', 5), ('self-efficacy', 3), ('group-based', 2), ('csii', 2), ('attended', 1), ('sessions', 2), ('hba1c', 2), ('mmol/mol', 1), ('.009', 1), ('girls', 5), ('.019', 1), ('ope', 1), ('opes', 2), ('ehdphp', 1), ('4-isopropylphenyl', 1), ('4ippdpp', 1), ('4-tert-butylphenyl', 1), ('4tbpdpp', 3), ('imidapril', 4), ('-inhibitor', 1), ('prodrug', 3), ('49.0', 1), ('myl9', 10), ('peritumoural', 1), ('pt', 15), ('microarray-based', 1), ('archived', 2), ('paraffin', 1), ('embedded', 2), ('idh1', 2), ('r132h', 2), ('rembrandt', 2), ('membranous', 1), ('patchy', 1), ('immunonegative', 1), ('variably', 1), ('conferring', 2), ('anti-epileptic', 4), ('polyvinylchloride', 1), ('hepatotoxicants', 1), ('juvenile/peripubertal', 1), ('23.', 1), ('udp-glucuronosyltransferase', 11), ('system-related', 1), ('17beta-hydroxysteroid', 2), ('pb-treated', 3), ('hepatotoxicity-associated', 1), ('m1-microglial', 5), ('organotypic', 4), ('slice', 7), ('m1-microglia', 2), ('p2', 4), ('cd16', 2), ('cd32', 1), ('p7', 7), ('srebp-2/hmgcr', 2), ('3-hydroxy-3-methylglutaryl', 2), ('protein-2', 1), ('nm~10', 1), ('non-monotonic', 3), ('u-shape', 1), ('lipotoxicity', 2), ('hyperphosphorylated', 2), ('neuron-related', 1), ('ad-associated', 1), ('p-gsk3alpha', 1), ('meth-mediated', 1), ('parp-1/pi3k/akt', 2), ('puerarin-mediated', 1), ('beneficially', 1), ('hfhs-induced', 1), ('hfhs-fed', 1), ('protections', 1), ('disabled', 1), ('refilling', 1), ('blimp-1/nlrp12', 2), ('blimp-1', 3), ('nlrp12', 3), ('interleukin-18', 2), ('para-phenylenediamine', 1), ('asc', 5), ('nlpr12', 1), ('allergen-induced', 2), ('ochratoxin-induced', 1), ('2-de', 1), ('maldi/tof', 1), ('ota-malignant', 1), ('ota-ges-1t', 3), ('actb', 1), ('f-actin-capping', 1), ('alpha-1', 1), ('capza1', 1), ('anxa3', 1), ('tpx-b', 1), ('mesylate', 2), ('gamete', 1), ('tk', 2), ('mammal', 1), ('im-induced', 3), ('30-day', 1), ('depuration', 2), ('folliculogenesis', 7), ('vegfaa', 1), ('igf2a', 1), ('reproductive-', 1), ('angiogenic-', 1), ('growth-related', 1), ('sulfone', 7), ('pesticide-drug', 2), ('hygiene', 3), ('cyp450', 14), ('drug-pesticide', 1), ('rac-fipronil', 2), ('s-fipronil', 2), ('r-fipronil', 2), ('enantioselective', 2), ('retroviral', 2), ('envelopes', 2), ('exchanging', 1), ('mother', 6), ('ervw-1', 2), ('ervfrd-1', 2), ('erv3-1', 2), ('beta-hcg', 2), ('herv', 1), ('gcm1', 1), ('syncytin', 1), ('proline', 4), ('4-hydroxylase', 2), ('nibea', 2), ('diacanthus', 2), ('hyp', 9), ('p4h', 2), ('col1as', 4), ('p4halphas', 2), ('p4halpha', 3), ('450', 2), ('fishes', 2), ('supplementary', 1), ('hyp-0', 1), ('acid-soluble', 1), ('intestines', 3), ('optimum', 2), ('piecewise', 1), ('9.66', 1), ('three-body', 5), ('dispersion', 8), ('well-separated', 1), ('trimers', 2), ('two-body', 2), ('counterpart', 3), ('grows', 3), ('rises', 2), ('dispersion-dominated', 1), ('na3', 1), ('mg3', 1), ('zn3', 1), ('cd3', 1), ('hg3', 1), ('cu3', 1), ('ag3', 1), ('au3', 1), ('triple-zeta', 1), ('mp3', 2), ('ccsd', 5), ('many-body', 1), ('mbd', 2), ('erratic', 1), ('distances', 3), ('appropriately', 1), ('excitations', 1), ('approximated', 1), ('situation', 3), ('neuromodulator', 1), ('129p2-cbstm1unc/j', 2), ('cystathionine', 1), ('beta-synthase', 1), ('nahs', 8), ('ischemia/reperfusion-induced', 1), ('metabolism-based', 1), ('chronotoxicity', 3), ('brucine', 12), ('strychni', 2), ('npas2-/-', 2), ('cyp3a11-overexpressing', 1), ('zeitgeber', 1), ('zt8', 1), ('zt14', 1), ('zt20', 1), ('fluctuations', 1), ('npas2', 1), ('rhythms', 1), ('gas6/mer', 2), ('crystalline', 3), ('arrest-specific', 1), ('gas6', 6), ('mer', 5), ('gas6-/-', 1), ('mer-/-', 1), ('silica-treated', 1), ('single-stage', 5), ('anammox', 2), ('nitritation', 2), ('snap', 3), ('backpropagation', 3), ('feedforward', 4), ('ann', 3), ('-based-models', 1), ('nh:1', 2), ('box-behnken', 1), ('nh4+', 2), ('tn', 2), ('upflow-sludge-bed', 1), ('usb', 2), ('nitrogen-rich', 1), ('optimizing', 2), ('goodness-of-fit', 1), ('three-layered', 1), ('ann-based-models', 2), ('trained', 1), ('levenberg-marquardt-algorithm', 1), ('computations', 1), ('deviations-', 1), ('+-2.1', 1), ('satisfactory', 2), ('variance-', 1), ('fv', 1), ('agreement-', 1), ('ia', 1), ('0.989-0.997', 1), ('0.003-0.031', 1), ('0.993-0.998', 1), ('affirmed', 1), ('ann-based', 2), ('efficiencies', 2), ('candidatus', 1), ('kuenenia', 1), ('13.11', 1), ('nitrosomonas-', 1), ('6.23', 1), ('proteocatella-', 1), ('3.1', 1), ('partial-nitritation/anammox', 1), ('friedreich', 2), ('fara', 2), ('meeting', 3), ('frataxin', 1), ('imaging-based', 1), ('multisite', 2), ('3-nitrobenzanthrone-derived', 1), ('3-nitrobenzanthrone', 1), ('3-nba', 2), (\"2'-deoxyguanosin-8-yl\", 1), ('-3-aminobenzanthrone', 1), ('dgc8-n-aba', 10), ('bypassed', 1), ('stall', 1), ('polymerases', 2), ('eta', 1), ('hpoleta', 2), ('hpolkappa', 10), ('tls', 3), ('site-specifically', 1), ('kinetically', 2), ('paused', 1), ('bypassing', 1), ('extending', 2), ('dctp', 2), ('116-fold', 1), ('undamaged', 3), ('pausing', 2), ('incorrect', 1), ('datp', 1), ('dgtp', 1), ('786-fold', 1), ('primer-terminal', 1), ('100-1000-fold', 1), ('error-prone', 1), ('swine', 4), ('tetracycline', 3), ('macrolide', 1), ('beta-lactam', 6), ('polypeptides', 1), ('oatps', 4), ('symbol', 1), ('slco/slco', 1), ('sodium-independent', 1), ('antifungals', 1), ('antivirals', 3), ('antihistamines', 1), ('antihypertensives', 1), ('fibrates', 1), ('immunosuppressants', 1), ('transported', 7), ('orthologue', 1), ('oatp1a2', 3), ('soatp1a2', 3), ('phylogenic', 1), ('tetracyclines', 1), ('macrolides', 2), ('doxycycline', 1), ('oxytetracycline', 1), ('chlortetracycline', 1), ('penicillin', 2), ('amoxicillin', 1), ('cefquinome', 1), ('tylosin', 1), ('tilmicosin', 1), ('clarithromycin', 1), ('oatp', 2), ('quick', 2), ('check', 3), ('promyelocytic', 7), ('react', 5), ('~15', 2), ('partake', 1), ('mpo-expressing', 1), ('uv-visible', 1), ('paramagnetic', 1), ('epr', 2), ('2-chloro-5,5-dimethyl-1,3-cyclohexanedione', 1), ('monochloro-dimedone', 1), ('mpo-catalyzed', 2), ('chlorination', 2), ('celltiter-glo', 1), ('gsh/gssg-glo', 1), ('uv-vis', 2), ('di-halogenated', 1), ('glutathionyl', 1), ('disulphide', 1), ('spite', 1), ('investigators', 2), ('wary', 1), ('luteolin', 27), ('5-flurouracil', 1), ('realistic', 3), ('guardian', 1), ('fights', 1), ('battle', 1), ('sec', 8), ('5-fluorouracil', 3), ('5-fu', 16), ('dram', 2), ('cylin', 1), ('hericium', 2), ('novae-zealandiae', 4), ('zealand', 2), ('fungus', 13), ('alkali-soluble', 1), ('du145', 4), ('pc3', 5), ('0.61', 2), ('casp8', 1), ('casp9', 3), ('hinted', 1), ('il24', 1), ('iiib', 3), ('endoleak', 2), ('suture', 2), ('endograft', 2), ('undetected', 2), ('enlarged', 5), ('endoleaks', 2), ('nitinol', 1), ('explanted', 1), ('graft', 6), ('glycoprotein', 8), ('recent-onset', 1), ('ro-dcm', 3), ('endomyocardial', 1), ('emb', 1), ('0.015', 3), ('annular', 2), ('-0.57', 1), ('borderline', 1), ('york', 1), ('synchronous', 2), ('bazex', 3), ('remitting', 2), ('seronegative', 2), ('symmetrical', 4), ('synovitis', 2), ('pitting', 2), ('69-year-old', 1), ('polyarthritis', 1), ('edematous', 1), ('extremities', 1), ('desquamation', 1), ('fingers', 1), ('paraneoplastic', 3), ('rs3pe', 2), ('death-1', 1), ('shrank', 1), ('nephrolithiasis', 10), ('ureteroscopic', 2), ('lithotripsy', 3), ('extracorporeal', 4), ('wave', 2), ('eswl', 1), ('ursl', 6), ('thiobarbituric', 3), ('isoprostane', 1), ('8-isopgf2alpha', 1), ('d-dimer', 5), ('thromboplastin', 1), ('aptt', 1), ('ubiquitin-specific', 1), ('usp9', 3), ('sex-linked', 2), ('y-chromosomal', 1), ('usp9y', 4), ('x-chromosomal', 1), ('usp9x', 5), ('escapes', 1), ('x-inactivation', 1), ('designing', 2), ('knockdowns', 1), ('infer', 2), ('x-', 1), ('y-form', 1), ('details', 4), ('geo', 1), ('gse79376', 1), ('koglsberger', 1), ('al', 14), ('re-use', 1), ('re-analysis', 1), ('brain-related', 1), ('specifications', 1), ('dispositional', 3), ('mindfulness', 5), ('alcohol-dependent', 2), ('momentary', 2), ('ema', 1), ('dutch', 1), ('personal', 4), ('assistant', 1), ('trying', 1), ('came', 4), ('brink', 1), ('attentional', 2), ('mindful', 5), ('maas', 5), ('ratings', 2), ('moderated', 2), ('stress/negative', 2), ('affect/cognitive', 1), ('biases', 2), ('recovering', 7), ('psycinfo', 2), ('apa', 2), ('rights', 3), ('reserved', 3), ('experimentally-induced', 1), ('endocrinological', 1), ('hyperandrogenism', 3), ('adiposity', 10), ('spl', 5), ('mineralocorticoid', 1), ('letrozole-induced', 2), ('letrozole', 2), ('let', 4), ('histomorphological', 1), ('let-induced', 1), ('pilra', 7), ('g78r', 1), ('hsv-1-specific', 4), ('titers', 4), ('mci', 4), ('immunoglobulin-like', 1), ('arginine-to-glycine', 1), ('r78', 4), ('rs1859788', 5), ('herpes', 2), ('simplex', 2), ('hsv-1', 6), ('infects', 1), ('pirla', 1), ('g78', 2), ('humoral', 3), ('ab', 2), ('igg1', 2), ('gg', 4), ('infective', 1), ('2-methyl-5-isopropyl-1,4-benzoquinone', 1), ('786-o', 1), ('786-o-si3', 6), ('transitional', 1), ('bftc-909', 2), ('oct-4', 2), ('ros/superoxide', 1), ('genitourinary', 2), ('artocarmitin', 3), ('toxicants-induced', 1), ('intervene', 2), ('acb', 5), ('aca', 2), ('trans-feruloyl', 1), ('substituent', 2), ('glutamate-cysteine', 4), ('acb-induced', 1), ('phosphatidylinositol-4,5-bisphosphate', 1), ('r-like', 1), ('axitinib', 8), ('n-demethylated', 3), ('uplc-ms/ms', 2), ('misuse', 2), ('considerations', 2), ('rlm', 2), ('hlm', 5), ('ultra-performance', 2), ('chromatography-tandem', 3), ('0-t', 1), ('conspicuous', 1), ('tmax', 1), ('clz/f', 1), ('18.34', 1), ('1.705', 1), ('1.604', 1), ('paid', 1), ('ugt-dependent', 1), ('regioselective', 1), ('ursodeoxycholic', 3), ('obeticholic', 2), ('acyl', 9), ('glucuronides', 2), ('udca', 14), ('bear', 1), ('pharmacopoeia', 1), ('granted', 1), ('approval', 9), ('oca', 8), ('semisynthetic', 1), ('chenodeoxycholic', 1), ('perplexing', 2), ('fates', 3), ('metabolically', 6), ('ugt1a3', 3), ('ugt2b7', 15), ('oatp1b1-', 1), ('1b3-transfected', 1), ('cruciate', 2), ('quadriceps', 10), ('aclr', 3), ('neuro-muscular', 1), ('nmes', 7), ('fes', 8), ('duty', 1), ('on/10', 1), ('pre-aclr', 4), ('stance', 1), ('symmetry', 4), ('weeks/peak', 1), ('inter-limb', 2), ('1-week', 1), ('post-surgery', 3), ('regained', 2), ('225', 1), ('0.605', 1), ('pre-quadriceps', 1), ('0.63', 2), ('post-aclr', 2), ('spatiotemporal', 1), ('isrctn', 1), ('02817399', 1), ('posted', 1), ('colorants', 2), ('sunset', 2), ('mlsd', 1), ('fcf', 1), ('sny', 6), ('multispectral', 2), ('-sny', 1), ('sny-catalase', 2), ('crowding', 3), ('naphthoquinones', 2), ('shikonin', 6), ('naphthazarin', 3), ('scarring', 1), ('intractable', 1), ('paucity', 3), ('scar-in-a-jar', 1), ('colleagues', 1), ('matrix-rich', 1), ('optimised', 3), ('scar-related', 1), ('scar-derived', 1), ('collagen-rich', 1), ('lkb1-ampk-ulk1', 3), ('axis-mediated', 2), ('cbnps', 3), ('pr-cbnps', 4), ('blm', 2), ('9-18', 1), ('blm-induced', 3), ('deteriorative', 1), ('matters', 1), ('applies', 1), ('childhood-onset', 1), ('cos', 2), ('age-', 3), ('sex-matched', 1), ('panss', 1), ('psp', 1), ('impression', 2), ('cgi', 4), ('g1793a', 3), ('c677t', 3), ('a1298c', 3), ('expectations', 2), ('multi-site', 2), ('age-specific', 1), ('antipsychotic-induced', 1), ('ocd', 7), ('obsessive', 1), ('compulsive', 1), ('clozapine-treated', 2), ('clozapine-induced', 1), ('ocd-onset', 1), ('clozapine', 1), ('strict', 1), ('minimise', 1), ('mis-identification', 1), ('obsessive-compulsive', 1), ('inventory-revised', 1), ('oci-r', 1), ('divide', 1), ('231', 1), ('oci', 2), ('checking', 2), ('subscale', 2), ('non-ocd', 1), ('gaf', 1), ('warwick-edinburgh', 1), ('wellbeing', 3), ('socio-demographic', 1), ('rated', 2), ('clinician', 2), ('causality', 3), ('cervix', 1), ('keystone', 1), ('recurring', 1), ('phenanthridinone-derived', 1), ('tbt-treated', 1), ('glucagon', 4), ('beta-cell', 2), ('alpha-cell', 1), ('ug/kg', 2), ('ins2', 1), ('gcg', 1), ('adipogenesis-related', 1), ('insulin/pi3k/akt', 1), ('silverskin', 1), ('husk', 1), ('31-500', 1), ('mug', 9), ('raw2643.7', 1), ('23-57', 1), ('42-60', 1), ('30-39', 1), ('7-13-', 1), ('macrophage-conditioned', 1), ('1.4', 2), ('4-fold', 3), ('8-15-fold', 1), ('44-85', 1), ('browning', 1), ('macrophages-adipocytes', 1), ('inflammation-triggered', 2), ('oleanolic', 2), ('chemosensitizes', 1), ('cp-intoxication', 1), ('activations', 2), ('3b', 1), ('atg', 1), ('coincided', 3), ('chemosensitization', 1), ('kw', 4), ('c20h26o3', 1), ('kw-induced', 2), ('mapk/nrf2/ho-1', 1), ('h2o2-challenged', 1), ('paeonol', 5), ('n=28', 1), ('capsules', 2), ('n=26', 1), ('covariance', 1), ('a1c', 2), ('endochondral', 2), ('dysplasias', 3), ('mis-expression', 1), ('uncharacterized', 1), ('dysplasia-like', 2), ('nabo', 8), ('microct', 1), ('clavicles', 1), ('e14', 2), ('cartilage', 9), ('condensations', 1), ('wider', 2), ('chondrocytes', 6), ('sox9', 10), ('spatially-restricted', 1), ('tibiae', 1), ('exosomal', 11), ('recipients', 6), ('dgf', 12), ('obstacles', 1), ('adequately', 2), ('recipient', 1), ('coexpressed', 1), ('hsa-mir-33a-5p_r-1', 1), ('hsa-mir-98-5p', 1), ('hsa-mir-151a-5p', 2), ('first-week', 1), ('uncover', 6), ('l29', 2), ('immunology', 1), ('virology', 1), ('outline', 2), ('organ-based', 1), ('il-1b', 2), ('629', 1), ('137', 2), ('interferon-stimulated', 1), ('rpl29', 2), ('heparin-binding', 2), ('tlr13', 1), ('23s', 1), ('-stimulated', 2), ('alkyladenine', 2), ('nucleosomes', 1), ('aag', 5), ('excising', 1), ('alkylated', 2), ('purines', 1), ('n6-ethenoadenine', 1), ('epsilona', 5), ('excise', 1), ('nucleosome', 1), ('ncp', 6), ('repeating', 1), ('eukaryotes', 2), ('ncps', 1), ('geometric', 1), ('epsilona-containing', 1), ('monophasic', 1), ('accessibility', 1), ('solution-accessible', 1), ('asymmetric', 2), ('unwrapping', 1), ('nucleosomal', 1), ('overuse', 4), ('delta-9-thc', 6), ('tail-flick', 1), ('catalepsy', 7), ('hypomotility', 2), ('equianalgesic', 1), ('tactile', 2), ('one-hour', 1), ('bright', 1), ('bls', 2), ('re-assessed', 1), ('periorbital', 2), ('hindpaw', 3), ('episodes', 3), ('migraine', 1), ('drug-inducible', 2), ('paraspeckle-forming', 1), ('web-available', 1), ('neuron-specific', 1), ('neat1-based', 1), ('paraspeckles', 2), ('coincreases', 1), ('interference-mediated', 1), ('2-mediated', 3), ('therapeutics.-simchovitz', 1), ('hanan', 1), ('niederhoffer', 1), ('madrer', 1), ('yayon', 1), ('bennett', 1), ('greenberg', 1), ('d.', 5), ('kadener', 1), ('soreq', 1), ('smoking-associated', 1), ('pac', 4), ('beta-adrenergic', 1), ('alpha-7', 1), ('alpha7nachr', 1), ('turns', 1), ('vaping', 1), ('clara', 1), ('pac-cl', 1), ('reducers', 1), ('warming-induced', 1), ('2-ethyl-hexyl', 2), ('gastritis', 1), ('coincidentally', 1), ('esculetin', 1), ('lovo', 11), ('esc', 4), ('esc-treated', 2), ('p27', 1), ('v/propidium', 1), ('outpatients', 1), ('adhere', 2), ('attending', 1), ('clinics', 3), ('sixty-one', 1), ('recalled', 1), ('school', 6), ('2.16', 1), ('4.6', 1), ('trade', 1), ('vocational', 1), ('university-level', 1), ('7-10', 1), ('1-233', 1), ('tocopherol-stripped', 1), ('ddr', 6), ('mre11a', 1), ('rad50', 1), ('msh3', 1), ('msh6', 1), ('xpc', 1), ('dose-specific', 1), ('nrf2-deficient', 3), ('foreskin', 2), ('ihfk', 5), ('nrf2-targeting', 1), ('short-hairpin', 1), ('marliolide', 3), ('ros-generating', 1), ('nrf2-independent', 1), ('ros-sensitive', 2), ('mir-23a/b', 3), ('vhl/hif', 1), ('adipocyte-secreted', 1), ('exosome-mirnas', 1), ('microrna-23a/b', 1), ('mir-23a', 2), ('mir-23b', 1), ('hippel-lindau/hypoxia-inducible', 1), ('bfr-related', 1), ('mir23-a/b', 1), ('peri-implantitis', 3), ('pip', 4), ('crevicular', 2), ('peri-implant', 1), ('picf', 4), ('3-months', 1), ('completers', 2), ('metalloproteinase-8', 1), ('mmp-8', 3), ('mip-1alpha', 2), ('probing', 4), ('depths', 2), ('1.7', 3), ('pg/mul', 1), ('suppuration', 1), ('12.1', 1), ('ng/mul', 1), ('hnf-4alpha', 8), ('rcc', 16), ('unusually', 1), ('factor-4alpha', 1), ('fucoxanthin', 9), ('d3/d4', 2), ('fucosterol', 5), ('lately', 2), ('abeta1-42-induced', 1), ('alghazwi', 1), ('al.', 2), ('aminergic', 2), ('multifactorial', 7), ('hmao', 1), ('g-protein', 3), ('underline', 1), ('197.41', 1), ('2.20', 1), ('211.12', 1), ('1.17', 2), ('hmao-a', 1), ('hmao-b', 1), ('16.87', 1), ('3.41', 1), ('81.87', 1), ('6.11', 1), ('tachykinin', 1), ('nk1', 4), ('h-bond', 1), ('ser196', 2), ('thr115', 1), ('asp115', 1), ('pic', 9), ('hg-induced', 9), ('over-production', 1), ('pic-mediated', 1), ('25.83', 1), ('55.61', 1), ('13.21', 1), ('33.91', 1), ('tadalafil', 8), ('barnes', 2), ('p-nf-kb', 1), ('pka/pkg/creb/bdnf/neun/synaptophysin', 1), ('physical-chemical', 3), ('ruaner', 8), ('pear', 2), ('pyrus', 2), ('ussuriensis', 2), ('freezing-thawing', 4), ('maxim', 1), ('crop', 2), ('postharvest', 2), ('ripening', 2), ('ripen', 1), ('eaten', 1), ('pears', 8), ('quality-related', 1), ('freezer', 1), ('-20', 1), ('thawing', 2), ('yellow-green', 1), ('titratable', 1), ('acidity', 1), ('0-12', 1), ('carotenoid', 2), ('peaking', 1), ('hat', 7), ('solids', 2), ('ssc', 2), ('firmness', 2), ('citric', 3), ('hardness', 1), ('table', 1), ('liensinine', 2), ('beige', 11), ('white-to-beige', 2), ('lie', 7), ('isoquinoline', 3), ('rosi', 4), ('i-v', 1), ('beige-to-white', 1), ('pro-cathepsin', 3), ('pro-ctsb', 2), ('pro-ctsd', 2), ('pro-ctsl', 2), ('hsa_circ_0058124', 9), ('notch3/gatad2a', 2), ('circrnas', 7), ('circrna', 2), ('sponge', 8), ('hsa_circ_0058124/notch3/gatad2a', 2), ('2q35', 1), ('mirna-218-5p', 1), ('numb', 1), ('unveils', 1), ('intervening', 1), ('depot-specific', 2), ('bmps', 1), ('characterise', 1), ('bmp2-smad1/5/8', 4), ('gluteal', 4), ('immortalised', 5), ('secreted/circulating', 1), ('preadipocyte', 2), ('id1', 2), ('pparg2', 2), ('smad1/5/8', 1), ('k02288', 2), ('pro-adipogenic', 1), ('erythroferrone', 1), ('restricting', 3), ('depot', 1), ('waist-hip', 1), ('ratio-increasing', 1), ('model-based', 3), ('replicate', 3), ('usa', 3), ('academies', 2), ('21st', 2), ('century', 1), ('encourages', 1), ('amiodarone', 1), ('0.312-2.5', 1), ('cyclosporine', 3), ('0.25-2', 1), ('0.625-10', 1), ('1-8', 3), ('carbamazepine', 2), ('6.25-50', 1), ('loec', 4), ('log-logistic', 2), ('principled', 1), ('uncertainty', 1), ('box-cox', 2), ('sides', 2), ('deal', 1), ('heteroscedastic', 1), ('non-normal', 1), ('residuals', 1), ('inferential', 1), ('cort', 1), ('nov', 1), ('nedd4-1', 10), ('indolamine', 1), ('cycloheximide', 1), ('dissociate', 2), ('rs19', 1), ('rl23a', 1), ('nucleophosmin', 2), ('s7', 1), ('60s', 1), ('l35', 1), ('ipa', 3), ('otof', 1), ('sf3b2', 1), ('ipo5', 1), ('st13', 1), ('mx1/mx2', 1), ('bde-47/209', 1), ('tbbpa/s', 1), ('tcbpa', 5), ('ectoderm', 3), ('bde-209', 2), ('tbbps', 2), ('development-related', 5), ('zic1', 1), ('zic3', 1), ('hes3', 1), ('igfbp3', 2), ('growth/guidance', 1), ('transmission-related', 1), ('cntn2', 1), ('slit1', 1), ('lrrc4c', 1), ('reln', 2), ('cbln1', 1), ('chrnb4', 1), ('gdf7', 1), ('neurochemical', 4), ('apds', 1), ('non-intoxicating', 1), ('polyinosinic-polycytidilic', 1), ('apd', 1), ('dimorphic', 1), ('rewarded', 1), ('t-maze', 1), ('sociability', 2), ('hpc', 2), ('gamma-aminobutyric', 3), ('converts', 6), ('co-inertia', 2), ('tyrrhenian', 2), ('coasts', 1), ('gc/ms', 1), ('engraulis', 1), ('encrasicolus', 1), ('trachurus', 2), ('gsa', 1), ('exactly', 1), ('campania', 1), ('coast', 2), ('sicily', 1), ('bioindicators', 2), ('dominance', 2), ('fishing', 1), ('bioaccumulate', 1), ('tahs', 1), ('salinity', 1), ('ecologically', 1), ('welfare', 3), ('chemometric', 2), ('ulva', 2), ('lactuca', 2), ('thiacloprid', 8), ('andin', 1), ('ps1', 1), ('ps2', 3), ('ft-ir', 1), ('hepatotoxcity', 1), ('starter', 1), ('arbor', 3), ('acres', 2), ('one-day-old', 1), ('saline-perfusion', 1), ('ns', 2), ('adfi', 1), ('adg', 1), ('fcr', 1), ('scd', 4), ('elovl6', 2), ('mttp', 1), ('tgfbeta2', 2), ('vulvovaginal', 1), ('candidiasis', 1), ('azoles', 1), ('0.017-0.184', 1), ('mic', 6), ('0.042-0.082', 1), ('0.041-1.2', 1), ('progestagens', 1), ('lyase', 2), ('bell-shaped', 1), ('cyp17a1-lyase', 1), ('114-209', 1), ('cyfluthrin', 13), ('ic30', 1), ('4.81', 1), ('19.39', 1), ('3.44', 1), ('mel', 5), ('sylibin', 2), ('cyfluthrin-induced', 2), ('proinflammation', 1), ('casp-3', 3), ('bnip3', 4), ('apaf1', 2), ('nfkappab1', 2), ('cybb', 2), ('duox1', 2), ('duox2', 1), ('cyfluthrin-upregulated', 1), ('o-glcnacase', 2), ('pc12', 5), ('oga', 5), ('multi-levels', 1), ('intend', 2), ('resultant', 4), ('electrochemical', 5), ('tetrabromo', 2), ('o-glcnacylation', 2), ('hnscs', 1), ('oga/bisphenol', 1), ('hydrophobicity-dominated', 1), ('isoniazide-induced', 1), ('sirt1/erk', 2), ('que', 8), ('inh-induced', 3), ('aminotransferase/aspartate', 1), ('ondansetron', 6), ('diclofenac-induced', 2), ('hyperemia', 2), ('ondansetron-diclofenac', 1), ('syzygium', 2), ('cymosum', 3), ('carbofuran-induced', 2), ('scl', 5), ('benzoic', 1), ('cf-exposed', 1), ('cf-intoxication', 1), ('genus', 5), ('e-cigarette', 15), ('liquids', 7), ('purported', 1), ('rigorously', 2), ('warm', 1), ('tail-withdrawal', 1), ('anti-nociceptive', 3), ('concentration-related', 1), ('dose-related', 2), ('anti-nociception', 1), ('vapor-inhalation', 1), ('hormone-induced', 1), ('resveratrol-induced', 8), ('l-thyroxine', 1), ('death-ligand', 2), ('-beta1', 2), ('s31-201', 3), ('t4-induced', 1), ('t4-activated', 1), ('sequentially', 2), ('reestablish', 1), ('cox-2/p53-dependent', 1), ('bacteria-stimulated', 1), ('sgp', 1), ('oxidase-1', 1), ('8-isoprostane', 1), ('8-isop', 4), ('0-10,000', 1), ('/ml', 1), ('heat-killed', 1), ('sgp130', 3), ('bioactivity', 3), ('1000-10,000', 1), ('bacteria-treated', 1), ('low-level', 2), ('mrc', 2), ('uncouples', 1), ('mitochondrial-derived', 1), ('glia', 5), ('segments', 8), ('t8', 2), ('t11', 2), ('limbs', 1), ('excitable', 1), ('dissections', 1), ('t9', 1), ('intersection', 2), ('t9/t10', 2), ('t10', 1), ('cadavers', 1), ('immunostained', 1), ('microphotographed', 1), ('counted', 1), ('t8-t11', 2), ('vertebral', 2), ('propionic', 13), ('social-communication', 1), ('ppa', 10), ('23rd', 1), ('hyperlocomotion', 1), ('acid-treated', 1), ('brainstem', 4), ('24th', 1), ('zeb2', 9), ('victims', 1), ('fibrogenic', 2), ('phmg-p-treated', 1), ('akt/notch', 1), ('jeopardizing', 1), ('utmost', 1), ('pgcs', 10), ('gametogenesis', 1), ('eventual', 2), ('testicle', 1), ('vasa', 1), ('genital', 3), ('cxcr4b', 1), ('sdf1a', 1), ('colonized', 1), ('ridges', 1), ('testicles', 1), ('progeny', 2), ('ifn-gamma-producing', 2), ('th17/th1', 11), ('th17', 7), ('secret', 1), ('never-smokers', 3), ('proportions', 5), ('cd4', 1), ('expiratory', 1), ('fev1', 1), ('0.244', 1), ('ex-smoker', 1), ('0.352', 1), ('hemangioma-derived', 4), ('hemecs', 8), ('dephosphorylation', 5), ('pdgf-bb-induced', 4), ('cvd', 10), ('tripartite', 2), ('motif-containing', 1), ('trim', 3), ('hasmcs', 6), ('homodimer', 1), ('pdgf-bb', 1), ('si-trim28', 1), ('calponin', 1), ('sm22alpha', 1), ('kcz', 6), ('adrenocarcinoma', 1), ('transcriptions', 2), ('vitellogenesis', 1), ('cyp3a65', 4), ('ube2t', 8), ('radiosensitivity', 2), ('clonal', 2), ('beta-glucosidases', 2), ('organics', 1), ('bgls', 14), ('unceasingly', 1), ('bioethanol', 1), ('engineer', 1), ('intermolecular', 2), ('glycosyl', 1), ('gh1', 4), ('diverged', 1), ('gh3', 5), ('wherein', 1), ('buried', 2), ('thermostability', 1), ('thermodynamics', 2), ('polar', 2), ('laminaribose', 1), ('gentibiose', 1), ('aryl-', 1), ('cello-substrates', 1), ('noticeably', 5), ('glucono-delta-lactone', 1), ('methanetriamine', 1), ('explicit', 1), ('cela2a', 5), ('whole-exome', 2), ('kindreds', 1), ('elastase', 3), ('chymotrypsin-like', 1), ('postprandially', 1), ('bioconjugation', 2), ('phenthoate', 2), ('existed', 1), ('story', 1), ('conjugations', 1), ('bioconjugate', 1), ('hsa-phenthoate', 2), ('autoregulation', 1), ('biosystems', 2), ('proteins-phenthoate', 1), ('distinctions', 1), ('biomolecular', 1), ('toxicokinetics', 3), ('pcreb/nrf-2', 1), ('re-positioning', 1), ('mili', 1), ('peptide-1', 3), ('advantageous', 2), ('pcreb', 2), ('neonicotinoid', 10), ('clothianidin', 3), ('nitenpyram', 1), ('oat4', 1), ('mate1', 2), ('oatp2b1', 1), ('oat1', 4), ('mate2-k', 1), ('neonicotinoids', 8), ('oct1', 3), ('oat3', 6), ('notification', 6), ('q-fever', 4), ('reassessed', 2), ('4026', 1), ('notified', 1), ('laboratory-confirmed', 1), ('health-seeking', 1), ('workflows', 1), ('instigated', 1), ('adjustments', 4), ('description', 1), ('notifications', 2), ('igg/igm', 1), ('seroprevalence', 6), ('seroconversion', 1), ('sero-epidemiology', 1), ('harmonisation', 1), ('mrna-sequencing', 2), ('305', 3), ('cardiotoxicity-', 2), ('nephrotoxicity-related', 1), ('30-', 1), ('48-hpf', 1), ('hepatotoxicity-related', 2), ('fenretinide', 2), ('tphp-induced', 3), ('128', 2), ('nephrotoxicity-', 1), ('trunk', 2), ('betaine', 14), ('osmoprotectant', 1), ('osmoregulation', 1), ('cannabichromene', 2), ('cbc', 9), ('phytocannabinoids', 6), ('spp', 5), ('delta9', 9), ('att20', 3), ('ha-tagged', 1), ('hyperpolarization', 2), ('pertussis', 2), ('co-application', 3), ('cp55,940', 3), ('desensitisation', 1), ('cb2-induced', 1), ('displaying', 1), ('hyperpolarising', 1), ('cb2-mediated', 3), ('clathrin-mediated', 3), ('endocytosis', 8), ('caenohabditis', 2), ('scattering', 2), ('endocytic', 2), ('methyl-beta-cyclodextrin', 1), ('caveolin-', 1), ('clathrin-', 1), ('pinocytosis-mediated', 1), ('cav-1', 1), ('cup-2', 1), ('chc-1', 1), ('rankl-induced', 1), ('bergenia', 1), ('mg-inhibited', 1), ('trap', 4), ('nephrosis', 3), ('grp75', 6), ('lon', 2), ('lonp1', 2), ('kim1', 1), ('acceleration', 1), ('otalgia', 7), ('innervations', 1), ('ent', 1), ('hayatabad', 1), ('peshawar', 1), ('non', 1), ('convenience', 2), (\"'otogenic\", 1), (\"'referred\", 1), ('29.15', 1), ('commonest', 2), ('21-35', 1), ('36-55', 1), ('tonsillar', 1), ('31.3', 1), ('23.3', 1), ('pharyngitis', 1), ('rhinosinusitis', 3), ('temporomandibular', 1), ('3.33', 2), ('earache', 2), ('indigenous', 1), (\"'normal\", 1), ('tonsils', 1), ('pharynx', 1), ('college', 2), ('pathologists/american', 2), ('preanalytic', 1), ('author', 2), ('specimen', 1), ('g/100', 1), ('-glyphosate', 1), ('gd19', 1), ('pnd7', 1), ('pnd21', 2), ('tgs', 1), ('t-cho', 1), ('cholesterols', 1), ('srebp2', 1), ('hmgcs', 1), ('catabolism', 2), ('nicorandil', 8), ('combats', 1), ('amendment', 2), ('tlr4/p38', 1), ('mapk/nfkappa-b', 1), ('tlr4/mapk', 2), ('p38/nfkappa-b', 2), ('stephanthraniline', 2), ('akt/p38', 1), ('sta', 7), ('c21', 2), ('aglycone', 2), ('stephanotis', 1), ('mucronata', 1), ('blanco', 1), ('merr', 1), ('whereby', 2), ('bcl-2/bcl-x', 1), ('disulfiram', 12), ('ataxin-3', 9), ('sca3', 7), ('spinocerebellar', 1), ('glutamine-encoding', 1), ('cag', 1), ('atxn3', 1), ('polyglutamine-expanded', 3), ('alcoholism', 1), ('garnered', 1), ('mind', 2), ('repurpose', 1), ('sca3-causing', 1), ('economics', 2), ('coping-related', 4), ('motives', 6), ('self-medication', 1), ('choices', 4), ('trauma-exposed', 3), ('variance', 4), ('91', 2), ('26.53', 1), ('36.26', 1), ('non-white', 1), ('41.75', 1), ('amazon', 1), ('turk', 1), ('discounting', 2), ('orientation', 4), ('deltar2', 2), ('deltar2s', 1), ('.04-.10', 1), ('.00-.05', 1), ('alcohol-related', 2), ('contrastive', 2), ('hebbian', 5), ('addresses', 2), ('plausibility', 1), ('chl', 3), ('boltzmann', 3), ('machines', 3), ('claim', 1), ('steer', 2), ('symmetric', 1), ('connections', 3), ('anti-hebbian', 2), ('excels', 1), ('stochastic', 2), ('outputs', 1), ('lies', 1), ('rule', 2), ('fundamentally', 1), ('hebbian/anti-hebbian', 1), ('correct/incorrect', 1), ('separates', 1), ('brain-gut', 1), ('preincubated', 1), ('pq-caused', 2), ('luteolin-7-o-glucoside', 2), ('estrogen-receptor-mediated', 1), ('lut-7g', 8), ('1-methyl-4-phenyl-1', 2), ('6-tetrahydropyridine', 2), ('bcl-2/bax', 1), ('erk1/2/stat3/c-fos', 1), ('bradykinesia', 1), ('balancing', 3), ('er-mediated', 1), ('diacetyl', 10), ('flavouring', 1), ('diacetyl-induced', 1), ('pbec', 1), ('pbec-ali', 2), ('vapour', 3), ('sampled', 2), ('injury/repair', 2), ('anti-protease', 3), ('beta-defensin', 1), ('amphiregulin', 2), ('slpi', 2), ('vv-sod2-like', 1), ('aa-sod2-like', 1), ('lipoperoxidation', 2), ('osseointegrated', 5), ('transfemoral', 3), ('amputees', 1), ('30-month', 2), ('amputation', 1), ('uncommon', 1), ('amputations', 1), ('nineteen', 1), ('25-hydroxyvitamin', 1), ('d2', 1), ('parathyroid', 1), ('propeptide', 1), ('c-telopeptide', 4), ('bone-specific', 1), ('fixtures', 1), ('abutments', 1), ('non-removed', 1), ('18-', 1), ('24-month', 1), ('0.07', 2), ('aseptic', 1), ('dual-energy', 3), ('absorptiometry', 1), ('androgenic', 2), ('a-like', 1), ('bpa-like', 1), ('twenty-two', 1), ('tmbpa', 1), ('4,4-bisphenol', 1), ('4,4-bpf', 1), ('tetrachlorobisphenol', 1), ('benzylparaben', 1), ('phbb', 2), ('erbeta-mediated', 2), ('4-phenylmethoxyphenyl', 1), ('sulfonylphenol', 1), ('bps-mpe', 1), ('2,4-bisphenol', 1), ('2,4-bps', 1), ('cr-dna', 2), ('chromate-treated', 1), ('damage-sensitive', 1), ('reducer', 1), ('ascorbate-restored', 2), ('ser15', 1), ('diffusible', 1), ('chromatin-bound', 1), ('radiomimetic', 1), ('-stabilized', 1), ('-upregulated', 1), ('ascorbate-metabolized', 1), ('genome-protective', 1), ('drug-processing', 2), ('pcn-activated', 1), ('dpgs', 5), ('16alpha-carbonitrile', 1), ('pcn', 6), ('5-8', 1), ('ugta1a1', 1), ('2b10', 2), ('abcc4', 1), ('papss2', 2), ('pcn-treated', 1), ('25-28.', 1), ('pcn-pretreated', 1), ('pxres', 1), ('influenza', 7), ('pneumocytes', 3), ('hemagglutinin', 2), ('proteases', 6), ('infectivity', 2), ('iav/ibv', 2), ('monobasic', 2), ('h1n1pdm', 2), ('h7n9', 3), ('iav', 8), ('h3n2', 2), ('ibv', 6), ('as-yet', 1), ('.here', 1), ('hbec', 4), ('aecii', 3), ('phosphorodiamidate', 1), ('oligomer', 1), ('t-ex5', 3), ('multiplication', 1), ('cells.this', 1), ('ha-activating', 2), ('infections.importanceinfluenza', 1), ('seasonal', 1), ('cleave', 1), ('ha-cleaving', 1), ('marrow-specific', 1), ('clofazimine', 2), ('extra-skeletal', 2), ('mycobacterium', 3), ('leprae', 1), ('anti-leprosy', 2), ('cfz', 8), ('~1mum', 1), ('osteotomy', 2), ('1/3rd', 1), ('callus', 1), ('bm-mscs', 1), ('homing', 1), ('hematologic', 4), ('unsaturated', 4), ('diphenylether', 1), ('de-71', 5), ('skews', 1), ('silurana', 2), ('tropicalis', 8), ('flame-retardant', 4), ('lifecycle', 2), ('nominal', 1), ('gastrula-stage', 1), ('post-metamorphosis', 1), ('dpm', 2), ('previtellogenic', 1), ('vitellogenic', 1), ('dht', 5), ('de-71-treated', 1), ('appreciably', 2), ('5alpha-reductase', 1), ('frogs', 1), ('skew', 1), ('argan', 9), ('expensive', 1), ('tree', 4), ('geographical', 1), ('morocco', 1), ('algeria', 1), ('healthful', 1), ('unsaponifiable', 2), ('carrageenan-induced', 1), ('lessen', 2), ('blunts', 2), ('townes', 2), ('sickle', 4), ('age/rage', 1), ('scd-related', 1), ('8-week-old', 1), ('ss', 3), ('rap', 2), ('rap-treated', 3), ('reticulocyte', 1), ('rap-ss', 1), ('nacl-treated', 2), ('deposits', 2), ('hypothalamic-pituitary-testicular', 1), ('coexistence', 2), ('polluted', 1), ('waters', 1), ('geogenic', 1), ('singly', 1), ('nicl2', 1), ('zncl2', 1), ('successive', 3), ('epididymis', 3), ('nickel-mediated', 3), ('diminutions', 1), ('intra-testicular', 1), ('nicked-induced', 1), ('nickel-induced', 1), ('spermato-protective', 1), ('tris', 6), ('1,3-dichloro-2-propyl', 5), ('tdcipp', 12), ('opfrs', 4), ('bent', 1), ('insulin-growth', 1), ('igf', 1), ('igfbp-1a', 1), ('igfbp1b', 1), ('cdx4', 1), ('igf1a', 1), ('ifg1b', 1), ('igf2b', 1), ('vegaa', 1), ('disorganized', 1), ('fli-gfp', 1), ('igfbp-1', 1), ('lactases', 3), ('digestibility', 2), ('beta-casein', 2), ('lactose-hydrolyzed', 1), ('heat-treated', 1), ('hydrolyzed', 1), ('post-hydrolysis', 1), ('proteolysis', 7), ('impurities', 1), ('lactase', 4), ('beta-cn', 6), ('peptidomic', 1), ('side-activities', 1), ('pro', 2), ('ile', 1), ('phe', 1), ('lys', 1), ('gln', 1), ('bitter', 1), ('pre-digestion', 1), ('digests', 1), ('inf-gamma', 4), ('anti-hyperalgesic', 3), ('3-amino-2-pyridine', 2), ('diselenide', 4), ('neurobiology', 2), ('bapd', 13), ('prototype', 2), ('immunologic', 2), ('0.1-50', 1), ('hot-plate', 1), (\"2,2'-azino-bis-3-ethylbenzothiazoline\", 2), ('6-sulfonic', 2), ('2,2-diphe-', 2), ('nyl-1-picrylhydrazyl', 2), ('licking', 2), ('propolis', 6), ('diabetic-induced', 1), ('gauged', 1), ('fifty-six', 2), ('saved', 2), ('diabetes/chlorpyrifos', 1), ('6th', 3), ('7th', 1), ('hypoinsulinemia', 1), ('pointers', 1), ('defender', 1), ('diet-specific', 1), ('enteroendocrine', 1), ('normal-', 1), ('high-', 2), ('chlorpyrifos/kg', 1), ('bodyweight/day', 1), ('follicule', 1), ('normal-fat', 1), ('pyy', 2), ('poly-peptide', 1), ('epinephrine', 1), ('chlorpyrifos-induced', 2), ('acid-producing', 2), ('romboutsia', 1), ('clostridium', 3), ('sensu', 1), ('stricto', 1), ('norank_f_coriobacteriaceae', 1), ('faecalibaculum', 1), ('norank_f__erysipelotrichaceae', 1), ('testosterone-related', 1), ('brevibacterium', 1), ('unclassified_f__ruminococcaceae', 1), ('ruminococcaceae_ucg-009', 1), ('hypothalamic-pituitary-adrenal', 1), ('endocrine-disturbing', 1), ('eased', 2), ('dysbiosis', 10), ('sensibility', 1), ('tributyltin-induced', 1), ('dff40', 13), ('endonuclease', 1), ('conducting', 3), ('oligonucleosomal', 1), ('nuclease', 1), ('tbt-induced', 1), ('v/pi', 1), ('caspase-6', 1), ('re-expression', 2), ('endotypes', 1), ('balls', 4), ('colonization', 2), ('crs', 4), ('ball', 15), ('sinonasal', 3), ('microorganic', 3), ('dacryocystorhinostomy', 1), ('gomori-methenamine-silver', 1), ('stain', 2), ('gram-positive/negative', 1), ('s100a7', 2), ('s100a8/a9', 2), ('palate', 2), ('splunc1', 2), ('discharge', 6), ('six-month', 5), ('22-month', 1), ('ahb', 4), ('dhb', 3), ('hb', 2), ('=10', 3), ('=9', 1), ('=8', 2), ('84/831', 1), ('9/67', 1), ('7/32', 1), ('5/19', 1), ('65/613', 1), ('21/183', 1), ('12/116', 1), ('7/39', 1), ('discharging', 1), ('rabl3', 7), ('prenylation', 3), ('options1', 1), ('families2', 1), ('truncating', 2), ('family-like', 1), ('rap1gds1', 1), ('smggds', 1), ('gtpases3', 1), ('rasopathy', 1), ('monocarbonyl', 2), ('b2brbc', 4), ('c66', 3), ('monocrotaline-induced', 7), ('monocrotaline', 11), ('2e,6e', 2), ('-2,6-bis', 2), ('2-bromobenzylidene', 1), ('cycloxehanone', 1), ('2-trifluoromethyl', 1), ('benzylidene', 1), ('cyclohexanone', 1), ('thiol-based', 1), ('nonenzymatic', 4), ('monocrotaline-associated', 1), ('optimally', 1), ('barium', 3), ('incite', 1), ('bacl2', 6), ('ba-treated', 1), ('tetramethylenedisulfotetramine', 3), ('gabaa', 2), ('tets', 10), ('arrhythmias', 5), ('promptly', 1), ('lorazepam', 2), ('pentobarbital', 1), ('allopregnanolone', 2), ('morsel', 1), ('1.56-25', 1), ('80-100', 1), ('non-benzodiazepine', 1), ('tets-induced', 1), ('5-20', 2), ('61.7', 1), ('70.3', 1), ('96.7', 1), ('29.7', 3), ('46.4', 1), ('79.5', 1), ('125.2', 1), ('hsp70s', 1), ('cytoskeleton-anchored', 1), ('kelch-like', 3), ('ech-associated', 3), ('antioxidantive', 1), ('3d-qsar', 1), ('178', 3), ('oxidative-injured', 1), ('medium-', 2), ('low-total-score', 1), ('high-total-score', 2), ('tft', 6), ('nadph-dependent', 2), ('irreversibility', 1), ('kinact', 2), ('93.2', 1), ('dismutase/catalase', 1), ('tft-mediated', 1), ('alpha-keto-aldehyde', 1), ('trapped', 3), ('incubations', 2), ('cyps2c19', 1), ('2d6', 3), ('zebrafish-based', 2), ('cyp19a1b-gfp', 1), ('zferalpha-mediated', 1), ('zferalpha-dependent', 1), ('zferbeta-dependent', 1), ('zferbeta-mediated', 1), ('zferbeta', 1), ('zferalpha', 1), ('prioritization', 1), ('vertebrates', 4), ('5alpha-dihydrotestosterone', 2), ('m-10-5', 1), ('dht-dependent', 1), ('co-chaperone', 1), ('90-kda', 1), ('dht-induced', 3), ('ar-hsp90', 1), ('citreoviridin', 2), ('ppar-gamma-mtorc2-mediated', 1), ('thiamine', 2), ('cit', 9), ('beriberi', 1), ('vb1', 5), ('mtorc2', 1), ('lysosomal-mitochondrial', 1), ('cit-induced', 1), ('ppar-gamma-mtorc2-autophagy', 1), ('no-observed', 1), ('noel', 1), ('upsetting', 1), ('spermatozoa', 2), ('5mc', 1), ('5hmc', 1), ('h3k27', 2), ('pay', 1), ('clonality', 9), ('plasmacytoma', 4), ('igh', 4), ('dlbcl', 2), ('hypermutation', 1), ('igk', 3), ('plasmacytomas', 2), ('dlbcls', 1), ('igkv', 6), ('igkj', 4), ('deleting', 2), ('kde', 3), ('82.8', 1), ('55.2', 2), ('primer', 6), ('78.3', 1), ('39.1', 1), ('adjunct', 2), ('polyphyllin', 2), ('paris', 2), ('polyphylla', 1), ('nb4', 1), ('cleaved-caspase-3', 2), ('phosphorylated-jnk', 1), ('mdc', 1), ('akt-mtor', 1), ('ppi-induced', 2), ('endow', 1), ('meh', 11), ('ma-induced', 4), ('unenhanced', 4), ('multiphase', 2), ('exams', 3), ('tue', 9), ('postcontrast', 2), ('criterion', 6), ('vue', 8), ('eliminating', 1), ('kvp-switching', 1), ('phantoms', 1), ('simulate', 2), ('nonenhancing', 3), ('10-20', 1), ('hounsfield', 1), ('=20', 2), ('inserts', 2), ('iodinated', 1), ('probabilities', 3), ('ground', 4), ('truth', 1), ('0.23-0.56', 1), ('91.2', 1), ('vue-based', 1), ('43.2', 1), ('classifying', 1), ('intermediately', 1), ('advisable', 1), ('special', 4), ('sirt2', 1), ('sirt5', 1), ('sirtuins', 3), ('aspp', 4), ('apoptosis-stimulating', 3), ('adenovirus-p53', 1), ('rad-p53', 13), ('ib2-iia2', 1), ('operative', 2), ('hysterectomy', 1), ('n=30', 2), ('cisplatin+paclitaxel', 1), ('n=20', 1), ('operated', 1), ('courses', 3), ('1x1012', 1), ('aspp2', 10), ('iaspp', 2), ('10.90+-2.62', 1), ('cm2', 2), ('15.25+-4.01', 1), ('76.7', 1), ('intratumor', 1), ('feto-placental', 2), ('basil', 5), ('fennel', 5), ('pepper', 2), ('sage', 1), ('fetal-like', 1), ('trophoblast-like', 1), ('estrone', 1), ('dehydroepiandrosterone', 1), ('dhea', 1), ('estriol', 1), ('3beta-hsd1/2', 1), ('hsd17beta1', 1), ('-5.', 1), ('placental-specific', 1), ('i.1', 1), ('pii-derived', 1), ('cyp19', 3), ('103078', 2), ('sep', 1), ('language', 4), (':0.30-0.53', 1), ('.00001', 2), ('0.26-0.53', 1), ('4.62', 1), ('2.90-7.34', 1), ('0.69', 4), ('0.47-1.03', 1), ('.07', 1), ('dapsone', 8), ('hydroxylamine', 3), ('procoagulant', 4), ('dds-nhoh', 7), ('n-hydroxylated', 1), ('sulfonamide', 1), ('methemoglobinemia', 1), ('dds-nhoh-induced', 1), ('prothrombotic', 2), ('sub-hemolytic', 1), ('ps-bearing', 1), ('microvesicles', 1), ('mv', 2), ('self-aggregation', 1), ('2,4,6-trinitrobenzene', 1), ('sulfonic', 3), ('anticolitis', 1), ('colosalazine', 2), ('interleukin-17', 1), ('chloride-induced', 6), ('gaad', 4), ('153', 5), ('1/ampk/akt', 1), ('/ampk/akt', 1), ('24/group', 1), ('memories', 1), ('ampk/akt', 1), ('hippocamapi', 1), ('enahnced', 1), ('caspase-12', 1), ('coadminsitration', 1), ('completley', 1), ('interstingly', 1), ('enhenced', 1), ('dwonregulated', 1), ('inhibtion', 1), ('compleltely', 1), ('apopotis', 1), ('sirt1/ampk/akt', 2), ('metals-induced', 1), ('genetic-based', 1), ('impose', 1), ('inosine', 2), ('adar1', 1), ('a-to-i', 1), ('maintains', 2), ('hyperglycaemia', 4), ('asl', 4), ('~0.4mm', 1), ('blood/interstitium', 1), ('5-6mm', 1), ('moves', 1), ('paracellular', 3), ('move', 1), ('transcellularly', 1), ('forster', 1), ('fret', 1), ('hexokinases', 2), ('normo-', 1), ('hyperglycaemic', 2), ('h441', 1), ('5mm', 1), ('normoglycaemia', 1), ('glut', 3), ('cytochalasin', 1), ('15mm', 1), ('3-bromopyruvate', 3), ('sorbitol', 1), ('enters', 2), ('hexokinase-dependent', 1), ('hexokinase-independent', 1), ('transcellular', 1), ('epidermoid', 1), ('a431', 10), (\"2',7'-dichlorofluorescein\", 2), ('tq-induced', 2), ('nod', 1), ('scid', 1), ('nsg', 1), ('demonstration', 2), ('xanthoquinodin', 9), ('jbir-99', 2), ('parengyodontium', 2), ('album', 2), ('mexu', 2), ('30054', 1), ('30,054', 1), ('ccd-112-con', 2), ('mtp', 3), ('apoptosis-pathway-related', 1), ('adp', 2), ('inertial', 6), ('cavitation', 6), ('lyophilized', 1), ('rehydrated', 1), ('l-lactic', 1), ('835', 4), ('1.8', 6), ('poly-l-lactic', 1), ('dispersed', 1), ('nanoprecipitation', 1), ('lyophilization', 2), ('trehalose', 1), ('rehydration', 3), ('nanodispersion', 2), ('broadband', 3), ('occurance', 1), ('bubbles', 1), ('encompasses', 1), ('cavities', 1), ('collapse', 2), ('compression', 2), ('inwardly-acting', 1), ('inertia', 1), ('contracting', 1), ('gas-liquid', 1), ('optison', 1), ('non-lyophilized', 1), ('nanodispersions', 1), ('aggregated', 1), ('micrographs', 1), ('non-spherical', 1), ('non-smooth', 1), ('inter-particulate', 1), ('ruled', 1), ('wetting', 1), ('lyophilizate', 1), ('nano-scale', 2), ('roughness', 1), ('coalesce', 1), ('nucleate', 1), ('insonation', 1), ('khz/1.8', 1), ('thr', 8), ('432', 1), ('1-day-old', 1), ('acre', 1), ('nrc', 2), ('9th', 2), ('edn', 1), ('washington', 1), ('press', 1), ('1994', 2), ('jejunal', 2), ('ileal', 4), ('siga', 5), ('quadratically', 7), ('instance', 4), ('ileum', 11), ('occludens-2', 1), ('zo-2', 1), ('occludens-1', 2), ('immunomodulator', 1), ('rhein', 11), ('4,5-dihydroxyanthraquinone-2-carboxylic', 1), ('rheum', 1), ('palmatum', 1), ('rhein-containing', 1), ('v-fluoresceine', 1), ('33258', 1), ('rhein-induced', 3), ('tnfr1', 1), ('tradd', 1), ('procaspase-8', 1), ('procaspase-9', 1), ('want', 2), ('weaken', 1), ('ouabain', 9), ('du', 6), ('cardiotonic', 1), ('-atpase', 2), ('-9.', 1), ('apoptosis-associated', 4), ('patmser1981', 1), ('p-h2a.xser139', 1), ('p-p53ser15', 1), ('er-stress-associated', 1), ('atf6beta', 1), ('p-perkthr981', 1), ('eif2a', 1), ('gadd153', 2), ('camkiibeta', 1), ('caspase-4', 1), ('time-dependently', 1), ('dr4', 1), ('apoptotic-associated', 1), ('bcl-x', 1), ('assisted', 2), ('ivm', 5), ('entail', 1), ('consists', 2), ('exogenously', 1), ('resumption', 1), ('advancing', 2), ('deepen', 2), ('phytocannabinoid', 6), ('genetic/', 1), ('observing', 2), ('gamma-tocopherol', 10), ('aging-related', 2), ('vitamins', 2), ('oxide-mediated', 1), ('justification', 1), ('lxr', 6), ('regulations', 2), ('interconnectedness', 1), ('gw3965', 1), ('gw7647', 1), ('gw4064', 1), ('cdca', 2), ('pro-proliferative', 1), ('tetraploid', 1), ('binucleated', 2), ('tetraploidism', 1), ('confrontation', 1), ('rhythm', 4), ('hypothalamic-pituitary-gonadal-liver', 1), ('hpgl', 3), ('8:00', 5), ('7:00', 5), ('gnrhr', 3), ('fsh', 3), ('vitellogenin1', 1), ('inhibition/down-regulation', 1), ('octn2', 3), ('olanzapine-induced', 7), ('fatp2', 1), ('beta-hydroxybutyrate', 1), ('l-carnitine', 2), ('l-car', 4), ('carnitine/organic', 1), ('mdck-hoctn2', 1), ('fatp2/fabp1', 1), ('down-regulation/inhibition', 1), ('tg-interacting', 2), ('exposure-promoted', 2), ('documents', 2), ('cd-promoted', 1), ('tgif', 5), ('cd-exposed', 4), ('exposure-accelerated', 1), ('linn', 3), ('pseudintermedius', 5), ('pyoderma', 4), ('meticillin-susceptible', 1), ('mssp', 6), ('meticillin-resistant', 1), ('mrsp', 8), ('multidrug-resistance', 1), ('superficial', 3), ('hypothesis/objectives', 1), ('alpha-mangostin', 8), ('twenty-three', 1), ('minimum', 10), ('broth', 1), ('microdilution', 1), ('time-kill', 1), ('100x', 2), ('17.72', 1), ('w/w', 2), ('0.47', 1), ('colitis2', 1), ('disease3', 1), ('digestive', 4), ('wild-type4', 1), ('tlr4-knockout', 1), ('mice5', 1), ('tlr4-/-', 1), ('commensal-depleted', 2), ('sodium6', 1), ('lipopolysaccharide7', 1), ('commensal', 1), ('guts', 2), ('tlr4-ko', 1), ('gm-csf', 3), ('underscore', 1), ('epigenetic-related', 2), ('zf-l', 1), ('epigenetics', 4), ('sciences', 2), ('zfl', 3), ('luma', 1), ('epigenome', 3), ('kdm5ba', 3), ('deaf', 1), ('cans', 2), ('toddlers', 1), ('unilateral', 3), ('polish', 1), ('caep', 2), ('subscales', 1), ('age-appropriate', 1), ('achieving', 4), ('holistically', 1), ('mpges-2', 10), ('apap-cysteine', 1), ('apap-cys', 2), ('aav', 2), ('voltammetric', 1), ('glassy', 2), ('nanocomposite', 2), ('ferrite', 2), ('pulse', 2), ('voltammetry', 1), ('dpv', 1), ('mno2', 1), ('mnfe2o4', 1), ('one-step', 1), ('gce', 2), ('thermogravimetric', 1), ('photoelectron', 1), ('ag/agcl', 1), ('6.0.', 1), ('1-400', 1), ('0.64', 2), ('0.48', 2), ('repeatable', 1), ('deviations', 4), ('population-level', 2), ('testers', 1), ('bc-htc', 1), ('hospitalizations', 2), ('virologic', 1), ('svr', 2), ('undiagnosed', 1), ('7686', 1), ('507', 1), ('716', 1), ('672', 1), ('inject', 1), ('eligibility', 2), ('restrictions', 1), ('equitably', 1), ('accessible', 1), ('sunitinib', 13), ('title', 2), ('enlarge', 1), ('permeabilized', 1), ('mito-tempo', 1), ('mitochondrial-specific', 1), ('etcwas', 1), ('vc', 10), ('angiosarcoma', 1), ('57.3', 1), ('286.7', 1), ('1433.6', 1), ('sealed', 1), ('plexiglass', 1), ('2e1', 3), ('glycoregulatory', 1), ('protein-78', 2), ('grp-78', 2), ('srebp-1', 2), ('co-activations', 1), ('iga', 1), ('sis3', 1), ('nrk52e', 1), ('nrk49f', 1), ('cooperate', 1), ('cooperatively', 2), ('tempo-spatial', 1), ('operates', 1), ('metsyn', 3), ('risen', 2), ('two-thirds', 2), ('americans', 3), ('omc', 9), ('hfd-treated', 1), ('epididymal', 5), ('pad', 1), ('0.010', 1), ('endotoxins', 1), ('0.032', 1), ('demonstrable', 1), ('vasodilation', 1), ('non-antioxidant-dependent', 1), ('harris-benedict', 2), ('enteral', 1), ('en', 3), ('cholecystectomy', 1), ('mhbe', 4), ('undertook', 1), ('france', 1), ('alcoholic-related', 1), ('overestimated', 2), ('sitagliptin', 4), ('dlm', 5), ('acaricide', 1), ('bug', 1), ('spray', 3), ('farming', 1), ('defensive', 3), ('sita', 11), ('dlm-intoxicated', 2), ('huge', 1), ('dlm-prompted', 1), ('poisonous', 1), ('finasteride', 6), ('gerbil', 2), ('accessory', 2), ('disrupters', 1), ('histochemistry', 2), ('mug.bw/d', 1), ('mongolian', 1), ('thickening', 3), ('periductal', 1), ('estrogen-alpha', 1), ('ultrasonography', 2), ('b-lines', 3), ('qluss', 11), ('semi-quantitative', 2), ('extravascular', 2), ('thermo-dilution', 1), ('lus', 4), ('frames', 2), ('nluss', 3), ('cluss', 3), ('luss', 4), ('evlw', 4), ('slr', 2), ('rlr', 2), ('spearman', 2), ('inter-observer', 1), ('intraclass', 1), ('icc', 2), ('two-way', 1), ('basing', 1), ('raters', 1), ('0.57', 1), ('0.000', 2), ('0.772', 1), ('0.757', 1), ('0.561', 1), ('0.058', 1), ('0.105', 1), ('0.998', 1), ('0.996', 1), ('computer-aided', 1), ('consolidations', 1), ('periodontium', 1), ('hplf', 2), ('dependency', 5), ('ethinylestradiol', 1), ('fetal/neonatal', 1), ('urogenital', 1), ('17alpha-ethinylestradiol', 1), ('ee2', 4), ('embryos/fetuses', 1), ('ee2-containing', 1), ('metazachlor', 18), ('479h', 1), ('8000', 8), ('metazachlor-induced', 3), ('replicative', 5), ('rds', 12), ('7-28', 1), ('3-28', 2), ('napb', 16), ('subfamily-dependent', 1), ('0.5-50', 1), ('0.5-25', 1), ('qualitatively', 3), ('metalloestrogenic', 1), ('metalloestrogen', 1), ('leiomyomas', 1), ('xenoestrogens', 4), ('phospho-epidermal', 1), ('phospho-egfr', 1), ('patient-matched', 1), ('myometrial', 1), ('gper-specific', 1), ('cd-activated', 1), ('gper/egfr', 1), ('phospho-src', 2), ('egf-like', 1), ('hb-egf', 1), ('expression/activation', 1), ('gper/p-src/egfr/mapk', 1), ('gastrodin', 2), ('nrf-2/ho-1/hmgb1/nf-kb', 3), (\"3,3'-iminodipropionitrile\", 1), ('stereotype', 3), ('transmitters', 1), ('glu', 7), ('/high', 1), ('factor-kb', 1), ('p-nf-kbp65', 1), ('elemicin', 6), ('stearoyl-coa', 3), ('desaturase', 4), ('phenylpropanoids', 1), ('spices', 1), ('elemicin-treated', 1), ('unsaturated-', 1), ('saturated-lysophosphatidylcholines', 1), ('scd1', 19), (\"1'-hydroxylelemicin\", 1), ('a939572', 1), ('alpha-naphthoflavone', 2), ('elemicin-induced', 2), ('melatonin-stabilized', 1), ('bilayers', 2), ('building', 2), ('laterally', 1), ('phase-separated', 2), ('rafts', 1), ('leaflet', 1), ('stabilizes', 2), ('liquid-ordered/liquid-disordered', 1), ('melatonin-mediated', 1), ('nanometer-', 1), ('micrometer-sized', 1), ('neutron', 1), ('sans', 1), ('landau-brazovskii', 1), ('heterogeneities', 1), ('thromboxane', 4), ('sos', 3), ('lsec', 5), ('txa2', 2), ('mct', 16), ('tp-deficient', 1), ('tp-/-', 4), ('mct-liver', 1), ('coagulative', 2), ('co-localized', 1), ('cd31-positive', 1), ('lsecs', 8), ('u46619', 1), ('mct-induced', 10), ('food-storage', 1), ('containers', 3), ('proteins-2', 1), ('hormone-responsive', 1), ('cell-resistance', 1), ('chemo-resistance', 2), ('hep-2', 3), ('transciptome', 1), ('key-player', 1), ('endorses', 1), ('endorsed', 1), ('urgency', 1), ('horizontal', 3), ('heidelberg', 12), ('ceca', 4), ('harbors', 1), ('taxa', 3), ('microorganisms', 2), ('cecum', 3), ('longest', 2), ('digesta', 1), ('horizontally', 2), ('bacteriophages', 1), ('salmonella', 2), ('enterica', 2), ('serovar', 3), ('resistome', 1), ('decipher', 2), ('microaerophilic', 1), ('inck2', 1), ('kb', 2), ('beta-lactamase', 3), ('bla', 9), ('cmy-2', 2), ('transferrable', 1), ('unsuccessful', 2), ('p1-like', 1), ('phages', 1), ('microbiome.importance', 1), ('serovars', 1), ('commensals', 1), ('agroecosystems', 1), ('transferring', 1), ('ampc', 1), ('bacteriophage', 1), ('lca', 11), ('1,25-dihydroxy', 1), ('substitute', 2), ('carry', 4), ('researched', 2), ('monolayers', 4), ('fitc-dextran', 1), ('tnf-alpha-mediated', 1), ('erythroid2-related', 1), ('p-ikappab-alpha', 1), ('facilitation', 1), (\"3'utr\", 5), ('interests', 2), ('scientists', 1), ('ecm1', 7), ('inconstant', 1), ('cocl2', 6), ('cobalt', 8), ('collagen-1', 4), ('sp7', 1), ('hypoxia-induced', 10), ('apoe3', 3), ('apoe4', 5), ('apoe-targeted', 1), ('tr', 1), ('apoe3-and', 1), ('apoe4-tr', 1), ('10-15', 1), ('cpf-supplemented', 1), ('three-chamber', 1), ('anorexigenic-peptide', 1), ('social-related', 1), ('orexigenic', 1), ('enlarges', 1), ('polyposis', 2), ('follow-ups', 2), ('sniffin', 1), ('sticks', 1), ('stagings', 2), ('liver-expressed', 1), ('ccl16', 2), ('sino-nasal', 1), ('test-22', 1), ('snot-22', 2), ('hyposmic', 1), ('radiologic', 1), ('polyp', 1), ('normosmic', 1), ('aripiprazole', 2), ('ozone-induced', 2), ('ozone', 6), ('o3', 28), ('o3-induced', 7), ('pollutant-induced', 1), ('reacts', 2), ('oxysterol', 2), ('7-dehydrocholesterol', 2), ('dhcr7', 4), ('7-dhc', 4), ('apz', 5), ('ay9944', 1), ('zingerone', 2), ('7,12-dimethylbenz', 4), ('anthracene-induced', 1), ('tumoregenesis', 1), ('ginger', 2), ('zingiber', 1), ('officinale', 1), ('spice', 2), ('remedies', 2), ('antique', 1), ('greece', 1), ('india', 3), ('curing', 2), ('upset', 1), ('colds', 1), ('dmba', 5), ('bwt', 1), ('soya', 1), ('looh', 3), ('carcinoembryonic', 2), ('dmba-induced', 2), ('cyt-b5', 1), ('michigan', 1), ('foundation-7', 1), ('xenopus', 2), ('laevis', 2), ('metamorphosis', 1), ('endogenous-hormones', 1), ('otps', 4), ('hypothalamus-pituitary-thyroid', 1), ('tadpoles', 3), ('fentin', 4), ('hydroxide', 4), ('fenbutatin', 4), ('0.20', 4), ('metamorphic', 1), ('hindlimb', 1), ('retarding', 1), ('trbeta', 1), ('bteb', 1), ('tshbeta', 3), ('slc5a5', 1), ('t3-tr', 1), ('hormone-', 1), ('grass', 2), ('phl', 20), ('p5', 3), ('p12', 5), ('beja', 1), ('southern', 1), ('portugal', 2), ('pollen', 1), ('grasses', 1), ('parietaria', 1), ('sensitizations', 1), ('immunocap', 1), ('singleplex', 1), ('phadia', 1), ('equipment', 2), ('g205', 1), ('g215', 1), ('p5b', 1), ('g210', 1), ('g212', 1), ('p1+/phl', 1), ('p5-/phl', 1), ('p7-/phl', 1), ('p12-', 1), ('averages', 2), ('10.46', 1), ('8.43', 1), ('22.49', 1), ('20.23', 1), ('3.89', 1), ('p=0.754', 1), ('p=0.806', 1), ('p=0.102', 1), ('p=0.018', 1), ('alpha-glycosidase', 4), ('acetazolamide', 1), ('tacrine', 1), ('acarbose', 1), ('graphs', 4), ('lineweaver-burk', 2), ('40.77', 1), ('17.47', 1), ('29.13', 1), ('3.57', 1), ('15.92', 1), ('1.90', 1), ('10.50', 1), ('2.46', 1), ('demise', 1), ('impediment', 1), ('gene-environment', 4), ('pre-symptomatic', 2), ('impending', 1), ('relish', 2), ('basket', 2), ('relish-dependent', 1), ('anti-microbial', 2), ('amps', 3), ('gram-negative', 8), ('underscoring', 2), ('molecular-scale', 1), ('initio', 1), ('ev', 2), ('stationary', 1), ('mg2', 2), ('sih4', 2), ('reproduced', 1), ('self-consistent', 1), ('small-mass', 1), ('light-emission', 1), ('commonalities', 1), ('radiation-resistance', 2), ('deinococcus', 5), ('up-to-date', 1), ('extremophilic', 1), ('microorganism', 1), ('habitats', 2), ('radiation-contaminated', 1), ('antarctic', 2), ('deserts', 1), ('etc.', 1), ('ionizing', 1), ('radiation-protection', 1), ('self-repair', 1), ('mmr', 1), ('esdsa', 1), ('desiccation', 1), ('chassis', 1), ('latest', 1), ('prospects', 1), ('biotechnological', 1), ('microrna-608', 1), ('tead2', 5), ('resistances', 1), ('mir-608', 7), ('transcription-quantitative', 2), ('hippo-yes-associated', 1), ('silk', 6), ('fibroin-alginate', 3), ('beads', 6), ('fibroin', 3), ('popularity', 2), ('tunable', 1), ('dimensional', 1), ('scaffolds', 2), ('allow', 7), ('unavailable', 1), ('destructive', 3), ('penetrate', 2), ('replicating', 1), ('retain', 2), ('cell-compatible', 1), ('desired', 1), ('hmsc', 2), ('alginate', 1), ('hmscs', 1), ('directing', 1), ('preeclamptic', 3), ('coherence', 6), ('optic', 9), ('octa', 3), ('ppw', 7), ('hpw', 7), ('cnpw', 5), ('choriocapillaris', 2), ('rsbfa', 1), ('0.101', 1), ('parafoveal', 2), ('rspfd', 1), ('0.685', 1), ('rdbfa', 1), ('rdpfd', 1), ('cbfa', 2), ('1.875', 1), ('mm2', 7), ('1.928', 1), ('1.464', 1), ('1.567', 1), ('1.690', 1), ('1.592', 1), ('sp/nk-1r', 1), ('leukemia-induced', 1), ('exciting', 1), ('cation-transporter-dependent', 1), ('cddp', 3), ('oct1/2-/-', 3), ('cddp-induced', 2), ('oct1/2', 1), ('oct-associated', 1), ('viz.', 1), ('proteome', 2), ('ablation-inductively', 1), ('plasma-mass', 1), ('redefine', 1), ('verteporfin', 2), ('embryonal', 3), ('rhabdomyosarcoma', 5), ('rms', 6), ('hpo', 2), ('erms', 1), ('paralog', 1), ('pdz-binding', 1), ('taz', 5), ('teads', 1), ('vp', 7), ('stop', 2), ('yap/tead', 1), ('foxp1', 11), ('esrd', 2), ('fox', 1), ('dose-and', 1), ('foxp1-mediated', 1), ('methylone', 7), ('3,4-methylenedioxymethcathinone', 1), ('advertised', 1), ('lc01', 1), ('lc10', 1), ('fingerprint', 1), ('2-methyl-1-pentanol', 1), ('4-methylheptane', 1), ('dodecane', 1), ('2,4-dimethyl-1-heptene', 1), ('1,3-di-tert-butylbenzene', 1), ('glyoxal', 1), ('defenses', 1), ('reflects', 1), ('exponential-time', 3), ('exponential', 2), ('integer', 1), ('ofr', 1), ('exp', 5), ('chromatic', 2), ('vertex', 2), ('omega', 2), ('k-hypergraph', 1), ('omit', 1), ('polyloglog', 1), ('polynomial', 1), ('bounds', 4), ('bourgeois', 1), ('discret', 1), ('appl', 1), ('math', 1), (':1954-1970', 1), ('cygan', 1), ('eth', 1), ('chalermsook', 1), ('foundations', 1), ('computer', 1), ('focs', 1), ('370-379', 1), ('laekhanukit', 1), ('inapproximability', 1), ('subexponential-time', 1), ('ph.d.', 1), ('thesis', 1), ('naturally-looking', 1), ('sparsification', 1), ('bounded-degree', 2), ('refute', 2), ('overly', 1), ('chan', 2), ('acm', 1), (':27:1-27:32', 1), ('gap-eth', 1), ('conjecture', 1), ('dinur', 1), ('colloq', 1), ('comput', 1), ('eccc', 1), ('23:128', 1), ('manurangsi', 1), ('raghavendra', 1), ('birthday', 1), ('repetition', 2), ('theorem', 1), ('approximating', 1), ('csps', 1), ('circ_0039569', 7), ('mir-34a-5p/ccl22', 1), ('folds', 1), ('hsa_circ_0039569', 1), ('ccl22', 1), ('mir-34a-5p', 1), ('hypoperfusion', 3), ('350-day-old', 1), ('cch', 3), ('four-vessel', 1), ('occlusion/internal', 1), ('4-vo/ica', 1), ('non-cch', 2), ('dnv', 1), ('dcv', 1), ('cbd/kg', 1), ('fructosamine', 2), ('insulinemia', 1), ('chloroethanol', 2), ('deactivation', 1), ('c-src', 1), ('vc-metabolite', 1), ('vc-associated', 1), ('n-dimethylformamide', 2), ('leather', 1), ('factories', 1), ('1500', 4), ('dmf/kg', 1), ('698', 1), ('dmf-exposed', 2), ('non-dmf-exposed', 1), ('rs6413432/rs2031920', 1), ('n-methylcarbmoylated-hemoglobin', 1), ('nmhb', 3), ('liver/body', 1), ('cyp2e1-dependent', 2), ('cyp2e1-rs6413432', 1), ('0.045', 1), ('dmf-induced', 1), ('damps-tlr4-myd88/trif-nfkappab', 1), ('hsos', 13), ('pyrrolizidine', 4), ('alanine/aspartate', 2), ('alt/ast', 2), ('tir-domain-containing', 1), ('adapter-inducing', 1), ('interferon-beta', 1), ('trif', 4), ('hsp60', 5), ('damps-initiated', 1), ('tlr4-myd88/trif-nfkappab', 1), ('cell-like', 2), ('csc-like', 8), ('proto-oncogene', 5), ('beas-2b-cr', 1), ('nontransformed', 2), ('microrna-494', 1), ('mir-494', 3), ('glioma-inflammation', 1), (\"indirubin-3'-\", 2), ('dihydroxypropyl', 2), ('-oximether', 2), ('e804', 12), (\"7-bromoindirubin-3'-oxime\", 2), ('7bio', 7), ('indirubins', 1), ('indirubin', 2), ('danggui', 1), ('longhui', 1), ('wan', 1), ('remedy', 4), ('ln-18', 2), ('glioblastomas', 1), (\"6,2',4'-trimethoxyflavone\", 1), ('tmf', 5), ('ptsg2', 1), ('il12b', 2), ('il10', 1), ('il13', 1), ('pd1', 1), ('pdl1', 1), ('mhc1a/b', 1), ('il1b', 1), ('il12a', 1), ('iconic', 1), ('beta-ionone-inhibited', 1), ('isoprenoids', 1), ('uncompleted', 1), ('chemoprevention', 5), ('3h-thymidine', 1), ('tdr', 1), ('qr', 2), ('hepa1c1c7', 1), ('peg2', 1), ('adventures', 4), ('smartphone', 1), ('game', 1), ('blended', 4), ('problem-solving', 5), ('provision', 1), ('game-based', 2), ('conduct', 1), ('premium', 1), ('pride', 1), ('programme', 1), ('transdiagnostic', 1), ('stepped', 1), ('indian', 2), ('schools', 2), ('iterative', 1), ('context-specific', 2), ('preferences', 4), ('school-going', 1), ('stakeholder', 1), ('counseling', 1), ('co-design', 2), ('workshops', 2), ('user-testing', 2), ('12-17', 1), ('delhi', 1), ('goa', 1), ('self-identified', 1), ('offline', 1), ('smartphones', 1), ('prototypes', 1), ('simplification', 1), ('concrete', 1), ('examples', 2), ('valued', 1), ('relatability', 1), ('interactivity', 1), ('real-world', 4), ('stories', 1), ('judicious', 1), ('in-app', 1), ('gamified', 1), ('vignettes', 1), ('structured', 1), ('consolidate', 1), ('generalize', 1), ('shaped', 2), ('open-access', 1), ('students', 3), ('help-seeking', 1), ('low-resource', 1), ('phosphine-catalyzed', 1), ('4+2', 2), ('cycloadditions', 1), ('allenic', 3), ('tetrahydropyridines', 3), ('amino-acid-derived', 1), ('phosphine', 2), ('cycloaddition', 4), ('alpha-substituted', 2), ('synthons', 1), ('n-sulfonyl', 1), ('ketimines', 1), ('tolerates', 1), ('sultam-fused', 1), ('stereocenter', 1), ('enantioselectivities', 1), ('first-trimester', 1), ('perfluorooctanesulfonic', 3), ('man-made', 2), ('fluorosurfactant', 1), ('abortion', 3), ('labor', 5), ('pfos-induced', 2), ('mir29-b', 1), ('mir-29b', 6), ('self-assembly', 4), ('facile', 2), ('heteropoly', 4), ('polyoxometalates', 2), ('photocatalytic', 1), ('semiconducting', 1), ('hpbs', 4), ('gew10mov2o40', 1), ('gemovi10mov2o40', 1), ('p2w16mov2o62', 1), ('p2w12movi2mov4o62', 1), ('mov2o4', 1), ('h2o', 1), ('ox', 1), ('vacant', 1), ('esi-ms', 1), ('mov', 1), ('locations', 1), ('dimethoxycurcumin', 2), ('dimc', 4), ('monopolar', 1), ('gadd45a', 2), ('bak1', 1), ('casp7', 2), ('competent', 1), ('aspp2+/+', 2), ('aspp2+/+and', 2), ('haploid', 2), ('aspp2+/-', 3), ('malat1', 9), ('mirna-26b', 1), ('l-02', 8), ('arsenite-treated', 5), ('microrna-26b', 1), ('5-b', 1), ('mir27b', 5), ('nm-10', 1), ('nm-100', 1), ('micronuclei', 8), ('bap-', 1), ('alkylation', 2), ('thereof', 3), ('hydrocortisone', 1), ('betamethasone', 1), ('desorption/ionization', 1), ('maldi-tof', 3), ('oh-group', 1), ('sm-alkylated', 2), ('gc-regulated', 2), ('hek293-cells', 1), ('gc-response', 1), ('sm-derivatized', 1), ('firefly-luciferase', 1), ('fluc', 1), ('fluc-activity', 1), ('sm-pre-exposed', 1), ('rt-qpcr-based', 1), ('il1r2', 1), ('gilz', 1), ('ugt', 18), ('ugt1a6', 11), ('ugt1a8', 4), ('ugt1a10', 2), ('cyp2c8', 5), ('pi-pi', 1), ('stacking', 2), ('silver', 17), ('vibrio', 1), ('natriegens', 1), ('ag-nps', 5), ('bacteriostatic', 1), ('ultraviolet-visible', 1), ('3-o-sulfotransferase', 1), ('sulfonation', 5), ('bioengineered', 3), ('beh', 5), ('in-process', 1), ('tracking', 2), ('3-ost', 2), ('antithrombin', 1), ('beh-induced', 1), ('conveniently', 1), ('robustness', 1), ('on-chip', 1), ('embryos/larvae', 7), ('1,1-trichloro-2-', 1), ('p-chlorophenyl', 2), ('o-chlorophenyl', 1), ('ethane', 1), ('1,1-dichloro-2,2-bis', 1), ('-ethylene', 1), ('15.7', 1), ('157', 2), ('crh', 2), ('nis', 2), ('tpo', 2), ('nkx2.1', 1), ('dio3', 3), ('lncrna-241', 1), ('1,2-dichloroethane-induced', 2), ('1,2-dichloroethane', 2), ('1,2-dce', 12), ('1,2-dce-induced', 6), ('long-non-coding', 1), ('lncrna241', 3), ('2-chloroacetic', 1), ('2-ca', 3), ('anti-apoptosis-associated', 1), ('mmu-mir-451a', 1), ('dichloro-diphenyl-trichloroethane', 1), ('nursing', 2), ('ddt-induced', 1), ('environmentally-relevant', 1), ('previously-tested', 1), ('gsto1', 1), ('abcc2', 3), ('fgf2', 1), ('glucomoringin-isothiocyanate', 1), ('ndds', 3), ('multi-systemic', 1), ('complexities', 1), ('purely', 2), ('glucomoringin', 1), ('gmg-itc', 6), ('moringa', 1), ('oleifera', 1), ('detoxifying', 4), ('bace1', 8), ('ikb', 2), ('mapt', 2), ('sod-1', 1), ('p52', 1), ('c-rel', 1), ('nephronophthisis', 2), ('pedigrees', 3), ('nphp1', 5), ('nphp', 3), ('nonconsanguineous', 1), ('tes', 2), ('1-20', 3), ('phlda1', 4), ('fenvalerate-induced', 1), ('krt8', 5), ('mal', 6), ('cd24', 1), ('lcn2', 3), ('fen-treated', 1), ('well-documented', 1), ('phlda1-mediated', 1), ('guanabenz', 2), ('synergizes', 2), ('anti-er', 1), ('n-acetyl-p-benzoquinone', 3), ('imine', 4), ('self-administration', 2), ('co-used', 1), ('co-use', 3), ('ingestive', 1), ('binge-drinking', 1), ('doughs', 1), ('etoh', 4), ('orders', 2), ('dough-fluid', 1), ('fluid-dough', 1), ('thc-induced', 5), ('whole-brain', 1), ('well-consumed', 1), ('lasting', 1), ('methylome', 1), ('overactivation', 3), ('tiia', 6), ('epigenomic', 4), ('mes13', 2), ('1780', 1), ('hg/lg', 1), ('1416', 1), ('tiia/hg', 1), ('leukotriene', 1), ('eicosanoid', 1), ('glutathione-mediated', 1), ('methyl-seq', 1), ('nmu', 1), ('fgl2', 1), ('glo', 1), ('kcnip2', 1), ('epigenetic/epigenomic', 1), ('nhnp', 1), ('ppa-treated', 1), ('biogenesis-related', 1), ('tfam', 2), ('cox4', 1), ('signaling-related', 3), ('ascl1', 1), ('lfng', 1), ('sarcoptes', 2), ('scabiei', 10), ('goats', 8), ('rabbits', 7), ('cox-1', 11), ('lamongan', 5), ('mojokerto', 5), ('align', 1), (\"zi'gong\", 2), ('eu256389.1', 1), ('phylogenetic', 3), ('mites', 1), ('qiaamp', 1), ('mini', 2), (\"5'-tcttaggggctggatttagtatg-3\", 1), (\"5'-agttcctctaccagttccac-3\", 1), ('manager', 1), ('professional', 1), ('//www.scied.com', 1), ('neighbor-joining', 1), ('mega6', 1), ('//www.megasoftware.net/', 1), ('bands', 2), ('hosts', 1), ('biotechnology', 1), ('u.s.', 3), ('newer', 1), ('tandem', 5), ('=95th', 1), ('sex-standardized', 1), ('norms', 1), ('circumference/height', 1), ('=0.5', 1), ('97.5', 1), ('87.8', 1), ('1.01', 1), ('z-score', 3), ('contemporary', 2), ('extrusion', 1), ('cgs', 3), ('2,917', 1), ('maturated', 1), ('mlt', 5), ('mal-exposed', 3), ('plin2', 1), ('parthenogenetic', 1), ('mal-induced', 1), ('bcd1', 6), ('c/d', 5), ('snornp', 4), ('rrnas', 2), ('ribosomes', 2), ('ribonucleoproteins', 1), ('snornps', 2), ('hit', 2), ('snornas', 3), ('snu13', 1), ('snorna', 1), ('snu13interactions', 1), ('ribosome', 1), ('nanomeulsions', 1), ('ultrasonication', 2), ('amg', 6), ('solubilizers', 1), ('nanoemulsion', 1), ('amg-ne', 6), ('surfactants', 4), ('nes', 4), ('staphyloccocus', 2), ('propionibacterium', 2), ('acnes', 3), ('renamed', 1), ('cutibacterium', 1), ('nanometer', 1), ('polydispersity', 1), ('intensities', 1), ('apalutamide', 9), ('nonmetastatic', 1), ('nmcrpc', 3), ('spartan', 2), ('titan', 2), ('prosper', 1), ('apalutamide-associated', 1), ('2-cyanophenyl', 1), ('dimethyl', 5), ('moieties', 1), ('2-cyanopyridine', 3), ('cyclobutyl', 2), ('nucleophile', 2), ('thiazoline', 1), ('radiolabeled', 2), ('nucleophiles', 5), ('amine', 3), ('lymphocyte', 2), ('cellularity', 1), ('mdam', 3), ('rd162', 1), ('cyanophenyl', 1), ('haptens', 1), (\"4'-dichlorodiphenyltrichloroethane\", 1), ('260', 2), ('0.05-5', 1), ('0.025-2.5', 1), ('compound-induced', 1), ('peripapillary', 1), ('prnfl', 5), ('cell-inner', 1), ('plexiform', 1), ('gc-ipl', 2), ('thicknesses', 4), ('aau', 6), ('non-infectious', 1), ('thirty-seven', 2), ('rnfl', 1), ('cmt', 1), ('fellow', 4), ('109.4', 1), ('96.5', 1), ('8.0', 2), ('99.3', 1), ('97.0', 1), ('0.236', 1), ('cmts', 1), ('261.6', 1), ('251.5', 1), ('17.3', 2), ('0.061', 1), ('macula', 1), ('tomatidine', 11), ('gelatinase', 2), ('ht1080', 3), ('gelatinases', 1), ('tricresyl', 3), ('tcp', 11), ('lubricant', 1), ('engine', 2), ('nru', 1), ('39.3', 1), ('49.85', 1), ('27.1-fold', 1), ('upsurge', 1), ('affirming', 1), ('rh123', 1), ('62.53', 1), ('subg1', 1), ('on-set', 1), ('caspase9', 8), ('reaffirming', 1), ('atp5a1', 1), ('igfbp5', 1), ('stmn1', 1), ('prominently', 4), ('candid', 1), ('specifying', 1), ('mast', 8), ('perimyocarditis', 1), ('bottles', 3), ('receipts', 1), ('cages/water', 2), ('soy-free', 2), ('bedding', 2), ('bpa/kg', 2), ('pericarditis', 1), ('caging/water', 1), ('bottle', 1), ('polyglutamine', 2), ('polyq', 5), ('adult-onset', 1), ('misfolding', 1), ('cag/polyq', 1), ('tracts', 2), ('hsp90/hsp70', 1), ('disaggregation', 3), ('misfolded', 4), ('co-chaperones', 1), ('multifaceted', 1), ('trypanosomes', 1), ('vsgs', 4), ('trypanosoma', 1), ('brucei', 1), ('parasites', 7), ('periodically', 1), ('coat', 2), ('vsg', 5), ('parasite', 7), ('tdp1', 1), ('mounted', 1), ('multi-vsg', 1), ('parasitemia', 2), ('30-d', 1), ('immunodeficient', 1), ('rag2', 1), ('tdp1-overexpressing', 1), ('trypanosomiasis', 1), ('fshr', 3), ('ctx', 5), ('pof', 1), ('free-radical', 1), ('ctx-induced', 2), ('metaphase', 1), ('mii', 1), ('pmsg/hcc', 1), ('ctx-treated', 1), ('multiorgan', 3), ('hour', 11), ('quantificational', 1), ('collagen-induced', 2), ('cia', 2), ('cyp21a2', 1), ('cyp11b1', 1), ('word', 1), ('famotidine', 8), ('akt/gsk-3beta/beta-catenin', 4), ('vivo/in', 3), ('antiulcer', 4), ('schizophrenic', 1), ('histaminergic', 2), ('415286', 2), ('beside', 1), ('pre-treatments', 1), ('hct15', 2), ('mkn45', 1), ('dox-resistant', 2), ('4-hydroxy-2-nonenal', 1), ('inferring', 1), ('akrs', 2), ('acquiring', 1), ('dox-elicited', 1), ('dox-reductase', 2), ('hne-sensitivity', 1), ('hne-reductase', 2), ('cross-resistance', 1), ('cis-diamminedichloroplatinum', 1), ('lycopene', 4), ('lyc', 9), ('pq7', 1), ('v-fitc', 1), ('bap-caused', 5), ('intratesticular', 1), ('bap-mediated', 1), ('gap-junction', 2), ('cam', 1), ('platelet-activating', 1), ('sphingosine-1-phosphoric', 1), ('sulfuric', 1), ('cortexolone', 1), ('ideas', 1), ('warning', 1), ('uroepithelial', 3), ('hypospadias', 6), ('14-18.', 1), ('hhip', 2), ('dbp-induced', 3), ('hypospadiac', 1), ('-hhip-gli1-autophagy', 1), ('dbp-treated', 1), ('urethral', 1), ('postzygotic', 2), ('rhoa', 3), ('mosaic', 2), ('neuroectodermal', 2), ('hypopigmentation', 2), ('blaschko', 1), ('acral', 1), ('pigmentary', 1), ('mosaicism', 1), (\"2'-o-methylation\", 2), ('dyskeratosis', 5), ('congenita', 5), ('compelling', 3), (\"2'-o-me\", 3), (\"2'-o-me-regulated\", 1), ('nonhematological', 1), ('let-7f-2-3p', 11), ('xpo1-mediated', 4), ('hax-1', 7), ('microrna-140-5p', 1), ('exportin-1', 1), ('xpo1', 4), ('hematopoietic-substrate-1', 1), ('x-1', 1), ('inhibitor/beta-blocker', 1), ('dorzolamide/timolol', 2), ('poag', 2), ('62.4+-9.7', 1), ('glauprost', 1), ('rompharm', 2), ('company', 2), ('romania', 2), ('dorzopt', 1), ('tonometry', 1), ('icare', 1), ('perimetry', 1), ('perimeter', 1), ('hrt', 1), ('tomograph', 1), ('spectralis', 2), ('svl', 1), ('dvl', 1), ('bruch', 1), ('rim', 2), ('bmo-mrw', 2), ('microcirculation', 2), ('choroid', 2), ('rheographic', 1), ('ri', 2), ('transpalpebral', 1), ('rheoophthalmography', 1), ('timolol', 2), ('dorzolamide', 2), ('51.5+-24.5', 1), ('62.2+-19', 1), ('p=0.084', 1), ('16476', 1), ('23767', 1), ('p=0.062', 1), ('omethoate', 9), ('akt/gsk-3beta/cyclin', 2), ('hnscc', 14), ('fadu', 6), ('g1-s', 1), ('omethoate-induced', 1), (\"2',3'-cyclic\", 1), ('cnpase', 1), ('glycoprotein-1', 1), ('mag-1', 1), ('neuropsychological', 1), ('neuromyelitis', 3), ('optica', 3), ('mays', 6), ('marble', 5), ('effluent', 4), ('morpho-physiological', 1), ('contours', 1), ('effluents', 2), ('m.e', 5), ('diluted', 1), ('biomass', 6), ('peroxidases', 1), ('catalases', 1), ('apx', 1), ('c.a', 1), ('zn', 3), ('varieties', 1), ('irrigated', 1), ('phyto-extraction', 1), ('galbanic', 2), ('antiproliferation', 2), ('receptor-negative', 1), ('ferula', 1), ('apiaceae', 1), ('3,4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium', 1), ('48.75', 1), ('56.65', 1), ('ga.', 1), ('apoptosis-mediated', 1), ('industries', 2), ('tslp', 9), ('toluene-diisocyanate-induced', 1), ('toluene-diisocyanate', 1), ('polyurethane', 1), ('foams', 1), ('bronchus', 2), ('ror-gammat', 2), ('tslp-ab', 2), ('tumor-resident', 1), ('anti-melanoma', 1), ('revolutionized', 2), ('anti-cytotoxic', 1), ('lymphocyte-associated', 1), ('anti-ctla-4', 2), ('microbiota-derived', 1), ('sentinels', 1), ('recruiting', 1), ('cxcl10', 4), ('conclusive', 2), ('trojan', 1), ('horse', 1), ('cancer-resident', 1), ('apo', 3), ('ligand-competent', 2), ('state-dependent', 2), ('hotspots', 2), ('transmitting', 1), ('endeavours', 1), ('retrieve', 1), ('reconstruct', 2), ('goal-oriented', 1), ('reconcile', 1), ('non-biased', 1), ('urate', 6), ('trans-ancestry', 1), ('457,690', 1), ('183', 5), ('147', 1), ('334,880', 1), ('pleiotropy', 2), ('urate-associated', 1), ('hnf1a', 1), ('transactivated', 2), ('p.thr139ile', 1), ('coregulation', 1), ('extended-spectrum', 2), ('beta-lactamases', 1), ('esbl', 7), ('-producing', 1), ('inactivate', 2), ('monobactams', 1), ('coresistance', 1), ('esbls', 1), ('kirby-bauers', 1), ('dilution', 2), ('ceftazidime', 1), ('esbl-positive', 1), ('ctx-m', 2), ('shv', 2), ('28.84', 1), ('klebsiella', 2), ('18.07', 1), ('9.61', 1), ('nonfermenter', 1), ('30.8', 2), ('oxytoca', 1), ('46.7', 1), ('122', 3), ('76.25', 1), ('109', 2), ('68.1', 1), ('43.12', 1), ('blatem', 1), ('blactx-m.', 1), ('bacilli', 1), ('gnb', 2), ('amikacin', 2), ('imipenem', 2), ('colistin', 2), ('setup', 1), ('aldh1a1', 7), ('aldh1a3', 6), ('aldh1alo', 1), ('braf/mek', 4), ('aldh1a3hi', 1), ('hpon1', 4), ('3.1.8.1', 1), ('354.91', 1), ('precipitation', 1), ('sepharose-4b-l-tyrosine-1-naphthylamine', 1), ('sds-polyacrylamide', 1), ('0.219', 1), ('salbutamol', 1), ('67.205', 1), ('montelukast', 1), ('varenicline', 1), ('tartrate', 1), ('risk-benefit', 1), ('malpractice', 1), ('allelic', 1), ('4-oh', 1), ('liquid-chromatography', 1), ('vmax/km', 2), ('1.53', 1), ('83.25', 1), ('e215k', 1), ('v327', 1), ('r497c', 1), ('attract', 1), ('hoped', 1), ('ineffectiveness', 1), ('neuro', 1), ('neuron-like', 3), ('drawback', 1), ('favour', 1), ('selenite', 1), ('selenate', 1), ('seleno-methionine', 1), ('alphatubulin-4a', 1), ('tuba4a', 4), ('dna-', 1), ('rna-binding', 1), ('glutathionylation', 1), ('selenium-dependent', 1), ('r320c', 1), ('a383', 1), ('rotenone', 21), ('3-brpa', 8), ('farms', 2), ('verp', 1), ('qt', 2), ('tachycardia/ventricular', 1), ('vt/vf', 1), ('kir2.1', 1), ('kir6.2', 1), ('dhpralpha1', 1), ('kcnh2', 1), ('upf2-dependent', 2), ('nonsense-mediated', 2), ('neurophysiological', 1), ('nmd', 5), ('protein-coding', 1), ('upf2', 4), ('up-frameshift', 1), ('ndd', 1), ('fb-ko', 2), ('ltp', 3), ('cranial', 3), ('monocentric', 2), ('bev', 7), ('antiedematous', 1), ('real-life', 1), ('ctcae', 1), ('timepoints', 1), ('twenty-one', 3), ('52.4', 3), ('90.5', 1), ('symptomatically', 1), ('pi3k/akt/gsk-3beta', 4), ('syringic', 2), ('glutamate-induced', 3), ('cerebrocortical', 1), ('0.01-0.1', 2), ('3,2-b', 5), ('hydrocarbon-androgen', 1), ('factual', 1), ('flutamide', 2), ('androgen-', 1), ('gamma-tocopherol-induce', 1), ('21.8', 2), ('14.4', 1), ('subgsubg1', 1), ('mir-99a', 8), ('erk/ap-1-dependent', 1), ('bitc', 11), ('c-jun/ap-1', 3), ('erk/c-jun', 1), ('labile', 3), ('pyrithione', 1), ('znt10', 1), ('zip5', 1), ('beta-naphthoflavone-induced', 1), ('liquiritigenin', 9), ('liquiritin', 8), ('hsp60-induced', 1), ('glycyrrhizae', 1), ('rhizoma', 2), ('gan-cao', 1), ('liquiritin-provided', 1), ('tbil', 4), ('nfkappab-downstream', 1), ('3rax', 4), ('phenazines', 2), ('archaeal', 1), ('methanosarcina', 1), ('nitrogen-containing', 1), ('antitumoral', 2), ('antiparasitic', 1), ('acceptors-donors', 1), ('biosensors', 1), ('phenazine', 1), ('safranine', 1), ('hyperbolic', 1), ('0.0003.', 1), ('nilotinib', 7), ('tweak', 3), ('hsp-70', 2), ('thiazole-derived', 2), ('oridonin', 3), ('allosterically', 1), ('ent-kaurane', 1), ('cyd0618', 4), ('cys-542', 2), ('stat3-targeted', 1), ('harbor', 2), ('stat3activation', 1), ('stat3-driven', 1), ('methylations', 2), ('1038', 1), ('3swr', 1), ('2qrv', 1), ('dnmts-pesticide', 1), ('binding-affinity', 1), ('dnmt-pesticides', 1), ('flocoumafen', 1), ('-12.5', 1), ('-9.9', 1), ('brodifacoum', 1), ('-12.4', 1), ('difenacoum', 1), ('-8.7', 1), ('rodenticides', 3), ('dnmt1-pesticide', 1), ('trp1170a', 1), ('phe1145a', 1), ('asn1578a', 1), ('arg1574a', 1), ('pro1225a', 1), ('arg271b', 1), ('lys740a', 1), ('glu303b', 1), ('anti-egfr', 8), ('monoclonal', 5), ('anti-epidermal', 1), ('moabs', 8), ('metastasized', 1), ('mcrc', 3), ('inception', 2), ('20th', 1), ('8848', 1), ('oxaliplatin-based', 2), ('0.80', 3), ('0.89', 2), ('0.78', 3), ('folfolx', 1), ('folfox', 1), ('tipping', 3), ('endoderm', 5), ('hipscs', 6), ('hipsc-derived', 4), ('192', 2), ('foxa2', 9), ('isotretinoin', 1), ('acne', 13), ('departure', 1), ('progranulin', 2), ('prosaposin', 4), ('glucocerebrosidase', 3), ('frontotemporal', 1), ('ftd', 3), ('neurogenerative', 1), ('pgrn', 6), ('saposins', 1), ('sphingolipid', 1), ('ftd-pgrn', 1), ('ipscs', 1), ('ftld-pgrn', 1), ('saposin', 2), ('gcase', 4), ('synuclein', 3), ('administraed', 1), ('mg/', 1), ('soybean', 1), ('penises', 6), ('mst1', 2), ('lats1', 2), ('yes-related', 1), ('2501+-2', 1), ('1253+-1', 1), ('3562', 1), ('05', 8), ('0293+-0', 1), ('0075', 1), ('4731+-0', 1), ('004', 1), ('3875+-0', 1), ('4524', 1), ('4688+-1', 1), ('2290', 1), ('diameters', 3), ('5513+-0', 1), ('1158', 1), ('6013+-0', 1), ('1469', 1), ('6097+-1', 1), ('3188', 1), ('3517+-0', 1), ('1524', 1), ('7071+-2', 1), ('7210', 1), ('1235+-0', 1), ('0658', 1), ('3937+-0', 1), ('1519', 1), ('2329+-0', 1), ('4339', 1), ('3348+-0', 1), ('0639', 1), ('8023+-0', 1), ('4275', 1), ('9940+-0', 1), ('2177', 1), ('3128+-0', 1), ('0867', 1), ('i-induced', 1), ('trp53', 16), ('+/+', 4), ('3.5', 4), ('genotype-dependent', 1), ('aminoaciduria', 1), ('aciduria', 1), ('glycosuria', 1), ('aai-dna', 2), ('32p-postlabelling', 1), ('p53-related', 1), ('mefs', 4), ('aai-exposed', 1), ('lupiwighteone', 8), ('-independent', 7), ('caspase-independent', 2), ('off-label', 4), ('ivig', 3), ('cogan', 3), ('deafness', 1), ('pregnancies', 2), ('senecionine', 7), ('cyp-dependent', 2), ('phytotoxins', 1), ('intravital', 4), ('two-photon', 2), ('pericentral', 3), ('senecionine-treated', 1), ('-dependency', 1), ('reductase-deficient', 1), ('lobules', 1), ('sinusoids', 1), ('abcb11', 1), ('abcc1', 4), ('destroys', 1), ('apoptosis-modulating', 1), ('auxiliary', 1), ('uvc', 2), ('ser9', 2), ('licl-induced', 6), ('unraveled', 1), ('lead-produced', 1), ('hydroperoxides', 8), ('rosmarinic', 2), ('nrf2-keap1', 2), ('cytotoxicities', 1), ('pb-produced', 3), ('lc/ms', 1), ('rma', 2), ('nrf2/keap1', 1), ('pcooh', 4), ('tgooh', 3), ('cholesteryl', 1), ('ceooh', 3), ('34:2', 1), ('34:3', 1), ('38:7', 1), ('60:14', 1), ('60:15', 1), ('18:3', 1), ('20:4.', 1), ('nrf2-regulated', 1), ('pretranscriptional', 1), ('phlpp2', 12), ('pleckstrin', 1), ('myocardial-infarction-induced', 1), ('dcfh-da', 3), ('hypoxia-injured', 2), ('-3beta', 1), ('nrf2/antioxidant', 2), ('phlpp2-inhibition-mediated', 1), ('phlpp2-overexpression-induced', 1), ('phlpp2/gsk-3beta/nrf2/are', 1), ('gamabufotalin', 6), ('u-87', 3), ('cdc25a', 1), ('ca9', 2), ('timp3', 1), ('invasion/metastasis', 1), ('vegf/vegfr2', 1), ('vegf/vegfr', 2), ('galanin', 1), ('galr2', 1), ('plague', 1), ('malaria', 2), ('afflictions', 1), ('resource', 2), ('lieu', 1), ('unintended', 1), ('abandoned', 1), ('eradicate', 2), ('lands', 1), ('ganoderma', 4), ('atrum', 4), ('psg-1', 15), ('t1dm', 2), ('restraint', 1), ('tlr4-dependent', 1), ('kinesin', 2), ('18b', 2), ('facilitator', 1), ('becomes', 4), ('incorrigible', 1), ('kif18b', 8), ('oncomine', 2), ('genotype-tissue', 1), ('m14', 2), ('erk/pi3k', 1), ('desmocollin-1', 2), ('migrating', 1), ('silac', 1), ('surfaceome', 1), ('824', 1), ('fdr', 1), ('dsc1', 1), ('luminal', 11), ('swath-ms', 2), ('copyright', 1), ('preweaning', 3), ('meaning', 1), ('hyposensitized', 1), ('hypersensitized', 1), ('gaba-a-alpha2', 1), ('ches', 1), ('ikkbeta-nf-kappab', 6), ('speculate', 2), ('tp-disturbed', 1), ('pftalpha', 1), ('c5b-9', 8), ('megalin', 4), ('cubilin-mediated', 1), ('degreasing', 1), ('multi-system', 1), ('questioned', 2), ('tce-induced', 1), ('sub-lytic', 3), ('cubilin', 3), ('isoflavones', 5), ('colon-derived', 1), ('track', 1), ('resemble', 1), ('flavone', 6), ('flavanones', 1), ('caco2', 3), ('colonocyte', 1), ('yamc', 2), ('ah-responsive', 1), ('flavonoid-induced', 1), (\"4',5,7-trihydroxyisoflavone\", 1), ('ahr-inactive', 2), (\"4',5,7-trihydroxyflavone\", 1), ('apigenin', 10), ('5,7-dihydroxy-4-methoxy', 1), ('isoflavone', 2), ('biochanin', 2), ('acacetin', 1), ('ahr-responsive', 1), (\"4',5,7-trimethoxyisoflavone\", 1), ('c-2', 1), ('4-h-chromen-4-one', 1), ('reminders', 3), ('ptsd', 4), ('basolateral', 5), ('hyper', 1), ('arousal/ptsd-', 1), ('microinjected', 1), ('npy1', 5), ('leu31', 1), ('pro34-npy', 1), ('intra-bla', 3), ('shock/reminders-induced', 1), ('ptsd-', 2), ('extinction', 2), ('startle', 2), ('depression-behaviors', 1), ('despair', 2), ('infralimbic', 1), ('isoenzyme', 1), ('31.25', 2), ('62.5', 3), ('thorough', 2), ('descriptions', 2), ('compartment-specific', 1), ('concentration-response', 1), ('o3-responsive', 1), ('promotercpg', 1), ('enigmatic', 1), ('cytosine-5', 1), ('-methyltransferase', 1), ('5-aza-dc', 1), ('cucumber', 1), ('holothuria', 2), ('leucospilota', 2), ('goto-kakizaki', 2), ('hlp', 6), ('gk', 2), ('pkb/akt', 1), ('transporter-4', 1), ('cd36', 3), ('opportunistic', 2), ('feces', 4), ('ctd', 16), ('mecamylamine', 1), ('sr16584', 2), ('shortly', 2), ('filopodia', 1), ('rhesus', 4), ('macaques', 4), ('nonhuman', 5), ('primate', 2), ('secoisolariciresinol', 1), ('diglucoside', 1), ('lgm2605', 4), ('methacholine', 1), ('bal', 4), ('brushing', 1), ('il25', 1), ('ilc2s', 2), ('cd1c+', 2), ('disproportionate', 1), ('group1', 1), ('rsi', 1), ('ccr', 1), ('b-p65', 1), ('nfkappab-p65', 1), ('posed', 1), ('celecoxib-treated', 1), ('oxidative/nitrosative', 1), ('dehydrogenase-1', 1), ('p-glycoprotein-mediated', 1), ('pax', 8), ('encounters', 1), ('innate/acquired', 1), ('mdr-1', 6), ('dehrogenase-1', 1), ('aldh-1', 6), ('rhizomes', 2), ('uplc-esi-ms/ms', 1), ('1,25', 3), ('2d3', 5), ('calcitriol', 6), ('pax+cur', 1), ('pax+1,25', 1), ('pax+cur+1,25', 1), ('pax+cur+d3', 1), ('enriching', 1), ('pregabalin-induced', 1), ('prg', 4), ('tel', 4), ('cap', 4), ('prg-induced', 5), ('guarding', 1), ('mas', 1), ('ace/ang', 1), ('ii/at1r', 1), ('ace2/ang', 2), ('1-7/masr', 2), ('counteracting', 1), ('amodiaquine', 3), ('n-desethylamodiaquine', 2), ('adq', 11), ('endemic', 2), ('hepatoxicity', 2), ('nadq', 7), ('adq-induced', 2), ('nadq-induced', 1), ('3a5', 1), ('hepg2/cyp', 1), ('snail-1/cx43/errgamma-dependent', 1), ('exposition', 8), ('controversies', 1), ('justify', 2), ('bpa-reactive', 1), ('e/n-cadherin', 1), ('vimentin/snail-1/connexin', 1), ('drug-resistance', 2), ('bpa-treated', 1), ('cx43/snail-1', 1), ('snail-1/cx43/errgamma', 1), ('pdk4', 8), ('dnr', 1), ('cytarabine', 4), ('ara-c', 1), ('glycolysis-related', 1), ('lipoamide', 1), ('isozyme', 1), ('bbp-induced', 2), ('mir-15b-5p/pdk4', 1), ('methylisothiazolinone', 2), ('mit', 8), ('disinfectant-associated', 1), ('nucleolus', 1), ('mit-treated', 1), ('adjust', 2), ('excreted', 2), ('misleading', 1), ('subsets', 3), ('under-', 1), ('overestimate', 1), ('requiring', 2), ('quantifying', 1), ('cockcroft-gault', 1), ('quit', 1), ('untapped', 1), ('striatum-a', 1), ('mesolimbic', 3), ('rewarding', 2), ('anxiogenic', 1), ('fructans', 5), ('advised', 1), ('gastro-esophageal', 1), ('reflux', 6), ('gerd', 3), ('fermentable', 1), ('oligo-', 1), ('mono-saccharides', 1), ('polyols', 1), ('fodmaps', 3), ('tlesrs', 7), ('hvs', 2), ('32.6', 1), ('high-caloric', 1), ('meal', 2), ('740', 1), ('fructan', 1), ('pcorr', 1), ('fodmap', 2), ('les', 2), ('prodrugs', 1), ('10/50/100/500', 1), ('adherent', 2), ('7.0-fold', 1), ('252.9', 1), ('42.9-fold', 1), ('prostacyclin', 1), ('43.1', 1), ('17.6-fold', 1), ('246.4', 1), ('106.3-fold', 1), ('activation/pertubation', 1), ('isothiocyanates-nuclear', 1), ('r3snx', 1), ('transforms', 1), ('itraq', 1), ('tbt-itc', 1), ('tpt-itc', 1), ('9cra', 1), ('neurotrophy', 1), ('initiatives', 1), ('aop', 4), ('aap', 4), ('pharmaceuticals/drugs', 1), ('tropomyosin', 1), ('parietal', 3), ('/kelch-like', 1), ('get', 4), ('endocannabinoid-mediated', 1), ('-trkb', 1), ('rrt', 2), ('pre-renal', 3), ('62.3', 1), ('67.5', 1), ('looked', 1), ('rtec', 2), ('granular', 3), ('casts', 1), ('20.17', 1), ('66.67', 1), ('3.51', 1), ('34.78', 1), ('86.81', 1), ('2.64', 1), ('auc-roc', 2), ('0.584', 1), ('0.445-0.723', 1), ('23.68', 1), ('92.11', 1), ('0.573', 1), ('0.465-0.680', 1), ('nitroxoline', 1), ('quinoline-based', 1), ('5-nitro-8-quinolinol', 1), ('nq', 7), ('satisfactorily', 1), ('sirt1-foxo3a', 1), ('crizotinib-induced', 2), ('crizotinib', 7), ('anaplastic', 6), ('ros1', 3), ('unfortunately', 3), ('c-parp', 1), ('acrolein-induced', 4), ('astrocytic', 5), ('254023x', 2), ('eaat1', 1), ('mapk-activated', 1), ('k1', 2), ('gla', 2), ('vk1', 13), ('hk2', 6), ('monohydrate', 1), ('mgp', 6), ('simgp', 1), ('semiquantitative', 1), ('rose', 1), ('crystals-exposed', 1), ('adhering', 1), ('upregulations', 1), ('leishmanicidal', 3), ('midgut', 5), ('lutzomyia', 2), ('evansi', 3), ('leishmaniasis', 5), ('phebotominae', 1), ('cancerogenus', 3), ('aerogenes', 1), ('otitidis', 3), ('cloacae', 2), ('soli', 1), ('ananatis', 3), ('83.3', 1), ('lipolytic', 1), ('58.3', 1), ('hormaechei', 5), ('calcoaceticus', 2), ('cellulolytic', 1), ('gyllenbergii', 2), ('amylolytic', 1), ('totality', 1), ('supernatants', 1), ('cfss', 1), ('gram-positive', 2), ('cfs', 2), ('aaods', 2), ('95.12', 1), ('faecalis', 1), ('86.90', 1), ('anova', 4), ('df=', 1), ('f=', 1), ('6.095', 1), ('0.007832', 1), ('ce-50', 1), ('47.7', 1), ('3.8', 1), ('metacyclic', 1), ('promastigotes', 2), ('leishmania', 6), ('braziliensis', 1), ('ua301', 1), ('lu', 1), ('organelle', 1), ('karyolysis', 1), ('oncotic', 1), ('sterile', 2), ('preponderance', 1), ('fulfill', 1), ('face', 6), ('synergist', 3), ('holoprosencephaly', 1), ('hpe', 4), ('22-1,800mg/kg', 1), ('7.75', 1), ('shh+/-', 3), ('hpe-associated', 1), ('teratogen', 1), ('cyclopamine', 1), ('dysmorphology', 2), ('midface', 1), ('hypotelorism', 1), ('67mg/kg', 1), ('shh-dependent', 1), ('interneurons', 6), ('teratogenicity', 4), ('33mg/kg', 1), ('30-fold', 1), ('etiologically', 2), ('//doi.org/10.1289/ehp5260', 1), ('linc01410/mir-3619-5p/foxm1', 2), ('backgrounds', 1), ('renowned', 1), ('intergenic', 1), ('1410', 1), ('linc01410', 7), (\"ethynyl-2'-deoxyuridine\", 1), ('mir-3619-5p', 1), ('mir-3619-5p/foxm1', 1), ('partner', 4), ('paced', 2), ('copulation', 1), ('scented', 2), ('solicit', 1), ('ejaculations', 2), ('unscented', 2), ('long-evans', 1), ('copulatory', 2), ('one-hole', 2), ('pacing', 3), ('divider', 3), ('four-hole', 1), ('unilevel', 1), ('conspecific', 2), ('open-field', 1), ('reconditioning', 1), ('ejaculation', 4), ('pvn', 9), ('mpoa', 1), ('vmh', 1), ('lead-mediated', 1), ('succinylation', 3), ('spermiogenesis', 2), ('kac', 5), ('ksuc', 4), ('pre-meiotic', 1), ('spermatogonia', 2), ('spg', 1), ('spermatocyte', 3), ('spc', 2), ('round', 2), ('spermatid', 2), ('succinyl-coa', 1), ('elongating', 1), ('rotenone-treated', 8), ('hm', 3), ('autolysosomes', 1), ('rfp-gfp-lc3b', 1), ('atp6v0a1', 3), ('autophagosome-lysosome', 3), ('confirmation', 1), ('argininosuccinate', 1), ('ass1', 3), ('adenosyhomocysteinase', 1), ('ahcy', 1), ('immunoblots', 1), ('dex-treated', 1), ('bromobenzene-induced', 1), ('duct', 2), ('adoption', 1), ('pre-approval', 1), ('feline', 2), ('cats', 7), ('restraining', 1), ('fiv', 1), ('fiv-infected', 4), ('anti-feline', 1), ('cd25', 1), ('lm-draining', 1), ('perforin', 1), ('granzyme', 2), ('cd1a+', 1), ('specific-pathogen-free', 1), ('cd80', 1), ('3271', 1), ('mtor-dependent', 1), ('investment', 1), ('spray-drying', 1), ('inhalable', 1), ('multifunctional', 4), ('biofilms', 1), ('biofilm', 4), ('mucolytic', 2), ('inhaler', 1), ('azithromycin', 1), ('azi', 1), ('tobramycin', 1), ('tobra', 1), ('ciprofloxacin', 7), ('cipro', 1), ('azi/nac', 2), ('tobra/nac', 2), ('cipro/nac', 1), ('drying', 1), ('co-amorphous', 1), ('5.0mum', 1), ('antibiotic/nac', 1), ('pa14', 1), ('abrupt', 1), ('salvia', 1), ('miltiorrhiza', 1), ('bunge', 3), ('plenty', 1), ('inflexibility', 1), ('poised', 1), ('acetyl', 1), ('coa', 1), ('luminometric', 1), ('phosphorylated-pdh', 1), ('e1alpha', 2), ('connects', 3), ('decarboxylation', 1), ('pdk-1', 1), ('genotoxic/carcinogenic', 1), ('ethoxyresorufin', 1), ('o-deethylase', 1), ('erod', 2), ('miricetin', 1), ('5-hydroxyflavone', 1), ('5-hf', 2), ('3-hydroxyflavone', 1), ('3-hf', 2), ('hydroxyl-groups', 1), ('phe224', 1), ('flavonoid-cyp', 1), ('pi/pi', 1), ('aminoacid', 1), ('c-ring', 1), ('helices', 2), ('ames', 1), ('non-nutritional', 1), ('sweeteners', 4), ('connecting', 1), ('sugar/sweetened', 1), ('taste', 2), ('aspartame', 1), ('rebaudioside', 1), ('stevioside', 1), ('steviol', 2), ('non-caloric', 1), ('fractalkine', 1), ('cx3cl1', 1), ('non-differentially', 1), ('cx3cl1/cx3cr1', 1), ('unpleasant', 1), ('astringency', 4), ('pellicle', 2), ('hsc-3', 2), ('procyanidin', 3), ('pf', 1), ('hscmusp', 1), ('pf+cells', 1), ('pf+saliva', 1), ('procyanidins', 3), ('dimers', 1), ('b7', 1), ('b2g', 1), ('cut-offs', 7), ('plasmas', 9), ('multi-centre', 1), ('confounder', 1), ('analyser', 1), ('screen/confirm', 1), ('nscr', 3), ('dilute', 1), ('russell', 1), ('viper', 1), ('venom', 1), ('la1/la2', 3), ('hemoclot', 2), ('la-s/la-c', 2), ('aptts', 1), ('fsl/fs', 3), ('cephen', 4), ('ls/cephen', 2), ('triple-positive', 3), ('la-negative', 2), ('1.12/1.08/8.3/1.09', 1), ('1.17/1.10/13.6/1.13', 1), ('1.12/1.13/9.7/1.10', 1), ('1.09/1.13/11.0/1.11', 1), ('la1', 1), ('la-s', 1), ('19/20', 2), ('16/20', 1), ('20/20', 1), ('fsl', 2), ('17/20', 1), ('5/25', 1), ('la-s/la-r', 1), ('between-reagent', 1), ('attention-deficit/hyperactivity', 2), ('adhd', 10), ('relied', 2), ('self-report', 1), ('physician-diagnosed', 2), ('dds', 3), ('996', 2), ('mother-infant', 1), ('dyads', 1), ('boston', 2), ('1998', 1), ('n-acetyl-l-cystein-s-yl', 1), ('-acetaminophen', 1), ('9.8', 1), ('548', 1), ('55.0', 1), ('257', 1), ('304', 1), ('30.5', 1), ('327', 1), ('32.8', 2), ('neurotypical', 1), ('tertiles', 1), ('1.40-3.69', 1), ('2.86', 1), ('1.77-4.67', 1), ('2.14', 1), ('0.93-5.13', 1), ('3.62', 1), ('1.62-8.60', 1), ('buden', 1), ('apobec3c', 2), ('dna-damage-mediated', 1), ('art', 15), ('dna-damage-intended', 1), ('apolipoprotein-b', 1), ('mrna-editing', 1), ('polypeptide-like', 1), ('3c', 1), ('a3c', 9), ('p53-deficient', 1), ('rpa32', 1), ('chk1', 2), ('employment', 1), ('zinc-coordinating', 1), ('c97s', 1), ('c100s', 1), ('deaminase-dependent', 1), ('art-induced', 1), ('igg4-related', 5), ('tracheobronchial', 3), ('miliary', 4), ('igg4-rd', 6), ('bronchovascular', 1), ('bundles', 1), ('52-year-old', 1), ('wheezing', 6), ('tapering', 1), ('lymphocytic', 1), ('stopped', 1), ('g4', 1), ('igg4', 4), ('7.35', 1), ('bronchoscopies', 1), ('igg4+', 2), ('igg4+/igg+', 1), ('hmsh2', 14), ('eoc', 6), ('discover', 3), ('platinum-sensitive/resistant', 1), ('rrbs', 2), ('hypermethylated', 2), ('a2780', 1), ('1193', 1), ('1125', 1), ('10-14', 2), ('1.85-2.31', 1), ('ppis', 9), ('iron-deficient', 1), ('omeprazole-induced', 1), ('4-methylesculetin', 2), ('glutathione-related', 1), ('collisional', 1), ('epitope', 1), ('lys70-b', 2), ('arg81-a', 2), ('glu381-b', 2), ('asp443-a', 1), ('ser444-a', 1), ('glu447-b', 1), ('ser475-a', 1), ('trp73', 1), ('phe377', 1), ('ala446', 1), ('rs5744256', 3), ('rs1834481', 3), ('rs3021094', 3), (\"'t\", 1), ('rs5744224', 3), ('il-12b', 1), ('rs3212227', 2), ('log-additive', 1), ('gga', 1), ('rs3790622', 1), ('lyn', 8), ('ige-mediated', 1), ('conjunctivitis', 6), ('anti-allergic', 2), ('substance-p', 1), ('eosinophil', 1), ('il-4/tnf-alpha', 1), ('dnp-hsa/ige', 2), ('lad2', 2), ('lyn/plcgamma/ip3r-ca2+', 2), ('lyn/erk1/2', 2), ('lyn/nf-kappab', 2), ('plcgamma1', 1), ('phosphorylation-lyn', 1), ('bafetinib', 1), ('tolimidone', 1), ('dampens', 2), ('10/per', 1), ('isocaloric', 1), ('monounsaturated', 1), ('mufa', 1), ('sfa', 6), ('assessment-insulin', 1), ('non-esterified', 1), ('nefa', 1), ('carboxylase-1', 1), ('acc1', 1), ('substrate-1', 3), ('irs1', 1), ('receptor-4', 2), ('mcp1', 1), ('acid-', 1), ('ku70', 7), ('bupivacaine-induced', 1), ('anaesthetic', 1), ('dna-pk', 5), ('nu7441', 2), ('v-fitc/pi', 2), ('calpain-mediated', 1), ('kcc2', 8), ('anesthetics', 1), ('westernblotting', 1), ('nr2a', 3), ('calpain-1', 1), ('calpain-2', 6), ('lentivirus-calpain-2', 1), ('plasmalemmal', 2), ('crossings', 1), ('ifenprodil', 3), ('isoflurane-induced', 2), ('acetoaceto-o-toluidide', 2), ('n-butyl-n-', 2), ('4-hydroxybutyl', 2), ('nitrosamine-induced', 1), ('aaot', 15), ('f344', 3), ('nitrosamine', 1), ('bbn', 1), ('0.167', 2), ('multiplicities', 1), ('o-toluidine', 1), ('otd', 2), ('jun', 3), ('urothelium', 4), ('bbn-induced', 1), ('amines', 2), ('plaque-type', 1), ('reinitiates', 2), ('hyperproliferation', 2), ('anti-psoriatic', 1), ('il-23', 2), ('resolve', 1), ('naked', 1), ('recur', 1), ('imprints', 1), ('anti-tnfalpha', 1), ('anti-il-17', 1), ('anti-il-23', 1), ('phototherapy', 1), ('hidden', 2), ('trms', 1), ('alpinetin', 5), ('ahr/suv39h1/tsc2/mtorc1/autophagy', 1), ('teer', 2), ('tnf-alpha-stimulated', 2), ('lc3b-ii', 2), ('p-ampkalpha', 1), ('ncm460', 2), ('h3k9me3', 3), ('suv39h1', 2), ('alpinetin-regulated', 1), ('ahr/suv39h1/tsc2/mtorc1', 1), ('siahr', 1), ('sitsc2', 1), ('alpinetin-mediated', 1), ('preservative', 3), ('ethoxyquin', 2), ('eq', 7), ('pigmentation', 2), ('locomotive', 1), ('paying', 1), ('duroc', 2), ('landrace', 3), ('yorkshire', 2), ('12.24', 1), ('35-day', 1), ('duodenum', 5), ('quadratic', 7), ('self-detoxification', 1), ('methionine-choline', 1), ('milieu', 1), ('nash-related', 1), ('steatohepatitic', 1), ('m1/m2', 2), ('its-associated', 1), ('wondered', 2), ('lkb1', 1), ('two-stage', 2), (\"trans-3'-hydroxy\", 1), (\"n'-nitrosonornicotine\", 1), ('rt4', 1), ('t24', 2), ('umuc3', 2), ('methyllycaconitine', 1), ('stattic', 1), ('pelvis', 2), ('nsp-116', 10), ('hemorrhagic', 4), ('ich', 4), ('collagenase-induced', 1), ('cbf', 2), ('hematoma', 2), ('collagenase', 2), ('hydrogensulfide', 1), ('hydrosulfide', 1), ('explorethe', 1), ('theliver', 1), ('four-timepoints', 1), ('atime-', 1), ('injuryeffect', 1), ('inhibitsthe', 1), ('promethazine', 7), ('noxa', 4), ('antihistaminic', 1), ('emesis', 10), ('philadelphia', 1), ('light/dark', 1), ('immobility', 1), ('thyrotropin', 1), ('trh', 1), ('axis-related', 1), ('destroyed', 4), ('scanty', 1), ('colloid', 2), ('periventricular', 1), ('heterotopia', 1), ('pnh', 4), ('flna', 1), ('consciousness', 1), ('admittance', 1), ('pacemaker', 3), ('antiepileptic', 2), ('th1/th17', 1), ('enteric-coated', 1), ('eudragit', 1), ('drug-delivery', 1), ('cargoes', 1), ('tacrolimus', 1), ('-loaded', 1), ('thioketal-based', 2), ('orally-administered', 2), ('fk506-loaded', 1), ('thioketal', 1), ('fk506-tkm', 2), ('inflamed', 1), ('dextran-sulfate', 1), ('colon-draining', 1), ('prioritised', 1), ('dispose', 1), ('flies', 1), ('sorghum', 3), ('hj', 1), ('541', 1), ('ssg', 1), ('59-3', 1), ('eradicates', 1), ('phenanthridine', 1), ('numa', 1), ('poles', 1), ('80-90', 1), ('panc1', 2), ('infiltrated', 1), ('stroma', 1), ('il-1ra', 4), ('108', 1), ('ended', 1), ('full-term', 2), ('rs1143634', 1), ('3953c', 1), ('36.4', 2), ('1.802', 1), ('1.420-2.288', 1), ('2r', 2), ('63.6', 1), ('42.8', 1), ('1.400', 1), ('1.009-1.943', 1), ('2r/2r', 1), ('2r/4r', 1), ('periconceptional', 1), ('prognosticates', 1), ('in-hospital', 2), ('60-day', 3), ('0.97', 1), ('0.951-981', 1), ('0.975', 1), ('0.964-0.986', 1), ('0.948', 1), ('0.571', 1), ('0.629.', 1), ('fair', 1), ('0.753', 1), ('golden', 1), ('tremulous', 3), ('jaw', 4), ('movements', 5), ('memantine-delta9', 2), ('neuroanatomical', 2), ('tremorolytic', 1), ('unstudied', 1), ('antitremor', 2), ('haloperidol-induced', 3), ('parkinsonian-like', 2), ('receptor-targeting', 1), ('l-glutamate', 2), ('entopeduncular', 1), ('reticulata', 1), ('supratrigeminal', 1), ('subthalamic', 1), ('cuneiform', 1), ('21680', 1), ('ventrolateral', 1), ('bicuculline', 1), ('rostral', 1), ('parvicellular', 1), ('reticular', 1), ('supra-additively', 1), ('involuntary', 1), ('epimedium', 2), ('tfe', 6), ('spraque-dawley', 1), ('begins', 1), ('fifth', 3), ('factor-beta-1', 1), ('3-beta-hydroxysteroid', 1), ('justicia', 2), ('gendarussa', 4), ('folk', 1), ('depurative', 1), ('laxative', 1), ('jgme', 6), ('-intoxicated', 1), ('1,1-diphenyl-2-picrylhydrazyl', 1), ('malonylaldehyde', 1), ('histo-architectural', 1), ('cf-intoxicated', 1), ('71.31', 1), ('0.42', 2), ('134.82', 1), ('47.69', 1), ('118.44', 1), ('scientifically', 1), ('justifies', 1), ('ginkgolide-a', 1), ('gut-liver-axis', 1), ('countering', 1), ('soothing', 1), ('ginkgolide', 1), ('terpene', 1), ('trilactone', 1), ('ginkgo', 1), ('biloba', 1), ('gut-liver', 4), ('tlr4/myd88/nfkappab', 1), ('lbp', 1), ('procalcitonin', 2), ('amlexanox', 11), ('ulcer', 6), ('noncanonical', 1), ('kinase-epsilon', 1), ('ikkepsilon', 3), ('tank-binding', 1), ('tbk1', 2), ('ampk/nrf2', 1), ('mir-30e-mediated', 1), ('tif', 7), ('ptcs', 3), ('limonin', 5), ('pyrene-induced', 2), ('cea', 2), (\"5'-nucleotidases\", 1), ('transpeptidase', 1), ('p-induced', 5), ('limonin-enhanced', 1), ('ikkgamma', 3), ('parkin-mediated', 1), ('/p65', 1), ('parkin/ikkgamma/p65', 2), ('mitofusin', 1), ('dynamin', 1), ('spots', 1), ('opa1-p65', 1), ('6-ohda-increased', 1), ('smad-dependent', 2), ('andro', 7), ('andrographis', 2), ('paniculata', 1), ('tgf-beta1-stimulated', 1), ('nih', 1), ('3t3', 1), ('plfs', 1), ('andro-induced', 1), ('cavin-1/ptrf', 4), ('lipodystrophy', 2), ('caveolae', 1), ('ultrastructures', 1), ('membrane-embedded', 2), ('caveolins', 1), ('caveolin-1', 1), ('peripherally', 3), ('cavins', 1), ('cavin-1', 2), ('caveolin', 1), ('cavin', 1), ('cgl', 2), ('lzd2', 2), ('analogous', 1), ('stretch', 1), ('frameshift', 2), ('p.glu176argfs', 2), ('trp-tagged', 1), ('negatively-charged', 1), ('raft-mimicking', 1), ('cholesterol/sphingomyelin-rich', 1), ('peptide-lipid', 1), ('hydrophilicity', 1), ('membrane-binding', 1), ('hitherto', 3), ('disinfecting', 1), ('drops', 3), ('ded', 2), ('medium-to-long', 1), ('bak-cm', 6), ('hce', 5), ('5.10-3', 1), ('prepare', 1), ('ccl2', 5), ('atf-3', 2), ('phospho-p38', 1), ('h-bak-cm', 1), ('phospho-p44/42', 1), ('paracrine', 1), ('subcortical', 1), ('narrowing', 1), ('arterioles', 1), ('myelinated', 1), ('constrictions', 1), ('swellings', 1), ('sheaths', 1), ('shortening', 7), ('ampa', 14), ('hypoxia/ischemia-induced', 1), ('clofibrate', 7), ('fluoride-induced', 5), ('gfap/iba-1/anti-calbindin', 1), ('rinses', 1), ('lisinopril', 3), ('hanging', 1), ('ionized', 1), ('adaptor', 4), ('-binding', 1), ('calbindin-d28k', 1), ('phthalate-mediated', 1), ('vite', 3), ('homogenate', 6), ('toluidine', 1), ('dbp-mediated', 1), ('dbp-associated', 1), ('bmp10', 10), ('smad-mediated', 2), ('stat3-mediated', 1), ('activin', 6), ('receptor-like', 1), ('alpha-myosin', 1), ('beta-adrenoreceptor', 1), ('smad-', 1), ('stat3-regulated', 1), ('d-serine', 5), ('offsprings', 3), ('racemase', 1), ('d-amino', 1), ('daao', 3), ('alanine-serine-cysteine', 1), ('transporter-1', 1), ('asc-1', 2), ('nmdars', 2), ('nr1', 2), ('pnd20', 1), ('precipitants', 4), ('acute-on-chronic', 2), ('aclf', 4), ('feared', 2), ('geography', 1), ('interleukin-4', 1), ('anti-il-6', 1), ('bpa-suppressed', 1), ('chemosensitivity', 1), ('nfat1', 1), ('2-aminoanthracene', 3), ('insulin-producing', 1), ('2aa', 5), ('accomplish', 1), ('mg/kg-2aa', 1), ('roughly', 2), ('bodyweight', 1), ('30.1', 1), ('2aa-treated', 1), ('spp1', 2), ('il-7', 1), ('erk/nf-kappab', 4), ('magnolol-inhibited', 3), ('sk-hep1/luc2', 1), ('phospho-erk', 1), ('ser536', 1), ('azoxymethane-induced', 1), ('style', 1), ('xha', 6), ('humulus', 1), ('lupulus', 1), ('azoxymethane', 2), ('aom', 2), ('enzymic', 1), ('aom-induced', 2), ('chemopreventive/therapeutic', 1), ('usnic', 10), ('dna-pkcs', 3), ('gamma-h2a.x', 1), ('dibenzofuran', 1), ('lichen', 1), ('snu-1', 1), ('cleaved-parp', 1), ('gammah2a.x', 3), ('patm', 1), ('ser1981', 1), ('chk-2', 1), ('bccs', 2), ('sk-br3', 1), ('her2-enriched', 2), ('informatics', 1), ('bpa-exposure', 1), ('mcf-7/bpa', 3), ('sk-br3/bpa', 3), ('mda-mb-231/bpa', 3), ('hif', 1), ('il19', 1), ('sparc', 1), ('/dss-induced', 1), ('cac', 1), ('apcmin/+', 1), ('ser', 1), ('mastitis', 3), ('bmecs', 2), ('coli-derived', 1), ('1019', 1), ('deps', 12), ('=1.3', 1), ('536', 1), ('483', 1), ('nlr', 3), ('tlr4/nf-kappab', 1), ('nlrp3-inflammasome', 1), (\"p'-dichlorodiphenyltrichloroethane\", 1), ('kinase/m2', 1), ('progressions', 1), ('transporter1', 2), (\"p'-ddt-induced\", 2), ('erk/pkm2', 1), ('professor', 3), ('chu', 3), ('hao-ran', 2), ('acupuncture', 4), ('moxibustion', 1), ('spleen-stomach', 4), ('meridians-collaterals', 2), ('successively', 1), ('famous', 1), ('doctors', 1), ('zhou', 1), ('mei-sheng', 1), ('thoughts', 1), ('classics', 1), ('proposition', 2), ('examines', 1), ('refines', 1), ('acupoint', 5), ('pays', 1), ('zusanli', 1), ('acupuncture-moxibustion', 1), ('acupoints', 1), ('inherits', 1), ('emphasizes', 2), ('spirit', 2), ('qi', 1), ('homes', 3), ('apoe-/-', 5), ('lxrs', 2), ('lxr-antagonistic', 1), ('indoor', 2), ('his-lxralpha-pull-down', 1), ('lxralpha-', 1), ('lxrbeta-antagonist', 1), ('foam', 2), ('lxr-dependent', 1), ('lxr-antagonist', 3), ('sr9238', 1), ('peritoneal', 2), ('//doi.org/10.1289/ehp5039', 1), ('calycosin', 4), ('diet-fed/stz', 1), ('il-33/st2', 1), ('microvasculature', 1), ('enforces', 1), ('impetus', 1), ('il33/st2', 3), ('il33', 1), ('diet/stz-induced', 1), ('hfd-stz', 1), ('albuminuria', 1), ('nf-kappabp65', 4), ('t2dm-induced', 1), ('ultramicroscopic', 1), ('homoharringtonine', 2), ('mapk/ekr1/2', 2), ('hht', 8), ('myelocytic', 1), ('nvp-bhg712', 1), ('cyclina2', 1), ('slam-family', 1), ('nkg2d', 6), ('dnam-1', 5), ('germline-encoded', 1), ('slam', 1), ('-family', 1), ('sfrs', 3), ('dnax', 1), ('redundantly', 1), ('slamf6', 1), ('sfr', 4), ('cd27+', 1), ('cd11b-', 1), ('sfr-deficient', 1), ('missing-self', 1), ('lactoperoxidase', 2), ('enzyme-a', 1), ('eliminates', 1), ('shelf', 1), ('hydroxytoluene', 1), ('propyl', 1), ('sepharose-4b-l-tyrosine-sulfanilamide', 1), ('377.7', 2), ('3397.8', 1), ('635.8', 1), ('weakening', 1), ('probes/inhibitors', 3), ('anti-schistosomal', 2), ('praziquantel', 1), ('frontline', 1), ('schistosomiasis', 1), ('ntd', 1), ('macro-parasitic', 1), ('fluke', 1), ('schistosomes', 1), ('schistosome', 3), ('anti-schistosome', 1), ('genomics', 1), ('methodology/principle', 1), ('writers', 1), ('erasers', 1), ('schistosoma', 1), ('mansoni', 2), ('schistosomula', 3), ('roboworm', 1), ('titrations', 1), ('nvs-cecr2-1', 1), ('writer', 1), ('lly-507', 2), ('bay-598', 2), ('eraser', 1), ('gsk-j4', 3), ('lly-507/bay-598', 2), ('smyd2', 2), ('jmjd3', 1), ('characterisation', 1), ('compounds/putative', 1), ('smp_000700', 1), ('compound-mediated', 1), ('catalysed', 1), ('sismp_000700', 1), ('oviposition', 1), ('vitelline', 1), ('laid', 1), ('permeable', 2), ('smp_034000', 1), ('gsk-j1', 1), ('impermeable', 1), ('conclusion/significance', 1), ('methylation/demethylation', 1), ('premenopausal', 1), ('-matched', 1), ('estrogen-metabolizing', 1), ('protein-1c', 1), ('ur-144', 4), ('prematurity', 1), ('childbearing', 1), ('-3/-7', 2), ('am281', 2), ('receptor-independent', 2), ('gender-dependent', 1), ('transferases', 1), ('drd4b', 1), ('zc4h2', 1), ('sequelae', 3), ('monoxide', 3), ('st2', 6), ('dns', 2), ('st2-mediated', 1), ('cd206-positive', 2), ('st2-positive', 2), ('microglia-associated', 2), ('55,212-2-mediated', 1), ('55,212-2-induced', 1), ('cannabinoid-induced', 5), ('cyp1b1-dependent', 1), ('catfish', 1), ('hydroxylate', 1), (\"3,3',4,4'-tetrachlorobiphenyl\", 1), ('unconfirmed', 1), ('dl-pcbs', 2), (\"3,4,4',5-tetrachlorobiphenyl\", 1), ('v79-derived', 2), ('h/18', 1), ('h/6', 1), ('exposure/recovery', 1), ('regimes', 2), ('v79-hcyp1b1', 1), ('regime', 2), ('v79-mz', 1), ('immuno-fluorescent', 1), ('centromere', 1), ('pcb-treated', 1), ('centromere-negative', 1), ('clastogenic', 2), ('microrna-29b-3p', 2), ('aqp4', 10), ('inflow', 1), ('1800', 1), ('vacuolations', 1), ('farmland', 1), ('acute-toxicity', 2), ('organogenesis', 3), ('degradations', 1), ('ptgs2b', 1), ('mir-181b-5p', 2), ('endothelial-mesenchymal', 2), ('endocan', 3), ('tgfbr1', 3), ('endmt', 7), ('mir-181b', 8), ('rpaecs', 2), ('i-endmt', 2), ('down-expressed', 1), ('endocan/tgfbr1-mediated', 1), ('cxcl14', 7), ('nhkcs', 6), ('lauryl', 1), ('sls', 2), ('urushiol', 1), ('sls-', 1), ('urushiol-induced', 1), ('deg', 2), ('tg429', 4), ('sensitizer-induced', 1), ('87.5', 1), ('mapk/erk', 1), ('jak3/stat6', 1), ('allergenic', 2), ('nio', 7), ('bears', 1), ('nio-induced', 1), ('instilling', 1), ('sb431542', 2), ('col-i', 1), ('col-iii', 1), ('p-smad3', 2), ('metalloproteinase9', 1), ('metalloproteinase1', 1), ('timp1', 1), ('nio-triggered', 1), ('abovementioned', 1), ('mmp9/timp1', 1), ('fuels', 2), ('cryo-em', 1), ('euglena', 1), ('gracilis', 1), ('phylum', 1), ('euglenozoa', 1), ('cardiolipins', 1), ('protein-lipid', 1), ('rotor-stator', 1), ('comprises', 4), ('phylum-specific', 1), ('subcomplex', 1), ('stalks', 1), ('if1', 1), ('trypanosomatids', 1), ('pomfret', 5), ('stearoyl-coenzyme', 1), ('stressors', 4), ('pampus', 1), ('argenteus', 1), ('9-fold', 1), ('18:1n-9/18:0', 1), ('293t', 3), ('neurokinin', 3), ('nk1-receptor-mediated', 1), ('cisplatin-evoked', 1), ('5-ht3-and', 1), ('nk1-receptors', 1), ('5-htp', 1), ('2-methyserotonin', 1), ('gr73632', 3), ('antiemetic', 10), ('shrews', 1), ('sp-evoked', 1), ('sp-induced', 1), ('non-emetic', 1), ('inverse-agonist/antagonist', 1), ('netupitant', 1), ('emetic', 2), ('tretinoin', 10), ('lotion', 9), ('once-daily', 2), ('race', 3), ('racial', 2), ('postinflammatory', 1), ('formulations.objective', 1), ('acne.methods', 1), ('vehicle-controlled', 1), ('n=1640', 1), ('noninflammatory', 3), ('2-grade', 1), ('evaluator', 1), ('egss', 1), ('clear/almost', 1), ('hypo-/hyper-pigmentation', 1), ('4-point', 1), ('0=none', 1), ('3=severe', 1), ('visit.results', 1), ('56.9', 1), ('53.4', 1), ('47.1', 1), ('39.4', 2), ('=0.001', 2), ('p=0.026', 1), ('51.7', 1), ('46.1', 1), ('34.9', 1), ('p=0.035', 1), ('23.6', 1), ('16.1', 1), ('p=0.013', 1), ('african/american', 1), ('12.', 1), ('races', 1), ('role-social', 1), ('dryness', 2), ('risk.j', 1), ('dermatol', 1), (':1128-1138.', 1), ('mycophenolic', 3), ('rejection', 1), ('mpa-glucuronide', 1), ('mpag', 2), ('mpa-acyl', 1), ('acmpag', 2), ('variabilities', 1), ('co-variates', 1), ('vitro-in', 1), ('ki=5.2', 1), ('ugt1a9', 12), ('1.8-fold', 2), ('ki=127.5', 1), ('mpa-glucuronidation', 1), ('indole-3-acetic', 1), ('3-carboxy-4-methyl-5-propyl-2-furanpropionic', 1), ('doxepin', 7), ('c6-glioma', 3), ('pi3k-mediated', 1), ('tcas', 2), ('nonantidepressant', 1), ('anti-insomnia', 1), ('glio-protective', 1), ('phosphatidylinositol-3-kinase-mediated', 1), ('neuroinflammatory-related', 1), ('estrus', 1), ('tunisia', 3), ('compiled', 1), ('pharmacy', 1), ('sidi', 1), ('thabet', 1), ('departments', 1), ('governmental', 1), ('veterinarians', 1), ('29.6', 1), ('rodenticides-anticoagulants', 1), ('non-anticoagulants', 1), ('71.4', 2), ('ruminants', 2), ('bee', 2), ('partition', 2), ('incriminated', 1), ('farm', 1), ('cartography', 1), ('polo-like', 2), ('plk1', 5), ('taxanes', 2), ('atp-competitive', 1), ('gsk461364', 3), ('onvansertib', 3), ('taxane', 2), ('sum149', 3), ('sum159', 4), ('0.62', 2), ('clonogenic', 3), ('tumorsphere', 2), ('capitalbio', 2), ('nucleic', 4), ('xpert', 2), ('mtb/rif', 2), ('extrapulmonary', 2), ('taqman', 2), ('eptb', 2), ('purulent', 1), ('summing', 2), ('prejudge', 1), ('facilitators', 3), ('enrollment', 6), ('ctn-0067', 1), ('extended-release', 1), ('naltrexone', 1), ('xr-ntx', 3), ('treatment-as-usual', 1), ('oud', 4), ('team', 1), ('semi-structured', 1), ('digitally', 1), ('recruitment-related', 1), ('staff', 2), ('engaging', 1), ('encourage', 1), ('thematically', 1), ('respondents', 2), ('homelessness', 1), ('criminal', 1), ('justice', 1), ('locating', 1), ('unsuppressed', 1), ('time-consuming', 1), ('stigma', 1), ('seeking', 1), ('distrust', 1), ('medication-related', 1), ('fear', 1), ('trusted', 1), ('peer', 2), ('outreach/recruitment', 1), ('partnerships', 1), ('referrals', 1), ('personnel', 1), ('outreach', 1), ('collaborating', 1), ('syringe', 1), ('cd63-enriched', 2), ('multivesicular', 2), ('turtles', 2), ('sertoli-germ', 1), ('mvbs', 4), ('immunopositivity', 2), ('surround', 2), ('elongated', 1), ('spermatids', 4), ('prolongations', 1), ('acrosome', 1), ('chrysanthemum', 1), ('cfcs', 1), ('amphiosomes', 1), ('turtle', 1), ('chromium-induced', 1), ('non-occupational', 1), ('disorganization', 1), ('fibril', 2), ('matrix-related', 1), ('pathway-mediated', 2), ('heterotropic', 3), ('dronedarone-induced', 1), ('distribute', 1), ('dronedarone', 1), ('dnd', 2), ('6-hydroxyflavone', 1), ('dnd-induced', 1), ('7-position', 1), ('4-position', 1), ('charging', 1), ('viii', 2), ('pzc', 3), ('potentiometric', 1), ('isoelectric', 1), ('iep', 4), ('electrokinetic', 1), ('apparatus', 2), ('hydroxides', 1), ('alumina', 1), ('titania', 1), ('nominally', 1), ('vo2', 1), ('bn', 1), ('zearalenone-induced', 1), ('post-weaning', 5), ('gilts', 10), ('intestine-related', 1), ('zea-induced', 3), ('0.5-1.5', 1), ('mlns', 5), ('homology-associated', 1), ('-nuclear', 1), ('14.01', 1), ('corn-soybean', 1), ('immunoreactive', 1), ('hemeoxygenase', 1), ('nonsurgical', 3), ('reinke', 4), ('1997', 2), ('cold', 1), ('steel', 1), ('microlaryngeal', 1), ('phonosurgery', 1), ('microdebrider', 1), ('photoangiolytic', 1), ('voice', 6), ('hyaluronidase', 1), ('handicap', 1), ('perceptual', 1), ('grbas', 1), ('laryngeoscopic', 1), ('vfs', 1), ('duplicates', 1), ('262', 2), ('217', 1), ('abstracts', 1), ('titles', 1), ('full-text', 1), ('read', 1), ('vocal', 1), ('randomization', 1), ('pranoprofen-induced', 1), ('pranoprofen', 2), ('ppf', 8), ('ophthalmic', 1), ('epithelialization', 1), ('scrape', 1), ('wounds', 1), ('stomal', 1), ('corneas', 2), ('0.0125', 1), ('ripk', 1), ('0.00625', 1), ('happened', 1), ('ligustilide', 8), ('prostate-cancer-associated', 1), ('cafs', 4), ('nfs', 1), ('prostate-cafs', 1), ('p-p53', 1), ('caf', 1), ('pedro-ximenez', 1), ('-dde-induced', 1), ('mus', 2), ('spretus', 2), ('biomolecules', 2), ('-dde', 3), ('noxious', 2), ('sun-dried', 1), ('pedro', 1), ('ximenez', 1), ('white-grape', 1), ('pxm', 3), ('polyphenol-rich', 1), ('enjoy', 1), ('sts', 5), ('sleep-waking', 4), ('kdrl', 1), ('mcherry', 1), ('myl7', 1), ('vegfr2', 1), ('rest', 2), ('hcrt', 1), ('hcrtr', 1), ('aanat2', 1), ('dicentrine', 10), ('aporphinic', 1), ('death-inducing', 1), ('ciap2', 1), ('cflip', 1), ('blockes', 1), ('tnf-alpha-activated', 1), ('tak-1', 1), ('tio2', 21), ('authorized', 1), ('biodegradation', 1), ('sera', 4), ('transposon', 1), ('methicillin', 1), ('underlines', 1), ('illnesses', 1), ('tn-seq', 1), ('kcl', 1), ('duf2538', 1), ('sausa300_0957', 1), ('957', 2), ('oxacillin', 2), ('peptidoglycan', 3), ('transglycosylase', 1), ('pbp2', 1), ('antibiofilm', 2), ('selenoesters', 3), ('selenoanhydrides', 1), ('isostere', 1), ('selenoanhydride', 1), ('vero', 1), ('virus-2', 1), ('hsv-2', 1), ('typhimurium', 1), ('candida', 1), ('anaerobes', 1), ('nosocomial', 1), ('pharmacokinetic/pharmacodynamics', 2), ('drug-loaded', 1), ('plga', 5), ('heterogeneously', 2), ('nanoparticle-mediated', 1), ('tumor-dependent', 1), ('vascular-induced', 1), ('unaggregated', 1), ('uptaken', 1), ('extra-', 1), ('intra-cellularly', 1), ('customization', 1), ('np-mediated', 1), ('aims/hypothesis', 1), ('metabolising', 1), ('min6', 4), ('betatc-6', 1), ('ins1', 1), ('alpha-tc1', 1), ('alpha-tc3', 1), ('inducers', 1), ('3-mc', 2), ('~2-fold', 1), ('~40-fold', 1), ('~80-fold', 1), ('conclusions/interpretation', 1), ('prairie', 3), ('vole', 3), ('amylin', 11), ('residue-22', 1), ('amyloidogenicity', 2), ('type-2', 2), ('non-amyloidogenic', 2), ('amylins', 1), ('non-conservative', 1), ('lys-1', 3), ('asn-22', 2), ('sidechain', 1), ('asn', 1), ('ladder', 1), ('7-fold', 1), ('buffer', 3), ('buffered', 1), ('22.', 2), ('mir-107', 18), ('insulted', 1), ('mir-107/pdcd10', 1), ('ad-related', 1), ('fibronectin-loaded', 2), ('polyelectrolyte', 1), ('interventional', 1), ('biofunctional', 2), ('poly-l-lysine/heparin', 1), ('nanoparticles-modified', 1), ('nanocoating', 1), ('endothelialization', 1), ('abusers', 3), ('pser396', 3), ('knocking-out', 1), ('circle', 2), ('carotenoids', 3), ('daucus', 2), ('carota', 2), ('l.-supercritical', 1), ('enzyme-assisted', 2), ('carrots', 1), ('supercritical', 1), ('tetraterpenoids', 1), ('pros', 1), ('cons', 3), ('fermentation', 1), ('aali', 3), ('high-dosage', 1), ('gpr109a', 1), ('slc58a', 1), ('pathomorphological', 1), ('spinetoram', 7), ('cxcl-c1c', 1), ('briefly', 2), ('well-accepted', 1), ('2-ag', 14), ('endocannabinoid-like', 1), ('excitotoxical', 2), ('ohsc', 2), ('abn-cbd', 1), ('entourage', 1), ('ramification', 2), ('vanished', 1), ('co-applied', 1), ('collecting', 1), ('osteoclast-associated', 1), ('fe', 1), ('5b', 1), ('tracp-5b', 1), ('tracp', 1), ('metalloprotein', 1), ('anhydrases', 1), ('rankl', 1), ('osteoprotegerin', 1), ('opg', 1), ('opg/rankl', 1), ('stenting', 5), ('flap', 7), ('velopharyngeal', 2), ('vpd', 3), ('commonplace', 1), ('superiorly', 2), ('lhsc', 2), ('ward', 1), ('bihourly', 1), ('checks', 1), ('11.0', 1), ('8.7', 1), ('60.0', 1), ('28.2', 1), ('pierre-robin', 1), ('8.2', 2), ('apnea', 4), ('stent-related', 1), ('captured', 1), ('self-limiting', 1), ('epistaxis', 1), ('extruded', 1), ('port', 1), ('granuloma', 1), ('lanthanum', 7), ('carbonate', 3), ('magnified', 2), ('endoscopy', 2), ('70-year-old', 1), ('esophagogastroduodenoscopy', 1), ('whitish', 3), ('cobblestone-like', 2), ('corpus', 2), ('antrum', 2), ('narrow-band', 1), ('yellowish-white', 2), ('subepithelial', 1), ('amphophilic', 1), ('interstitium', 2), ('cd68', 2), ('histiocytes', 2), ('histiocyte-mediated', 1), ('phagocytosis', 3), ('energy-dispersive', 1), ('rough', 1), ('commencement', 1), ('interferon-beta-induced', 1), ('mir-1', 4), ('clearing', 1), ('detrimentally', 1), ('orthologous', 3), ('tre-2/bub2/cdc16', 1), ('tbc', 1), ('rab', 1), ('gtpase-activating', 1), ('tbc-7', 1), ('tbc1d15', 2), ('tbc-7/tbc1d15', 1), ('interferon-b', 1), ('ifn-b', 1), ('safeguarding', 1), ('proteotoxic', 1), ('-protopanaxadiol', 2), ('-ppd', 7), ('egfr/mapk', 2), ('raf-1', 1), ('variously', 1), ('syb-prii', 5), ('syb-prii-1', 7), ('syb-prii-2', 2), ('biting', 1), ('flicking', 1), ('paws', 1), ('formalin-induced', 2), ('xylene-induced', 1), ('nav1.8', 2), ('ttx-resistant', 3), ('rickettsial', 3), ('pyrexia', 2), ('puo', 1), ('weil', 3), ('felix', 2), ('scrub', 3), ('typhus', 3), ('spotted', 2), ('101', 2), ('felix-positive', 1), ('=320', 1), ('titres', 1), ('40.1', 1), ('tends', 2), ('originating', 3), ('microflora', 1), ('ain-93-based', 1), ('diet-containing', 1), ('treg-related', 1), ('haptoglobin', 1), ('radiomics', 5), ('18f-fdg', 2), ('durable', 1), ('dcb', 3), ('iiib-iv', 1), ('pet+ct', 1), ('kullback-leibler', 1), ('kld', 1), ('mprs', 3), ('operator', 1), ('lasso', 1), ('nomogram', 2), ('aucs', 1), ('0.79-0.94', 1), ('0.71-0.94', 2), ('0.68-0.92', 1), ('c-indices', 2), ('0.68-0.80', 1), ('0.66-0.82', 1), ('0.69-0.84', 1), ('0.77-0.88', 1), ('0.69-0.91', 1), ('pet/ct-based', 1), ('electrotunable', 1), ('nanoplasmonics', 2), ('metamaterials', 1), ('photonics', 2), ('photonic', 1), ('reflectors/absorbers', 1), ('electrovariable', 1), ('disassembly', 1), ('reflectivity', 2), ('~93', 1), ('~1', 1), ('tunability', 1), ('voltage-controlled', 1), ('au-nanoparticle', 1), ('tin/ag', 1), ('electrolyte', 1), ('physics', 1), ('precisely', 2), ('nonlinearity', 1), ('1,3-dichloropropene', 2), ('kinetically-derived', 1), ('1,3-d', 6), ('bronchioloalveolar', 1), ('nose-only', 1), ('h/d', 1), ('d/week', 1), ('area-under-the-curve', 1), ('=30', 1), ('shifts', 1), ('cis-', 1), ('trans-1,3-d', 1), ('non-relevance', 1), ('1,3-d-induced', 1), ('matrices', 2), ('gst-m1', 1), ('ugt-1a1', 1), ('40-50', 1), ('ng/l', 3), ('chemico-biological', 1), ('pdk4-deficient', 2), ('pdk4-/-', 4), ('apap-adduct', 1), ('ucp2', 2), ('render', 2), ('seizurogenic', 1), ('gabaar', 7), ('seizure-like', 1), ('ptx', 4), ('listed', 2), ('credible', 2), ('5d', 2), ('nhgri', 1), ('tupfel', 1), ('concentration-effect', 1), ('tectum', 2), ('spiking', 1), ('pams', 2), ('validating', 1), ('throughput-screening', 1), ('antiseizure', 1), ('countermeasures', 1), ('4g/kg', 1), ('pw24', 1), ('desmin', 1), ('remarked', 2), ('at2r', 2), ('1a9', 2), ('ugt2b15', 1), ('ugt2b4', 1), ('ugt1a7', 3), ('ugt2b17', 1), ('4-mu', 1), ('cleared', 4), ('precautions', 2), ('tendon', 1), ('serum-free', 3), ('n2', 1), ('b27', 1), ('raybio', 1), ('line-derived', 1), ('mir-185', 7), ('sept5', 4), ('bibliography', 1), ('shsy-5y', 5), ('lrrk2', 15), ('sybr', 1), ('bromfenac', 10), ('udpga', 1), ('alamethicin', 1), ('indolinone', 2), ('thioether', 2), ('driscoll', 1), ('methide', 1), ('add', 1), ('zafirlukast', 7), ('cyslt1r', 2), ('hbmvecs', 1), ('rescuing', 1), ('ogd/r-induced', 6), ('gant61', 4), ('fibrosis/regeneration', 1), ('gli1/2', 2), ('shh-egfp-cre', 1), ('injury/fibrosis', 2), ('ligand/pathway', 1), ('glis', 1), ('inconsistencies', 3), ('rcts', 2), ('pubmed/medline', 1), ('web', 1), ('scopus', 1), ('wmd', 6), ('specify', 2), ('=1000', 1), ('iu/day', 3), ('=12', 1), ('durations', 3), ('hyperuricemic', 1), ('and-if', 1), ('available-cardiovascular', 1), ('distinguished', 1), ('calorie', 1), ('purine-low', 2), ('mediterranean-style', 3), ('+0.3', 1), ('-2.9', 1), ('diets/dash', 1), ('at-risk', 1), ('onfh', 10), ('vte', 6), ('sharing', 1), ('12,232', 2), ('revision', 6), ('insurance', 1), ('files', 1), ('matching', 1), ('socioeconomic', 4), ('non-onfh', 5), ('53.8', 1), ('61.9', 1), ('insignificantly', 1), ('p-values', 1), ('concordantly', 1), ('1.14', 2), ('0.91-1.42', 1), ('0.262', 1), ('pain-killer', 1), ('coplanar', 2), ('gh-igf-1', 2), ('4-5-week-old', 1), ('3,3', 1), ('5-pentachlorobiphenyl', 1), ('micromol/kg', 1), ('soy', 1), ('hypocalcemia', 1), ('hyperparathyroidism', 1), ('cyp27b1', 1), ('cyp24', 1), ('gh-pattern-regulated', 1), ('ratlaps', 1), ('trpv6', 1), ('pmca1b', 1), ('ch-223191', 1), ('hcho', 1), ('sixth', 3), ('eighth', 2), ('lysate', 1), ('tcp1-eta', 7), ('unified', 1), ('semantic', 1), ('sub-stratifying', 2), ('atn', 2), ('unambiguously', 1), ('co-relating', 1), ('perfused', 2), ('krebs-dextran', 1), ('reabsorbed', 1), ('uphill', 1), ('photosystem', 2), ('aerial', 2), ('prasiola', 2), ('crispa', 3), ('antarctica', 2), ('lightf', 1), ('menegh', 1), ('draught', 1), ('sunlight', 1), ('light-absorption', 1), ('long-wavelength', 1), ('lwc', 4), ('710', 2), ('consist', 1), ('thallus', 2), ('terrestrial', 1), ('680', 1), ('713', 1), ('emitted', 1), ('735', 1), ('p700', 1), ('photo-oxidation', 1), ('far-red', 1), ('thalli', 1), ('repressors', 1), ('socs3', 6), ('pik3r1', 5), ('mir-221-mediated', 1), ('trail-induced', 1), ('interferon-mediated', 1), ('things', 1), ('tnfsf10', 1), ('trail-friendly', 1), ('sensitises', 1), ('trail-inhibiting', 1), ('context-', 1), ('entity-dependent', 1), ('calcineurin-drp1', 2), ('xx', 2), ('xy', 2), ('inevitably', 1), ('h1', 1), ('karyotype', 2), ('h9', 1), ('h1-', 2), ('h9-cm', 2), ('noncytotoxic', 1), ('hypertrophic-related', 1), ('nppa', 2), ('nppb', 1), ('cnabeta-mediated', 1), ('cnabeta-drp1', 1), ('cnabeta-knockdown', 1), ('xx-karyotyped', 1), ('xy-karyotyped', 1), ('chemoprotective', 1), ('phoenix', 2), ('dactylifera', 2), ('pd-1', 2), ('palm', 1), ('ethanolic', 1), ('hp-extract', 4), ('adr-induction', 1), ('hemistepsin', 2), ('hemistepta', 1), ('lyrata', 3), ('viability-guided', 1), ('lyrata-mediated', 1), ('hsa-induced', 1), ('ccl4-mediated', 1), ('nf-kappab/akt-dependent', 1), ('sulfasalazine-induced', 1), ('sasp', 9), ('sasp-induced', 3), ('187', 6), ('sasp-treated', 2), ('epoxygenase', 1), ('hub', 2), ('cyp2b50', 1), ('cyp2c50', 1), ('cyp2c39', 1), ('cyp2c38', 1), ('cyp2c54', 1), ('cyp2a5', 1), ('gsta1', 2), ('gstt2', 1), ('gstm2', 1), ('multi-biological', 1), ('corannulene', 2), ('non-planar', 1), ('cor', 5), ('bowl-shaped', 1), ('myriad', 1), ('hepa1-6', 1), ('cyp1/cyp1', 1), ('cyp1a/cyp1a', 1), ('derivatization', 1), ('bowl-like', 1), ('-responsive', 1), ('lecithin', 1), ('lec', 1), ('lec-cur-plga-mms', 3), ('payload', 1), ('s3', 2), ('12mug/ml', 1), ('20mug/ml', 1), ('non-cancerous', 1), ('-acetyl-n', 2), ('-formyl-5-methoxykynuramine', 2), ('afmk', 6), ('alzheimer-like', 1), ('intracerebroventricularly', 1), ('arteriosclerosis', 2), ('dentist', 1), ('dentists', 1), ('hesitate', 1), ('bleed', 1), ('dmft', 3), ('written', 1), ('consent', 1), ('0.0302', 1), ('0.0042', 1), ('pectoris', 1), ('dialkyl', 1), ('phosphates', 1), ('daps', 2), ('high-exposure', 1), ('thyroid-related', 1), ('enzymes/proteins', 2), ('hormone-disrupting', 1), ('cautious', 1), ('glp', 6), ('rs1056827', 1), ('rs1056836', 1), ('rs1048943', 1), ('glp-induced', 3), ('interrelated', 1), ('230', 1), ('rs619586', 2), ('nonsmoker', 1), ('nondrinker', 1), ('diacetoxyscirpenol', 2), ('das', 5), ('nscs', 3), ('subgranular', 1), ('sgz', 2), ('metallothionein-i/ii+', 1), ('gamma-h2ax+', 1), ('malondialdehyde+', 1), ('ogg1', 12), ('break-related', 1), ('cdkn2a', 1), ('hilar', 2), ('pvalb+', 1), ('grin2a', 1), ('chrna7', 1), ('type-2-progenitor', 1), ('reln+', 1), ('reln-related', 1), ('itsn1', 1), ('arc+', 1), ('arc-mediated', 1), ('0.09-0.29', 1), ('c57bl/10j', 3), ('dna/rna', 2), ('hras', 3), ('napb-induced', 5), ('non-tumour', 2), ('napb-treated', 1), ('oxazepam', 1), ('anle145c', 6), ('thermodynamically', 1), ('traps', 1), ('oligomers', 4), ('hiapp', 7), ('diphenylpyrazole', 1), ('nm-sized', 1), ('anle145c-stabilized', 1), ('sink', 1), ('sub-stoichiometric', 1), ('hiapp-induced', 1), ('ins-1e', 1), ('convert', 1), ('preformed', 1), ('hipk2', 11), ('hypoxia/reoxygenation-induced', 1), ('homeodomain', 1), ('kinase-2', 2), ('stress-responsive', 2), ('hypoxia/reoxygenation', 1), ('h/r', 2), ('h/r-induced', 3), ('comparatively', 2), ('h/r-impaired', 1), ('hipk2-mediated', 1), ('hur', 7), ('ym155-treated', 2), ('ym155', 4), ('ym155-induced', 7), ('destabilized', 1), ('abt-199', 2), ('bcl2/bcl2l1', 1), ('circumvented', 1), ('meg01', 1), ('licocoumarone', 2), ('bxpc-3', 3), ('dyrk1a', 9), ('dual-specificity', 1), ('activity-guided', 1), ('glycyrrhiza', 1), ('uralensis', 2), ('fisch', 2), ('expect', 1), ('isopentenyl-substituted', 1), ('benzofuran', 1), ('g.', 1), ('lc', 6), ('12.56', 1), ('microscale', 4), ('thermophoresis', 4), ('mst', 1), ('darts', 1), ('dyrk1a-overexpressing', 1), ('50.77', 1), ('c-met', 1), ('farrerol', 8), ('ros/nox4/erk1/2', 1), ('rhododendron', 1), ('tgf-beta1/smad2', 1), ('diphenyliodonium', 1), ('nox4-mediated', 1), ('ros/erk1/2', 1), ('propranolol', 9), ('ang-2', 8), ('angiopoietin-2', 1), ('tie-2', 3), ('kinase-b', 1), ('phospholyrated-akt', 1), ('hemec', 1), ('mechanistical', 1), ('futhermore', 1), ('pept1in', 1), ('cinnabar', 13), ('mercury-containing', 2), ('oligopeptide', 1), ('pept1', 4), ('hgs', 5), ('hgcl2', 8), ('bl', 2), ('chromatography-inductively', 1), ('uplc-icp/ms', 1), ('h+', 1), ('western-blot', 3), ('49.39', 1), ('30.41', 1), ('pept1-sirna', 1), ('dickkopf-1', 1), ('dickkopf-related', 1), ('8/22', 1), ('48/53', 1), ('90.6', 1), ('57.6', 1), ('19/33', 1), ('0.019', 3), ('dkk1-mediated', 1), ('mir-130a-5p/foxa2', 4), ('shh/gli1', 2), ('e13.5', 1), ('e15.5', 1), ('e17.5', 1), ('e19.5', 4), ('e21.5', 1), ('mir-130a-5p', 4), ('ish', 1), ('cdh-associated', 2), ('foxa2-driven', 1), ('parameritannin', 2), ('a-2', 2), ('urceola', 2), ('huaitingii', 2), ('pa-2', 11), ('hgc27', 4), ('isobolographic', 1), ('gap-43', 2), ('disease-like', 1), ('1-40', 1), ('25-35', 1), ('beta-secretase', 1), ('colliculus', 2), ('h2s-induced', 6), ('thalamus', 1), ('283', 1), ('296', 1), ('q-value', 1), ('initiators', 1), ('menaquinone-4', 2), ('avs', 5), ('high-pi', 5), ('wfn', 4), ('clots', 1), ('wfn-induced', 4), ('mk-4', 9), ('alpha-modified', 1), ('mk-4-induced', 1), ('physiological-pi', 1), ('statement', 4), ('deemed', 1), ('unsuitable', 1), ('avs-patient', 1), ('adamts19', 6), ('non-syndromic', 1), ('population1', 1), ('handful', 1), ('disease2-7', 1), ('consanguineous', 1), ('recapitulating', 1), ('lacz', 1), ('inference', 2), ('enhancer-binding', 1), ('endocardial', 1), ('wnt-adamts19-klf2', 1), ('foot-and-mouth', 2), ('chad', 3), ('fmd', 2), ('batha', 6), ('wadi', 3), ('fira', 3), ('ennedi', 1), ('1,520', 1), ('928', 1), ('216', 1), ('dromedaries', 1), ('fmdv', 2), ('nsp', 1), ('375/928', 1), ('cri', 1), ('19-63', 1), ('seroprevalences', 2), ('27/32', 1), ('35/45', 1), ('21/25', 1), ('18/27', 1), ('14/22', 1), ('13/22', 1), ('pastures', 1), ('herds', 1), ('caprine', 1), ('priocheck', 1), ('serotyping', 1), ('sat1', 1), ('sat2', 3), ('serotypes', 7), ('circulated', 1), ('29/67', 1), ('vp1', 1), ('topotype', 1), ('cameroon', 1), ('98.60', 1), ('nachr/hdac4', 2), ('intergenerational', 1), ('anesthetized', 1), ('hdac4', 3), ('star/3beta-hsd', 3), ('editorial', 1), ('neuro-inflammation', 1), ('triphosphate-binding', 2), ('tumor-related', 1), ('abcc', 3), ('gc.the', 1), ('plotter', 2), ('lauren', 2), ('annotation', 2), ('visualization', 2), ('database.abcc1', 1), ('abcc3', 4), ('abcc7', 5), ('abcc8', 4), ('abcc9', 5), ('abcc10', 4), ('abcc6', 1), ('classifications', 1), ('abcc5', 2), ('.abcc1', 1), (\"4'-\", 1), ('5-hydroxylations', 1), ('s-warfarin', 4), ('tienilic', 4), ('7-hydroxywarfarin', 4), ('aucinfinity', 2), ('5-hydroxydiclofenac', 1), ('acylglucuronide', 1), (\"4'-hydroxydiclofenac\", 2), ('~0.8', 1), ('transplants', 2), ('reconstructive', 5), ('microsurgeons', 5), ('necessitating', 1), ('living-donor', 1), ('scheduling', 1), ('anastomosis', 3), ('loupes', 2), ('opted', 2), ('48.5', 1), ('liver-related', 1), ('stent-assisted', 4), ('coiling', 3), ('stent-coiling', 1), ('pharmacy-mediated', 5), ('stent-coiled', 1), ('aru', 2), ('p2y12', 1), ('pru', 2), ('angiographic', 1), ('2.6-14.0', 1), ('58.5', 1), ('coil', 1), ('basilar', 1), ('pre-procedure', 1), ('442.5', 1), ('363-594', 1), ('123.5', 1), ('1-252', 1), ('88.5', 1), ('violated', 1), ('83.9', 1), ('places', 1), ('cedrelone', 5), ('limonoid', 1), ('trichilia', 1), ('catigua', 1), ('meliaceae', 1), ('t4-2', 1), ('beta1-integrin', 1), ('pdha1', 3), ('herpesvirus', 2), ('neoplasm', 2), ('hhv8', 2), ('latently', 1), ('glutaminolysis', 1), ('gdh1', 2), ('supplying', 1), ('anaplerosis', 1), ('glut3', 1), ('e1-alpha', 1), ('oncometabolite', 1), ('d-2-hydroxyglutarate', 1), ('d2hg', 1), ('anti-neuroinflammatory', 2), ('eudesmanolides', 4), ('wedelia', 5), ('sphagneticola', 2), ('trilobata', 3), ('pruski', 1), ('syn', 1), ('notoriously', 1), ('weed', 1), ('flowers', 1), ('1-3.', 2), ('11.77', 1), ('guides', 1), ('thinking', 1), ('mapbbr3', 4), ('homogeneous', 1), ('quantum-dot', 1), ('nucleation', 1), ('organometal', 1), ('halide', 1), ('perovskite', 1), ('ohp', 1), ('large-crystalline', 1), ('low-defect', 1), ('ch3nh3pbbr3', 1), ('plane', 2), ('uniformity', 1), ('seedless', 1), ('photocurrent', 1), ('hysteresis', 1), ('nonsaturated', 1), ('photodetectors', 1), ('beam', 1), ('crispr-generated', 1), ('loss-', 1), ('reliance', 1), ('lof', 4), ('gof', 4), ('gstp', 4), ('prdx1', 1), ('hydroperoxide', 2), ('tbhp', 2), ('12.6-fold', 1), ('0.8-fold', 1), ('cumene', 1), ('chp', 2), ('r-', 1), ('-carvone', 1), ('nrf2a-dependent', 1), ('nootropic', 1), ('neferine', 6), ('aluminium', 3), ('age-associated', 1), ('alcl3', 7), ('occurrences', 1), ('aggressively', 1), ('neferine-treated', 2), ('neuropreventive', 1), ('lysosomes', 6), ('lysosomal-associated', 1), ('rab7', 3), ('obstructed', 1), ('exacerbating', 1), ('hla-f-as1/mir-330-3p/pfn1', 1), ('hla-f', 1), ('hla-f-as1', 9), ('mir-330-3p', 7), ('profilin', 1), ('pfn1', 5), ('lymphoma/leukmia-2', 1), ('over-expressions', 1), ('sponging', 3), ('mir-330-3p/pfn1', 1), ('phenyltetrahydroisoquinoline', 2), ('aldoximes', 3), ('anti-triazoles', 1), ('phosphylated', 4), ('crises', 1), ('terminating', 1), ('sarin', 2), ('vx', 1), ('cyclosarin', 2), ('tabun', 1), ('piq', 2), ('huisgen', 1), ('1,3', 1), ('dipolar', 1), ('alkyne-', 1), ('azide-building', 1), ('anchor', 1), ('aldoxime', 1), ('oximes', 8), ('assure', 1), ('reactivator', 1), ('100-', 1), ('6-times', 1), ('2-pam', 7), ('universality', 1), ('sulfoxide', 4), ('smo2', 5), ('divinyl', 1), ('dvs', 5), ('cimetidine', 1), ('pregnenolone-induced', 1), ('nr1i2', 1), ('defensome', 1), ('approached', 1), ('surprise', 1), ('down-stream', 2), ('osthole', 12), ('cnidium', 1), ('monnieri', 1), (\"'cusson\", 1), ('regrettably', 1), ('utilize', 1), ('cyclinb1', 1), ('caspase3/9', 1), ('acetaldehyde', 4), ('binge-like', 1), ('two-bottle', 1), ('post-transcriptionally', 1), ('irf5', 2), ('stat4', 4), ('tnfsf4', 5), ('mecp2', 3), ('tlr7', 1), ('jordanian', 2), ('tlr-7', 1), ('urgently', 2), ('ga-dm', 8), ('nci-h460', 2), ('prap', 1), ('ga-dm-induced', 1), ('reactivated', 2), ('words', 1), ('subchondral', 8), ('non-ovariectomy', 1), ('osteoarthritis-like', 1), ('mankin', 2), ('articular', 7), ('glyphosate-containing', 1), ('indiscriminate', 2), ('aminomethylphosphonic', 3), ('caspase-glo', 1), ('glyphosate-', 1), ('ampa-induced', 1), ('wnt3a', 2), ('wnt5a', 2), ('wnt7a', 2), ('camk2a', 2), ('camk2b', 2), ('tubb3', 2), ('sycp2', 1), ('pik3c3', 2), ('snca', 1), ('sqstmt', 1), ('hspbap1', 1), ('kcnipi', 1), ('chemicals/agents', 1), ('1.25-2.5', 1), ('h4k12', 1), ('h4r3', 3), ('prmt1', 2), ('methylates', 1), ('dialehyde', 1), ('adox', 1), ('trichostation', 1), ('relay', 1), ('sonchus', 1), ('oleraceus', 2), ('ampk/akt/', 1), ('sol', 5), ('ampk/akt/gsk-3beta', 1), ('suppressions', 1), (\"5'-monophosphate\", 2), ('phytocannabinoid-', 1), ('tetrad', 14), ('-thc-', 1), ('win55212-2-', 1), ('xlr11-induced', 1), ('cb1-', 1), ('cb2-', 1), ('gpr55-knockout', 1), ('win55212-2', 3), ('xlr11', 2), ('cb2rs', 3), ('microinjections', 1), ('cb1-ko', 1), ('cb2-ko', 1), ('intra-ventricle', 1), ('-thc-induced', 1), ('gpr55s', 2), ('cb1/cb2rs', 1), ('refers', 1), ('otto', 1), ('tri-level', 1), ('pseudo-coding', 1), ('reaction-based', 1), ('subsystems', 1), ('genecards', 1), ('mapk1', 1), ('cdk8', 1), ('ndat', 10), ('nano-diamino-tetrac', 1), ('tetraiodothyroxine', 1), ('deaminated', 1), ('nano-particulated', 1), ('oec-m1', 1), ('scc-25', 1), ('thyroxine-induced', 1), ('chloropicrin', 2), ('majorly', 1), ('lacrimating', 1), ('h2a.x', 1), ('kinase-c-jun', 1), ('catabolic', 1), ('prompting', 1), ('lead-hit', 1), ('coaching', 3), ('palliative', 3), ('caregivers', 4), ('appalachia', 1), ('eolpc', 6), ('comfort', 1), ('virginia', 1), ('wv', 3), ('fampalcare', 6), ('nurses', 2), ('coach', 1), ('family-managed', 1), ('caregiver', 1), ('5-weekly', 1), ('affiliated', 1), ('selecting', 1), ('directives', 1), ('collaboration', 1), ('leaders', 1), ('nct04153890', 1), ('complexation', 1), ('uranium', 4), ('anoxic', 2), ('sediments', 4), ('threatens', 1), ('ore-processing', 1), ('alluvial', 2), ('tetravalent', 1), ('immobile', 1), ('hydrologic', 1), ('geochemical', 1), ('groundwater', 1), ('belief', 1), ('subsurface', 2), ('density-based', 1), ('dominantly', 1), ('+iv', 1), ('adsorbed', 2), ('clay', 2), ('minerals', 2), ('om-coated', 1), ('om-associated', 1), ('chondroprotective', 3), ('human-enriched', 1), ('acknowledged', 1), ('hydroxytyrosol', 2), ('ht', 2), ('pcy', 2), ('anti-osteoathritic', 1), ('osteoarticular', 1), ('grapeseed', 1), ('opco', 2), ('psychotherapy', 2), ('bodily', 10), ('smartphone-triggered', 4), ('kptk', 1), ('bpt', 7), ('bi-center', 1), ('switzerland', 1), ('pre-post', 1), ('waiting-period', 1), ('nested', 4), ('curatively', 1), ('plan', 1), ('aiming', 2), ('t0', 2), ('t1', 1), ('post-intervention', 1), (\"'body\", 1), ('cohesion', 1), ('semi', 1), ('acceptance', 1), ('biopsychosocial', 1), ('nct03707548', 1), ('component-resolved', 1), ('mite', 2), ('hdm', 3), ('ait', 2), ('hdm-ait', 1), ('sige', 1), ('sigg4', 1), ('pan-serotype', 1), ('dengue', 6), ('non-structural', 2), ('denv', 4), ('mosquito-borne', 1), ('flavivirus', 1), ('antigenically', 1), ('ns1', 8), ('anthocyanin-functionalized', 2), ('anthocyanin', 3), ('pigments', 2), ('postocular', 1), ('keratoconjunctivitis', 1), ('lenses', 7), ('wearable', 1), ('brassica', 1), ('functionalize', 1), ('soaking', 3), ('drop-casting', 1), ('purple', 1), ('rgb', 1), ('triplets', 1), ('colors', 1), ('delphinidin', 1), ('deionized', 1), ('poly-2-hydroxy', 1), ('ethylmethacrylate', 1), ('cross-linked', 1), ('7.4.', 1), ('sepimostat', 5), ('nmda-induced', 1), ('gabexate', 1), ('camostat', 1), ('spermidine', 1), ('ifenprodil-binding', 1), ('bell', 1), ('saga', 1), ('tetrahydrocannabinolic', 2), ('cannabidiolic', 4), ('gaping', 6), ('anti-nausea', 2), ('cbda', 10), ('thca', 7), ('0.5-5', 1), ('way100635', 2), ('5-ht1a', 1), ('sr141716', 7), ('mk886', 2), ('anti-emetic', 1), ('celastrol', 9), ('gaussia', 1), ('princeps', 1), ('luciferase-based', 1), ('split', 1), ('slca', 4), ('beta-arrestin2', 3), ('366', 1), ('htrf-based', 1), ('sirius', 1), ('arrestin-based', 1), ('pten/akt/mtor', 3), ('mir-153-3p', 8), ('1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-hydrochloride', 1), ('mpp+-treated', 3), ('mir-153-3p-mediated', 1), ('hastens', 2), ('beta-associated', 1), ('tied', 2), ('protein-tyrosine', 3), ('trodusquemine', 1), ('happ-j20', 1), ('coincides', 1), ('ad.significance', 1), ('neuron-targeted', 1), ('alkylphenols', 2), ('4-cumylphenol', 1), ('4-cp', 7), ('estrogen-like', 1), ('progressed', 2), ('2ag', 4), ('aka', 1), ('pkb', 1), ('141716a', 1), ('hipsc-neurons', 1), ('label', 2), ('encephalopathies', 1), ('synthetically', 1), ('pharmacoresistant', 3), ('drks00013177', 1), ('anticonvulsive', 1), ('up-titrated', 1), ('april', 3), ('19.7', 1), ('7.5-52.5', 1), ('3.7-28.3', 1), ('aed', 1), ('drop-outs', 1), ('40.0', 3), ('18.2-58.5', 1), ('somnolence', 1), ('34.3', 1), ('5.7', 1), ('36-824', 1), ('reasonable', 1), ('insulin-mediated', 3), ('arboviruses', 1), ('arthropod-borne', 1), ('wnv', 1), ('debilitating', 5), ('mosquito', 3), ('arboviral', 1), ('malleable', 1), ('modules', 2), ('sting-mediated', 1), ('host-pathogen', 1), ('arthropod', 1), ('pertain', 1), ('non-cancer', 7), ('gcts', 3), ('cov434', 4), ('2,2-dichlorodiphenyldichloroethylene', 1), ('hexachlorobenzene', 3), ('gtcs', 1), ('hgrc1', 3), ('eugenol', 9), ('restricts', 1), ('ser37', 3), ('phosphorylation-an', 1), ('phenylpropanoid', 1), ('clove', 1), ('cuisine', 1), ('eac', 1), ('cd44+/cd24-/low', 1), ('distorted', 2), ('hplc-tof/ms-based', 1), ('non-targeted', 1), ('hplc-tof/ms', 1), ('glycerophospholipid', 1), ('hypotaurine', 1), ('d-glutamine', 1), ('d-glutamate', 1), ('nicotinate', 1), ('m-trifluoromethyl-diphenyl', 2), ('m-cf3-phse', 6), ('hypernociceptive', 2), ('frey', 1), ('hypernociception', 1), ('ampk/mtor', 2), ('freely', 1), ('lc3ii/lc3i', 4), ('nicotine-treated', 1), ('ampk-mtor-p70s6k', 1), ('11beta-hydroxysteroid', 2), ('organotins', 6), ('unborn', 1), ('11beta-hsd2', 6), ('tpt', 17), ('inhibition/knock-down', 1), ('glucocorticoid-dependent', 1), ('pasmcs', 4), ('1alpha-kv1.5', 1), ('remodelling', 2), ('pasmc', 2), ('kv1.5', 3), ('oxide-1', 1), ('dpo-1', 1), ('apigenin-induced', 2), ('hif-1alpha-kv1.5', 1), ('famoxadone-cymoxanil', 7), ('zabrafish', 1), ('sinuosity', 1), ('arid1a', 7), ('estrogen-receptor-positive', 2), ('swi/snf', 3), ('endocrine-resistant', 1), ('degrader', 1), ('fulvestrant', 1), ('degraders', 1), ('arid1a-dependent', 1), ('lineage-determining', 1), ('foxa1', 3), ('gata-binding', 1), ('gata3', 1), ('er-foxa1', 1), ('safety-related', 2), ('adrs', 1), ('properly', 3), ('launch', 1), ('srras', 3), ('srra', 10), ('issuance', 1), (\"'yellow\", 1), ('letter', 4), (\"'blue\", 1), ('publicly', 1), ('backward/forward', 1), ('akaike', 1), ('0.94-2.4', 1), ('issued', 2), (\"'acute\", 1), (\"'clinically\", 1), ('revised', 2), ('3-year', 1), ('6.4-24.4', 1), ('27.8-52.3', 1), ('56.8', 1), ('41.8-68.0', 1), ('non-monoclonal', 2), ('postmarketing', 2), ('aetiologies', 1), ('skim-1', 6), ('ukim-1', 6), ('non-febrile', 6), ('pct', 1), ('3.88', 1), ('0.82', 1), ('cisplatin-resistance', 4), ('cisplatin-resistant', 3), ('ovcar3/ddp', 11), ('oc', 2), ('atcc', 1), ('ovcar3/dpp', 1), ('emt-related', 1), ('trigonelline', 10), ('deprivation-induced', 1), ('deprivation/reperfusion', 1), ('ogd/r-caused', 1), ('dismutases', 1), ('failure-related', 1), ('benzoquinones', 1), ('5-isopropyl-2-methyl-1,4-benzoquinone', 1), ('2-tert-butyl-1,4-benzoquinone', 1), ('tbu-q', 1), ('2,5-dimethyl-p-benzoquinone', 1), ('dime-q', 1), ('p-benzoquinone', 1), ('ph-q', 1), ('ros-scavenging', 1), ('tlr4-cd14', 1), ('procaspase-1', 1), ('flip', 1), ('multi-lineage', 1), ('col-1', 1), ('sb202190', 1), ('acetamiprid-based', 1), ('neo', 3), ('0.1-100', 3), ('macromolecule', 1), ('gluthatione', 1), ('diclofop-methyl', 2), ('sv-ba', 1), ('cardiac-related', 1), ('disordering', 1), ('precardiac', 1), ('mesoderm', 7), ('wnt-mediated', 1), ('benzophenone-3', 4), ('propylparaben', 2), ('r-loops', 5), ('estrogen-receptor', 1), ('bp-3', 15), ('53bp1', 1), ('hybrid-specific', 1), ('s9.6', 1), ('1mum', 2), ('5mum', 2), ('r-loop', 1), ('//doi.org/10.1289/ehp5221', 1), ('bioaccumulative', 1), ('0.5mg/kg', 1), ('3.07mum', 1), ('noael', 3), ('dam', 1), ('preconception', 1), ('sires', 1), ('longitudinally', 2), ('ghr', 1), ('stat5', 1), ('unappreciated', 1), ('//doi.org/10.1289/ehp5414', 1), ('hypersecretion', 1), ('burning', 1), ('pine', 4), ('2.5mum', 1), ('gel-forming', 1), ('sub-acute', 1), ('oropharyngeal', 1), ('ankyrin-1', 1), ('coniferaldehyde', 1), ('aitc', 1), ('egfr/erbb1', 1), ('cantharidin', 2), ('migration/invasion', 2), ('ccat1', 3), ('decidualization', 7), ('escs', 12), ('receptive', 1), ('pregnancy-related', 3), ('metabolism/signaling', 1), ('anti-aromatase', 1), ('labyrinth-specific', 1), ('cited', 1), ('motivation', 1), ('fetal-placental', 1), ('maternal-fetal', 1), ('born', 1), ('21.', 1), ('delta9-thc-exposed', 1), ('labyrinth', 4), ('epcam', 2), ('pericytes', 1), ('diepoxybutane', 2), ('p53-target', 1), ('xcl1', 9), ('lymphoblasts', 6), ('deb', 1), ('x-c', 1), ('3.3-fold', 1), ('deb-induced', 4), ('deduce', 1), ('p53scan', 1), (\"5'-agacatgcctagacatgcct-3\", 1), ('tss', 3), ('deb-exposed', 3), ('p53-binding', 1), ('-2.579', 1), ('over-stimulation', 1), ('cannard', 1), ('antimuscarinic', 1), ('pralidoxime', 1), ('obidoxime', 1), ('obi', 6), ('na-ache', 1), ('thiermann', 1), ('worek', 1), ('dms', 1), ('autoinjector', 5), ('isometrically', 1), ('scaled', 1), ('equimolar', 1), ('racine', 2), ('centrally', 1), ('multitrait', 2), ('photographs', 1), ('67,040', 1), ('myoc', 1), ('p.gln368ter', 1), ('glaucoma-associated', 1), ('myocilin', 1), ('decile', 2), ('bottom', 1), ('15-fold', 1), ('4.20', 1), ('manifest', 2), ('lower-risk', 1), ('atox1', 13), ('a-induced', 4), ('deadly', 1), ('antioxidant-1', 1), ('trans-well', 1), ('non-metastatic', 1), ('p47', 1), ('phox', 1), ('nuclear-targeted', 1), ('domain-mutated', 1), ('road', 6), ('greenness', 4), ('non-alzheimer', 6), ('administrative', 1), ('45-84', 1), ('residents', 1), ('678,000', 1), ('built', 1), ('1.07-1.20', 1), ('highway', 1), ('1.02-1.16', 1), ('0.97-1.08', 1), ('1.05-1.20', 1), ('irbesartan', 2), ('-overdose', 1), ('irb', 7), ('nitrosative', 2), ('apap-caused', 1), ('c57bl6', 1), ('0-16', 1), ('1-24h', 1), ('5-50mg/kg', 1), ('alcl3-treated', 3), ('38-fold', 1), ('//doi.org/10.1289/ehp5701', 1), ('shrapnel', 4), ('intra-articular', 3), ('nails', 2), ('74-year-old', 1), ('sri', 1), ('lankan', 1), ('sided', 1), ('limp', 1), ('8-year', 1), ('wear', 1), ('shrapnel-induced', 1), ('exclude', 1), ('periarticular', 1), ('foreign', 2), ('dihydroartemisinin', 2), ('r248q', 14), ('-expressing', 9), ('adm', 7), ('adm.', 2), ('-erk1/2-nf-kappab', 1), ('-harbored', 1), ('enolate-forming', 1), ('cispt', 1), ('oxaliplatin', 3), ('life-saving', 1), ('pt-based', 1), ('neuropathies', 1), ('cipn', 2), ('sensorineural', 2), ('complicates', 1), ('devoted', 1), ('underwhelming', 1), ('enol', 2), ('4-acetyl-3,5-dihydroxyphenyl', 1), ('-2-oxocytclopentane-1-carboxamide', 1), ('gavinol', 1), ('hsab', 1), ('character', 2), ('electrophiles', 1), ('separable', 1), ('4alpha', 5), ('hbv', 9), ('sometime', 1), ('nucleot', 1), ('ide', 1), ('anti-hbv', 4), ('hepg2-hntcp', 2), ('postinfection', 1), ('closed', 3), ('2.77', 1), ('40.4', 1), ('rimonabant-treated', 1), ('trim47', 11), ('zucker', 2), ('zdf', 1), ('~160', 1), ('~59', 1), ('microalbumin', 1), ('protein-based', 1), ('~64', 1), ('pdgfr-beta', 1), ('gper/cam/enos', 1), ('microfilaments', 2), ('myh7b', 1), ('esc-based', 1), ('cetylpyridinium', 2), ('cpc', 10), ('aerosols', 1), ('two-step', 1), ('surfacten', 1), ('1,2-dipalmitoyl-sn-glycero-3-phosphocholine', 1), ('homologues', 1), ('c16-bac', 1), ('c12-', 1), ('c14-bac', 1), ('bac-', 1), ('cpc-exposed', 1), ('caspase-3-inhibitor', 1), ('pressure/trough', 1), ('pi-a', 2), ('isotherm', 2), ('langmuir-wilhelmy', 1), ('afm', 2), ('subphase', 1), ('pyridinium', 1), ('isotherms', 2), ('topographic', 1), ('condensed', 1), ('caspase-3-dependent', 1), ('interneuronopathy', 3), ('sex-dimorphic', 2), ('dimorphism', 1), ('cck-containing', 1), ('cck-interneuron', 1), ('pointing', 2), ('cell-autonomous', 1), ('lfps', 1), ('stratum', 1), ('pyramidale', 1), ('sharp-wave', 1), ('ripples', 1), ('high-frequency', 1), ('oscillation', 1), ('consolidation', 1), ('circuitries', 1), ('cck+', 1), ('tg2576', 4), ('mid-life', 1), ('cras', 2), ('cras-targeting', 1), ('anti-hypertensive', 1), ('rras', 2), ('underactive', 1), ('diminazene', 1), ('aceturate', 1), ('dize', 4), ('mid-aged', 1), ('13-14-month-old', 1), ('abeta42', 1), ('synaptosomes', 1), ('9-10-month-old', 1), ('cognitively', 1), ('12-13-month-old', 1), ('amyloid-related', 1), ('plt', 8), ('3911', 1), ('wuhan', 2), ('-5.02', 1), ('-9.53', 1), ('-4.63', 1), ('-7.50', 1), ('-1.67', 1), ('-4.56', 1), ('-8.11', 1), ('-0.86', 1), ('1.80', 2), ('1.26', 1), ('2.56', 1), ('2.59', 1), ('1.54', 2), ('2.33', 1), ('beijing', 4), ('rolling', 1), ('hourly', 1), ('stations', 1), ('geocoded', 1), ('mixed-effect', 1), ('first-year', 2), ('fvc', 2), ('pred', 2), ('eotaxin', 1), ('displacing', 1), ('cd40', 1), ('scd40l', 1), ('anti-amnesic', 5), ('7-fluoro-1,3-diphenylisoquinoline-1-amine', 2), ('fdpi', 7), ('multitarget', 1), ('5-25', 1), ('i.g', 1), ('scopolamine', 3), ('3-5.', 1), ('vehicle-control', 1), ('afterward', 1), ('orts', 1), ('amnesia', 1), ('scopolamine-treated', 1), ('scopolamine-exposed', 1), ('pearson', 1), ('reinforced', 2), ('fundc1', 6), ('pink1/parkin-dependent', 3), ('removes', 1), ('pink1/parkin', 2), ('coordinate', 1), ('fundc1-knocked', 1), ('cyazofamid', 8), ('0.21', 1), ('cm/s', 1), ('83.1', 1), ('oct3', 1), ('oat3-', 1), ('oat1-mediated', 1), ('cyazofamid-drug', 1), ('resistance-related', 2), ('dulaglutide', 6), ('aggrecan', 3), ('sw1353', 2), ('glp-1r', 1), ('mmp-13', 1), ('adamts', 1), ('adamts-5', 1), ('ages-induced', 1), ('fluoroquinolones', 6), ('1,6-bisphosphatase', 4), ('monkey', 2), ('dysglycemia', 2), ('gatifloxacin', 3), ('gluconeogenic', 3), ('enscs', 2), ('enecs', 2), ('prl', 1), ('hoxa10', 1), ('denscs', 1), ('enec', 1), ('pursued', 1), ('mutation-driven', 1), ('phosphoribosyltransferase', 1), ('nampt', 17), ('kaplan', 1), ('meier', 1), ('mononucleotide', 1), ('gastroprotective', 6), ('lupeol-derived', 1), ('lupeol-stearate', 1), ('hexane', 1), ('maytenus', 1), ('salicifolia', 1), ('stearate', 1), ('laurate', 1), ('caprylate', 1), ('ethanol/hcl', 3), ('np-sh', 2), ('alpha-2', 1), ('alpha2-ar', 2), ('prostaglandins', 1), ('pge', 2), ('euthanasia', 1), ('anti-secretory', 1), ('pylorus-ligated', 1), ('ulcerated', 1), ('64.45', 1), ('6.58', 1), ('ed50', 1), ('ulcerogenesis', 1), ('gastroprotection', 1), ('indomethacin-induced', 1), ('obtention', 1), ('diversified', 1), ('scant', 1), ('+-2', 1), ('regressions', 1), ('ptrend', 1), ('2.08', 1), ('3.36', 1), ('2.09', 1), ('eicosadienoic', 1), ('acid/eicosapentaenoic', 1), ('stearic', 1), ('odd-chain', 1), ('n-3', 2), ('pufas', 6), ('pufas/n-6', 1), ('aa-mediated', 1), ('inflammasomes', 1), ('phoenixin-20', 5), ('pulp', 4), ('pulpal', 1), ('manifestation', 3), ('sort', 1), ('fairly', 1), ('sirt1-p53', 2), ('annually', 2), ('pressure-loaded', 1), ('2days', 1), ('operation', 1), ('agglutinin', 1), ('wga', 1), ('malonyldialdehyde', 1), ('nad+/nadh', 4), ('acetyl-p53', 1), ('lipoic', 5), ('liash/h', 6), ('lias', 2), ('~150', 1), ('systemically', 2), ('silica-instillated', 1), ('paroxetine', 8), ('2-signal', 1), ('jak2-stat3', 2), ('phytohemagglutinin-induced', 1), ('immunomodulation', 1), ('jak2/stat3-modulated', 1), ('toxicologic', 1), ('alpha-cypermethrin', 4), ('ak', 2), ('nefl', 1), ('nefh', 1), ('syn1', 1), ('netosis', 4), ('galphai/o/', 1), ('ros/', 1), ('cbs', 3), ('ly6g', 1), ('burst', 2), ('galphai/o', 1), ('jwh133', 1), ('cb1-mediated', 1), ('ccl4-treated', 1), ('galphai/o/ros/p38', 1), ('injury-mediated', 1), ('catecholaminergic', 1), ('notify', 1), ('timed', 2), ('19th', 1), ('2.31', 1), ('quercetin-fenitrothion', 1), ('fenitrothion-intoxicated', 1), ('worth', 1), ('mentioning', 1), ('shortfalls', 1), ('catecholamines', 1), ('fluoroquinolone', 1), ('trovafloxacin', 2), ('vitros', 1), ('idili', 3), ('lps/tnf', 1), ('tnf/lps', 1), ('pulsatile', 1), ('a20', 1), ('coherently', 1), ('tnf-induced', 1), ('translocations', 1), ('tvx-induced', 1), ('underlining', 2), ('convincingly', 1), ('alpha-asarone', 13), ('phenylpropene', 1), ('venosus-bulbus', 1), ('t-wave', 1), ('gata5', 1), ('puma', 3), ('afap1', 1), ('precocious', 3), ('icpp', 9), ('gm', 8), ('gnavus', 2), ('callidus', 1), ('bromii', 1), ('roseburia', 1), ('inulinivorans', 1), ('coprococcus', 1), ('eutactus', 1), ('leptum', 1), ('lactatifermentans', 1), ('fusobacterium', 1), ('gemmiger', 1), ('cd163deltasrcr5', 5), ('marc-145', 5), ('prrsv-2', 4), ('uncoating', 5), ('cd163', 11), ('srcr5', 5), ('prrsv', 3), ('li11', 1), ('chr6', 1), ('tjm', 1), ('vr2332', 1), ('prrsv-n', 1), ('endosomes', 2), ('gp2a', 1), ('gp3', 1), ('gp5', 1), ('cd163-binding', 1), ('virions', 1), ('3-phenoxybenzoic', 5), ('trans-dichlorochrysanthemic', 5), ('associative', 1), ('nephrotoxicants', 3), ('non-nephrotoxicants', 2), ('gentamicin-', 1), ('25-fold', 1), ('gentamicin-treated', 1), ('allicin', 10), ('allicin-treated', 1), ('halt', 1), ('apap-stimulated', 1), ('kisspeptin1', 2), ('weakens', 1), ('peroxide-caused', 1), ('htr8', 8), ('-impaired', 4), ('imprecise', 1), ('-triggered', 1), ('valuation', 1), ('si-kiss1', 1), ('aforesaid', 1), ('ascertaining', 1), ('3-kinase/protein', 1), ('b/mammalian', 1), ('annulled', 1), ('diverting', 1), ('-caused', 1), ('bpf-induced', 1), ('exposured', 1), ('2/signal', 1), ('3/suppressor', 1), ('jak2/stat3/socs3', 1), ('ag490', 1), ('er-jak2/stat3/socs3', 1), ('ptp4a3-mediated', 4), ('vertically', 1), ('4a3', 2), ('ptp4a3', 7), ('endosulfan-exposed', 2), ('-composed', 1), ('synchronization', 1), ('ckd-related', 1), ('jnk1', 2), ('jnk2', 1), ('is-mediated', 1), ('nephrectomy-induced', 1), ('intercalated', 1), ('discs', 1), ('toxin-is', 1), ('gliclazide', 8), ('universal', 1), ('immune-associated', 1), ('ailments', 1), ('costing', 1), ('withheld', 1), ('spotlight', 1), ('propitious', 1), ('regenerates', 1), ('phx', 6), ('transcriptomics', 3), ('hgf', 2), ('temporality', 1), ('background/objective', 1), ('necessitates', 1), ('h1792', 1), ('phase-contrast', 1), ('recolonization', 1), ('thc/cbd', 1), ('mir-126-3p', 2), ('mir-181a', 2), ('phthalate-induced', 1), ('dehp-induced', 3), ('dehp-alone', 1), ('acid-binding', 1), ('protein-9', 1), ('factor2', 1), ('haeme', 1), ('dismutase2', 1), ('stress-mir-126/mir-181a-sirt1', 1), ('dimethylarsinic', 2), ('dma', 10), ('h3k9', 3), ('transplacental', 5), ('15.1', 1), ('dma-treated', 3), ('6-week-old', 2), ('keratin', 5), ('heterochromatin', 3), ('agreeing', 1), ('remdesivir', 8), ('gs-5734', 2), ('macaque', 2), ('mers', 3), ('fatality', 2), ('sars', 1), ('-cov', 1), ('mers-cov-induced', 1), ('postinoculation', 1), ('2019-ncov', 1), ('meg3', 7), ('scha', 10), ('resistance-reversing', 1), ('bromodeoxyuridine', 2), ('v-fluorescein', 1), ('isothiocyanate/propidium', 1), ('hairpin-rna', 1), ('kinase/protein', 1), ('b/nuclear', 1), ('transducers', 2), ('meg3-silenced', 1), ('drug-exposed', 2), ('148', 1), ('mica', 1), ('micb', 1), ('ulbps', 1), ('nkp30', 1), ('b7-h6', 1), ('co-cultivated', 1), ('alf', 3), ('anaesthetized', 1), ('oroduodenal', 1), ('0.5-4g/h', 1), ('pre-alf', 1), ('apap-g', 1), ('p-aminophenol', 1), ('pap-g', 1), ('n-deacetylated', 1), ('n-deacetylation', 2), ('methaemoglobinemia', 1), ('glutathione-derived', 1), ('cysteinyl', 1), ('mercapturate', 1), ('sulfation', 2), ('hydrolysed', 1), ('unmask', 1), ('dog', 1), ('diosmin', 7), ('antimutagenic', 1), ('explores', 1), ('sam', 1), ('15th', 1), ('diosmin-100', 1), ('diosmin-200', 1), ('microcystin-lr', 5), ('microcystins', 1), ('bloom-forming', 2), ('alpha-la', 8), ('bel7420', 1), ('regenerate', 2), ('microcystin-leucine', 1), ('mc-lr', 15), ('bel7402', 1), ('rgsh', 2), ('rgsh/oxidized', 1), ('mc-lr-induced', 7), ('alpha-la-induced', 1), ('h1r', 8), ('anesthetic-induced', 1), ('angioedema', 7), ('histamine', 1), ('la-induced', 3), ('high-expressed', 1), ('uncycled', 1), ('n-methyl', 2), ('procaine', 4), ('tetracaine', 3), ('lidocaine', 3), ('drug-h1r', 1), ('cycled', 1), ('ropivacaine', 1), ('cmc', 1), ('h1r-hek293', 1), ('nc-hek293', 1), ('transendothelial', 1), ('h1r-dependent', 1), ('plcgamma/ip3r/pkc', 1), ('ve-cad', 1), ('adjuvant-induced', 1), ('paniculate', 1), ('synovial', 5), ('footpad', 1), ('14th', 2), ('35th', 1), ('cxc', 1), ('ligand2', 1), ('anti-injury', 1), ('bf', 8), ('mpges-1', 2), ('kappaappab', 1), ('mtt-tetrazolio', 1), ('irs-1', 8), ('foxo3', 5), ('ancient', 2), ('atrophy-related', 2), ('s473', 1), ('t308', 1), ('s302', 1), ('polarised', 1), ('food-related', 1), ('ag0', 1), ('vectorized', 1), ('s-sulfhydration', 4), ('idh2', 1), ('nrf2-knockdown', 1), ('sirt3/idh2', 1), ('combinatory', 3), ('cereulide', 2), ('cer', 8), ('maize', 1), ('porridge', 1), ('cereal-based', 3), ('1:100', 1), ('interleukin-1beta-stimulated', 1), ('habitual', 7), ('co-contaminated', 1), ('co-occurring', 2), ('isa', 2), ('lrtis', 3), ('wheeze', 1), ('costa', 1), ('rica', 1), ('ethylenethiourea', 1), ('etu', 8), ('355', 1), ('272', 1), ('11-19', 1), ('lrti', 2), ('25-75th', 1), ('gravity-corrected', 1), ('2.1-5.0', 1), ('2.2-4.7', 1), ('2.4-5.0', 1), ('2.45', 1), ('6.26', 1), ('0.50', 3), ('mother-child', 1), ('mancozeb/etu', 1), ('helicobacteraceae', 1), ('coriobacteriaceae', 1), ('m1-like', 4), ('fecal', 8), ('mwcnts-treated', 1), ('mwcnts-exacerbated', 1), ('particle-driven', 1), ('5-methylcytosine', 3), ('c3h', 3), ('42.5', 1), ('chromatin-immunoprecipitation', 1), ('143', 1), ('718', 1), ('mir-205', 1), ('mir-203', 1), ('mir-215', 1), ('mir-217', 1), ('xist', 1), ('prrc2', 1), ('krit1', 1), ('nish', 1), ('prss2', 1), ('lox', 1), ('phenethyl', 5), ('peitc', 10), ('indole-3-carbinol', 1), ('i3c', 2), ('xan', 6), ('panc-1', 4), ('47-60', 1), ('28-48', 1), ('tsc2-deficient', 2), ('lymphangioleiomyomatosis', 1), ('lam', 8), ('tsc1', 1), ('leiomyoma-derived', 1), ('mtorc1-hyperactive', 1), ('phospho-pkm2', 1), ('faslodex', 1), ('inhibitor-insensitive', 1), ('pkm2-mediated', 1), ('female-specific', 3), ('divalent', 1), ('melastatin-related', 1), ('magnesium', 4), ('rounded', 1), ('cell-to-cell', 2), ('trpm7-dependent', 1), ('phmg', 1), ('koreans', 1), ('multi-omics', 1), ('instilled', 1), ('times/week', 1), ('granulomatous', 1), ('bronchiol-alveolar', 1), ('bronchiol-alveoli', 2), ('orbitrap', 1), ('q-exactive', 1), ('418', 1), ('arginase', 4), ('arg1', 2), ('lipocalin', 2), ('merged', 1), ('repeated-dose', 3), ('o-linked-glycosylation', 1), ('concanavalin', 2), ('glycosylation', 1), ('o-glycosylation', 3), ('aih', 3), ('benzyl-alpha-galnac', 5), ('phosphatase-3', 1), ('nalp3', 2), ('nalp6', 2), ('pro-inflammation', 1), ('cd4+cd25-cd69+', 1), ('anti-alzheimer', 1), ('rivastigmine', 4), ('erythrocytes', 4), ('dimyristoylphosphatidylcholine', 1), ('dmpc', 1), ('dimyristoylphosphatidylethanolamine', 1), ('dmpe', 1), ('displacement', 1), ('hydrophobic-hydrophilic', 1), ('biconcave', 1), ('stomatocytes', 1), ('cup-shaped', 1), ('echinocytes', 1), ('rna-dependent', 2), ('posing', 1), ('syndrome-coronavirus', 1), ('cov-2', 1), ('rdv', 4), ('syndrome-cov', 1), ('rdrps', 1), ('co-expressed', 2), ('nonstructural', 1), ('nsp5', 1), ('nsp7', 1), ('nsp8', 2), ('nsp12', 2), ('rdrp', 2), ('polyprotein', 1), ('rdv-tp', 2), ('competes', 1), (\"3'-5\", 1), ('exonuclease', 1), ('metabolize', 1), ('eu', 4), ('sixty-four', 1), ('histomorphometric', 1), ('exercises', 1), ('tan', 7), ('/smad', 1), ('fructo-oligosaccharides', 2), ('scfa', 4), ('glycerol-3-phosphate', 2), ('msg-treated', 1), ('crown-like', 1), ('22.8', 1), ('n-butyric', 1), ('dioxygenases', 1), ('hydroxymethylation', 16), ('bisphenols-stimulated', 1), ('dioxygenase-catalyzed', 1), ('bpa/bps-related', 1), ('uhplc-ms/ms', 2), ('sequencing-pcr', 1), ('immunoprecipitation-qpcr', 1), ('chip-qpcr', 2), ('tet2-catalyzed', 1), ('bpa/bps-stimulated', 2), ('tet2', 4), ('dimerized', 1), ('bpa/bps', 2), ('activation-dnmt-tet2-dna', 1), ('tet2-mediated', 1), ('tumor-associated', 1), ('//doi.org/10.1289/ehp5862', 1), ('versicolorin', 2), ('aflatoxins', 1), ('vera', 7), ('foodstuff', 1), ('002', 1), ('dividing', 1), ('reabsorption', 3), ('gelatinase-associated', 1), ('low-molecular', 1), ('iron-siderophore', 1), ('iri', 2), ('cisp', 1), ('mrna/protein', 1), ('filtrate', 2), ('kreb', 2), ('reestablishment', 1), ('sub-clinical', 2), ('concert', 1), ('optimise', 1), ('lcb3', 1), ('bafilomycin', 4), ('non-parenchymal', 3), ('specialised', 1), ('toxicologically', 1), ('apap-gsh', 1), ('npc-containing', 1), ('mir-382', 1), ('elucidation', 1), ('ribavirin', 10), ('mid-phase', 3), ('gammah2ax-positive', 1), ('exposuring', 1), ('gas5', 2), ('hbl1', 1), ('antileishmanial', 1), ('host-cell', 1), ('protozoa', 1), ('pressing', 1), ('amazonensis', 2), ('axenic', 1), ('amastigotes', 4), ('intramacrophagic', 1), ('j774a.1', 2), ('antimoniate', 2), ('promastigote', 2), ('5.71', 1), ('amastigote-like', 1), ('5.39', 1), ('1631-', 1), ('70.92-fold', 1), ('4.24', 1), ('antileishmania', 1), ('microbicidal', 2), ('e-cigarettes', 3), ('trans-epithelial', 2), ('p63', 2), ('da-exposed', 1), ('ubiquitin-proteasome-pathway', 1), (\"5'-diphospho-glucuronyltransferase\", 1), ('nonsmokers', 2), ('stored', 1), ('-80', 2), ('longterm', 1), ('ethoxyresorufin-o-deethylase', 1), ('melamine', 2), ('buprenorphine', 1), ('antipyrine', 2), ('perfusions', 1), ('cope', 1), ('monoterpene', 1), ('alpha-zearalenol', 1), ('zearalenol', 3), ('ehmt2', 1), ('esco1', 1), ('hat1', 1), ('kat2b', 1), ('prmt6', 1), ('setd8', 1), ('l-fabp', 1), ('glut2', 1), ('walnut', 2), ('malathion-', 1), ('tlrx-nox-ros', 1), ('wpe', 5), ('mt-', 3), ('cpf-induced', 2), ('mt-exposed', 1), ('splenocytes', 2), ('t-lymphocyte', 1), ('cd3+', 1), ('t-cell-related', 1), ('cd19+', 1), ('b-cell-related', 1), ('nox2', 1), ('cpf-mediated', 1), ('x-nox-ros', 1), ('dox-cur', 5), ('427', 2), ('answered', 1), ('438', 1), ('interaction=0.005', 1), ('marginal', 1), ('applicators', 3), ('organodithioate', 2), ('carolina', 1), ('iowa', 1), ('883', 1), ('1993', 1), ('exposure-response', 1), ('dimethoate', 1), ('1.37', 1), ('triclopyr', 1), ('hr=0.44', 1), ('ci=0.26', 1), ('cees-induced', 2), ('2-chloroethyl', 2), ('cees', 6), ('mnsod', 1), ('copper-zinc', 1), ('cu-znsod', 1), ('mtdna', 2), ('mtdna-encoded', 1), ('cgas-sting', 3), ('factor3', 1), ('coinciding', 1), ('l-nomega-nitroarginine', 1), ('hydralazine', 2), ('hyd', 1), ('hcl', 2), ('phosphoinositide3-kinase', 1), ('pi3-k', 1), ('pi3-k/akt', 1), ('cyanobacteria', 1), ('beta-cells', 1), ('microrna-34a-3p', 2), ('apoptotic-regulating', 1), ('intends', 1), ('endotoxin', 3), ('mir-34a-3p', 4), ('mac', 4), ('weight/dry', 1), ('stress-', 2), ('ir-34a-3p', 1), ('paraventricular', 2), ('normotensive', 1), ('ng/day', 1), ('0.11', 1), ('mul/h', 1), ('radiotelemetry', 2), ('sympathoexcitation', 1), ('calcitriol-induced', 1), ('diob', 7), ('hyperbilirubinemia', 1), ('utinized', 1), ('chlopyrifos', 1), ('overconsumption', 1), ('contradiction', 1), ('foremost', 1), ('depletes', 1), ('prepubertal', 3), ('spermatic', 1), ('egr2', 1), ('rhcg', 1), ('lrrc34', 1), ('iga-secreting', 1), ('tlr-2', 1), ('tlr-6', 1), ('il-12p70', 1), ('il-21', 1), ('tgf-beta3', 1), ('t-bet', 1), ('gata-3', 1), ('rorgammat', 1), ('apart', 2), ('cy-induced', 1), ('onwards', 1), ('analog-induced', 1), ('hypoxemia', 1), ('ena', 5), ('cees-exposed', 2), ('hexadimethrine', 1), ('hdmbr', 5), ('alveolar-capillary', 1), ('oxygenation', 4), ('pao2/fio2', 1), ('il-1a', 1), ('cxcl-1', 1), ('ccl-2', 1), ('clot', 1), ('hdmbr-treated', 2), ('hyaline', 1), ('cees-associated', 1), ('cees-only', 1), ('cees/sm-induced', 1), ('enzyme-mediated', 1), ('columbin-induced', 3), ('columbin', 8), ('furanoid', 2), ('sagittata', 1), ('oliv', 1), ('gagnep', 1), ('spotty', 1), ('tetrahydrocolumbin', 1), ('furan', 6), ('columbin-caused', 1), ('cis-butene-1,4-dial', 1), ('reacted', 1), ('n-acetyllysine', 1), ('m5', 4), ('crisis', 1), ('heterocyclic', 1), ('haas', 2), ('haa', 2), ('ad-relevant', 2), ('beta-site', 2), ('cleaving', 2), ('188-mediated', 1), ('pd-mci', 2), ('nonmotor', 1), ('p188', 6), ('amphipathic', 1), ('illusive', 1), ('snpc', 2), ('m-mediated', 2), ('m-induced', 1), ('csf1r', 2), ('csf2ra', 1), ('engulfment', 1), ('icam1', 3), ('icam2', 1), ('cd11b', 10), ('bombyx', 2), ('sericulture', 1), ('instar', 1), ('silkworm', 3), ('hemolymph', 2), ('detoxifying-related', 1), ('mug/mg', 1), ('cyp4m5', 1), ('cyp6ab4', 1), ('care-11', 1), ('h-72', 1), ('gste3', 1), ('gstd1', 1), ('foxo', 1), ('cncc', 1), ('gsts', 1), ('foxo/cncc/keap1', 1), ('atc', 11), ('1/permeability', 1), ('heightened', 2), ('sh-klf5-treated', 1), ('-c-jun', 1), ('ox-ldl-induced', 6), ('haecs', 4), ('ox-ldl', 3), ('antiatherosclerosis', 1), ('lectin-type', 1), ('lox-1', 1), ('egr-1', 4), ('urolithin', 2), ('urolithins', 2), ('uros', 4), ('ellagitannins', 1), ('ellagic', 1), ('acid-derived', 1), ('senescent-mediated', 1), ('metabotypes', 1), ('ccd18-co', 1), ('uro-a', 1), ('uro-c', 1), ('isouro-a', 1), ('uro-b', 1), ('anti-clonogenic', 1), ('senescence-associated', 4), ('p21cip1/waf1', 1), ('p53-wild', 1), ('senescence-mediated', 1), ('phase-ii', 1), ('anticipates', 1), ('mdv3100', 1), ('b4', 1), ('rnai-based', 1), ('re-sensitize', 1), ('gata4-targeted', 2), ('ipsc-derived', 2), ('3i-1000', 3), ('hipsc-cm', 1), ('14-day', 1), ('hipcs-cm', 1), ('probnp', 1), ('methylenedioxymethamphetamine', 1), ('dynamin-dependent', 1), ('clathrin-independent', 1), ('cathepsins', 1), ('autophagy-lysosomal', 2), ('sacubitril/valsartan', 2), ('val', 3), ('inside', 1), ('taurine-upregulated', 1), ('tempted', 1), ('defences', 1), ('val-treated', 1), ('gper1', 4), ('nontumorigenic', 1), ('mcf-12a', 1), ('g-15', 1), ('gper1-selective', 1), ('-cell', 1), ('positive-feedback', 1), ('mir-486-5p-directed', 1), ('magi1/rap1/rassf5', 1), ('mir-486-5p', 6), ('induced-suppression', 1), ('mirtar', 1), ('ras-associated', 1), ('rap1', 2), ('pathway-associated', 1), ('magi1', 6), ('rassf5', 5), ('fluorescence-based', 1), ('fremsa', 1), ('rapgef2', 2), ('rap1a', 2), ('notopterol', 2), ('notopterygium', 1), ('incisum', 1), ('ting', 1), ('chang', 1), ('forbesii', 1), ('boiss', 1), ('qianghuo', 1), ('10.8', 1), ('kobs', 1), ('29.', 3), ('quinidine', 1), ('not-induced', 1), ('fortified', 1), ('catalase/superoxide', 1), ('brf1', 13), ('pol', 14), ('runt-related', 1), ('iii-dependent', 1), ('tfiib-related', 1), ('medium-dose', 1), ('glutamyl', 1), ('dbil', 2), ('tba', 3), ('gamma-interferon', 1), ('dealt', 1), ('non-malignant', 1), ('=100', 1), ('mucins-muc5ac', 1), ('mucin-inducing', 1), ('pathway-egfr', 1), ('activators-', 1), ('il1beta', 1), ('il17', 1), ('override', 2), ('t-ra', 1), ('fills', 1), ('0-400', 1), ('monocarboxylate', 1), ('1c1', 1), ('oatp1c1', 1), ('paes', 1), ('thioredoxin-1', 2), ('trx-1', 7), ('resisting', 1), ('contioned', 1), ('n-methyl-d-asparate', 1), ('c/ebp', 4), ('procaspase12', 1), ('procaspase3', 1), ('ciss', 6), ('cb1/cb2-receptor-independent', 1), ('glyralpha1s296a', 2), ('hydrogen-bonding', 1), ('cocaine-exaggerated', 1), ('rehabilitating', 1), ('extra-synaptic', 1), ('microinjection', 1), ('cocaine-puzzled', 1), ('glyr-hypersensitive', 1), ('shuxuetong', 3), ('prostatitis', 7), ('sxt', 7), ('cp/cpps', 3), ('15-day', 1), ('health-chronic', 1), ('nih-cpsi', 7), ('pedt', 5), ('27.5', 1), ('47.4', 1), ('baselines', 1), ('24.82', 1), ('5.89', 1), ('15.45', 1), ('6.74', 1), ('26.10', 1), ('6.59', 1), ('22.10', 1), ('8.42', 1), ('14.87', 1), ('3.70', 1), ('10.29', 1), ('4.25', 1), ('14.98', 1), ('3.09', 1), ('13.00', 1), ('4.53', 1), ('0.340', 1), ('0.133', 1), ('0.413', 1), ('cp/cpps-induced', 1), ('genx', 15), ('2,3,3,3-tetrafluoro-2-', 1), ('heptafluoropropoxy', 1), ('propanoic', 1), ('fluoropolymers', 1), ('bbb', 6), ('capillaries', 2), ('microscopy-based', 1), ('p-gp-', 1), ('bcrp-associated', 1), ('//doi.org/10.1289/ehp5884', 1), ('pre-implantation', 2), ('icm', 1), ('derive', 1), ('r1', 2), ('embryoid', 1), ('ebs', 2), ('waves', 1), ('redox-related', 1), ('fgf5', 1), ('brachyury', 1), ('per-', 3), ('polyfluoroalkyl', 3), ('pfas', 10), ('coatings', 1), ('teflon', 1), ('legacy', 2), ('birthweight', 1), ('matrigel', 1), ('ccr4', 1), ('alox15', 1), ('coagulopathy', 3), ('covid-19', 19), ('worrying', 1), ('disseminated', 1), ('intravascular', 1), ('nonusers', 3), ('sic', 3), ('449', 1), ('.910', 1), ('=4', 1), ('64.2', 1), ('.029', 1), ('6-fold', 1), ('.017', 1), ('pufa', 3), ('dcl', 10), ('c20:4n-6', 1), ('dihomo-gamma-linolenic', 1), ('dgla', 1), ('c20:3n-6', 1), ('c20:5n-3', 1), ('c22:6n-3', 1), ('cox-', 1), ('pla2', 2), ('buildup', 1), ('dcl-induced', 1), ('myricetin', 13), ('bulk', 6), ('mgus', 5), ('genoprotective', 1), ('pre-cancerous', 5), ('gammopathy', 2), ('mono-nucleated', 1), ('linc00844-mediated', 2), ('dmes', 2), ('linc00844', 7), ('toxicity-responsive', 1), ('hnf', 1), ('hsa-mir-486-5p', 2), ('mirna-mediated', 1), ('dme', 2), ('sacral', 2), ('shockwave', 2), ('type-iiib', 4), ('snms', 1), ('ecsw', 1), ('renji', 1), ('34.56', 1), ('7.47', 1), ('12.95', 1), ('10.73', 1), ('snms+ecsw', 2), ('biofeedback', 1), ('qd', 1), ('qmax', 2), ('qavg', 2), ('self-rating', 2), ('sds', 2), ('urination', 1), ('75.8', 1), ('46.9', 1), ('silica-activated', 1), ('gradient-dose', 1), ('knock', 1), ('tralpha', 1), ('silica-alone', 1), ('tralpha-knockdown', 1), ('t3/tralpha', 1), ('footprint', 1), ('nps-free', 4), ('20.2', 1), ('25.1', 1), ('26.6', 1), ('22.4', 1), ('28.7', 1), ('40.7', 1), ('59.2', 1), ('65.5', 1), ('sftpb', 2), ('tomentosin', 4), ('gccs', 1), ('anti-cell', 2), ('gcc', 1), ('tomentosin-induced', 1), ('hcn4', 4), ('aconitine-induced', 3), ('dysrhythmia', 2), ('tcms', 1), ('elaborate', 1), ('kdm5a', 2), ('non-detectable', 1), ('ck2alphahi', 1), ('hcn4-mediated', 1), ('aconitine-caused', 1), ('beating', 2), ('notch1/nicd/kdm5a/hcn4', 1), ('tri-o-cresyl', 2), ('ocean', 1), ('degrades', 1), ('microplastic', 4), ('leaching', 1), ('microplastic-derived', 1), ('tocp', 5), ('hek-esr1', 2), ('tocp-mediated', 1), ('tocp-treated', 1), ('slc7a11', 3), ('stc2', 3), ('klhl24', 1), ('ccng2', 2), ('ceacam5', 1), ('slc7a2', 2), ('map1b', 1), ('slc7a5', 3), ('fosl2', 2), ('hspa13', 2), ('prkcd', 2), ('cebpa', 1), ('sfpq', 1), ('tnfaip2', 1), ('krt19', 2), ('favor', 1), ('parasympathetic', 1), ('machrs', 5), ('machr', 1), ('hl7702', 1), ('m3', 2), ('mir-148a/ldlr', 1), ('pde', 6), ('gd21', 2), ('hepatoid', 1), ('digeorge', 1), ('dgcr8', 2), ('mir-148a', 3), ('hapmap', 3), ('smoking-induced', 2), ('11-24', 1), ('ethnic/racial', 1), ('hawaiian', 1), ('whites', 1), ('latinos', 1), ('60+', 1), ('1,3-', 1), ('20-75', 1), ('205-361', 1), ('stream', 1), ('3,4-epoxy-1-butene', 1), ('theta', 1), ('gstt1', 4), ('1-hydroxy-3-buten-2-yl', 1), ('eb-gii', 2), ('ebv-transformed', 1), ('formation/repair', 1), ('gstt1-', 1), ('butadiene-derived', 1), ('traf2-deficient', 1), ('beta/delta', 2), ('abrogation', 2), ('fiber-type', 1), ('pparbeta/delta-specific', 2), ('gw501516', 2), ('disappearance', 1), ('-driven', 1), ('gsk0660/st-247', 1), ('pparbeta/delta-related', 1), ('fibrinolytic', 6), ('tissue-type', 1), ('dysontogenesis', 2), ('gut-brain', 2), ('cldn-1', 1), ('tjs', 2), ('mest/peg1', 7), ('ntds', 4), ('massarray', 2), ('acid-insufficient', 1), ('acid-deficient', 2), ('lrp6', 3), ('lindane', 9), ('abcg5', 7), ('abcg8', 7), ('554', 1), ('neuromast', 1), ('lindane-induced', 1), ('abcg', 1), ('genes-', 1), ('1956/2024', 1), ('652/676', 1), ('abcg5/abcg5', 1), ('abcg8/abcg8', 1), ('myd88-dependent', 3), ('tlrs', 3), ('toll-interleukin-1', 1), ('tir', 1), ('-domain-containing', 1), ('adaptor-inducing', 1), ('myd88-independent', 3), ('phyto', 1), ('tamm-horsfall', 1), ('tlr3/tlr4', 1), ('tlr3/4-induced', 1), ('cxcl10/ifn-beta', 1), ('tlr4-induced', 3), ('ikappab-alpha', 1), ('tnf-alpha/cxcl8', 1), ('her2-targeted', 1), ('idarubicin-zher2', 7), ('immunoconjugates', 1), ('affibody', 4), ('her2-overexpressing', 2), ('qualified', 1), ('titer', 1), ('malaysian', 3), ('malaysia', 4), ('haze', 1), ('pm10', 9), ('modelled', 1), ('nearest', 1), ('station', 1), ('annual', 5), ('21.2', 1), ('underdiagnosed', 2), ('overweight', 1), ('1.125', 1), ('1.042', 1), ('1.213', 1), ('1.553', 1), ('1.328', 1), ('1.816', 1), ('1.271', 1), ('1.088', 2), ('1.486', 1), ('1.124', 1), ('1.048', 1), ('1.207', 1), ('1.087', 1), ('1.024', 1), ('1.153', 1), ('nhms', 4), ('1.187', 1), ('1.294', 1), ('1.701', 1), ('1.387', 1), ('2.086', 1), ('1.120', 1), ('1.026', 1), ('1.222', 1), ('1.110', 1), ('1.028', 1), ('1.199', 1), ('0.911', 1), ('0.910', 1), ('policy', 1), ('lps-primed', 1), ('wave2', 5), ('cx3cr1', 1), ('cd11b+', 1), ('multi-hit', 1), ('fenobucarb-induced', 1), ('fenobucarb', 1), ('2-sec-butylphenyl', 1), ('methylcarbamate', 1), ('bpmc', 7), ('a1-tubulin', 1), ('shha', 3), ('manf', 1), ('bpmc-treated', 1), ('indeno', 2), ('1,2,3-cd', 2), ('picene', 2), ('debris', 1), ('microplastic-ingestion', 1), ('indpy', 5), ('pice', 4), ('ier3', 2), ('adora1', 2), ('cebpb', 1), ('celsr2', 2), ('ctsd', 1), ('cxcl12', 2), ('pgr', 2), ('pkib', 1), ('rara', 2), ('ret', 4), ('sema3b', 1), ('siah2', 1), ('tfap2c', 1), ('esr1-regulation', 1), ('esr1-overexpressing', 1), ('esr1-mediated', 1), ('salidroside', 2), ('furan-induced', 2), ('fur', 1), ('furan+10', 1), ('furan+20', 1), ('mg/kg/day+40', 1), ('16.', 1), ('heatmap', 1), ('thirty-eight', 1), ('7a-hydroxylase', 1), ('fgf15', 2), ('furan-treated', 1), ('water-', 1), ('dirt-repellent', 1), ('authority', 1), ('efsa', 1), ('homoeostasis', 1), ('camk', 2), ('ii/pkc/pka-erk-creb', 2), ('6.25', 1), ('p-treated', 1), ('high-fat/high-fructose', 1), ('high-fructose', 1), ('hff', 3), ('lipotoxicity-induced', 1), ('accumulation-induced', 1), ('hff-induced', 2), ('lipotoxicity-related', 1), ('injury-associated', 1), ('tlr4/nf-kappabp50', 2), ('bambi', 4), ('mirna-9', 5), ('mirna-29', 1), ('and29', 1), ('tempering', 1), ('tgf-betar1', 3), ('cis-induced', 10), ('croc', 4), ('cis-induce', 1), ('emphasizing', 1), ('oatp1b1-mediated', 4), ('ddi', 1), ('bosentan', 4), ('hispidulin', 1), ('oatp1b1-hek293', 2), ('28.27', 1), ('-82.71', 1), ('bosentan-induced', 2), ('54.17', 1), ('monocrotophos', 2), ('opi', 1), ('lipin', 1), ('malic', 1), ('pesticide-treated', 1), ('opis', 1), ('hyperinsulinemic', 1), ('casticin', 2), ('mir-148a-3p', 7), ('polymethyl', 1), ('viticis', 1), ('agomir-148a-3p', 1), ('interruption', 1), ('erk/foxo3a', 1), ('beta-i/ii', 1), ('lc3b-i/ii', 1), ('wingless-related', 1), ('/beta-catenin', 1), ('o3a', 2), ('pd0325901', 1), ('erk-dependent', 1), ('erk/foxo3a-dependent', 1), ('erianin', 7), ('sulphate', 1), ('pathomechanism', 1), ('bibenzyl', 1), ('sulphate-induced', 2), ('three-week', 1), ('laye', 1), ('immunochemokines', 1), ('peroxidative', 1), ('anti-uc', 1), ('o-linked', 2), ('beta-n-acetylglucosamine', 1), ('overrides', 1), ('overriding', 2), ('mode-of-action', 2), ('idh1/2-mutated', 2), ('-delta9-tetrahydrocannabinol', 1), ('dronabinol', 4), ('ogt', 6), ('dronbinol', 1), ('leukemia-initiating', 1), ('beta-n-acetyl', 1), ('glucosamine', 1), ('o-glcnac', 3), ('autoimme', 1), ('ogt-knock', 1), ('proves', 1), ('antileukemic', 2), ('dual-mechanism', 1), ('subentities', 1), ('drugable', 1), ('unrestricted', 1), ('grant', 1), ('izkf', 1), ('faculty', 1), ('tubingen', 2), ('mms', 1), ('brigitte', 1), ('schlieben-lange', 1), ('margarete', 1), ('wrangell', 1), ('arts', 1), ('baden-wurttemberg', 1), ('kks', 2), ('athene', 1), ('excellence', 1), ('rhtgf-beta1', 4), ('rhpdgf-bb', 4), ('pyk2', 6), ('orthodontic', 5), ('factor-bb', 1), ('1,4,7,10', 1), ('appliance', 1), ('spss19.0', 1), ('moved', 1), ('points.the', 1), ('h2o2-stimulated', 2), ('sesn2-mediated', 1), ('sesn2/keap1/nrf2', 1), ('chemoresistant', 4), ('tubulin-suppressive', 1), ('antihelmintic', 1), ('dismal', 1), ('chances', 1), ('ccrf-cem', 1), ('cem/c1', 3), ('mbz-treated', 1), ('t-alls', 1), ('cdk5/gsk3beta/pp2a', 2), ('resins', 3), ('mug/kg/d', 1), ('p6-pnd21', 1), ('cdk5', 1), ('phosphatases', 1), ('tauopathies', 1), ('mir-200', 4), ('tfg-beta1/smad', 1), ('fea', 4), ('twice/week', 1), ('edps', 6), ('epidemiologically', 1), ('1.1.1.', 1), ('downloaded', 1), ('databank', 1), ('sybyl', 1), ('x-2.0', 1), ('-11.0', 1), ('flucythrinate', 1), ('fluvalinate', 1), ('cyhalothrin', 1), ('prioritize', 1), ('stavudine', 9), ('anti-aids', 1), ('underdeveloped', 1), ('price', 1), ('somite', 2), ('crown-rump', 1), ('phospho-chk1', 1), ('re-examined', 1), ('anti-rheumatic', 1), ('deacetylase-1', 1), ('incessant', 1), ('troublesome', 1), ('affair', 1), ('subplantarly', 1), ('arthritic', 2), ('stair', 2), ('climbing', 2), ('anti-rheumatoid', 1), ('nephrotic', 1), ('mapk10', 1), ('perigestational', 4), ('plethysmography', 1), ('60.', 1), ('twitch', 1), ('ventilatory', 1), ('kynurenine', 2), ('indoleamine', 2), ('2,3-dioxygenase', 3), ('kyn', 7), ('check-point', 1), ('ido', 2), ('tdo', 2), ('ido1', 1), ('ido2', 8), ('ido2-/-', 3), ('1-methyl-d-tryptophan', 1), ('d-1mt', 1), ('d-kyn', 1), ('canceled', 1), ('alpha/beta', 3), ('ost', 1), ('ostalpha/beta', 7), ('acid-mediated', 1), ('transports', 1), ('ostalpha/beta-overexpressing', 1), ('taurochenodeoxycholate', 2), ('glycochenodeoxycholate', 3), ('glycocholate', 3), ('ostalpha/beta-mediated', 2), ('5microm', 1), ('fidaxomicin', 2), ('troglitazone', 2), ('210', 1), ('334', 1), ('1050microm', 1), ('97.6', 1), ('337microm', 1), ('265', 1), ('527microm', 1), ('59.8', 1), ('117microm', 1), ('glycine-conjugated', 1), ('sandwich-cultured', 1), ('schh', 4), ('chenodeoxycholate', 1), ('100microm', 1), ('cells+bile', 1), ('4.0-fold', 1), ('accentuate', 1), ('25mg/kg/day', 1), ('2.5mmol/l', 1), ('10,000u/kg/day', 1), ('46mmhg', 1), ('n1-methylnicotinamide', 2), ('ovulation', 1), ('nam', 6), ('visfatin', 4), ('nnmt', 1), ('mnam', 7), ('anti-thrombosis', 1), ('resistin', 2), ('alleviative', 1), ('bcr-abl1-positive', 2), ('meg-01', 4), ('bcr-abl1', 2), ('gsk3beta-mediated', 1), ('mapk-mediated', 1), ('ato-treated', 1), ('mapk-', 1), ('adrenaline', 3), ('exercise-induced', 1), ('hl60', 1), ('additivity', 1), ('hints', 1), ('exhaustion', 1), ('scutellaria', 1), ('baicalensis', 1), ('georgi', 1), ('mate2k', 1), ('hek293-oatp1b1', 1), ('hek293-oatp1b3', 1), ('hek293-oat1', 1), ('hek293-oat3', 1), ('hek293-oct2', 1), ('hek293-mate1', 1), ('hek293-mate2k', 1), ('half-inhibitory', 1), ('7.03', 1), ('0.961', 1), ('0.112', 1), ('0.477', 1), ('18.75', 2), ('dose/time-effect', 1), ('lc3i', 1), ('rapa', 3), ('whlie', 1), ('5-fluorouracil-induced', 1), ('enteritis', 4), ('c57b6/j', 2), ('5-', 2), ('mul/d', 7), ('dsdna', 8), ('cd11c', 1), ('bmdcs', 3), ('lipofectaminetm', 1), ('3000.', 1), ('5-fu-treated', 1), ('5-fu-induced', 1), ('repolarization', 4), ('surviving', 1), ('repolarize', 1), ('sub-hepatotoxic', 1), ('millimeter-scale', 1), ('spatio-temporal', 1), ('60-fold', 1), ('rhodamine123', 1), ('texasred-dextran', 1), ('surrounded', 2), ('time-series', 1), ('neighbors', 1), ('ewes-ex', 1), ('gonadotropins', 2), ('presumption', 1), ('gonadotrophic', 1), ('secretions', 1), ('anestrous', 1), ('ewes', 1), ('gonadoliberin', 1), ('crystalline-', 1), ('nano-sized', 1), ('non-crystalline', 1), ('manufactured', 1), ('tri-culture', 2), ('si10', 5), ('thp-1-derived', 1), ('interleukin-1alpha', 1), ('postponed', 1), ('geneexpressions', 1), ('metalloproteases', 1), ('mmp-1', 1), ('cytokine-release', 1), ('cytokines/adhesion', 1), ('epithelial/macrophage', 1), ('il-1alpha/beta', 1), ('bilobalide', 8), ('assuages', 1), ('microrna-101', 1), ('morphine-led', 1), ('oxa', 2), ('sch772984', 2), ('dilutions', 1), ('mir-101', 5), ('orexin1', 1), ('ox1r', 2), ('p/t-erk/pkc', 2), ('p/t-pkc', 1), ('p/t-erk', 2), ('pbo-induced', 4), ('30-300', 1), ('7-pentoxyresorufin', 1), ('o-depentylase', 1), ('prod', 1), ('lauric', 1), ('12-hydroxylase', 1), ('cyp4a10', 1), ('ko/pxr', 2), ('5-50', 1), ('10-1000', 2), ('5-500', 1), ('norfloxacin', 2), ('keratitis', 1), ('side-effects', 2), ('hcep', 4), ('tissue-engineered', 1), ('te-hcep', 2), ('0.1875', 1), ('caspase-2/-8/-9/-3', 1), ('ripk1', 2), ('caspase-2/-8', 1), ('0.1875-3.0', 1), ('multilayer', 1), ('0.1875-0.75', 1), ('mitochondrion-dependent', 1), ('1.5-3.0', 1), ('ripk1-ripk3-mlkl', 1), ('pfoa-induced', 2), ('5-mc', 1), ('methycytosine', 1), ('dioxygenase', 1), ('tet1', 1), ('pfoa-mediated', 1), ('triclosan', 9), ('5-chloro-2-', 1), ('2,4-dichlorophenoxy', 1), ('uncoupler', 1), ('dlns', 3), ('correspondingly', 1), ('pro-il-1b', 1), ('s100a8', 1), ('dln', 1), ('adhesions', 1), ('erk2', 3), ('gs', 1), ('bpa/gper', 1), ('estrogen-active', 1), ('rack1', 9), ('hormone-active', 2), ('interconnections', 1), ('diethylstilbestrol', 1), ('rack-1', 1), ('rack1/pkcbeta', 1), ('non-cell', 1), ('diethylstilbestrol-induced', 1), ('steroid-active', 1), ('4-nerolidylcatechol', 1), ('4-nc', 7), ('nras-mutant', 4), ('nras-mutations', 1), ('15-20', 1), ('4-nerolidylcathecol', 1), ('pothomorphe', 1), ('umbellata', 1), ('braf/meki-resistant', 1), ('mmp-14', 1), ('inductors', 1), ('nano-forms', 2), ('mutagen', 1), ('proteinaceous', 2), ('heated', 1), ('well-researched', 1), ('supplementing', 1), ('atm-', 1), ('rad3-related', 1), ('periostin-dependent', 1), ('curcumol', 10), ('guaiane-type', 1), ('sesquiterpenoid', 1), ('hemiketal', 1), ('curcumae', 2), ('multiple-pharmacological', 1), ('periostin', 1), ('postn', 10), ('-gfp-periostin', 1), ('-p65', 1), ('ccl4-caused', 1), ('curcumol-reduced', 1), ('gw9508', 10), ('ldl-induced', 1), ('ampk/creb/pgc1alpha', 1), ('gw1100', 1), ('camp-responsive', 1), ('er-stress', 4), ('ire1', 2), ('er-stress-induced', 1), ('term-placenta', 1), ('/chop', 1), ('jak1/stat3', 3), ('combinational', 3), ('1/signal', 1), ('sex-', 1), ('phase-out', 1), ('opfr', 5), ('underexplored', 1), ('sesame', 1), ('14.', 2), ('pup', 2), ('mediobasal', 1), ('tac2', 1), ('insr', 1), ('dgat2', 1), ('cyb2b10', 1), ('maturing', 1), ('amino-polyphosphonate', 1), ('protooncogenes', 1), ('eaats', 2), ('slc1', 1), ('glutamate/aspartate', 1), ('bpa-dependent', 1), ('slc1a3', 1), ('slc1a2', 1), ('radioactive', 1), ('d-aspartate', 1), ('immunochemical', 1), ('yin', 1), ('yang', 1), ('somatotropin', 3), ('rbst', 9), ('non-lactating', 3), ('ovulatory', 1), ('jersey', 1), ('n=11', 1), ('n=10', 1), ('-60', 2), ('lactotropin', 1), ('elanco', 1), ('intravaginal', 1), ('progesterone-releasing', 1), ('cidr', 2), ('zoetis', 3), ('factrel', 1), ('pgf2alpha', 1), ('lutalyse', 1), ('d8', 1), ('p4', 2), ('hsd-3b1', 1), ('igfr', 1), ('pappa', 2), ('-53', 1), ('-46', 1), ('-14', 1), ('pre-ovulatory', 2), ('e2/p4', 1), ('fasd-associated', 1), ('interrupted', 1), ('arches', 1), ('tbx1', 1), ('flk-1', 1), ('huc', 1), ('titin', 1), ('c-myb', 1), ('gastrula', 1), ('5.25-10', 1), ('pten/akt/foxo3a', 3), ('gef', 8), ('cyanide-', 1), ('methoxylamine-adducts', 1), ('-naphthoflavone', 1), ('expression/function', 1), ('cyp1a1-mediated', 1), ('arina-1', 9), ('nebulized', 1), ('micro-optical', 1), ('mucociliary', 2), ('f508del/f508del', 1), ('mucoactive', 1), ('ciliary', 1), ('microrheology', 1), ('cfbe41o-', 2), ('f508del', 1), ('vx-809', 1), ('cftr-independent', 1), ('coeruleus', 2), ('noradrenergic', 2), ('lc/ne', 10), ('alpha-chain', 1), ('complex-1', 1), ('mac-1', 1), ('cr3', 1), ('cd11b-mediated', 2), ('cd11b-/-', 1), ('glybenclamide', 3), ('sulfonylurea', 1), ('inflammation-dependent', 1), ('pm2.5-induced', 2), ('eom', 1), ('eom-induced', 4), ('sox9b', 1), ('axin2', 2), ('nrf2b', 1), ('gstp2', 1), ('1a6', 4), ('2b1', 1), ('2b2', 2), ('ugt2b3', 1), ('2b12', 1), ('ugt2b', 1), ('3,4-dimethylmethcathinone', 2), ('4-methylmethcathinone', 2), ('cathinones', 7), ('beta-keto', 2), ('3,4-dmmc', 1), ('4-mmc', 1), ('gbr', 1), ('12909', 1), ('pre-incubation', 1), ('h+-atpase', 1), ('biotin', 5), ('ptyr', 2), ('pser', 2), ('pser-irs-1', 2), ('ptyr-irs-1', 2), ('reflecting', 2), ('abeta-induced', 1), ('aggregations', 1), ('benzofluoranthenes', 1), ('duplicate', 1), ('fluoranthene', 1), ('bkf', 2), ('bkf-exposed', 1), ('appendage', 1), ('morphogenic', 1), ('retinaldehyde', 1), ('metacore', 1), ('clarivate', 1), ('analytics', 1), ('r-smads', 1), ('irinotecan-mediated', 1), ('sn-38', 8), ('irinotecan-induced', 1), ('iid', 5), ('fvb', 2), ('mdr1a', 2), ('toxicokinetic', 1), ('biodistribution', 1), ('pk/tk', 1), ('esterases', 1), ('bile-cannulate', 1), ('sn-38/sn-38g', 3), ('0.805', 1), ('css', 1), ('bisphenolic', 3), ('viewed', 1), ('4mebpa', 2), ('bcas3', 1), ('phf19', 1), ('pyrimethanil', 10), ('botrytis', 1), ('cinerea', 1), ('deformity', 1), ('casp6l1', 1), ('tbx2b', 1), ('myh6', 1), ('vmhc', 1), ('bmp2b', 1), ('bml-284', 2), ('malformed', 1), ('mildronate', 10), ('proteobacteria', 2), ('prohibited', 1), ('anti-doping', 1), ('wada', 1), ('athletes', 1), ('mildronate-induced', 1), ('high-metabolic-rate', 1), ('anxiety-related', 1), ('explorative', 1), ('endurance', 1), ('prebiotics', 1), ('chemical-genes', 1), ('c18', 1), ('2,581', 1), ('449,683', 1), ('c20', 1), ('1,244', 1), ('451,020', 1), ('ncbi-geo', 1), ('gse106582', 1), ('twas', 2), ('statistics', 1), ('chemical-gene', 1), ('methylnitronitrosoguanidine', 1), ('0325901', 1), ('importazole', 1), ('beauvericin', 2), ('bea', 2), ('non-legislated', 1), ('0.01-0.1-0.5', 1), ('1821', 1), ('=1.5', 1), ('mtrf1l', 1), ('benzophenone-8', 1), ('benzopenone-8', 1), ('bp-8', 7), ('25.05', 1), ('43.20', 1), ('72.69', 1), ('coactivator-2', 1), ('src-2', 1), ('metabolism-associated', 1), ('filters', 6), ('tunicamycin-induced', 1), ('2-dependent', 1), ('sestrin', 2), ('designates', 1), (\"3',4',5,7-tetrahydroxyflavone\", 1), ('tunicamycin', 1), ('hepatocyte-derived', 1), ('tm-', 1), ('thapsigargin-mediated', 1), ('asparagine', 1), ('luteolin-mediated', 1), ('luteolin-dependent', 1), ('tm-mediated', 1), ('province', 2), ('hubei', 2), ('spatial-temporal', 2), ('prefectures', 1), ('dec', 1), ('1.046', 1), ('1.038-1.054', 1), ('0-1', 1), ('moving', 1), ('bioaccumulates', 1), ('snail2', 1), ('p-smad2/smad2', 1), ('cleaved-notch1', 1), ('jagged1', 1), ('permeates', 1), ('dermally', 1), ('farmers', 1), ('commodities', 1), ('sparsely', 1), ('prostaglandin-e2', 1), ('mapkks', 1), ('p90-rsk', 1), ('c-', 1), ('phospho-nf-kb', 1), ('ro-31-8220', 1), ('protein-kinase-c', 1), ('don-mediated', 1), ('prospect', 1), ('busulfan-induced', 6), ('oligospermia', 4), ('busulfan', 3), ('busulfan-treated', 2), ('prostaglandin-endoperoxide', 1), ('ferrostatin-1', 1), ('fer-1', 3), ('factor-e2-related', 1), ('fpn1', 4), ('nrf2-gpx4', 1), ('thiolate', 1), ('dioxygen', 1), ('expedites', 1), ('alkoxyresorufin', 1), ('resorufin', 1), ('426', 1), ('393', 1), ('cyp2b1', 1), ('mir200c-5p-abca1', 2), ('mrna/mirnas', 1), ('mir200c-5p', 3), ('non-linear', 1), ('monomethyl', 1), ('vacuolation', 3), ('fluctuated', 1), ('mir-423-5p', 2), ('mir-128-3p', 2), ('1,3-dinitrobenzene', 2), ('nitrofurazone', 1), ('tlr4/nf-kappab/nlrp3', 3), ('10/group', 1), ('/kg', 1), ('ii-b', 1), ('tfiib', 1), ('alcohol-caused', 1), ('alcohol-associated', 1), ('hrugt-1a1', 1), ('1a3', 1), ('1a4', 1), ('1a7', 1), ('1a8', 1), ('1a10', 1), ('2b4', 1), ('2b7', 2), ('2b15', 1), ('2b17', 1), ('hrugt1a6', 2), ('hrugt1a9', 2), ('hill', 1), ('amentoflavone', 1), ('niflumic', 1), ('78.4-81.3', 1), ('54.3-62.9', 1), ('35.5', 1), ('72.6+-11.3', 1), ('mean+-sd', 1), ('5.7+-4.1', 1), ('r=-0.784', 1), ('e/i', 1), ('vpa', 6), ('ionotropic', 1), ('mglur7', 1), ('100-fold', 1), ('tert-butylhydroquinone', 1), ('tbhq', 2), ('mitochondrial-independent', 1), ('erectile', 5), ('abolition', 1), ('nos/cgmp/pkg', 3), ('nrg', 9), ('nomega-nitro-l-arginine', 2), ('penis', 1), ('+50', 1), ('+80', 1), ('l-name+50', 1), ('phosphodiesterase-51', 1), ('pde-51', 1), ('il-b', 1), ('mao-a', 1), ('adpase', 1), ('ampase', 1), ('penile', 4), ('cd43', 1), ('caspace-9', 1), ('validates', 1), ('atp-hydrolysis', 1), ('beta-amyloid', 6), ('4-aminobiphenyl', 2), ('mir-630', 10), ('rad18', 5), ('mcm8', 5), ('4-abp', 1), ('microm-300', 1), ('dsbs', 2), ('creb-mir-630', 1), ('ros/creb/-mir-630', 1), ('fluxapyroxad', 2), ('sdhi', 3), ('pyrazole-carboxamide', 1), ('hatch', 1), ('foxb1a', 1), ('ntl', 1), ('eve1', 1), ('crx', 1), ('neurod', 1), ('nkx2.4b', 1), ('dieldrin-induced', 4), ('400-', 1), ('2700-fold', 1), ('11-fold', 1), ('2.0-', 1), ('3.7-fold', 1), ('1.7-', 1), ('2.8-fold', 1), ('car/pxr', 1), ('car-mediated', 1), ('stress/damage', 1), ('exit', 4), ('fractures', 1), ('else', 1), ('two-staged', 1), ('audit', 1), ('revisions', 1), ('284', 1), ('micro-organisms', 1), ('hips', 1), ('coagulase', 1), ('staphylococci', 1), ('vancomycin', 1), ('carbapenam', 1), ('30mm', 2), ('wash', 1), ('theatre', 1), ('prudent', 1), ('opt', 1), (\"5'utr\", 4), ('transcriptional/translational', 1), ('toluene-exposed', 3), ('voc', 2), ('pcr-pyrosequencing', 1), ('exposed-workers', 1), ('amelanotic', 3), ('microphthalmia', 1), ('mitf/mcl-1', 1), ('c32', 2), ('mcl-1proteins', 1), ('glycochenodeoxycholic', 2), ('gcdca', 4), ('gcdca-induced', 2), ('tmt', 1), ('searches', 1), ('313', 1), ('242', 1), ('tfe3', 3), ('gcdca-inhibited', 1), ('ros/tfe3', 1), ('micrornas-mediated', 1), ('moldy', 1), ('mir-1343', 1), ('mir-331-3p', 1), ('pak4', 1), ('mirnas-mediated', 1), ('integrins', 3), ('alphav', 3), ('beta3', 3), ('recommends', 1), ('inclusive', 1), ('erk-mediated', 1), ('betel', 3), ('chew', 1), ('nut', 1), ('chewing', 1), ('cbp', 6), ('mood-stabilizing', 1), ('akt-p300', 1), ('gd10', 7), ('gd13', 3), ('post-dosing', 2), ('gd9', 2), ('non-exencephalic', 1), ('exencephalic', 1), ('tubes', 1), ('vpa-induced', 1), ('vitally', 1), ('passion', 1), ('blueberry', 1), ('4-methylumbelliferoneglucuronide', 1), ('n-glucuronide', 1), ('obeyed', 1), ('daidzin', 10), ('ptz-induced', 2), ('bdnf/vegf', 2), ('centuries', 1), ('pentylenetetrazole-induced', 1), ('epileptogenesis', 2), ('sulfotransferase', 1), ('nitrite', 1), ('hplc-uv', 1), ('p13k', 1), ('hif-1-alpha', 1), ('ptz-kindled', 1), ('obesity-induced', 1), ('250-300', 1), ('6/group', 1), ('opr', 1), ('ot', 1), ('garlic', 1), ('lipopolysaccharide/', 1), ('d-galactosamine', 1), ('lps/d-gal', 4), ('d-gal', 1), ('sac-lowered', 1), ('inappropriate', 1), ('frap', 1), ('xrcc1', 1), ('rad51', 1), ('repair-related', 1), ('mir-140-5p', 6), ('xuebijing', 2), ('xbj', 7), ('mir-140-5p-induced', 1), ('arbitrarily', 1), ('transglutaminase-2', 1), ('tg2', 3), ('wnt-1', 2), ('adcmv-mir-140-5p', 1), ('xbj-treated', 2), ('wnt-1/beta-catenin', 1), ('oroxylina', 1), ('oroa', 7), ('blood-vessel', 1), ('myography', 1), ('morphological/histological', 1), ('-4-mediated', 1), ('interleukin-1-receptor-associated-kinase', 1), ('irak', 1), ('vcam', 1), ('irak-4-targeted', 1), ('hyporeactivity', 1), ('irak-4-mediated', 1), ('ikkalpha/beta', 1), ('cp-456773', 2), ('hsp-90', 4), ('clients', 1), ('csr', 2), ('csr/cp', 1), ('ccct', 3), ('dai', 1), ('mdi', 1), ('interrupting', 1), ('ampk/mtor-dependent', 1), ('becn1', 2), ('inflammasome-dependent', 1), ('hsp78', 2), ('donovani', 3), ('anti-leishmanial', 3), ('advocates', 1), ('ldhsp78', 5), ('clpb', 1), ('hamsters', 2), ('ldhsp78+/-', 5), ('mexicana', 1), ('lmxhsp78+/-', 1), ('flanking', 1), ('untranslated', 1), ('multi-fragment', 1), ('no-mediated', 1), ('episomal', 1), ('p5-di', 1), ('adenosine-5', 1), ('-penta-phosphate', 1), ('ap5a', 2), ('amastigote', 1), ('amb', 2), ('sa-beta-gal', 1), ('beta-tc-6', 2), ('p19', 1), ('senescence-inducing', 1), ('insulinoma', 1), ('ins-1', 1), ('fat-induced', 1), ('intrigue', 1), ('nicotine-triggered', 1), ('peels', 1), ('sildenafil', 1), ('intracavernosal', 1), ('icp', 1), ('cavernous', 1), ('gp91phox', 1), ('nitrate/nitrite', 2), ('icp/map', 2), ('at1r/gp91phox', 2), ('n-hydroxy-3-phenyl-2-', 2), ('4-phenylbenzenesulfonamido', 2), ('propanamide', 2), ('bips', 6), ('basement', 3), ('bmz', 2), ('collagenases', 2), ('degrade', 1), ('dermal-epidermal', 1), ('vesicant', 1), ('microblistering', 1), ('dermal/epidermal', 1), ('24-168', 1), ('p450-mediated', 2), ('fraxinellone', 10), ('dictamni', 1), ('dictamnus', 1), ('dasycarpus', 1), ('turcz', 1), ('alert', 1), ('cis-enedial', 1), ('n-acetyl-lysine', 1), ('1,2-', 1), ('1,4-addition', 1), ('fraxinellone-induced', 1), ('over-gene', 1), ('butralin', 6), ('4.16', 1), ('312', 1), ('3120', 1), ('adi', 2), ('benchmark', 1), ('bmd', 1), ('activity-profiling', 1), ('cumyl-pegaclone', 5), ('fluorination', 1), ('scras', 2), ('europe', 2), ('entailing', 1), ('5f-cumyl-pegaclone', 2), ('legislation', 1), ('ethylbenzyl', 3), ('n-propylphenyl', 3), ('receptor-proximal', 1), ('bio-assays', 1), ('mini-galphai', 2), ('sub-nanomolar', 1), ('steric', 1), ('hindrance', 1), ('5-fluorination', 1), ('activitation', 1), ('9,10-phenanthrenequinone', 2), ('s-oxidation', 3), ('9,10-pq', 6), ('2.5.', 1), ('acceptor', 1), ('ptp', 2), ('cys215', 1), ('cis-9,10-dihydroxy-9,10-dihydrophenanthrene', 1), ('ddp', 2), ('uplc-mse', 1), ('peg-cat', 1), ('9,10-pq-generated', 1), ('egfr-erk1/2', 2), ('ptps', 1), ('nicotine-metabolizing-enzyme', 1), ('flavorings', 1), ('flavored', 2), ('cinnamaldehyde', 9), ('benzaldehyde', 1), ('bruton', 2), ('hyperinflammatory', 1), ('btk', 4), ('acalabrutinib', 3), ('hospitalized', 1), ('discernable', 1), ('lymphopenia', 1), ('8/11', 1), ('72.7', 1), ('4/8', 1), ('extubated', 1), ('2/8', 1), ('confirmatory', 1), ('aucubin', 9), ('parenteral', 4), ('4-hne', 1), ('oxadiazon-butachlor', 2), ('ob', 8), ('weeds', 2), ('includinglef1', 1), ('ob-induced', 1), ('mir-132', 2), ('lymphomas', 1), ('affectation', 1), ('mir-132-3p', 2), ('disbalance', 1), ('oligomeric', 2), ('mtor-tfeb', 2), ('abetao', 8), ('pp242', 1), ('cyprodinil', 9), ('cyp1a1-12dre', 1), ('tnnt2', 1), ('dioscorea', 2), ('nipponica', 3), ('makino', 3), ('bronchitis', 1), ('dne', 9), ('agmatine', 5), ('beta1-42', 1), ('intra-hippocampal', 1), ('abeta1-42peptide', 1), ('ram', 1), ('bace', 2), ('immunocontent', 1), ('8-27', 1), ('sex-differences', 1), ('hypothalamus-pituitary-thyroid-liver', 1), ('cyp1b', 1), ('cyp1c', 1), ('sult1st1', 1), ('capacities', 1), ('triphenylstannyl', 2), ('benzylcarbamoyl', 2), ('benzoate', 2), ('impedes', 2), ('akt/foxo3a', 2), ('surging', 1), ('ch-319', 9), ('pten-/-', 1), ('pc3m', 1), ('pten+/-', 1), ('p85/p110', 1), ('akt-1', 3), ('met281', 1), ('phe442', 1), ('glu234', 1), ('po-pulation', 1), ('pre-sensitization', 1), ('cabazitaxel', 1), ('ptenp-/-', 1), ('pras40', 1), ('proto', 1), ('acly', 1), ('increased-histone', 1), ('hcb', 8), ('factor-a', 1), ('vegf-a', 5), ('neovasculogenesis', 1), ('tubulogenesis', 1), ('va', 5), ('vad', 6), ('transit', 1), ('ens', 3), ('ros-regulated', 1), ('high-concentration', 1), ('acrolein-adducted', 5), ('adduction', 3), ('beta-unsaturated', 1), ('beta-carbon', 2), ('schiff', 1), ('albumin-acrolein', 1), ('nci-h441', 2), ('haec', 2), ('cys34', 1), ('nlc-ms/ms', 1), ('boldine', 9), ('prostanoids', 2), ('peumus', 1), ('boldus', 2), ('molina', 1), ('ethanol/0.3', 1), ('mucin-like', 2), ('ethanol-ulcerated', 2), ('nem', 1), ('yohimbine', 1), ('alpha-adrenergic', 1), ('h+/k+-atpase', 1), ('h+/k', 1), ('rs6093966', 1), ('rs2868094', 1), ('rs2071197', 2), ('rs6073433', 1), ('5.83', 1), ('7.68-fold', 1), ('2.03-fold', 1), ('36.6', 2), ('19.8', 1), ('24.4', 1), ('+3', 2), ('ias', 2), ('environment-related', 1), ('as3mt', 8), ('stata', 1), ('prospero', 1), ('id', 1), ('crd42019133947', 1), ('rs3740393', 2), ('rs11191438', 2), ('168', 1), ('tgca', 1), ('pre-pregnancy', 6), ('time-to-pregnancy', 2), ('selma', 2), ('fecundability', 6), ('swedish', 1), ('818', 1), ('18-43', 1), ('frs', 1), ('contraception', 1), ('menses', 1), ('=29', 1), ('coc', 2), ('156', 4), ('187.', 1), ('transnonachlor', 1), ('hfe', 5), ('h63d', 2), ('h67d-hfe', 5), ('wt-hfe', 5), ('variant-associated', 1), ('paraquat-treated', 1), ('ppmi', 1), ('h63d-hfe', 2), ('csf', 1), ('pbl', 3), ('0-20', 1), ('nucleus/', 1), ('dichlorofluorescein', 1), ('dcf', 1), ('dj-1', 1), ('cys106-', 1), ('pifithrin-alpha', 1), ('sr144528', 1), ('blunt', 1), ('cp55940-induced', 1), ('cbr-independent', 1), ('h2o2-mediated', 1), ('oxaliplatin-induced', 1), ('atf-6', 1), ('oxl', 4), ('oxl-induced', 5), ('kinase-14', 1), ('mapk14', 1), ('enzyme-1', 1), ('ncam', 1), ('tetralogy', 3), ('fallot', 3), ('unplanned', 1), ('reoperation', 1), ('paralysis', 1), ('1.1-1.2', 1), ('annulus', 2), ('0.3-0.9', 1), ('p=0.01', 1), ('septal', 3), ('54.6', 1), ('1.6-1,874.2', 1), ('12.4', 1), ('1.5-99.9', 1), ('transannular', 1), ('distinguishing', 1), ('moas', 5), ('triazoles', 2), ('am580', 1), ('cd3254', 1), ('ra-receptor', 1), ('retinoid-x-receptor', 1), ('dithiocarbamates', 2), ('lysyl', 1), ('aryl-hydrocarbon-receptor', 1), ('2,4-dinitrophenol', 1), ('fenpropimorph', 1), ('match', 1), ('toxcast', 1), ('upfront', 1), ('dis', 1), ('sterigmatocystin-induced', 1), ('sterigmatocystin', 1), ('ste', 6), ('decided', 1), ('sars-cov-2', 2), ('1980', 1), ('italian', 1), ('spanish', 1), ('epicenters', 1), ('outliers', 1), ('1255', 1), ('italy', 1), ('775', 1), ('950', 1), ('spain', 1), ('8,582,968', 1), ('cross-replicating', 1), ('rs11385942', 1), ('3p21.31', 3), ('rs657152', 1), ('9q34.2', 2), ('5x10-8', 1), ('2.11', 1), ('1.15x10-10', 1), ('1.20', 2), ('4.95x10-8', 1), ('spanned', 1), ('slc6a20', 1), ('lztfl1', 1), ('ccr9', 1), ('fyco1', 1), ('cxcr6', 1), ('xcr1', 1), ('abo', 2), ('blood-group-specific', 1), ('1.48x10-4', 1), ('1.06x10-5', 1), ('blood-group', 1), ('stein', 1), ('erik', 1), ('hagen', 1), ('others.', 1), ('tonic', 2), ('spasms', 1), ('pts', 3), ('nmosd', 3), ('myelitis', 1), ('steven-johnson', 1), ('sjs', 2), ('carbamazepine-induced', 1), ('spasticity', 1), ('primates', 3), ('cannabinergic', 1), ('treatment-resistant', 1), ('antiemetics', 1), ('methanandamide', 2), ('maea', 5), ('0.032-0.1', 1), ('3.2-10.0', 1), ('nicotine-', 2), ('prodromal', 1), ('hypersalivation', 4), ('squirrel', 1), ('monkeys', 1), ('verification', 1), ('liability', 1), ('evolutionary', 2), ('carvedilol', 8), ('l-arginine', 5), ('22nd', 1), ('alpha-amylase', 1), ('stat1-alpha', 1), ('pap2', 1), ('paf', 1), ('meth-treated', 2), ('nurr1', 3), ('internalized', 1), ('flaxseed', 2), ('fs', 5), ('3.76', 1), ('architectures', 1), ('deps-', 1), ('anti-apoptotic/pro-apoptotic', 1), ('4-flourophenylacetamide-acetyl', 2), ('4-fpac', 6), ('noncancerous', 1), ('nih3t3', 1), ('bromide/acridine', 1), ('etbr/ao', 1), ('4,6-diamidino-2-phenylindole', 1), ('dichlorodihydrofluorescein', 1), ('minimizes', 1), ('reaffirmed', 1), ('substantiated', 1), ('cell-type-specific', 2), ('emerge', 2), ('sox9/lncrna', 1), ('oligoribonucleotides', 1), ('aso', 1), ('sox9/h19', 4), ('sew2871', 5), ('sphingosine-1-phosphate', 1), ('s1pr1', 4), ('t-', 1), ('mir-152-3p/errfi1/stat3', 1), ('mir-152-3p', 7), ('erbb', 1), ('errfi1', 4), ('radically', 1), ('summarily', 1), ('chemoregimens', 1), ('intensively', 1), ('leukaemia', 1), ('dau', 4), ('dau-ol', 1), ('cladribine', 2), ('1b10', 1), ('7a2', 1), ('41.73', 1), ('78.33', 1), ('kiapp', 1), ('kg1a', 1), ('atra-dau', 1), ('perfluorononanoic', 2), ('pfna', 4), ('cholesterogenic', 2), ('pfass', 4), ('omnipresent', 1), ('perk/atf4', 1), ('trna', 1), ('amino-acylation', 1), ('glycolysis/gluconeogenesis', 1), ('pio', 6), ('kinase/mammalian', 1), ('sw1736', 2), ('c643', 2), ('signalization', 1), ('17.69', 1), ('11.64', 1), ('27.12', 1), ('23.17', 1), ('isobologram', 1), ('akt3', 2), ('chuk', 1), ('cdc42', 1), ('ikbkb', 1), ('pik3ca', 1), ('pik3cg', 1), ('prkca', 2), ('rictor', 1), ('combination-treated', 1), ('ddit4l', 1), ('eif4ebp2', 1), ('fkbp1a', 1), ('fkbp8', 1), ('gsk3b', 1), ('myo1c', 1), ('ulk2', 1), ('deptor', 1), ('pik3c', 1), ('scoulerine', 8), ('corydalis', 1), ('scoulerine-treated', 1), ('scoulerine-induced', 3), ('sappanchalcone', 6), ('caesalpinia', 2), ('sappan', 2), ('aif-dependent', 1), ('p53-mutant', 1), ('sappanchalcone-treated', 1), ('billion', 1), ('tackled', 1), ('fortification', 1), ('/100', 2), ('follistatin', 1), ('modulators/effectors', 1), ('jam-a', 1), ('tricellulin', 1), ('ectoplasmic', 1), ('specialization', 1), ('integrin-', 1), ('claudin1', 1), ('testin', 1), ('car-f', 1), ('c-kit', 2), ('parallelly', 1), ('cdk-4', 1), ('mercuric', 2), ('categorization', 1), ('kidney-injury', 1), ('-a', 1), ('nephrotoxicant-to', 1), ('kidney-injury-module', 2), ('histopathology-specific', 1), ('readout', 1), ('bio-nano', 2), ('zno', 4), ('bio-reactivity', 1), ('nanosafety', 1), ('bio/nano', 1), ('nm-protein', 1), ('nm-110', 3), ('nm-101', 3), ('nm-203', 3), ('adsorption-induced', 1), ('enthalpy-controlled', 1), ('enthalpic', 2), ('favourable', 1), ('gstk1', 1), ('bsa-nm', 1), ('cell-death', 1), ('corona', 1), ('spectrometry-based', 1), ('descriptors', 1), ('spiraeoside', 10), ('pi3k/akt/nrf2', 2), ('glucoside', 1), ('stimulation-caused', 1), ('uvr', 6), ('octinoxate', 7), ('sunscreens', 1), ('off-target', 2), ('p4501b1', 1), ('586', 1), ('dihydropyrazines', 2), ('lipopolysaccharide-stimulated', 2), ('tlr4-myd88-mediated', 2), ('dhps', 2), ('3-hydro-2,2,5,6-tetramethylpyrazine', 1), ('dhp-3', 6), ('dhp-response', 1), ('post-staphylococcal', 1), ('ensue', 1), ('superantigen', 1), ('storm', 6), ('delta9tetrahydrocannabinol', 1), ('seb-induced', 2), ('tregs', 5), ('myeloid-derived', 1), ('mdscs', 2), ('lung-infiltrated', 1), ('mncs', 1), ('let7a-5p', 1), ('mir-34-5p', 1), ('nos1', 1), ('thc-mediated', 2), ('seb-mediated', 6), ('rhodojaponin', 2), ('r-ii', 8), ('flss', 1), ('metalloproteinase-1', 1), ('ra-flss', 1), ('/myd88', 1), ('tlr4/myd88', 2), ('metallosis', 1), ('cobalt-induced', 1), ('lifespan', 1), ('nematodes', 1), ('egl-1', 1), ('ced-9', 1), ('bec-1', 1), ('lgg-1', 1), ('tgf-beta/smad2/3', 1), ('wnt1/beta-catenin', 1), ('penicillium', 1), ('ota-treated', 1), ('sw1990', 2), ('gr-positive', 1), ('h-ras', 5), ('nrf2-pin1', 1), ('peptidyl-prolyl', 2), ('isomerase', 4), ('pin1', 5), ('cis/trans', 1), ('isomerizes', 1), ('prevalently', 1), ('activation/accumulation', 1), ('gtp-h-ras', 1), ('clonogenicity', 1), ('mcf10a-ras', 1), ('pin1-nrf2', 1), ('tdf', 7), ('phosphodiesterase-5', 1), ('pde5', 2), ('protoporphyrin-ix', 1), ('znpp', 2), ('tdf-mediated', 1), ('chlormequat', 7), ('-insulin-like', 1), ('gh-releasing', 1), ('ghrh', 1), ('11.', 1), ('hypoglycemia', 1), ('hyperproteinemia', 1), ('sinapic', 2), ('safeguards', 1), ('anti-mitochondrial', 2), ('above-', 1), ('iso-treated', 1), ('antioxidant-rich', 1), ('d-1', 3), ('fluoride-containing', 2), ('bisphinol', 1), ('il-6/jak1/stat3', 3), ('cinnamon', 1), ('3a4-mediated', 1), ('nomilin-induced', 3), ('nomilin', 8), ('furan-containing', 1), ('nal', 2), ('m1-m6', 1), ('lc-hrms', 1), ('cis-butene-dial', 1), ('bda', 1), ('m1-m4', 1), ('pyrrolinone', 1), ('13c-nmr', 1), ('tetrahydro-nomilin', 1), ('non-hepatotoxic', 1), ('teneligliptin', 8), ('klf15-fgf15', 1), ('dipeptidyl', 1), ('peptidase-4', 1), ('dpp-4', 1), ('27-hydroxylase', 1), ('cyp27a1', 1), ('cyp7b1', 1), ('12alpha-hydroxylase', 1), ('cyp8b1', 1), ('/akt/kruppel-like', 1), ('klf15', 2), ('hepato-nephrotoxicity', 1), ('fpn-treated', 1), ('trpv1/trpv3', 6), ('energy-sensing', 1), ('aaps', 1), ('insulin/leptin', 1), ('anticipation', 1), ('trpv3', 5), ('ruthenium', 3), ('capsazepine', 3), ('2,2-diphenyltetrahydrofuran', 1), ('dpthf', 3), ('appetite-regulating', 1), ('nutrient-sensing', 1), ('hedonic', 1), ('flubendazole', 2), ('mictotubule-targeting', 1), ('benzimidazole', 1), ('flu-induced', 1), ('bclxl', 1), ('discernible', 1), ('cytotoxicity-related', 1), ('killing', 1), ('calling', 1), ('amyloidogenic/rage', 2), ('kindling-induced', 1), ('antiepileptics', 1), ('deteriorate', 1), ('kindling', 3), ('subconvulsive', 1), ('conceivably', 1), ('amended', 1), ('ser404', 1), ('-tau', 1), ('boosted', 1), ('beta-secretase-1', 1), ('subdues', 1), ('upshots', 1), ('gsk-3beta/mmp-9/bdnf', 1), ('boosting', 1), ('glp-1/glp-1r', 1), ('mical2/mir-203a-3p', 1), ('p66shc', 14), ('casl2', 1), ('mical2', 4), ('mir-203a-3p', 4), ('agomir', 1), ('compose', 1), ('dechlorination', 1), ('ota-m', 3), ('ota-cl/m', 5), ('lactone-ring', 1), ('delivers', 1), ('beta-elemene', 7), ('anthracene/12-o-tetradecanoylphorbol-13-acetate-induced', 1), ('nf-kappab-associated', 1), ('1-methyl-1-vinyl-2,4-diisopropenyl-cyclohexane', 1), ('sesquiterpene-derived', 1), ('executes', 1), ('/12-o-tetradecanoylphorbol-13-acetate', 1), ('-promoted', 1), ('execute', 1), ('nmol', 1), ('dmba/tpa-promoted', 1), ('cell-proliferative', 2), ('dmba/tpa', 3), ('abate', 1), ('pdi', 7), ('securinine', 1), ('16f16', 1), ('rhaponticin', 2), ('nrf2/ho-1/nf-kappab', 1), ('rn', 8), ('rn-treated', 1), ('retinae', 2), ('hypoglycaemic', 1), ('ceftriaxone', 6), ('pentylenotetrazole', 1), ('glt-1', 1), ('unopposed', 1), ('delaq', 8), ('laquinimod', 1), ('eecs', 11), ('cyp1a1/1b1', 2), ('hormone-treated', 1), ('22-fold', 1), ('16-33-fold', 1), ('estradiol-induced', 2), ('growth-regulated', 1), ('greb1', 1), ('cyp1a1/1b1/cyp1a1/1b1', 1), ('lipoprotein-associated', 2), ('darapladib', 9), ('lp-pla2', 2), ('pla2g7', 1), ('u251mg', 2), ('slice-glioma', 1), ('akt/pkb', 1), ('wogonin', 6), ('txnrd2', 2), ('non-autonomous', 1), ('7-dihydroxy-8-methoxy-2-phenyl-4h-1-benzopyran-4-one', 1), ('50-100', 1), ('wogonin-induced', 2), ('senescent', 2), ('xenografted', 1), ('non-autonomously', 1), ('protoapigenone', 1), ('wyc0209', 7), ('unresectable', 1), ('promised', 1), ('anti-carcinogenic', 1), ('as-prepared', 1), ('derivative-wyc0209', 1), ('bftc905', 1), ('bftc909', 1), ('akt/nfkb', 1), ('emt-cscs', 1), ('bmi-1', 1), ('sox-2', 1), ('cd133-driven', 1), ('isatidis', 2), ('folium', 2), ('rationality', 1), ('napqi-gsh', 2), ('gsh-associated', 2), ('pa.', 1), ('underneath', 1), ('cyp3as', 2), ('hpxr-transfected', 1), ('hpxr', 1), ('pxr-dependent', 1), ('self-metabolic', 1), ('honey', 2), ('foragers', 3), ('bees', 3), ('expressional', 3), ('royal', 1), ('jelly', 1), ('mrjp', 1), ('ilp1', 4), ('hbg3', 3), ('sima', 3), ('buffy', 3), ('mrjp1', 2), ('mrjp2', 1), ('mmp1', 1), ('compound-specific', 1), ('nurse', 1), ('forager', 1), ('mrjps', 1), ('ros/erk/elk1/mlck', 2), ('ros/p38', 2), ('p-elk1', 1), ('mlck', 1), ('ml-7', 1), ('swietenine', 4), ('swietenia', 2), ('isoprenaline', 2), ('macrophylla', 2), ('hypertrophy-promoting', 1), ('anti-hypertrophic', 1), ('articaine', 2), ('art-treated', 1), ('baicalin', 2), ('hnf4alpha-hnf1alpha', 2), ('hnfs', 2), ('hbv-related', 1), ('phbv1.2', 1), ('hnf1alpha', 4), ('hnf1alpha-shrna', 1), ('remarkedly', 1), ('hnf4alpha/hnf1alpha', 1), ('entecavir', 1), ('etv', 1), ('hbvrtm204v/rtll80m', 1), ('hnf4alpha-hnf1alpha-dependent', 1), ('p53/akt/mtor', 2), ('dpdtc', 10), (\"2,2'-di-pyridylketone\", 1), ('sgc-7901and', 1), ('ferritinophagic', 2), ('fenton', 1), ('pft-alpha', 1), ('ferrtinophagy-mediated', 1), ('ferritinophagy-ros', 1), ('short-acting', 1), ('ab-fubinaca', 17), ('indazole-3-carboxamide-type', 1), ('0-3', 1), ('kolliphor', 1), ('twitches', 1), ('tremors', 1), ('short-lived', 2), ('reactivates', 1), ('268', 1), ('spanning', 1), ('transitions-from', 1), ('metastases-in', 1), ('reprogrammed', 2), ('prepopulated', 1), ('hoxb13', 2), ('commissioned', 1), ('hijack', 1), ('accessing', 1), ('metastasis-specific', 1), ('enhancers', 1), ('nkx3-1', 1), ('lipidation', 1), ('obs', 2), ('s317', 1), ('ulk1s555', 2), ('ulk1s757', 2), ('phosphorylating', 2), ('sers555', 1), ('ser757', 1), ('ulk1s317', 1), ('mtorc1-mediated', 1), ('hydroxysafflor', 2), ('carthamus', 1), ('tinctorius', 1), ('hsya', 7), ('david', 1), ('website', 1), ('vcam1', 2), ('phosphor-nuclear', 1), ('phosphor-i', 1), ('b-alpha', 1), ('oxygenase-1-mediated', 1), ('ho-1-regulating', 1), ('cbd-induced', 3), ('cannabinoid-activated', 1), ('lc3a/b-ii', 3), ('tin', 2), ('snppix', 3), ('cbd-mediated', 1), ('phenylurea', 2), ('embryo/larvae', 1), ('run-off', 1), ('rain', 1), ('catchments', 1), ('vegetative', 1), ('~6-h', 1), ('erm', 1), ('agilent', 1), ('xfe24', 1), ('oligomycin-induced', 1), ('atp-linked', 1), ('atp06', 1), ('cox1', 1), ('cox4-1', 1), ('cox5a1', 1), ('cytb', 1), ('nd1', 1), ('0.625', 1), ('gad1b', 2), ('0.056', 1), ('ziram', 12), ('ziram-induced', 1), ('monocytes-derived', 1), ('mumol.l-1', 7), ('4-24', 1), ('znso4', 1), ('zymosan', 2), ('associated-disulfiram', 2), ('disulfiram-zinc', 2), ('cd209', 1), ('m2-like', 1), ('rs12524494', 1), ('rs17883901', 2), ('rs606548', 1), ('rs636933', 2), ('rs648595', 2), ('rs761142', 1), ('rs2301022', 2), ('rs3827715', 1), ('rs7517826', 2), ('rs41303970', 3), ('2096', 1), ('russian', 1), ('respectively.the', 1), ('rs12524494-g', 2), ('rs3827715-c', 1), ('rs41303970-a', 1), ('0.208', 1), ('explication', 1), ('sped', 1), ('fight', 1), ('map1lc3a/map1lc3a', 1), ('nup62/nup62', 1), ('cinpa', 1), (\"p'-dde-\", 2), (\"p'-dde-induced\", 2), (\"p'-\", 1), ('neocortical', 1), ('1a1-', 1), ('1a2-null', 1), ('bioactivate', 1), ('susceptibilities', 1), ('pah-induced', 2), ('cyp1a1-null', 1), ('cyp1a1-/-', 4), ('cyp1a2-null', 1), ('cyp1a2-/-', 4), ('ualcan', 1), ('luad', 2), ('low/medium', 1), ('hipsc-based', 1), ('ofcannabis', 1), ('breastfeeding', 1), ('drug-consuming', 2), ('hipsc', 1), ('thj-018', 1), ('eg-018', 1), ('cb83', 9), ('cyquant', 1), ('v-propidium', 1), ('5-fuorouracil', 1), ('mainstay', 1), ('enterotoxin-induced', 1), ('enterotoxin-b', 1), ('superantigens', 1), ('fmt', 2), ('akkermansia', 4), ('muciniphila', 4), ('lysozyme-1', 1), ('beta-defensin-2', 1), ('zonula-1', 1), ('occludin-1', 1), ('mucin2', 1), ('beta-defensin-1', 1), ('dysmorphologies', 1), ('modifiers', 1), ('structurally-diverse', 1), ('teratogens', 1), ('single-allele', 1), ('alcohol-', 1), ('synergized', 1), ('heterozygotes', 1), ('ayurvedic', 1), ('biacore', 2), ('cause-specific', 2), ('high-volume', 1), ('sparse', 1), ('nationally', 2), ('3883', 2), ('2003-2008', 1), ('solid-phase', 1), ('chromatography-isotope', 1), ('43.6', 1), ('2032', 1), ('51.4', 1), ('514', 1), ('person-years', 1), ('9.6', 1), ('13.1', 2), ('344', 1), ('race/ethnicity', 1), ('0.67-3.15', 1), ('0.40-2.39', 1), ('cbl-dependent', 1), ('ccin', 3), ('granulocyte', 1), ('colony-stimulating', 1), ('gcsf', 1), ('infection-related', 1), ('immune-modulatory', 1), ('fighting', 1), ('cbl-erk1/2', 2), ('pu.1', 1), ('cebp', 1), ('ccin-associated', 1), ('iprodione', 11), ('trees', 1), ('watercourses', 1), ('rainfall', 1), ('entering', 1), ('6-72', 1), ('21.15', 1), ('cyclization', 1), ('developmental-related', 2), ('astaxanazin', 1), ('gulf', 3), ('nlrp3-mediated', 1), ('veterans', 2), ('gwi', 4), ('leaky', 1), ('him-5', 1), ('fibrous', 1), ('body-membranous', 1), ('fb-mos', 1), ('wee-1.3', 1), ('spe-4', 1), ('spe-6', 1), ('spe-17', 1), ('puf-8', 4), ('spe-10', 3), ('swm-1', 1), ('try-5', 1), ('spe-15', 1), ('mos', 2), ('pseudopods', 1), ('pfos-', 1), ('palmitoylation', 1), ('grapical', 1), ('reconstitution', 1), ('versatility', 1), ('hypolocomotion', 2), ('cataleptic', 1), ('sufficiency', 1), ('cell-type', 2), ('unsuspected', 1), ('hyperlocomotive', 1), ('occluded', 1), ('wild-types', 1), ('unequivocally', 1), ('mt1g', 5), ('luhmes', 3), ('awaiting', 1), ('valid', 1), ('dimethyldithiocarbamate', 2), ('zn2+ddc2', 1), ('ms275', 1), ('slc30a1', 1), ('slc30a2', 1), ('antiporter', 1), ('fibin', 1), ('apelin', 1), ('apln', 1), ('chelates', 1), ('chelators', 1), ('ni2+ddc2', 1), ('bolster', 1), ('coronavirus-induced', 1), ('propionyl', 1), ('readthrough', 2), ('ache-r', 5), ('problematic', 1), ('re-sequenced', 1), ('refseq', 1), ('intron', 1), ('yet-unannotated', 1), ('amplify', 1), ('ache-s', 1), ('cgcs', 1), ('conservation', 1), ('bandrowski', 1), ('bb', 2), ('rtpcr', 1), ('mirna-155', 1), ('mirna-21', 1), ('de-activation', 1), ('predisposes', 1), ('antigen-presenting', 1), ('dcs', 3), ('anti-cd40', 2), ('cd103', 1), ('apcs', 2), ('quenches', 1), ('attendant', 1), ('scavenge', 1), ('hydrogen-rich', 2), ('hrw', 6), ('chich', 1), ('progresses', 1), ('bronchioles', 2), ('exudate', 1), ('post-sm', 2), ('vacuolated', 1), ('sp-d.', 1), ('proinflammatory/profibrotic', 1), ('gal-3', 1), ('bronchiolar', 1), ('biokinetics', 3), ('ethical', 1), ('toxicodynamic', 1), ('cpf-oxon', 1), ('indazole', 1), ('carboxamide', 1), ('ab-fubinaca-induced', 1), ('p450s', 1), (\"5'-diphospho-glucuronosyltransferases\", 1), ('oat', 1), ('cyp2b6-mediated', 1), ('cyp2c8-catalyzed', 1), ('n-de-ethylation', 1), ('cyp2c9-catalyzed', 1), (\"4'-hydroxylation\", 2), ('cyp2c19-catalyzed', 1), ('-mephenytoin', 1), ('cyp2d6-catalyzed', 1), ('bufuralol', 1), (\"1'-hydroxylation\", 1), ('19.9', 1), ('20.8', 1), ('oct2-mediated', 1), ('54.2', 1), ('estrone-3-sulfate', 1), ('oat1/3', 1), ('ab-fubinaca-mediated', 1), ('houston', 2), ('texas', 1), ('atmospheric', 3), ('reevaluated', 1), ('outdoor', 1), ('field-based', 1), ('ship', 1), ('atmosphere', 1), ('irfn1', 1), ('pristane-induced', 2), ('engages', 1), ('oxyguanine', 1), ('repairs', 1), (\"8-oxo-2'-deoxyguanosine\", 1), ('8-oh-dg', 1), ('ly6chi', 1), ('ifn-driven', 1), ('pristane', 2), ('auto-antibodies', 1), ('anti-dsdna', 1), ('anti-rnp', 1), ('isg', 1), ('thicker', 1), ('ifnb', 3), ('cgamp-dependent', 1), ('bmdms', 1), ('sting', 1), ('h151', 1), ('cgamp-driven', 1), ('lesional', 1), ('non-lesional', 1), ('discoid', 1), ('tissue-derived', 2), ('admscs', 3), ('post-transplant', 1), ('mitogen-deficient', 1), ('-methanandamide', 1), ('cannabinoid-binding', 1), ('cannabinoid-treated', 1), ('ho-1-independent', 1), ('ho-1-dependent', 1), ('microcystin', 1), ('inflammasome-related', 1), ('mc-lr-treated', 1), ('health-relevant', 1), ('scfas', 1), ('10ml/kg', 1), ('20-week-old', 1), ('14-23/group', 1), ('beta-diversity', 1), ('tbppa', 1), ('qiime', 1), ('clostridia', 1), ('s24-7', 1), ('rikenellaceae', 1), ('lefse', 1), ('community-wide', 1), ('fishtaco', 2), ('12alpha', 1), ('ba-synthetic', 1), ('g6pdx', 1), ('immune-suppressive', 1), ('dyslipidemia-prone', 1), ('steroidogenesis-associated', 1), ('neurocognitive', 1), ('hsd3b1', 1), ('hsd17b1', 1), ('peripartum', 1), ('late-term', 1), ('mmp10', 1), ('fzd1', 1), ('fms-like', 1), ('sflt-1', 1), ('gd20-exposed', 1), ('phosphoproteomic', 1), ('cardiomyopathic', 1), ('guizhi', 2), ('fuling', 2), ('gfc', 8), ('dysmenorrhea', 1), ('imitate', 1), ('gfc-triggered', 1), ('cyclooxygenase-1', 1), ('anti-dysmenorrhea', 3), ('paeoniflorin', 3), ('benzoylpaeoniflorin', 3), ('amygdalin', 3), ('coxs', 1), ('0-postnatal', 1), ('gd0-pnd10', 1), ('pnd42', 2), ('exposure-related', 1), ('pnd120', 1), ('perigonadal', 1), ('pnd1', 1), ('syndrome-like', 1), ('soiled', 4), ('paramedics', 4), ('satiated', 1), ('manikin', 3), ('ohca', 2), ('extremis', 1), ('suctioning', 1), ('compressions', 1), ('timeliness', 1), ('defibrillation', 1), ('teaching', 1), ('suction', 2), ('laryngoscopy', 1), ('salad', 4), ('intubate', 2), ('oesophagus', 1), ('reservoir', 1), (\"'vomit\", 1), ('bilge', 1), ('propelling', 1), ('vomit', 1), ('oropharynx', 1), ('aab', 2), ('pre-training', 2), ('post-training', 3), ('abb', 2), ('90.2', 2), ('53.7', 1), ('24-49.1', 1), ('11.71', 1), ('seconds', 4), ('1.95-21.47', 1), ('-2.52', 1), ('-11.64-6.61', 1), ('confounded', 1), ('89.0', 1), ('86.6', 1), ('7.6-12.4', 1), ('intubating', 1), ('click-immobilization', 1), ('vitro/vivo', 1), ('-functionalized', 1), ('clickable', 2), ('silane', 1), ('alkynyl', 1), ('azido-amps', 1), ('peg-hhc36', 1), ('n3-peg12-krwwkwwrr', 1), ('click', 1), ('azide-alkyne', 1), ('cuaac', 1), ('897.4', 1), ('67.3', 1), ('ng/cm2', 1), ('nm2', 1), ('88.1', 1), ('69.5', 1)])"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "freq_dist.items()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Entity Recognition"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><h2 style=\"margin: 0\">Molecular Mechanisms of Polybrominated Diphenyl Ethers (BDE-47, BDE-100, and BDE-153) in Human Breast Cancer Cells and Patient-Derived Xenografts.</h2>\n",
       "\n",
       "<div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Molecular Mechanisms of Polybrominated \n",
       "<mark class=\"entity\" style=\"background: #E9DF85; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diphenyl Ethers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Chemical</span>\n",
       "</mark>\n",
       " (BDE-47, BDE-100, and BDE-153) in Human \n",
       "<mark class=\"entity\" style=\"background: #ff6961; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Breast Cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Disease</span>\n",
       "</mark>\n",
       " Cells and Patient-Derived Xenografts. \n",
       "<mark class=\"entity\" style=\"background: #E9DF85; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Polybrominated diphenyl ethers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Chemical</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #E9DF85; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PBDEs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Chemical</span>\n",
       "</mark>\n",
       ") have been used as \n",
       "<mark class=\"entity\" style=\"background: #ff6961; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    flame retardants\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Disease</span>\n",
       "</mark>\n",
       " in household materials. Their environmental persistence has led to continuous human exposure and significant tissue levels. Three \n",
       "<mark class=\"entity\" style=\"background: #E9DF85; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PBDE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Chemical</span>\n",
       "</mark>\n",
       " congeners (BDE-47, BDE-100, and BDE-153) have been frequently detected in human serum. Although these compounds appear to possess endocrine disrupting activity, studies are largely missing to determine the biological mechanisms of \n",
       "<mark class=\"entity\" style=\"background: #E9DF85; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PBDEs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Chemical</span>\n",
       "</mark>\n",
       " in \n",
       "<mark class=\"entity\" style=\"background: #ff6961; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breast cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Disease</span>\n",
       "</mark>\n",
       " cells. Here, we assessed \n",
       "<mark class=\"entity\" style=\"background: #E9DF85; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PBDE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Chemical</span>\n",
       "</mark>\n",
       " bioactivities with three complementary strategies: receptor binding/activity assays; nonbiased RNA-sequencing analysis using an estrogen-dependent \n",
       "<mark class=\"entity\" style=\"background: #ff6961; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breast cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Disease</span>\n",
       "</mark>\n",
       " cell line MCF-7aroERE; and in vivo assessments using patient-derived xenograft (PDX) models of human \n",
       "<mark class=\"entity\" style=\"background: #ff6961; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breast cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Disease</span>\n",
       "</mark>\n",
       ". According to the results from in vitro experiments, the \n",
       "<mark class=\"entity\" style=\"background: #E9DF85; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PBDE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Chemical</span>\n",
       "</mark>\n",
       " congeners regulate distinct nuclear receptor signaling pathways. BDE-47 acts as a weak agonist of both \n",
       "<mark class=\"entity\" style=\"background: #85C1E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    estrogen receptor alpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Gene</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #85C1E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ERalpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Gene</span>\n",
       "</mark>\n",
       ") and \n",
       "<mark class=\"entity\" style=\"background: #85C1E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    estrogen-related receptor alpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Gene</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #85C1E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ERRalpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Gene</span>\n",
       "</mark>\n",
       "); it could stimulate proliferation of MCF-7aroERE and induced expression of ER-regulated genes (including cell cycle genes). BDE-153 was found to act as a weak antagonist of \n",
       "<mark class=\"entity\" style=\"background: #85C1E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ERalpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Gene</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #E9DF85; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BDE-100\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Chemical</span>\n",
       "</mark>\n",
       " could act as (1) an agonist of \n",
       "<mark class=\"entity\" style=\"background: #85C1E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aryl hydrocarbon receptor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Gene</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #85C1E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AhR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Gene</span>\n",
       "</mark>\n",
       "), inducing expression of \n",
       "<mark class=\"entity\" style=\"background: #85C1E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CYP1A1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Gene</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #85C1E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CYP1B1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Gene</span>\n",
       "</mark>\n",
       " and (2) as a very weak agonist/antagonist of \n",
       "<mark class=\"entity\" style=\"background: #85C1E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ERalpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Gene</span>\n",
       "</mark>\n",
       ". In vivo, a mixture of the three congeners with ratios detected in human serum was tested in an ER+ PDX model. The mixture exhibited estrogenic activity through apoptosis/cell cycle regulation and increased the expression of a proliferation marker, Ki-67. These results advance our understanding of the mechanisms of \n",
       "<mark class=\"entity\" style=\"background: #E9DF85; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PBDE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Chemical</span>\n",
       "</mark>\n",
       " exposure in \n",
       "<mark class=\"entity\" style=\"background: #ff6961; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breast cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Disease</span>\n",
       "</mark>\n",
       " cells.</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from spacy import displacy\n",
    "\n",
    "doc = test_json[500]\n",
    "\n",
    "doc_dict = {\n",
    "    \"title\": doc['title'],\n",
    "    \"text\": doc['title']+\" \"+doc['abstract'],\n",
    "    \"ents\": doc['entity']\n",
    "    }\n",
    "\n",
    "entity_colors = {\n",
    "    \"Chemical\": \"#E9DF85\", \"Disease\": \"#ff6961\", \"Gene\": \"#85C1E9\"\n",
    "    }\n",
    "\n",
    "displacy.render(doc_dict, manual=True, style=\"ent\",\n",
    "                 options={\"colors\": entity_colors})"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Relation Extraction"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import networkx as nx\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "source, target, relations = [], [], []\n",
    "\n",
    "for rel in doc['relation']:\n",
    "    source.append(rel['subj'])\n",
    "    target.append(rel['obj'])\n",
    "    relations.append(rel['type'])\n",
    "    \n",
    "graph_df = pd.DataFrame({'source_id':source, \n",
    "        'target_id':target, 'edge_id':relations})\n",
    "\n",
    "G=nx.from_pandas_edgelist(graph_df, \"source_id\", \"target_id\", \n",
    "                          edge_attr=True, create_using=nx.MultiDiGraph())\n",
    "\n",
    "pos = nx.spring_layout(G, seed=42)\n",
    "\n",
    "nx.draw(G, with_labels=True, pos=pos)\n",
    "plt.title('Document PMID: '+doc['docid'])\n",
    "plt.axis('on')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'type': 'chem_gene:decreases^expression',\n",
       "  'subj': 'MESH:C006780',\n",
       "  'obj': '2706'}]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "doc['relation']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Manual Curation"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Construct a network representation from the corpus of 523 abstracts, with entity mentions from PubTator Central that were *manually curated* by a team of biologists."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "# collect information for network analysis\n",
    "docids, source, target, relations = [], [], [], []\n",
    "e1_names, e2_names, e1_type, e2_type = [], [], [], []\n",
    "\n",
    "for doc in test_json:\n",
    "    for rel in doc['relation']:\n",
    "        docids.append(doc['docid'])\n",
    "        source.append(rel['subj'])\n",
    "        # \n",
    "        result = [item for item in doc['entity'] if item['id'] == rel['subj']]\n",
    "        e1_names.append(result[0]['mention'])\n",
    "        e1_type.append(result[0]['label'])\n",
    "\n",
    "        target.append(rel['obj'])\n",
    "\n",
    "        result = [item for item in doc['entity'] if item['id'] == rel['obj']]\n",
    "        e2_names.append(result[0]['mention'])\n",
    "        e2_type.append(result[0]['label'])\n",
    "\n",
    "        relations.append(rel['type'])\n",
    "    \n",
    "\n",
    "# constructing a knowledge graph \n",
    "kg_df = pd.DataFrame({'document': docids, 'source_id':source, 'source_name': e1_names, 'source_type': e1_type,\n",
    "                        'target_id':target, 'target_name': e2_names, 'target_type': e2_type,\n",
    "                         'edge_id':relations})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>document</th>\n",
       "      <th>source_id</th>\n",
       "      <th>source_name</th>\n",
       "      <th>source_type</th>\n",
       "      <th>target_id</th>\n",
       "      <th>target_name</th>\n",
       "      <th>target_type</th>\n",
       "      <th>edge_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>29883990</td>\n",
       "      <td>MESH:C103505</td>\n",
       "      <td>AM251</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>1268</td>\n",
       "      <td>CB1</td>\n",
       "      <td>Gene</td>\n",
       "      <td>chem_gene:decreases^activity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>29883990</td>\n",
       "      <td>MESH:C103505</td>\n",
       "      <td>AM251</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>4313</td>\n",
       "      <td>matrix metalloproteinase (MMP) 2</td>\n",
       "      <td>Gene</td>\n",
       "      <td>chem_gene:increases^expression</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>29902480</td>\n",
       "      <td>3569</td>\n",
       "      <td>IL-6</td>\n",
       "      <td>Gene</td>\n",
       "      <td>MESH:D001249</td>\n",
       "      <td>asthma</td>\n",
       "      <td>Disease</td>\n",
       "      <td>gene_disease:marker/mechanism</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>29953732</td>\n",
       "      <td>MESH:D013311</td>\n",
       "      <td>streptozotocin</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>MESH:D005355</td>\n",
       "      <td>fibrosis</td>\n",
       "      <td>Disease</td>\n",
       "      <td>chem_disease:marker/mechanism</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>30020114</td>\n",
       "      <td>MESH:D001564</td>\n",
       "      <td>benzo(a)pyrene</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>595</td>\n",
       "      <td>cyclinD1</td>\n",
       "      <td>Gene</td>\n",
       "      <td>chem_gene:increases^expression</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5111</th>\n",
       "      <td>33146391</td>\n",
       "      <td>MESH:D010126</td>\n",
       "      <td>Ozone</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>2321</td>\n",
       "      <td>FMS-like tyrosine kinase-1</td>\n",
       "      <td>Gene</td>\n",
       "      <td>chem_gene:increases^transport</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5112</th>\n",
       "      <td>33146391</td>\n",
       "      <td>MESH:D010126</td>\n",
       "      <td>Ozone</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>4319</td>\n",
       "      <td>mmp10</td>\n",
       "      <td>Gene</td>\n",
       "      <td>chem_gene:decreases^expression</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5113</th>\n",
       "      <td>33149750</td>\n",
       "      <td>MESH:D008070</td>\n",
       "      <td>Lipopolysaccharide</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>5742</td>\n",
       "      <td>cyclooxygenase-1</td>\n",
       "      <td>Gene</td>\n",
       "      <td>chem_gene:increases^expression</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5114</th>\n",
       "      <td>33259630</td>\n",
       "      <td>MESH:D002104</td>\n",
       "      <td>Cd</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>MESH:D009765</td>\n",
       "      <td>obesity</td>\n",
       "      <td>Disease</td>\n",
       "      <td>chem_disease:marker/mechanism</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5115</th>\n",
       "      <td>33259630</td>\n",
       "      <td>MESH:D002104</td>\n",
       "      <td>Cd</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>MESH:D024821</td>\n",
       "      <td>Metabolic Syndrome</td>\n",
       "      <td>Disease</td>\n",
       "      <td>chem_disease:marker/mechanism</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5116 rows  8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      document     source_id         source_name source_type     target_id  \\\n",
       "0     29883990  MESH:C103505               AM251    Chemical          1268   \n",
       "1     29883990  MESH:C103505               AM251    Chemical          4313   \n",
       "2     29902480          3569                IL-6        Gene  MESH:D001249   \n",
       "3     29953732  MESH:D013311      streptozotocin    Chemical  MESH:D005355   \n",
       "4     30020114  MESH:D001564      benzo(a)pyrene    Chemical           595   \n",
       "...        ...           ...                 ...         ...           ...   \n",
       "5111  33146391  MESH:D010126               Ozone    Chemical          2321   \n",
       "5112  33146391  MESH:D010126               Ozone    Chemical          4319   \n",
       "5113  33149750  MESH:D008070  Lipopolysaccharide    Chemical          5742   \n",
       "5114  33259630  MESH:D002104                  Cd    Chemical  MESH:D009765   \n",
       "5115  33259630  MESH:D002104                  Cd    Chemical  MESH:D024821   \n",
       "\n",
       "                           target_name target_type  \\\n",
       "0                                  CB1        Gene   \n",
       "1     matrix metalloproteinase (MMP) 2        Gene   \n",
       "2                               asthma     Disease   \n",
       "3                             fibrosis     Disease   \n",
       "4                             cyclinD1        Gene   \n",
       "...                                ...         ...   \n",
       "5111        FMS-like tyrosine kinase-1        Gene   \n",
       "5112                             mmp10        Gene   \n",
       "5113                  cyclooxygenase-1        Gene   \n",
       "5114                           obesity     Disease   \n",
       "5115                Metabolic Syndrome     Disease   \n",
       "\n",
       "                             edge_id  \n",
       "0       chem_gene:decreases^activity  \n",
       "1     chem_gene:increases^expression  \n",
       "2      gene_disease:marker/mechanism  \n",
       "3      chem_disease:marker/mechanism  \n",
       "4     chem_gene:increases^expression  \n",
       "...                              ...  \n",
       "5111   chem_gene:increases^transport  \n",
       "5112  chem_gene:decreases^expression  \n",
       "5113  chem_gene:increases^expression  \n",
       "5114   chem_disease:marker/mechanism  \n",
       "5115   chem_disease:marker/mechanism  \n",
       "\n",
       "[5116 rows x 8 columns]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "kg_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "kg_df.to_csv(data_dir + \"/test_kg.txt\", sep='\\t', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "# What can i do with this graph?\n",
    "# 1. Analyze clusters in the gene-disease network\n",
    "# 2. Align parts of the network with Wikipathways"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "nlp",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.10"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
